data_5wbt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5wbt _Structure_validation_residue.Date_analyzed 2018-01-09 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.953 ' CE1' HD11 ' A' ' 17' ' ' LEU . 6.0 p90 . . . . . 0 C--O 1.206 -1.196 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 3' ' ' ASN . 87.1 t -145.94 91.2 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 118.524 0.602 . . . . 0.0 110.0 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 2' ' ' VAL . 1.7 m120 40.01 51.56 2.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.689 -0.632 . . . . 0.0 110.162 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.8 161.05 35.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.491 -0.756 . . . . 0.0 110.006 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 0.3 OUTLIER -50.43 124.93 11.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 110.334 -179.254 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.25 109.69 9.59 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.3 m -121.92 -177.88 3.7 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.32 -150.96 2.98 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.1 p -77.25 -12.64 59.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.952 -1.323 . . . . 0.0 109.135 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -51.63 -25.17 6.56 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.434 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.6 tp -81.31 -49.68 10.42 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 13' ' ' GLU . 19.4 t -46.53 -46.48 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.491 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 35.7 tt0 -47.83 -59.69 3.13 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.429 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.02 -61.39 1.65 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.1 mt -45.86 -45.05 14.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.553 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.79 -49.81 74.22 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.953 HD11 ' CE1' ' A' ' 1' ' ' PHE . 29.1 mt -54.19 -62.42 1.67 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.098 0.951 . . . . 0.0 110.821 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.36 -36.75 78.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.169 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 41.9 t -80.55 -22.57 40.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.844 -1.16 . . . . 0.0 110.002 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 68.29 -146.05 45.3 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' GLY . 1.8 mp0 -83.23 -17.13 43.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.16 -1.2 . . . . 0.0 109.211 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -45.56 -13.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.776 -0.577 . . . . 0.0 110.352 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 81.17 130.74 1.09 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -116.43 149.42 39.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.677 -0.896 . . . . 0.0 109.27 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -85.48 116.57 23.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.145 -0.972 . . . . 0.0 110.015 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -161.48 -11.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.445 ' CG2' ' H ' ' A' ' 28' ' ' ASP . 1.8 m 58.03 -140.43 0.78 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 109.69 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.445 ' H ' ' CG2' ' A' ' 27' ' ' THR . 0.4 OUTLIER -103.09 167.07 10.76 Favored Pre-proline 0 N--CA 1.487 1.412 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.44 -19.62 19.14 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 123.007 2.471 . . . . 0.0 110.285 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -111.19 -128.92 0.29 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.908 -179.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.41 ' H ' ' HB ' ' A' ' 30' ' ' THR . 1.4 mt-10 60.35 -80.76 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -159.03 155.42 27.42 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.425 -1.31 . . . . 0.0 112.058 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.485 ' HA2' ' HD2' ' A' ' 34' ' ' PRO . . . -37.36 109.1 0.08 OUTLIER Glycine 0 N--CA 1.492 2.408 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.114 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.872 ' O ' ' N ' ' A' ' 36' ' ' ARG . 15.0 Cg_endo -50.35 -176.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 124.084 3.189 . . . . 0.0 112.914 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 34' ' ' PRO . 1.3 ttm180 -19.07 -31.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.836 -0.54 . . . . 0.0 111.967 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.872 ' N ' ' O ' ' A' ' 34' ' ' PRO . 1.8 tpp180 72.17 31.72 1.88 Allowed 'General case' 0 N--CA 1.511 2.578 0 O-C-N 120.555 -1.34 . . . . 0.0 107.825 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.54 -63.01 0.01 OUTLIER Glycine 0 C--N 1.274 -2.915 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 5.4 tt -67.43 -39.3 82.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 122.106 0.955 . . . . 0.0 109.699 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.777 HG22 ' CG ' ' A' ' 34' ' ' PRO . 45.0 t -70.35 -61.87 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.74 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.87 -21.85 32.58 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.405 -0.81 . . . . 0.0 109.717 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -94.24 -49.22 5.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.158 -0.964 . . . . 0.0 110.699 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' SER . 3.0 t -80.03 -29.99 39.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.82 -1.175 . . . . 0.0 111.013 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.4 t -78.61 -49.67 12.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.658 -1.276 . . . . 0.0 109.708 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -80.94 -23.08 39.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.046 -1.034 . . . . 0.0 109.349 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 m -139.96 -173.04 3.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.305 -0.872 . . . . 0.0 108.951 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 mm -86.5 168.33 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.174 -0.954 . . . . 0.0 108.791 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 23.1 p -149.45 161.08 42.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.07 -1.019 . . . . 0.0 109.259 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.93 164.85 14.4 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.083 0.945 . . . . 0.0 111.079 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.74 -36.92 25.34 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.91 -26.3 62.01 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 122.757 1.265 . . . . 0.0 108.094 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.528 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 6.5 tt0 -76.49 -22.53 54.37 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.736 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.7 mt -85.28 -30.9 23.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.861 -1.15 . . . . 0.0 108.235 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -64.2 -19.29 65.24 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.564 -0.71 . . . . 0.0 111.049 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 14.8 p30 -87.51 -8.57 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.926 -1.109 . . . . 0.0 108.045 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.482 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 4.9 m-85 -84.78 -28.69 26.0 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.3 t -68.48 112.31 5.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.444 -0.785 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--N 1.29 -1.992 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.445 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.742 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.476 0.655 . . . . 0.0 109.815 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 4' ' ' GLN . 3.3 t 54.88 48.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.267 0.556 . . . . 0.0 110.021 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 4' ' ' GLN . 22.2 m-80 56.68 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.107 -0.996 . . . . 0.0 110.28 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 3' ' ' ASN . 5.8 pt20 35.43 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.69 -0.631 . . . . 0.0 111.498 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 51.8 p-80 -90.86 123.9 34.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.126 -0.984 . . . . 0.0 109.612 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.88 116.75 19.12 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.6 m -122.41 -176.91 3.48 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.542 -0.724 . . . . 0.0 109.123 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 44.02 -149.21 0.87 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.506 ' H ' ' HG ' ' A' ' 9' ' ' SER . 2.2 p -80.81 -9.48 59.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.942 -1.328 . . . . 0.0 108.865 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 9' ' ' SER . 50.6 m80 -52.29 -24.63 7.74 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.458 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.0 tp -77.76 -53.82 7.07 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 13' ' ' GLU . 5.0 t -46.55 -42.56 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.6 tt0 -46.84 -59.21 3.22 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.635 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.37 -61.42 1.68 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 19' ' ' CYS . 7.1 mt -46.14 -48.41 17.37 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -51.24 -48.47 62.13 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.626 HD12 ' CE1' ' A' ' 1' ' ' PHE . 19.6 mt -57.31 -63.66 1.15 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.168 -0.957 . . . . 0.0 110.532 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -64.55 -47.59 88.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.965 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' A' ' 15' ' ' LEU . 67.0 m -73.05 -20.81 60.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.908 -1.12 . . . . 0.0 109.756 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 42.55 -125.74 4.33 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -83.63 -15.2 49.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -1.015 . . . . 0.0 110.077 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -46.73 -29.12 1.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.103 -0.998 . . . . 0.0 109.481 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.45 127.54 4.29 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.705 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CD1' ' C ' ' A' ' 24' ' ' PHE . 29.1 p90 -132.83 176.29 8.6 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -154.01 125.75 7.66 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 119.589 -1.944 . . . . 0.0 112.527 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.421 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 20.3 m-85 -141.33 -179.93 6.41 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.588 HG22 ' CB ' ' A' ' 31' ' ' GLU . 1.4 m -152.35 171.88 17.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.001 -1.062 . . . . 0.0 109.629 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.454 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -74.64 164.77 59.02 Favored Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 121.493 -0.755 . . . . 0.0 108.969 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 28' ' ' ASP . 16.8 Cg_endo -53.93 -34.74 77.74 Favored 'Trans proline' 0 C--N 1.276 -3.27 0 C-N-CA 123.7 2.933 . . . . 0.0 111.559 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.896 ' C ' ' H ' ' A' ' 32' ' ' GLU . 14.3 t -102.54 -34.17 9.21 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.45 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.645 ' N ' HG23 ' A' ' 30' ' ' THR . 46.7 mm-40 -62.28 10.19 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.896 ' H ' ' C ' ' A' ' 30' ' ' THR . 0.4 OUTLIER 106.99 123.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.708 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 32' ' ' GLU . . . -48.01 156.46 1.04 Allowed Glycine 0 N--CA 1.478 1.481 0 N-CA-C 107.261 -2.335 . . . . 0.0 107.261 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 36' ' ' ARG . 42.7 Cg_endo -94.73 -147.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.288 -2.641 0 C-N-CA 123.34 2.694 . . . . 0.0 111.595 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.71 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.4 OUTLIER -63.07 84.06 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.5 -1.375 . . . . 0.0 109.004 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.574 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -47.22 110.73 0.33 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 158.2 -89.83 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -176.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.554 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 6.3 tt -46.9 -40.26 4.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 122.009 0.909 . . . . 0.0 109.982 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.498 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 47.1 t -69.45 -61.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 O-C-N 121.298 -0.876 . . . . 0.0 110.308 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.457 ' HG3' ' HD2' ' A' ' 36' ' ' ARG . 42.6 mt-10 -62.53 -19.42 63.62 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.141 -0.974 . . . . 0.0 109.724 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -94.18 -39.31 10.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.082 -1.011 . . . . 0.0 110.088 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 33.7 m -88.47 -40.43 13.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.967 -1.083 . . . . 0.0 110.365 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.0 t -71.02 -25.77 62.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.792 -1.192 . . . . 0.0 109.541 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -102.95 -25.88 13.3 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.334 -0.854 . . . . 0.0 109.195 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -137.41 -168.06 2.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.404 -0.81 . . . . 0.0 108.964 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.2 mm -94.98 169.95 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.131 -0.98 . . . . 0.0 109.499 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 98.3 m -149.21 167.85 24.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.088 -1.008 . . . . 0.0 110.104 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.21 165.24 12.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.831 . . . . 0.0 109.521 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.67 -35.24 27.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.17 -25.28 65.42 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.756 1.265 . . . . 0.0 108.238 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.474 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 14.1 tt0 -75.81 -22.41 56.36 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.545 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -84.42 -33.29 23.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.852 -1.155 . . . . 0.0 107.983 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -64.19 -17.88 63.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.624 -0.672 . . . . 0.0 110.319 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -86.48 -8.41 57.61 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 108.607 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.524 ' CE2' ' HD3' ' A' ' 35' ' ' ARG . 5.0 m-85 -88.12 -39.85 14.24 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.765 0.793 . . . . 0.0 109.606 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.99 110.15 0.36 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.549 -0.719 . . . . 0.0 109.636 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.7 t30 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.485 179.916 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.794 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 1.2 t80 . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.236 0.541 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER 39.65 -96.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.272 -1.517 . . . . 0.0 110.792 176.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.51 ' O ' ' O ' ' A' ' 4' ' ' GLN . 23.7 m-20 -139.06 -43.63 0.47 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.882 -1.136 . . . . 0.0 109.85 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.51 ' O ' ' O ' ' A' ' 3' ' ' ASN . 2.4 pt20 -18.28 143.55 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.674 ' H ' ' HD1' ' A' ' 5' ' ' HIS . 3.2 p-80 -46.21 141.98 3.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.692 . . . . 0.0 110.284 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.726 HD22 ' CE1' ' A' ' 1' ' ' PHE . 0.7 OUTLIER -131.1 109.96 10.84 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.8 m -114.87 146.1 41.47 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.32 -0.862 . . . . 0.0 109.106 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.61 -175.57 54.84 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.9 p -56.05 -15.07 3.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.984 -1.304 . . . . 0.0 109.115 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -52.12 -24.16 6.53 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' A' ' 9' ' ' SER . 15.0 tp -81.83 -47.64 12.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.419 HG11 ' CZ ' ' A' ' 24' ' ' PHE . 24.4 t -49.66 -46.66 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.8 tt0 -48.7 -59.97 3.11 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.484 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.794 ' HB1' ' CE2' ' A' ' 1' ' ' PHE . . . -44.45 -60.66 1.85 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.7 mt -45.81 -51.38 12.93 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -50.03 -50.95 45.88 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 27.0 mt -53.65 -62.33 1.72 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.179 0.99 . . . . 0.0 111.299 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.27 -40.71 83.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.662 -176.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.647 ' O ' ' NH2' ' A' ' 22' ' ' ARG . 95.4 m -78.31 -28.44 47.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.72 -1.238 . . . . 0.0 112.581 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.709 ' C ' HH22 ' A' ' 22' ' ' ARG . . . 86.89 -150.2 22.86 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.314 -1.422 . . . . 0.0 111.046 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 23' ' ' GLY . 30.6 tt0 -87.8 -18.72 28.72 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.63 -0.923 . . . . 0.0 113.338 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.715 ' NH1' ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -43.12 -15.07 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 O-C-N 120.798 -1.189 . . . . 0.0 110.932 -177.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.715 ' H ' ' NH1' ' A' ' 22' ' ' ARG . . . 85.8 93.43 0.83 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.683 ' N ' HH11 ' A' ' 22' ' ' ARG . 29.9 p90 -76.88 161.58 28.3 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.305 -1.115 . . . . 0.0 109.383 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.623 ' CB ' ' NH1' ' A' ' 35' ' ' ARG . 60.5 m-85 -89.9 132.69 35.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.303 -0.873 . . . . 0.0 110.631 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -173.16 -22.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.72 168.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.489 -0.757 . . . . 0.0 110.012 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -85.51 163.64 43.68 Favored Pre-proline 0 N--CA 1.485 1.316 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.829 ' O ' ' C ' ' A' ' 30' ' ' THR . 1.2 Cg_endo -48.24 -134.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 124.76 3.64 . . . . 0.0 113.099 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.829 ' C ' ' O ' ' A' ' 29' ' ' PRO . 69.2 p 9.95 -119.79 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.49 1.138 . . . . 0.0 108.278 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.743 ' C ' ' O ' ' A' ' 30' ' ' THR . 8.5 mt-10 3.07 90.11 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.215 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 2.4 mt-10 46.58 -129.61 1.4 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.535 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 32' ' ' GLU . . . -149.69 -173.16 19.9 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.169 -177.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.502 ' HG3' HG22 ' A' ' 39' ' ' VAL . 72.5 Cg_endo -67.84 -126.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 124.163 3.242 . . . . 0.0 111.124 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.766 ' O ' ' O ' ' A' ' 36' ' ' ARG . 12.5 ttm180 -110.91 14.7 22.05 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.766 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 45.37 110.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.86 -67.32 0.36 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 116.138 -2.934 . . . . 0.0 107.745 -176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.551 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 7.3 tt -67.78 -44.61 85.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.805 0.812 . . . . 0.0 109.348 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.551 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 44.4 t -65.53 -61.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.425 0.631 . . . . 0.0 111.078 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.537 ' OE2' ' HG3' ' A' ' 36' ' ' ARG . 3.0 mt-10 -51.7 -26.42 9.26 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.658 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 45' ' ' SER . 17.8 tt0 -93.96 -61.21 1.58 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.122 -0.986 . . . . 0.0 110.414 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 45' ' ' SER . 98.0 m -58.36 -37.0 74.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.139 -0.976 . . . . 0.0 110.652 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.19 -38.54 31.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.903 -1.123 . . . . 0.0 110.516 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -86.99 -17.31 33.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.838 -1.164 . . . . 0.0 109.249 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 41' ' ' GLN . 7.9 t -140.42 -164.89 1.81 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.432 -0.792 . . . . 0.0 109.071 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 47' ' ' CYS . 4.5 mm -76.46 167.4 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.082 -1.011 . . . . 0.0 109.328 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.421 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 4.5 t -121.15 139.14 53.76 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.451 -0.781 . . . . 0.0 110.381 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -101.15 150.88 22.48 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 tp -82.34 -38.52 24.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.479 1.133 . . . . 0.0 108.038 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.53 -24.24 60.15 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 123.005 1.383 . . . . 0.0 108.199 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.729 HE21 HD22 ' A' ' 54' ' ' ASN . 6.5 tp60 -79.8 -24.62 41.29 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.033 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.739 HD11 ' CZ ' ' A' ' 1' ' ' PHE . 33.9 mt -85.3 -30.99 23.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.494 -1.379 . . . . 0.0 109.107 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -62.32 -20.81 64.73 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.682 -0.637 . . . . 0.0 111.549 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.729 HD22 HE21 ' A' ' 51' ' ' GLN . 15.6 p30 -88.53 -7.79 55.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.823 -1.173 . . . . 0.0 108.838 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.493 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 5.1 m-85 -83.72 -9.79 58.59 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.671 0.748 . . . . 0.0 109.465 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.429 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -91.42 115.82 28.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.569 -0.707 . . . . 0.0 109.351 -179.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.429 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 55.9 t-20 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.026 -1.046 . . . . 0.0 109.282 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.686 ' C ' ' CD1' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.728 0.299 . . . . 0.0 110.687 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 4' ' ' GLN . 14.0 p -66.02 163.62 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 119.967 -1.708 . . . . 0.0 108.708 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -49.04 98.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.04 -1.038 . . . . 0.0 109.531 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 2' ' ' VAL . 1.8 pt20 -159.03 -163.94 1.32 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.841 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -89.86 131.2 35.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.743 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.93 109.65 11.79 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.5 m -118.58 152.59 35.73 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.523 -0.736 . . . . 0.0 109.248 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.57 -163.24 54.34 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.456 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -66.47 -14.63 62.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.864 -1.374 . . . . 0.0 109.261 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' SER . 4.5 m-70 -51.18 -24.67 4.43 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.456 ' N ' ' C ' ' A' ' 9' ' ' SER . 14.1 tp -81.86 -46.67 13.8 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' A' ' 9' ' ' SER . 18.7 t -50.15 -46.15 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 20.7 tt0 -49.16 -59.72 3.41 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.446 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 15' ' ' LEU . . . -44.43 -60.67 1.84 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.2 mt -45.38 -53.68 8.3 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.554 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -47.75 -49.62 27.8 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 26.4 mt -56.01 -62.59 1.6 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.106 0.955 . . . . 0.0 111.304 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.56 -48.12 77.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.643 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.501 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 30.9 m -73.86 -26.48 60.59 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.868 -1.145 . . . . 0.0 112.787 -175.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' C ' ' HE ' ' A' ' 22' ' ' ARG . . . 85.15 -161.21 35.71 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 119.473 -2.017 . . . . 0.0 111.156 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.57 ' C ' ' H ' ' A' ' 23' ' ' GLY . 11.8 mt-10 -86.85 -13.26 45.48 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -177.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.704 ' NE ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.66 0.1 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 119.513 -1.992 . . . . 0.0 110.712 -178.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.594 ' N ' ' CZ ' ' A' ' 22' ' ' ARG . . . 88.52 113.48 1.21 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.68 ' N ' HH12 ' A' ' 22' ' ' ARG . 26.9 p90 -98.45 141.83 30.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -1.024 . . . . 0.0 109.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.33 126.75 30.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.516 -0.74 . . . . 0.0 110.33 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 27' ' ' THR . 53.9 t80 -173.14 -22.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.595 -0.69 . . . . 0.0 109.164 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.615 ' CG2' ' H ' ' A' ' 28' ' ' ASP . 56.6 m 49.29 -176.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.179 -0.951 . . . . 0.0 109.548 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.615 ' H ' ' CG2' ' A' ' 27' ' ' THR . 0.3 OUTLIER -50.6 -171.91 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.338 -0.852 . . . . 0.0 108.94 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.551 ' CD ' ' H ' ' A' ' 30' ' ' THR . 76.9 Cg_endo -92.36 -34.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.261 2.64 . . . . 0.0 108.913 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.945 ' CG2' ' H ' ' A' ' 31' ' ' GLU . 3.8 t -66.6 -92.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.68 1.228 . . . . 0.0 109.539 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.945 ' H ' ' CG2' ' A' ' 30' ' ' THR . 9.5 tp10 57.76 5.39 0.34 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.338 -1.476 . . . . 0.0 108.394 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.62 ' HG2' ' C ' ' A' ' 31' ' ' GLU . 2.6 pt-20 43.13 35.87 0.88 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.197 -0.939 . . . . 0.0 108.696 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.12 98.87 2.56 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.464 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 30.2 Cg_endo -87.38 -117.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.683 2.922 . . . . 0.0 112.439 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.628 ' O ' ' C ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -82.09 -13.91 56.59 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.212 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.677 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER 34.66 70.22 0.14 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.88 -83.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 CA-C-N 113.482 -1.69 . . . . 0.0 109.008 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.536 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 6.3 tt -55.31 -42.4 66.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.721 -0.87 . . . . 0.0 110.145 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.536 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 42.2 t -63.93 -60.68 2.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.306 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.677 ' OE2' ' HD2' ' A' ' 36' ' ' ARG . 38.7 mt-10 -59.23 -20.11 51.33 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.215 -0.928 . . . . 0.0 109.872 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -94.58 -36.18 11.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.042 -1.037 . . . . 0.0 110.021 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 45' ' ' SER . 92.2 m -88.46 -38.17 15.22 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.232 -0.917 . . . . 0.0 110.537 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.5 t -77.86 -44.92 25.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -0.996 . . . . 0.0 110.597 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -82.76 -20.35 36.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.992 -1.068 . . . . 0.0 109.822 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.8 m -140.38 -171.85 3.3 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.271 -0.893 . . . . 0.0 109.61 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.5 mm -64.85 170.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 108.97 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.3 t -128.19 122.51 32.02 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.459 -0.775 . . . . 0.0 110.157 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.5 m -79.75 146.72 32.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 108.728 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 tp -82.34 -40.5 21.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -57.15 -25.62 59.21 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.979 1.371 . . . . 0.0 108.147 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.477 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 7.0 tt0 -77.62 -24.12 49.66 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.933 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.3 mt -84.68 -29.48 25.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.777 -1.202 . . . . 0.0 108.487 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -64.6 -19.35 65.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.756 -0.59 . . . . 0.0 111.058 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -88.31 -7.24 57.05 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.027 -1.046 . . . . 0.0 109.188 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.477 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 5.1 m-85 -86.6 -6.72 58.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.579 -0.701 . . . . 0.0 111.147 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.87 113.86 20.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.148 -0.97 . . . . 0.0 110.314 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.4 t30 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.842 -179.932 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.621 ' H1 ' ' NE2' ' A' ' 4' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.62 ' C ' ' O ' ' A' ' 1' ' ' PHE . 0.8 OUTLIER 32.23 -153.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 118.655 -2.528 . . . . 0.0 110.643 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.49 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 1.6 m120 -101.74 93.95 5.59 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.053 -1.03 . . . . 0.0 109.551 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.621 ' NE2' ' H1 ' ' A' ' 1' ' ' PHE . 16.4 pt20 -152.5 -178.81 7.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.217 -0.927 . . . . 0.0 109.26 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -75.54 133.2 41.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.999 -1.063 . . . . 0.0 109.378 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.95 120.01 24.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.7 m -127.18 -178.26 4.37 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.448 -0.782 . . . . 0.0 109.207 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.56 -149.05 2.29 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.439 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.4 p -77.97 -14.12 59.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.026 -1.279 . . . . 0.0 109.241 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -51.86 -24.07 5.69 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.439 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.7 tp -81.56 -51.14 8.56 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 13' ' ' GLU . 24.6 t -45.44 -46.77 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.697 0.761 . . . . 0.0 108.988 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.491 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 35.8 tt0 -47.89 -59.81 3.06 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.378 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.05 -61.5 1.61 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.7 mt -45.66 -46.84 14.94 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.554 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.54 -48.73 71.66 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 24.7 mt -55.91 -62.8 1.46 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.156 0.979 . . . . 0.0 110.827 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 m -64.94 -31.93 56.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.221 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.1 m -92.12 -7.38 48.68 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.999 -1.063 . . . . 0.0 110.096 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 47.4 -144.0 5.61 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 23' ' ' GLY . 14.3 tp10 -79.35 -19.29 50.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.594 -0.945 . . . . 0.0 109.996 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -42.58 -17.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.457 -0.777 . . . . 0.0 110.653 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 88.02 137.5 5.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -131.33 144.95 51.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.69 -0.888 . . . . 0.0 109.473 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -87.89 127.55 35.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.327 -0.858 . . . . 0.0 109.646 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' ' 27' ' ' THR . 85.9 t80 -163.14 -48.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 108.961 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.476 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 2.4 m 53.6 172.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.451 -0.781 . . . . 0.0 109.842 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.82 171.04 12.65 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 31' ' ' GLU . 19.2 Cg_endo -52.12 -83.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.515 2.745 0 C-N-CA 123.699 2.932 . . . . 0.0 114.546 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.573 ' H ' ' HG2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -43.65 4.09 0.0 OUTLIER 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 109.493 -3.503 . . . . 0.0 112.454 -176.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.921 ' O ' ' O ' ' A' ' 32' ' ' GLU . 1.1 tp10 -95.26 138.45 32.95 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 119.917 -1.74 . . . . 0.0 107.97 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.921 ' O ' ' O ' ' A' ' 31' ' ' GLU . 3.7 mp0 13.03 -140.93 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.396 -1.44 . . . . 0.0 109.161 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 35' ' ' ARG . . . -121.66 97.95 0.63 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.401 ' HD2' ' HA2' ' A' ' 33' ' ' GLY . 39.4 Cg_endo -62.98 30.06 0.07 OUTLIER 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.906 3.07 . . . . 0.0 113.751 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER 62.14 123.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.85 -1.156 . . . . 0.0 112.035 179.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' N ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -92.52 112.33 24.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.551 -0.718 . . . . 0.0 110.787 179.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.93 -48.49 0.06 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 13.3 tt -82.21 -42.47 18.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.541 -0.976 . . . . 0.0 110.332 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.522 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 54.1 t -69.42 -62.17 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 O-C-N 121.63 -0.669 . . . . 0.0 111.016 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -59.21 -22.01 60.39 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -94.31 -41.61 9.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.995 -1.065 . . . . 0.0 110.497 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 45' ' ' SER . 1.8 t -86.46 -29.73 22.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.867 -1.145 . . . . 0.0 110.737 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 51.8 t -81.58 -51.62 8.05 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.604 -1.31 . . . . 0.0 109.446 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -24.81 53.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.045 -1.034 . . . . 0.0 108.743 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' CYS . 5.1 m -140.52 -174.88 4.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.314 -0.866 . . . . 0.0 109.123 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.5 mt -90.64 148.92 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.233 -0.917 . . . . 0.0 109.216 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 20.6 p -128.88 167.39 17.45 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.378 -0.827 . . . . 0.0 109.775 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.82 165.3 13.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.303 -0.873 . . . . 0.0 110.79 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.68 -36.61 25.76 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.11 -25.27 61.15 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.862 1.315 . . . . 0.0 108.097 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.461 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 13.1 tt0 -77.8 -22.19 50.46 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.695 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.3 mt -84.5 -33.66 23.51 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.748 -1.22 . . . . 0.0 107.869 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -62.89 -18.72 63.38 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.554 -0.716 . . . . 0.0 110.162 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -84.84 -8.52 58.76 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -90.39 -37.33 14.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.695 -0.628 . . . . 0.0 109.643 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 m -49.8 110.94 0.44 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.507 -0.746 . . . . 0.0 109.718 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.1 t30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.464 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.618 ' CE1' HD22 ' A' ' 6' ' ' LEU . 1.9 t80 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 123.251 1.501 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.551 ' N ' HE21 ' A' ' 4' ' ' GLN . 6.1 p -90.23 84.55 2.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.335 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 2' ' ' VAL . 1.1 m120 41.29 70.25 0.28 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 110.567 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.551 HE21 ' N ' ' A' ' 2' ' ' VAL . 14.0 pt20 -141.69 169.86 16.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.057 -1.027 . . . . 0.0 109.639 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -63.16 126.63 28.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.895 . . . . 0.0 110.482 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.618 HD22 ' CE1' ' A' ' 1' ' ' PHE . 0.8 OUTLIER -129.89 123.75 31.52 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.3 m -130.77 179.47 5.95 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.344 -0.847 . . . . 0.0 108.929 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.51 -147.68 2.78 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.44 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -77.29 -14.38 59.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.026 -1.279 . . . . 0.0 109.328 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -52.53 -24.02 7.36 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.4 tp -81.29 -49.58 10.56 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.414 ' CG2' ' CD2' ' A' ' 26' ' ' TYR . 22.3 t -46.56 -45.73 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 14.8 tt0 -48.08 -60.03 2.93 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.244 -0.983 . . . . 0.0 109.476 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.0 -61.55 1.58 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.7 mt -45.65 -45.98 14.32 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.81 -51.52 67.19 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.0 mt -51.68 -62.38 1.66 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.113 0.959 . . . . 0.0 110.778 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 m -66.06 -36.7 78.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.23 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.8 m -87.09 -4.93 59.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.935 -1.103 . . . . 0.0 110.146 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 46.88 -146.75 3.47 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 23' ' ' GLY . 32.0 mt-10 -83.39 -0.11 48.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -1.176 . . . . 0.0 109.719 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -58.79 -0.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 109.939 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 73.5 131.58 0.19 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -126.4 148.61 49.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.589 -0.947 . . . . 0.0 109.347 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -82.51 123.53 29.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 0.0 110.042 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.47 ' CE2' ' O ' ' A' ' 27' ' ' THR . 36.4 t80 -172.27 160.44 5.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 109.21 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.47 ' O ' ' CE2' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -154.73 -156.16 0.64 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.322 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.505 ' CB ' ' OE1' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -91.86 172.17 6.82 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.603 ' O ' ' C ' ' A' ' 30' ' ' THR . 57.0 Cg_endo -68.66 -145.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 118.067 -1.596 . . . . 0.0 112.718 176.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.321 ' O ' ' N ' ' A' ' 32' ' ' GLU 0.255 36.8 m 14.14 -107.66 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.024 -1.443 . . . . 0.0 112.982 175.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.73 ' C ' ' O ' ' A' ' 30' ' ' THR . 18.9 mt-10 16.59 -56.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 123.622 1.677 . . . . 0.0 107.093 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 1.321 ' N ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -156.16 -179.13 7.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.109 -2.314 . . . . 0.0 107.024 178.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.403 ' HA3' ' HD2' ' A' ' 36' ' ' ARG . . . -112.42 122.03 5.81 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.287 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.86 ' C ' ' H ' ' A' ' 36' ' ' ARG . 80.1 Cg_endo -75.08 81.26 2.26 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 124.217 3.278 . . . . 0.0 110.837 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.862 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 57.49 -10.65 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.86 ' H ' ' C ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER 30.12 21.35 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.973 -0.454 . . . . 0.0 110.327 -179.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.862 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -104.1 -36.57 3.12 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 107.779 -2.128 . . . . 0.0 107.779 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 11.3 tt -81.83 -45.92 20.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.551 0.691 . . . . 0.0 110.344 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.553 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 55.8 t -64.62 -61.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.78 -0.575 . . . . 0.0 111.726 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.52 -23.59 64.67 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.223 -0.923 . . . . 0.0 110.126 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' NE2' HE22 ' A' ' 51' ' ' GLN . 29.5 tt0 -94.33 -33.96 12.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.982 -1.074 . . . . 0.0 109.954 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.47 ' N ' ' O ' ' A' ' 38' ' ' ILE . 51.0 t -88.51 -43.58 11.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.152 -0.967 . . . . 0.0 110.568 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.78 -24.22 62.55 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 110.73 -178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -104.82 -19.07 14.02 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.201 -0.937 . . . . 0.0 109.524 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -140.1 179.52 6.57 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.264 -0.898 . . . . 0.0 109.035 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.557 ' CG2' ' H ' ' A' ' 47' ' ' CYS . 5.0 mm -64.62 -177.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.996 . . . . 0.0 108.324 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.579 ' HB2' ' HZ ' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -146.03 150.45 36.01 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.897 -1.127 . . . . 0.0 110.222 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -97.16 151.74 19.51 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.57 -40.46 20.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -57.67 -24.79 58.54 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 122.841 1.305 . . . . 0.0 107.943 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.454 HE22 ' NE2' ' A' ' 41' ' ' GLN . 7.7 tt0 -78.44 -23.03 46.78 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.802 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.595 HD11 ' HE2' ' A' ' 1' ' ' PHE . 46.1 mt -84.8 -36.89 21.36 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.69 -20.66 50.47 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.507 -0.746 . . . . 0.0 110.002 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -82.99 -8.94 59.51 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.7 m-85 -90.34 -36.72 14.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.551 -0.718 . . . . 0.0 109.316 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -51.51 110.49 0.46 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.376 -0.827 . . . . 0.0 109.565 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.6 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.505 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.851 ' CD1' ' O ' ' A' ' 1' ' ' PHE . 48.8 p90 . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 9.1 p -55.27 167.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 116.145 -2.222 . . . . 0.0 108.976 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.409 ' N ' ' CG2' ' A' ' 2' ' ' VAL . 2.6 m120 -52.78 105.77 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.002 -1.061 . . . . 0.0 109.952 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -164.49 -160.77 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.172 -0.955 . . . . 0.0 109.77 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -95.45 132.66 40.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.247 -0.908 . . . . 0.0 109.609 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.1 113.71 15.45 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.01 148.72 50.54 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.42 -169.99 53.05 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.412 ' C ' ' N ' ' A' ' 11' ' ' LEU . 4.3 p -60.95 -14.8 25.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.612 -1.523 . . . . 0.0 109.202 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -52.81 -25.74 12.33 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.412 ' N ' ' C ' ' A' ' 9' ' ' SER . 13.0 tp -81.11 -47.9 12.88 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 13' ' ' GLU . 27.2 t -48.08 -47.35 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.1 tt0 -47.51 -59.91 2.9 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.561 -176.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.717 ' HB2' ' CE2' ' A' ' 1' ' ' PHE . . . -45.23 -61.38 1.68 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 19' ' ' CYS . 13.0 mt -45.76 -45.94 14.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.75 -52.46 63.86 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.7 mt -50.59 -62.32 1.67 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.079 0.942 . . . . 0.0 110.614 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.25 -31.92 55.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.036 -177.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 15' ' ' LEU . 47.7 m -91.72 0.51 57.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.045 -1.034 . . . . 0.0 109.995 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 45.86 -158.7 0.29 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.32 -2.94 43.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -1.152 . . . . 0.0 109.354 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -46.62 -58.63 3.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.865 . . . . 0.0 109.487 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.58 131.18 2.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -131.4 143.72 50.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.68 -0.894 . . . . 0.0 108.846 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -86.29 134.35 33.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.324 -0.86 . . . . 0.0 110.266 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' THR . 86.3 t80 -172.9 -24.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.44 -0.788 . . . . 0.0 109.399 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' TYR . 3.1 p 47.62 -175.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.734 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.84 ' O ' ' N ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -98.84 162.53 21.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.751 ' C ' HG22 ' A' ' 30' ' ' THR . 53.2 Cg_exo -42.51 32.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 124.212 3.275 . . . . 0.0 113.593 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.84 ' N ' ' O ' ' A' ' 28' ' ' ASP . 3.6 p -158.39 -101.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.708 -1.245 . . . . 0.0 111.437 -177.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.67 ' C ' ' O ' ' A' ' 30' ' ' THR . 14.5 mt-10 0.9 69.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.095 -1.003 . . . . 0.0 111.017 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.947 ' OE2' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER 62.49 -40.63 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.736 -1.227 . . . . 0.0 110.415 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 85.05 178.12 50.94 Favored Glycine 0 N--CA 1.503 3.113 0 O-C-N 119.824 -1.797 . . . . 0.0 109.23 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.418 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 94.3 Cg_endo -77.82 -148.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.893 3.062 . . . . 0.0 112.292 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.857 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -120.12 85.71 2.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.722 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -15.11 104.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.668 1.223 . . . . 0.0 109.368 -178.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.12 -54.25 0.02 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 8.4 tt -81.9 -45.34 20.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.664 -0.904 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.538 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 40.3 t -64.69 -62.24 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.625 -0.672 . . . . 0.0 111.962 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.514 ' CG ' ' HG3' ' A' ' 36' ' ' ARG . 25.3 mt-10 -47.77 -33.63 7.4 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.284 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.2 mt-30 -93.52 -59.54 1.99 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.003 -1.06 . . . . 0.0 109.415 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 38' ' ' ILE . 17.6 t -52.8 -34.07 51.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.108 -0.995 . . . . 0.0 110.738 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.7 t -85.28 -53.03 5.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.863 -1.148 . . . . 0.0 110.831 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.446 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 2.3 m-70 -86.17 -5.06 59.27 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.966 -1.084 . . . . 0.0 110.511 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.0 m -140.39 -177.82 5.21 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.054 -1.029 . . . . 0.0 109.362 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.598 ' CG2' ' H ' ' A' ' 47' ' ' CYS . 6.0 mm -64.66 -178.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.173 -0.954 . . . . 0.0 108.524 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.598 ' H ' ' CG2' ' A' ' 46' ' ' ILE . 1.3 t -134.91 130.46 35.93 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.162 -0.961 . . . . 0.0 110.543 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.7 m -95.03 145.97 24.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 tp -82.5 -40.33 21.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -56.41 -24.97 48.4 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 122.945 1.355 . . . . 0.0 108.147 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.472 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 9.3 tt0 -79.39 -22.83 43.79 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.142 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.658 HD11 ' CZ ' ' A' ' 1' ' ' PHE . 38.8 mt -85.46 -38.33 18.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.597 -1.314 . . . . 0.0 108.223 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.31 -20.17 26.82 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.487 -0.758 . . . . 0.0 110.368 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -83.87 -8.69 59.14 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.472 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 3.6 m-85 -90.55 -39.18 12.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.6 -0.688 . . . . 0.0 109.758 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -49.67 110.65 0.4 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.353 -0.842 . . . . 0.0 109.546 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.6 t30 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.509 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.72 ' CD2' HD13 ' A' ' 17' ' ' LEU . 33.3 p90 . . . . . 0 CA--C 1.56 1.364 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 1' ' ' PHE . 60.1 t 42.55 -99.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.409 -1.432 . . . . 0.0 109.23 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.519 ' O ' ' O ' ' A' ' 4' ' ' GLN . 1.9 m-20 -147.46 -30.77 0.32 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.07 -1.019 . . . . 0.0 109.89 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.519 ' O ' ' O ' ' A' ' 3' ' ' ASN . 4.3 pt20 -25.44 152.92 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.959 0.885 . . . . 0.0 112.98 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -45.77 136.07 6.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.327 -0.858 . . . . 0.0 109.603 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tp -134.38 109.38 8.75 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' GLY . 59.5 m -106.64 -176.39 3.06 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.153 -0.967 . . . . 0.0 109.685 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 7' ' ' CYS . . . 43.26 -164.43 0.03 OUTLIER Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.467 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.0 p -69.0 -8.65 46.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.985 -1.303 . . . . 0.0 109.23 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -53.33 -22.84 7.95 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.467 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.0 tp -78.99 -52.33 8.39 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 13' ' ' GLU . 4.4 t -48.11 -40.72 9.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.494 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.2 tt0 -48.36 -59.39 3.49 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.534 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.45 -61.28 1.74 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 19' ' ' CYS . 6.6 mt -45.74 -49.17 15.06 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.553 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -50.45 -48.71 56.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.72 HD13 ' CD2' ' A' ' 1' ' ' PHE . 19.2 mt -56.96 -63.87 1.06 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.962 0.887 . . . . 0.0 110.464 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -64.12 -51.46 68.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.601 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' LEU . 78.6 m -72.88 -1.57 17.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.028 -1.045 . . . . 0.0 109.346 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 40.2 -142.74 0.63 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.36 -6.89 59.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.608 -0.937 . . . . 0.0 109.793 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.0 mtp85 -42.48 -59.11 1.98 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.844 -0.535 . . . . 0.0 109.767 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.4 102.85 0.81 Allowed Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -103.68 -170.48 1.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 63.4 t80 -154.33 120.58 5.37 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 119.638 -1.914 . . . . 0.0 112.9 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 32.4 m-85 -150.25 92.8 1.91 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.652 ' HG1' ' H ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -54.3 -171.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 -179.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.652 ' H ' ' HG1' ' A' ' 27' ' ' THR . 0.1 OUTLIER -85.58 168.34 20.42 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' O ' ' C ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -54.26 -125.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.196 0 C-N-CA 123.829 3.019 . . . . 0.0 113.724 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.05 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER 27.91 -132.17 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.042 0 O-C-N 121.329 -0.857 . . . . 0.0 110.808 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 1.135 ' O ' ' N ' ' A' ' 33' ' ' GLY . 2.7 mt-10 -12.62 168.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.147 0.498 . . . . 0.0 111.204 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.669 ' C ' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -17.69 58.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.563 0.697 . . . . 0.0 109.938 178.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 1.135 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 10.37 -138.48 0.0 OUTLIER Glycine 0 N--CA 1.499 2.897 0 CA-C-O 122.14 0.856 . . . . 0.0 112.892 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.602 ' HG2' ' H ' ' A' ' 35' ' ' ARG . 69.5 Cg_endo -80.22 -89.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 123.538 2.826 . . . . 0.0 113.183 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.79 ' O ' ' CB ' ' A' ' 36' ' ' ARG . 62.8 ttt180 -127.56 -46.74 1.44 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.347 -0.846 . . . . 0.0 108.929 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.79 ' CB ' ' O ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER 101.4 73.31 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.803 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.06 -79.32 0.14 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 5.0 tt -56.04 -44.05 77.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.816 -0.814 . . . . 0.0 109.491 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.541 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 46.6 t -65.29 -61.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.622 -0.674 . . . . 0.0 110.39 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.506 ' OE2' ' HG3' ' A' ' 36' ' ' ARG . 2.4 mt-10 -57.56 -18.47 19.65 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.141 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' SER . 44.8 tt0 -94.08 -51.92 4.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.224 -0.922 . . . . 0.0 110.755 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -75.69 -54.06 7.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.745 -1.222 . . . . 0.0 110.091 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 48.6 t -52.73 -23.45 6.77 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.025 -1.047 . . . . 0.0 110.406 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -111.82 -29.13 7.79 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.062 -1.024 . . . . 0.0 110.122 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -132.83 -163.96 1.41 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.365 -0.834 . . . . 0.0 109.232 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.5 mm -106.46 159.64 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.269 -0.894 . . . . 0.0 109.233 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 m -145.61 168.82 19.74 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.951 -1.093 . . . . 0.0 109.943 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.43 165.76 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.908 0.861 . . . . 0.0 110.182 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.59 -33.33 28.03 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.29 -25.88 68.1 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.794 1.283 . . . . 0.0 108.177 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.528 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 8.5 tt0 -73.11 -23.07 60.46 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.33 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.9 mt -84.62 -28.98 26.13 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.59 -18.19 64.9 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.602 -0.686 . . . . 0.0 110.856 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 13.7 p30 -88.19 -8.84 54.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.818 -1.176 . . . . 0.0 108.368 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.604 ' CE2' ' NH2' ' A' ' 35' ' ' ARG . 6.4 m-85 -82.88 -38.12 23.37 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.576 0.703 . . . . 0.0 109.318 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 m -49.81 110.5 0.39 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.741 -0.599 . . . . 0.0 109.816 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.551 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.885 ' CG ' ' O ' ' A' ' 1' ' ' PHE . 1.6 p90 . . . . . 0 C--O 1.195 -1.784 0 CA-C-O 122.333 1.063 . . . . 0.0 108.613 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.598 ' C ' ' H ' ' A' ' 4' ' ' GLN . 3.9 t -92.56 50.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.294 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.989 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 4' ' ' GLN . 0.6 OUTLIER 69.86 -33.95 0.27 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.389 -0.819 . . . . 0.0 109.57 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.598 ' H ' ' C ' ' A' ' 2' ' ' VAL . 8.5 pt20 -28.81 157.99 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.921 0.867 . . . . 0.0 112.338 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -44.35 125.71 4.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.382 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.75 109.2 10.43 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.6 m -114.91 -176.49 2.91 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.433 -0.792 . . . . 0.0 109.403 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.79 -152.95 0.85 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.47 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.1 p -79.16 -9.24 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.895 -1.356 . . . . 0.0 108.888 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 9' ' ' SER . 14.9 m-70 -52.0 -24.39 6.53 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.47 ' N ' ' C ' ' A' ' 9' ' ' SER . 8.7 tp -78.22 -54.02 6.69 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 13' ' ' GLU . 4.7 t -46.4 -41.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 19.4 tt0 -47.24 -58.94 3.54 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.939 -1.104 . . . . 0.0 108.385 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.53 -61.4 1.7 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 19' ' ' CYS . 7.6 mt -46.01 -48.01 16.73 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -51.75 -49.01 63.43 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 19.5 mt -56.58 -63.64 1.13 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.002 0.906 . . . . 0.0 110.651 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 m -64.7 -48.27 85.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.761 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' LEU . 60.9 m -73.26 -15.24 61.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.045 -1.034 . . . . 0.0 109.852 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 43.01 -133.09 5.17 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -83.75 -9.7 58.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -1.044 . . . . 0.0 110.016 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -47.12 -25.53 0.89 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 109.613 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.7 117.95 2.26 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.273 -0.965 . . . . 0.0 110.73 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.488 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 32.8 p90 -122.06 -178.91 3.98 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.509 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 64.3 m-85 -150.72 125.92 9.98 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 119.552 -1.968 . . . . 0.0 112.783 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.509 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 29.7 m-85 -151.47 114.78 4.8 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -57.35 -163.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.068 -1.02 . . . . 0.0 108.8 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.68 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -49.17 -178.54 0.02 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 108.625 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.68 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 29.5 Cg_endo -66.85 -114.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.676 2.251 . . . . 0.0 111.235 177.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.036 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -61.65 -15.12 37.04 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.504 -0.747 . . . . 0.0 111.844 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 1.036 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.2 pp20? -6.78 -146.78 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 122.157 0.98 . . . . 0.0 112.541 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.435 ' H ' ' HB2' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -71.08 -125.01 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.251 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.434 ' H ' ' HB3' ' A' ' 32' ' ' GLU . . . -100.48 135.54 12.2 Favored Glycine 0 N--CA 1.504 3.23 0 C-N-CA 119.681 -1.247 . . . . 0.0 111.649 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.927 ' O ' ' HG2' ' A' ' 36' ' ' ARG . 18.5 Cg_endo -94.97 173.42 1.28 Allowed 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 124.872 3.714 . . . . 0.0 112.446 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.752 ' O ' ' O ' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -54.03 -5.11 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.927 ' HG2' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 48.82 164.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.54 -77.53 0.43 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 118.797 -1.668 . . . . 0.0 109.553 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.548 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 8.8 tt -65.34 -45.99 91.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.403 -1.057 . . . . 0.0 111.188 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.548 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 55.7 t -65.88 -61.03 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.72 -0.612 . . . . 0.0 110.946 -177.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -57.23 -22.42 40.95 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 109.228 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.66 ' NE2' HE22 ' A' ' 51' ' ' GLN . 26.2 tt0 -94.22 -32.79 13.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.16 -0.963 . . . . 0.0 109.569 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.52 ' N ' ' O ' ' A' ' 38' ' ' ILE . 99.7 m -89.7 -47.75 7.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.034 -1.041 . . . . 0.0 109.992 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' VAL . 44.9 t -66.89 -52.52 42.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 110.855 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -85.89 -18.04 33.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.923 -1.111 . . . . 0.0 110.47 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' CYS . 13.1 m -140.59 179.84 6.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.078 -1.013 . . . . 0.0 109.613 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 mm -95.92 139.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.317 -0.864 . . . . 0.0 108.802 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.65 168.22 14.03 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.309 -0.87 . . . . 0.0 109.978 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.1 166.89 14.1 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.071 0.939 . . . . 0.0 111.044 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.4 ' HB2' ' HZ ' ' A' ' 1' ' ' PHE . 0.3 OUTLIER -82.93 -36.88 24.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -57.98 -25.37 60.95 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 122.898 1.332 . . . . 0.0 108.172 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.66 HE22 ' NE2' ' A' ' 41' ' ' GLN . 6.9 tt0 -76.28 -21.82 55.82 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.559 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.3 mt -84.49 -35.46 22.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.856 -1.153 . . . . 0.0 107.941 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -62.29 -18.29 60.91 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.63 -0.669 . . . . 0.0 110.148 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 2.3 m-20 -85.43 -8.67 58.28 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 51' ' ' GLN . 4.6 m-85 -89.23 -40.67 12.69 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.818 0.818 . . . . 0.0 109.316 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.5 m -49.77 110.28 0.37 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.739 -0.601 . . . . 0.0 109.993 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.0 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.491 179.699 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 1.045 ' CZ ' ' CD1' ' A' ' 17' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.65 76.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.538 -0.726 . . . . 0.0 109.132 167.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 4' ' ' GLN . 3.8 m120 53.63 -102.06 0.13 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.219 -0.925 . . . . 0.0 109.37 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ASN . 14.6 pt20 37.8 -162.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.541 0.686 . . . . 0.0 111.392 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -93.19 137.12 32.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.351 -0.843 . . . . 0.0 109.639 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.701 HD13 ' H1 ' ' A' ' 1' ' ' PHE . 1.3 mp -133.72 109.63 9.28 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 m -118.78 -176.95 3.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.501 -0.749 . . . . 0.0 109.186 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.67 -145.97 3.66 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.2 p -81.66 -12.89 58.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.061 -1.258 . . . . 0.0 109.471 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -51.22 -24.54 4.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.2 tp -81.83 -49.86 9.88 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 13' ' ' GLU . 22.1 t -46.84 -48.3 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.494 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.6 tt0 -47.42 -59.7 3.04 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.528 -176.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -44.89 -61.65 1.53 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ALA . 14.6 mt -45.77 -45.46 14.65 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.554 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.12 -49.44 73.89 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 1.045 ' CD1' ' CZ ' ' A' ' 1' ' ' PHE . 27.5 mt -54.85 -62.85 1.39 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.101 0.953 . . . . 0.0 110.909 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -64.23 -37.69 80.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.943 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 42.5 t -80.25 -22.41 41.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.977 -1.077 . . . . 0.0 110.039 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 68.87 -146.73 45.4 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.6 tt0 -83.16 -15.26 51.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.333 -1.098 . . . . 0.0 109.656 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -47.45 -9.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.665 -0.647 . . . . 0.0 110.529 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 78.6 131.42 0.68 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -116.91 157.0 26.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.642 -0.916 . . . . 0.0 109.925 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -85.52 122.1 29.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.388 -0.82 . . . . 0.0 110.113 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.4 ' O ' ' O ' ' A' ' 27' ' ' THR . 39.2 t80 -170.42 71.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.841 . . . . 0.0 108.911 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.507 HG21 ' HB3' ' A' ' 31' ' ' GLU . 1.3 m -47.65 171.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.74 . . . . 0.0 109.717 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.9 168.94 23.32 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.764 ' O ' ' CG2' ' A' ' 30' ' ' THR . 57.1 Cg_endo -71.76 90.18 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.635 2.223 . . . . 0.0 111.439 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.822 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.9 OUTLIER 145.65 -55.67 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.452 0.644 . . . . 0.0 109.898 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.524 ' C ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -35.44 78.3 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.185 -178.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.822 ' N ' ' O ' ' A' ' 30' ' ' THR . 2.6 mt-10 51.47 19.21 0.78 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.52 ' N ' ' C ' ' A' ' 31' ' ' GLU . . . 58.73 176.3 0.71 Allowed Glycine 0 N--CA 1.479 1.555 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.567 ' HG2' ' H ' ' A' ' 35' ' ' ARG . 40.0 Cg_endo -83.25 -97.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 123.49 2.794 . . . . 0.0 109.828 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.794 ' O ' ' O ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -158.0 9.27 0.16 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.985 -1.072 . . . . 0.0 108.233 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.794 ' O ' ' O ' ' A' ' 35' ' ' ARG . 1.2 mpt_? 43.81 133.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.429 1.109 . . . . 0.0 108.434 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.16 -63.77 0.36 Allowed Glycine 0 C--N 1.275 -2.826 0 C-N-CA 117.493 -2.289 . . . . 0.0 108.402 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 8.1 tt -80.61 -41.12 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.618 -0.93 . . . . 0.0 109.712 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.524 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 55.0 t -70.75 -61.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.317 0.58 . . . . 0.0 110.876 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -59.15 -18.9 40.21 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.3 -0.875 . . . . 0.0 110.01 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.465 ' NE2' HE22 ' A' ' 51' ' ' GLN . 13.3 tt0 -94.29 -43.59 8.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.047 -1.033 . . . . 0.0 110.439 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' SER . 1.8 t -88.1 -31.46 19.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.89 -1.131 . . . . 0.0 110.82 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.6 t -76.91 -48.97 16.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.815 -1.178 . . . . 0.0 109.841 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -83.15 -22.94 33.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.063 -1.023 . . . . 0.0 109.47 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' CYS . 4.5 m -140.14 -170.04 2.88 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.374 -0.829 . . . . 0.0 108.917 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.01 168.32 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.032 -1.043 . . . . 0.0 108.831 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.7 p -150.7 167.27 27.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.138 -0.976 . . . . 0.0 109.728 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.18 164.94 12.28 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 122.047 0.927 . . . . 0.0 111.153 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.53 -36.94 25.89 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.82 -25.95 61.34 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.843 1.306 . . . . 0.0 108.282 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.465 HE22 ' NE2' ' A' ' 41' ' ' GLN . 6.5 tt0 -76.72 -22.08 54.39 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.577 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 mt -84.82 -33.39 22.92 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.941 -1.099 . . . . 0.0 108.036 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -62.81 -18.78 63.3 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 110.34 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -84.51 -8.72 58.84 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.55 ' CE2' ' NH1' ' A' ' 35' ' ' ARG . 3.7 m-85 -90.11 -27.59 19.54 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.62 -0.675 . . . . 0.0 109.648 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.9 t -66.97 112.04 4.13 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.845 0.831 . . . . 0.0 109.793 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 . . . . . 0 C--N 1.291 -1.972 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.429 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.772 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.896 0.855 . . . . 0.0 108.758 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 3' ' ' ASN . 4.0 p -55.97 -20.31 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -177.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 2' ' ' VAL . 13.4 m-20 154.82 71.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -151.04 170.72 18.69 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.593 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 5.2 p80 -61.2 136.59 58.11 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.012 -1.055 . . . . 0.0 109.252 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.496 ' CD2' ' HB2' ' A' ' 1' ' ' PHE . 1.0 OUTLIER -134.07 110.06 9.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.39 -0.819 . . . . 0.0 108.883 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 m -122.61 -176.89 3.49 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 47.2 -149.54 2.6 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.433 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.2 p -79.49 -12.75 59.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.912 -1.346 . . . . 0.0 109.291 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -52.39 -24.04 7.05 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.433 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.5 tp -80.59 -52.43 7.6 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 13' ' ' GLU . 22.6 t -44.13 -47.66 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.626 0.727 . . . . 0.0 109.225 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.482 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 28.3 tt0 -46.62 -59.52 2.96 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.471 -176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.15 -61.81 1.5 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.8 mt -45.97 -43.96 14.53 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.558 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -57.58 -50.45 73.08 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 29.6 mt -52.68 -62.68 1.49 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.211 1.005 . . . . 0.0 110.789 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 m -65.14 -42.36 94.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.432 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.0 t -75.15 -22.45 58.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.779 -1.201 . . . . 0.0 110.118 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 69.33 -151.57 51.12 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 23' ' ' GLY . 22.5 mt-10 -83.24 0.53 45.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -1.209 . . . . 0.0 109.694 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -62.42 1.36 0.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.173 -0.954 . . . . 0.0 109.988 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 68.65 121.05 0.03 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.405 ' CD2' ' N ' ' A' ' 24' ' ' PHE . 16.1 p90 -105.34 170.25 7.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.569 -0.959 . . . . 0.0 109.58 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -98.54 123.67 42.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.33 -0.856 . . . . 0.0 110.135 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' THR . 49.5 t80 -172.45 86.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.503 -0.748 . . . . 0.0 109.141 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -53.12 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.294 -0.879 . . . . 0.0 109.296 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.52 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -83.62 177.18 3.15 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.52 ' HD2' ' CB ' ' A' ' 28' ' ' ASP . 51.0 Cg_endo -60.12 -6.06 4.62 Favored 'Trans proline' 0 N--CA 1.525 3.355 0 C-N-CA 124.267 3.311 . . . . 0.0 116.523 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.106 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -121.84 -168.63 1.73 Allowed 'General case' 0 C--N 1.284 -2.267 0 O-C-N 120.051 -1.656 . . . . 0.0 111.36 -178.354 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 1.106 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.3 OUTLIER 33.12 134.64 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 1.17 ' O ' ' O ' ' A' ' 33' ' ' GLY . 25.0 mp0 13.01 48.92 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.35 -0.844 . . . . 0.0 111.243 -177.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 1.17 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -25.49 -139.16 0.0 OUTLIER Glycine 0 N--CA 1.506 3.365 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.829 ' HG2' HG23 ' A' ' 39' ' ' VAL . 32.5 Cg_exo -61.94 148.25 93.51 Favored 'Trans proline' 0 N--CA 1.51 2.453 0 C-N-CA 122.698 2.265 . . . . 0.0 112.282 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.842 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -55.63 7.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 119.544 -1.973 . . . . 0.0 108.355 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.842 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 75.9 92.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.732 -1.23 . . . . 0.0 110.351 -179.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.19 -53.86 0.21 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 117.005 -2.522 . . . . 0.0 109.371 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.539 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 7.1 tt -75.58 -42.16 41.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.705 -0.88 . . . . 0.0 110.487 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.829 HG23 ' HG2' ' A' ' 34' ' ' PRO . 49.0 t -65.75 -60.62 2.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.268 0.556 . . . . 0.0 111.029 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -58.5 -21.34 51.63 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.671 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.525 ' NE2' ' OE1' ' A' ' 51' ' ' GLN . 8.8 tt0 -94.08 -36.32 12.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.237 -0.914 . . . . 0.0 109.85 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 38' ' ' ILE . 96.6 m -88.35 -50.42 6.34 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.112 -0.993 . . . . 0.0 109.96 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.3 t -62.51 -50.43 71.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.292 -0.88 . . . . 0.0 110.882 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -83.84 -26.24 29.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.86 -1.15 . . . . 0.0 110.752 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 41' ' ' GLN . 37.2 m -140.6 -179.43 6.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.969 -1.082 . . . . 0.0 110.249 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mm -84.55 157.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 p -143.16 167.22 22.62 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.893 -1.13 . . . . 0.0 109.474 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.28 161.86 21.33 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.078 0.942 . . . . 0.0 110.682 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.04 -35.14 26.0 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -59.62 -25.95 65.08 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.674 1.226 . . . . 0.0 108.203 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.531 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 6.8 tt0 -74.45 -23.33 58.89 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.41 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.9 mt -84.64 -27.41 27.16 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.039 -1.038 . . . . 0.0 108.303 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -68.08 -18.65 64.73 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.564 -0.71 . . . . 0.0 110.887 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 15.7 p30 -87.27 -9.03 56.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.499 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 5.0 m-85 -84.32 -32.26 24.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.8 t -60.88 112.28 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.873 0.844 . . . . 0.0 109.932 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 t30 . . . . . 0 C--N 1.292 -1.902 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.533 179.866 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.521 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 2.6 p90 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 1' ' ' PHE . 87.7 t -158.71 87.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 O-C-N 120.532 -1.355 . . . . 0.0 109.252 -171.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 2' ' ' VAL . 1.2 m120 42.49 51.1 4.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.639 -0.663 . . . . 0.0 110.069 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -128.79 165.05 21.7 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.484 -0.76 . . . . 0.0 109.812 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.459 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 31.8 p80 -60.05 130.07 44.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.38 -0.825 . . . . 0.0 110.35 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -135.12 118.92 17.22 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.0 t -123.28 -176.82 3.53 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.459 -0.776 . . . . 0.0 109.408 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.23 -152.82 0.69 Allowed Glycine 0 N--CA 1.499 2.898 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.453 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.0 p -77.93 -10.18 59.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.73 -1.453 . . . . 0.0 108.734 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' SER . 68.7 m80 -53.01 -22.96 6.4 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.453 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.4 tp -79.82 -50.99 9.71 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 13' ' ' GLU . 4.0 t -47.36 -40.06 6.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.489 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.0 tt0 -48.68 -59.36 3.6 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.661 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.53 -60.64 2.07 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 19' ' ' CYS . 7.3 mt -46.37 -47.54 18.69 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.55 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -52.49 -48.34 66.0 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 20.1 mt -56.8 -63.34 1.24 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.01 0.909 . . . . 0.0 110.542 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -65.56 -46.16 90.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.014 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 15' ' ' LEU . 58.6 m -72.97 -22.51 60.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.96 -1.088 . . . . 0.0 109.596 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 39.67 -120.92 1.4 Allowed Glycine 0 N--CA 1.496 2.662 0 O-C-N 121.284 -0.885 . . . . 0.0 111.131 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -81.67 -20.75 38.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.547 -0.972 . . . . 0.0 110.001 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -46.26 -34.04 4.15 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.343 -0.848 . . . . 0.0 109.402 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.36 137.04 8.53 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 24' ' ' PHE . 28.1 p90 -140.99 174.83 10.13 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 7.2 p90 -154.37 125.92 7.51 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.69 -1.881 . . . . 0.0 112.439 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 27' ' ' THR . 18.7 m-85 -139.38 3.26 2.12 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 26' ' ' TYR . 1.8 p 45.88 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.807 0.813 . . . . 0.0 110.28 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.518 ' O ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -69.02 167.53 20.03 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.518 ' C ' ' O ' ' A' ' 28' ' ' ASP . 2.5 Cg_endo -33.89 -45.06 0.37 Allowed 'Trans proline' 0 C--N 1.278 -3.148 0 C-N-CA 121.706 1.604 . . . . 0.0 111.604 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.821 ' OG1' ' N ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -114.82 -144.88 0.39 Allowed 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.527 0.679 . . . . 0.0 109.656 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 1.066 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 5.3 mt-10 72.99 65.94 0.11 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.113 -0.992 . . . . 0.0 112.334 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 1.066 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER 103.21 -57.17 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 O-C-N 120.789 -1.194 . . . . 0.0 112.553 177.458 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.678 ' C ' ' H ' ' A' ' 35' ' ' ARG . . . 152.85 122.73 0.94 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 117.435 -2.317 . . . . 0.0 113.22 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.517 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 5.4 Cg_exo -56.91 11.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.92 2.413 . . . . 0.0 111.376 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.823 ' NH2' ' CE2' ' A' ' 55' ' ' TYR . 9.1 ttt-85 84.88 -16.57 0.49 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.471 HH21 ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER 53.07 -173.79 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.095 -1.003 . . . . 0.0 110.671 179.087 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.49 -81.45 0.08 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 4.5 tt -52.0 -40.36 28.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.856 -0.791 . . . . 0.0 110.757 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.479 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 40.3 t -71.63 -61.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.724 -0.61 . . . . 0.0 110.565 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -55.7 -23.47 28.92 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.369 -0.832 . . . . 0.0 109.135 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -94.53 -34.45 12.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.277 -0.889 . . . . 0.0 109.852 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 38' ' ' ILE . 42.0 t -88.35 -46.29 9.3 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.052 -1.03 . . . . 0.0 110.233 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.8 t -63.59 -34.24 77.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 110.643 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -103.34 -15.4 15.95 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.167 -0.958 . . . . 0.0 110.28 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER -140.07 -179.14 5.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.109 -0.994 . . . . 0.0 109.19 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.606 ' CG2' ' H ' ' A' ' 47' ' ' CYS . 5.3 mm -66.2 -179.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 0.0 109.305 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.606 ' H ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -146.93 134.49 20.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.042 -1.037 . . . . 0.0 109.365 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 m -87.68 155.27 20.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.438 -0.789 . . . . 0.0 109.182 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 tp -82.83 -39.83 21.16 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -57.95 -23.34 53.24 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 123.179 1.466 . . . . 0.0 107.826 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.506 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 10.5 tp-100 -80.69 -23.28 39.67 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.109 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.05 -38.52 19.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.399 -1.438 . . . . 0.0 108.213 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -58.24 -19.61 35.39 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.646 -0.659 . . . . 0.0 110.293 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -85.15 -8.57 58.55 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 108.634 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.823 ' CE2' ' NH2' ' A' ' 35' ' ' ARG . 4.4 m-85 -90.54 -40.29 12.05 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.937 0.875 . . . . 0.0 109.212 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.2 m -49.74 110.67 0.41 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.259 0.552 . . . . 0.0 110.03 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.55 179.829 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 1.085 ' CE1' ' HA ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 122.304 1.05 . . . . 0.0 110.072 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.5 m -73.37 55.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 120.778 -1.201 . . . . 0.0 109.114 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 1.085 ' HA ' ' CE1' ' A' ' 1' ' ' PHE . 0.8 OUTLIER 67.42 -88.4 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.365 -0.834 . . . . 0.0 109.096 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 3' ' ' ASN . 28.4 pt20 31.46 -151.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.463 -0.773 . . . . 0.0 111.787 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.512 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 7.6 p80 -98.92 132.59 44.14 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.367 -0.833 . . . . 0.0 109.236 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.796 HD22 ' CD1' ' A' ' 1' ' ' PHE . 1.4 mp -133.81 111.12 10.26 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.6 m -123.36 -177.57 3.74 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.84 -148.19 5.0 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.432 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -80.31 -13.38 59.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.947 -1.325 . . . . 0.0 109.425 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -52.01 -24.45 6.65 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.432 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.0 tp -81.67 -49.01 10.98 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 13' ' ' GLU . 20.9 t -47.41 -46.61 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.491 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 27.5 tt0 -47.9 -59.76 3.1 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.499 -176.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.06 -61.49 1.61 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 19' ' ' CYS . 13.4 mt -45.61 -46.8 14.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.555 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.83 -50.18 69.24 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 27.9 mt -53.75 -62.69 1.49 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 122.111 0.958 . . . . 0.0 110.727 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.38 -31.83 55.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.006 -177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 15' ' ' LEU . 54.6 m -93.11 -0.52 56.99 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.08 -1.013 . . . . 0.0 109.936 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 47.9 -148.79 3.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 2.0 mp0 -83.21 -15.18 51.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -1.084 . . . . 0.0 109.328 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -42.73 -18.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.8 -0.562 . . . . 0.0 110.568 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 92.74 138.19 8.46 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -129.82 155.84 45.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.591 -0.946 . . . . 0.0 109.71 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.519 ' HD1' ' HE ' ' A' ' 35' ' ' ARG . 48.1 t80 -84.51 124.05 30.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 0.0 110.193 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 27' ' ' THR . 44.4 t80 -172.47 77.97 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 109.324 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -52.33 -176.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.08 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.51 154.52 68.75 Favored Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 121.133 -0.979 . . . . 0.0 108.606 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.561 ' O ' ' CG2' ' A' ' 30' ' ' THR . 59.2 Cg_endo -75.07 57.42 4.61 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.307 2.671 . . . . 0.0 111.766 -175.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.561 ' CG2' ' O ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -162.6 -61.7 0.04 OUTLIER 'General case' 0 C--N 1.262 -3.234 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 33' ' ' GLY . 4.9 mm-40 -54.98 122.53 11.09 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 117.778 -1.569 . . . . 0.0 108.703 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 1.1 pt-20 39.67 7.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.43 -0.794 . . . . 0.0 110.531 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.786 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 82.86 168.06 42.12 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 118.356 -1.878 . . . . 0.0 109.246 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.95 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 28.5 Cg_endo -63.84 -28.41 67.58 Favored 'Trans proline' 0 C--N 1.285 -2.781 0 C-N-CA 122.804 2.336 . . . . 0.0 117.421 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.95 ' HB2' ' O ' ' A' ' 34' ' ' PRO . 9.2 ttt-85 151.71 7.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 119.79 -1.819 . . . . 0.0 107.119 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.592 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER 29.4 102.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.747 0.784 . . . . 0.0 109.924 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.47 -68.79 0.3 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 6.4 tt -73.83 -41.28 53.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.594 -0.945 . . . . 0.0 109.74 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.613 HG22 ' CG ' ' A' ' 34' ' ' PRO . 44.9 t -68.99 -61.05 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.329 0.585 . . . . 0.0 110.774 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -57.28 -22.0 38.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.343 -0.848 . . . . 0.0 109.802 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -94.57 -43.15 8.44 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.025 -1.047 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 45' ' ' SER . 0.9 OUTLIER -85.44 -29.22 24.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.88 -1.137 . . . . 0.0 110.642 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.7 t -80.9 -54.16 5.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.798 -1.189 . . . . 0.0 109.802 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -76.12 -24.53 54.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.996 -1.065 . . . . 0.0 109.121 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' CYS . 9.9 m -140.23 -173.99 3.81 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.2 mt -93.9 146.13 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.024 -1.048 . . . . 0.0 109.445 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p -122.04 165.37 16.15 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.606 -0.684 . . . . 0.0 109.263 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.74 166.74 13.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.242 -0.911 . . . . 0.0 110.52 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.31 -36.65 26.77 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -58.77 -25.54 63.15 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.837 1.303 . . . . 0.0 108.199 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.429 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 6.4 tt0 -77.31 -22.19 52.32 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.694 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.3 mt -84.63 -34.53 23.06 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -61.58 -19.28 62.02 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 110.209 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -84.02 -8.72 59.06 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -89.91 -37.79 14.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.689 -0.632 . . . . 0.0 109.529 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.3 m -50.64 110.61 0.43 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.316 -0.865 . . . . 0.0 109.477 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.469 -179.815 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.859 ' C ' ' CD1' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 120.685 0.279 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 4' ' ' GLN . 11.7 p -69.66 167.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 170.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -49.18 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 0.0 109.485 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 2' ' ' VAL . 1.7 pt20 -157.64 -177.81 6.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 110.119 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -78.09 135.33 37.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.316 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.6 109.82 8.91 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -118.11 174.65 6.09 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.71 -153.07 29.95 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 10' ' ' HIS . 3.3 p -78.41 -11.12 59.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.026 -1.279 . . . . 0.0 109.671 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 9' ' ' SER . 1.8 t-80 -53.24 -30.56 38.81 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.91 -48.18 25.98 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.5 t -48.81 -46.3 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.483 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.8 tt0 -49.05 -60.19 2.99 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.492 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.03 -60.96 1.82 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 19' ' ' CYS . 13.5 mt -45.81 -46.84 15.71 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.72 -51.02 66.9 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.2 mt -52.84 -62.49 1.62 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.101 0.953 . . . . 0.0 110.718 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.09 -30.86 50.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.209 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.461 ' N ' ' O ' ' A' ' 15' ' ' LEU . 56.4 m -90.4 -10.85 42.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.002 -1.061 . . . . 0.0 110.325 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 43.71 -131.42 6.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 23' ' ' GLY . 1.9 mp0 -83.91 -19.08 35.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.492 -1.005 . . . . 0.0 110.354 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -46.0 -12.84 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.348 -0.845 . . . . 0.0 110.174 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 76.04 133.54 0.45 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -124.36 142.34 51.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.841 -0.8 . . . . 0.0 109.374 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -83.34 138.13 33.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.428 -0.795 . . . . 0.0 109.776 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 27' ' ' THR . 39.0 t80 -171.86 -39.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.356 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 26' ' ' TYR . 1.6 m 53.93 172.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 109.359 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.18 158.61 69.41 Favored Pre-proline 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 108.715 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 1.256 ' O ' HG22 ' A' ' 30' ' ' THR . 87.7 Cg_endo -82.98 96.19 0.83 Allowed 'Trans proline' 1 C--N 1.253 -4.487 0 N-CA-C 114.932 1.089 . . . . 0.0 114.932 -172.151 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.256 HG22 ' O ' ' A' ' 29' ' ' PRO . 13.9 p 157.45 -54.17 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.646 0 CA-C-O 122.762 1.268 . . . . 0.0 108.951 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 30' ' ' THR . 79.2 mm-40 -31.9 -76.03 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.749 -1.219 . . . . 0.0 112.285 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.36 -26.15 4.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.898 -1.126 . . . . 0.0 109.379 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.01 148.98 5.36 Favored Glycine 0 N--CA 1.513 3.794 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.647 ' O ' ' CB ' ' A' ' 35' ' ' ARG . 80.2 Cg_endo -78.79 26.13 0.54 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 CA-C-N 119.741 1.77 . . . . 0.0 111.524 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.647 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER 83.42 -20.46 0.33 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -178.372 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 38' ' ' ILE . 43.6 mtt-85 52.48 -159.32 0.12 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.406 ' C ' HE21 ' A' ' 41' ' ' GLN . . . 62.44 -81.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' ARG . 6.2 tt -55.6 -41.83 66.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.736 -0.861 . . . . 0.0 109.973 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.51 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 41.8 t -72.41 -60.68 2.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.546 0.689 . . . . 0.0 111.214 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -49.42 -31.84 10.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.604 -0.685 . . . . 0.0 110.771 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.9 pt20 -93.58 -37.11 12.06 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.842 -1.161 . . . . 0.0 110.068 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.3 t -78.14 -55.29 5.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.04 -1.038 . . . . 0.0 109.69 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.8 t -54.89 -27.84 45.94 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.432 -0.792 . . . . 0.0 110.516 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -111.35 -15.53 13.57 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.235 -0.916 . . . . 0.0 110.451 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -140.43 -173.83 3.79 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.934 -1.104 . . . . 0.0 109.78 -179.513 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.469 ' CG2' ' H ' ' A' ' 47' ' ' CYS . 6.5 mm -64.94 178.73 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.469 ' H ' ' CG2' ' A' ' 46' ' ' ILE . 0.7 OUTLIER -143.99 127.77 17.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.957 -1.09 . . . . 0.0 109.866 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 m -80.79 149.32 29.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.333 -0.854 . . . . 0.0 109.171 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 tp -82.83 -41.59 18.88 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -55.79 -25.72 42.68 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 123.02 1.39 . . . . 0.0 108.128 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.533 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 18.6 tt0 -77.98 -22.34 49.54 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.029 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.0 mt -85.38 -28.17 25.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.661 -1.274 . . . . 0.0 108.584 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -65.49 -19.73 66.05 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.631 -0.668 . . . . 0.0 111.354 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 15.2 p30 -88.01 -8.37 55.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.813 -1.179 . . . . 0.0 108.123 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.522 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 4.7 m-85 -86.74 -26.01 24.42 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.681 0.753 . . . . 0.0 109.163 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 57' ' ' ASN . 4.2 m -67.36 95.91 0.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.705 -0.622 . . . . 0.0 111.088 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 56' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 117.923 -1.037 . . . . 0.0 108.38 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 1.267 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.151 0.501 . . . . 0.0 110.162 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p -82.4 164.27 2.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.739 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -47.87 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.991 -1.068 . . . . 0.0 109.493 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -158.66 -160.39 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.419 ' O ' ' CG ' ' A' ' 5' ' ' HIS . 44.8 p-80 -97.95 110.6 23.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.87 139.34 41.45 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.0 t -149.46 -178.47 6.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.282 -0.886 . . . . 0.0 108.792 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.96 -141.68 10.02 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.759 -1.737 . . . . 0.0 108.759 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' VAL . 3.3 p -84.07 -13.35 53.31 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.853 -1.381 . . . . 0.0 109.194 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -52.02 -27.68 14.44 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.455 ' CD2' ' OH ' ' A' ' 26' ' ' TYR . 22.4 tp -81.67 -37.25 27.74 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' SER . 13.8 t -58.73 -48.47 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.494 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 36.0 tt0 -47.74 -59.69 3.12 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.432 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 1.267 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -44.65 -61.76 1.45 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 mt -46.05 -45.55 16.14 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.552 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.22 -48.25 76.82 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.806 HD12 ' CD2' ' A' ' 1' ' ' PHE . 30.1 mt -55.75 -62.81 1.44 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 122.089 0.947 . . . . 0.0 110.836 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -64.18 -36.32 76.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.436 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.7 t -84.4 -22.68 30.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.929 -1.107 . . . . 0.0 110.559 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 70.76 -153.06 51.13 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 23' ' ' GLY . 14.7 mt-10 -83.66 3.61 32.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.244 . . . . 0.0 109.776 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.47 1.8 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 71.93 124.81 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.431 ' CZ ' HG13 ' A' ' 12' ' ' VAL . 13.2 p90 -111.52 170.42 8.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -1.034 . . . . 0.0 110.845 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -98.5 134.85 40.89 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.579 0.704 . . . . 0.0 110.034 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.464 ' CE2' HG23 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -175.92 -149.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.491 ' OG1' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 170.3 166.28 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.152 -0.967 . . . . 0.0 109.227 178.025 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.582 ' HB2' ' HG3' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -96.76 161.47 26.44 Favored Pre-proline 0 N--CA 1.487 1.397 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.56 -7.1 20.12 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 123.856 3.037 . . . . 0.0 110.493 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.449 HG21 ' N ' ' A' ' 31' ' ' GLU . 10.1 t -103.2 -28.28 12.01 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.752 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -76.85 -9.27 58.57 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 176.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 1.032 ' O ' ' O ' ' A' ' 33' ' ' GLY . 53.3 mt-10 107.89 119.9 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.574 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 1.032 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -6.14 147.86 0.0 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.962 ' HG3' HG23 ' A' ' 39' ' ' VAL . 86.0 Cg_endo -84.49 59.14 5.69 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 123.767 2.978 . . . . 0.0 115.774 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.57 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER 80.43 -37.04 0.14 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 111.187 177.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.57 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 81.93 114.55 0.06 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.082 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.5 -60.64 0.42 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.528 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 3.3 tt -82.09 -44.63 19.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.733 -0.863 . . . . 0.0 110.065 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.962 HG23 ' HG3' ' A' ' 34' ' ' PRO . 43.7 t -70.47 -61.29 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 O-C-N 121.308 -0.87 . . . . 0.0 111.37 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.28 -24.55 28.98 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.089 -1.007 . . . . 0.0 110.156 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.509 ' NE2' HE22 ' A' ' 51' ' ' GLN . 20.2 tt0 -94.42 -47.76 6.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.914 -1.116 . . . . 0.0 110.284 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 31.3 m -76.85 -33.28 57.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.069 -1.019 . . . . 0.0 110.535 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.7 t -78.65 -29.26 45.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.851 -1.156 . . . . 0.0 109.874 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -102.42 -21.5 14.24 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.301 -0.874 . . . . 0.0 109.915 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 t -140.03 -171.33 3.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.225 -0.922 . . . . 0.0 109.858 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.3 mm -82.88 174.97 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.9 m -152.08 167.16 29.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.992 -1.068 . . . . 0.0 109.701 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.75 163.44 12.26 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.634 0.73 . . . . 0.0 109.246 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.95 -32.5 30.74 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.58 -28.06 69.67 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.648 1.213 . . . . 0.0 108.569 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.528 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 6.3 tt0 -71.55 -26.3 62.58 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.517 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.657 ' CD1' ' HZ ' ' A' ' 1' ' ' PHE . 47.7 mt -85.78 -23.75 27.11 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.116 -0.99 . . . . 0.0 108.501 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -71.73 -18.37 62.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.333 -0.855 . . . . 0.0 110.89 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 16.8 p30 -86.33 -9.19 56.89 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.526 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 5.7 m-85 -84.24 -28.14 27.46 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.4 t -67.33 112.46 4.58 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.843 0.83 . . . . 0.0 110.106 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.1 m120 . . . . . 0 C--N 1.292 -1.918 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.579 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 1.468 ' CE2' ' HB3' ' A' ' 14' ' ' ALA . 8.2 p90 . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.38 169.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 119.101 -2.249 . . . . 0.0 108.902 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.38 110.02 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.057 -1.027 . . . . 0.0 109.412 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -169.33 -165.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.06 -1.025 . . . . 0.0 110.018 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 30.9 p80 -93.71 132.15 38.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.373 -0.829 . . . . 0.0 109.723 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.5 127.8 41.55 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.4 m -136.15 -177.3 4.64 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.27 -0.894 . . . . 0.0 108.758 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.62 -147.78 2.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.45 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.5 p -79.9 -14.1 58.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.326 . . . . 0.0 109.133 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -51.94 -24.25 6.17 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.45 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.1 tp -81.22 -51.34 8.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 13' ' ' GLU . 25.3 t -46.16 -46.7 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 121.908 0.861 . . . . 0.0 108.98 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.491 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.8 tt0 -47.78 -59.92 2.95 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.51 -176.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 1.468 ' HB3' ' CE2' ' A' ' 1' ' ' PHE . . . -44.99 -62.0 1.41 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.8 mt -45.53 -45.68 13.53 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.558 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.92 -52.01 65.6 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.8 mt -51.03 -62.33 1.68 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.028 0.918 . . . . 0.0 110.753 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 m -66.39 -34.92 73.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.409 -177.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.0 m -88.53 -6.87 57.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.949 -1.095 . . . . 0.0 110.305 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 45.87 -142.58 4.46 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 23' ' ' GLY . 19.9 mt-10 -83.13 -3.26 57.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -1.116 . . . . 0.0 109.6 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -55.64 -4.82 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.772 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 72.8 127.83 0.1 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -122.29 145.9 47.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.627 -0.925 . . . . 0.0 108.971 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -83.17 133.11 35.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.189 -0.944 . . . . 0.0 109.891 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.528 ' CE2' ' O ' ' A' ' 27' ' ' THR . 43.6 t80 -172.82 174.24 3.65 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.559 HG21 ' HB3' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -153.18 -178.01 6.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.028 -1.045 . . . . 0.0 109.494 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.06 159.93 64.28 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.268 -0.895 . . . . 0.0 108.857 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.52 -24.43 9.13 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 124.188 3.259 . . . . 0.0 113.258 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.6 p -115.07 -27.49 7.31 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.57 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 32' ' ' GLU . 4.1 mm-40 -54.22 138.07 39.49 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.892 -1.13 . . . . 0.0 109.643 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.597 ' C ' ' O ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER 24.74 -105.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.51 ' H ' ' HB2' ' A' ' 32' ' ' GLU . . . -175.2 100.37 0.15 Allowed Glycine 0 C--N 1.29 -2.014 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.675 ' O ' ' C ' ' A' ' 35' ' ' ARG . 12.0 Cg_endo -51.23 120.41 6.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.407 2.738 . . . . 0.0 113.493 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.675 ' C ' ' O ' ' A' ' 34' ' ' PRO . 0.4 OUTLIER 11.0 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 122.041 -0.412 . . . . 0.0 111.349 177.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.435 ' HD3' ' CD ' ' A' ' 40' ' ' GLU . 8.5 mmt-85 -59.6 102.18 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.5 -49.36 0.28 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 9.6 tt -82.52 -44.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.608 -0.937 . . . . 0.0 110.894 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.538 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 46.1 t -67.76 -62.61 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.379 -0.825 . . . . 0.0 111.448 -177.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.435 ' CD ' ' HD3' ' A' ' 36' ' ' ARG . 15.2 mt-10 -55.29 -25.92 37.03 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.084 -1.01 . . . . 0.0 110.369 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' SER . 16.1 tt0 -93.92 -55.92 3.06 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.05 -1.031 . . . . 0.0 110.493 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 14.4 m -67.88 -33.93 75.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.053 -1.029 . . . . 0.0 111.238 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.6 t -77.95 -32.23 51.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.726 -1.234 . . . . 0.0 110.355 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -101.97 -18.33 15.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.059 -1.026 . . . . 0.0 109.781 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLN . 3.2 m -140.17 -179.38 5.95 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.221 -0.925 . . . . 0.0 109.235 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.5 mm -78.16 173.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 108.921 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.5 m -152.11 167.45 28.46 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.197 -0.94 . . . . 0.0 109.559 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.97 163.42 12.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 109.338 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.42 -35.07 27.95 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.29 -26.26 66.37 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.729 1.252 . . . . 0.0 108.27 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.444 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 6.5 tt0 -74.69 -23.01 58.56 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.452 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.885 ' CD1' ' CZ ' ' A' ' 1' ' ' PHE . 57.4 mt -84.93 -36.75 21.23 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.75 -19.31 49.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.548 -0.72 . . . . 0.0 110.156 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -84.02 -8.51 59.12 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -90.03 -37.79 14.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.514 -0.741 . . . . 0.0 109.744 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.421 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 3.2 m -49.92 109.24 0.27 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.413 -0.804 . . . . 0.0 109.587 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.421 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 33.3 t-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.576 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 1.106 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 1.5 t80 . . . . . 0 C--O 1.174 -2.92 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.678 ' CG1' ' O ' ' A' ' 1' ' ' PHE . 16.7 m -166.79 -30.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 118.95 -2.344 . . . . 0.0 107.715 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 2' ' ' VAL . 22.4 m-80 -175.22 -102.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.586 HE22 ' CG2' ' A' ' 2' ' ' VAL . 0.1 OUTLIER 33.81 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.265 1.031 . . . . 0.0 112.879 179.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 16.8 p-80 -101.37 110.96 23.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.764 -0.585 . . . . 0.0 109.778 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.533 ' C ' ' CE1' ' A' ' 10' ' ' HIS . 0.3 OUTLIER -102.02 104.02 14.66 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.729 ' N ' ' CE1' ' A' ' 10' ' ' HIS . 17.0 m -122.0 115.35 22.37 Favored 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.59 -141.16 15.86 Favored Glycine 0 N--CA 1.507 3.426 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 12' ' ' VAL . 7.4 p -87.23 -27.32 23.03 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 120.712 -1.463 . . . . 0.0 113.783 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 1.119 ' HD1' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -45.34 -22.66 0.14 Allowed 'General case' 0 N--CA 1.527 3.395 0 CA-C-N 121.525 1.966 . . . . 0.0 106.453 178.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 1.119 ' N ' ' HD1' ' A' ' 10' ' ' HIS . 32.9 tp -79.46 -51.34 9.48 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 9' ' ' SER . 41.4 t -49.77 -53.39 10.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.3 tt0 -49.78 -59.4 3.86 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -44.53 -61.6 1.49 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.466 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 14.6 mt -46.43 -47.95 18.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.57 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.37 -55.15 31.52 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.452 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.89 HD11 ' CE1' ' A' ' 1' ' ' PHE . 31.7 mt -47.41 -62.17 1.56 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.156 0.979 . . . . 0.0 110.64 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.17 -26.6 34.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.88 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 58.6 m -97.75 1.47 48.47 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.229 -0.919 . . . . 0.0 110.723 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 48.47 -152.2 2.57 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' GLY . 43.5 tt0 -83.58 -15.05 50.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -1.138 . . . . 0.0 109.915 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.523 ' H ' ' CD ' ' A' ' 22' ' ' ARG . 7.7 mpt_? -42.84 -18.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.679 -0.638 . . . . 0.0 110.438 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 95.04 138.54 9.59 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.438 ' CZ ' HG12 ' A' ' 12' ' ' VAL . 26.6 p90 -129.29 178.0 6.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.65 -0.912 . . . . 0.0 109.047 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 55' ' ' TYR . 51.9 m-85 -104.71 132.53 50.85 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.064 -1.022 . . . . 0.0 111.244 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -175.91 -143.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 10.2 t -172.49 -151.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.06 -1.025 . . . . 0.0 109.776 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.439 ' N ' ' OG1' ' A' ' 27' ' ' THR . 0.4 OUTLIER -112.45 165.24 13.43 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 31' ' ' GLU . 10.8 Cg_endo -73.85 -75.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.291 -2.485 0 C-N-CA 122.457 2.105 . . . . 0.0 111.087 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.35 -25.93 0.16 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' PRO . 4.1 mm-40 -94.43 86.11 4.77 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.12 96.89 0.1 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.155 -0.966 . . . . 0.0 111.369 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.664 ' N ' ' CD ' ' A' ' 34' ' ' PRO . . . -151.24 45.06 0.65 Allowed Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.508 -1.806 . . . . 0.0 111.218 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 30.9 Cg_endo -61.8 170.35 5.99 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 124.833 3.688 . . . . 0.0 112.757 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.432 ' HD3' HH21 ' A' ' 35' ' ' ARG . 3.6 ttm180 -86.52 -16.11 37.95 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.605 ' HE ' ' HG2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 69.02 53.67 0.47 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.546 -0.721 . . . . 0.0 110.026 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.4 -60.02 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 18.2 tt -69.99 -47.54 68.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.72 -0.871 . . . . 0.0 110.117 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.552 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 43.9 t -62.7 -61.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 121.723 -0.61 . . . . 0.0 111.101 -177.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.584 ' OE2' ' NH2' ' A' ' 36' ' ' ARG . 18.1 mt-10 -49.61 -26.54 3.69 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.393 -0.817 . . . . 0.0 110.11 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -94.56 -61.44 1.51 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.956 -1.09 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.435 ' O ' ' O ' ' A' ' 45' ' ' SER . 59.6 m -59.31 -28.74 67.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.31 -0.869 . . . . 0.0 110.466 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.9 t -85.61 -54.51 4.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.767 -1.208 . . . . 0.0 110.499 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.535 ' H ' ' HD1' ' A' ' 44' ' ' HIS . 3.1 m80 -71.37 -15.68 62.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.816 -1.177 . . . . 0.0 109.413 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 t -140.37 178.88 6.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.4 mm -64.6 163.74 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 9.0 t -108.55 140.43 41.91 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.237 -0.914 . . . . 0.0 111.169 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 m -98.65 145.37 26.94 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 tp -82.22 -40.97 20.91 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -54.09 -26.59 27.91 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 122.796 1.284 . . . . 0.0 108.478 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.526 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 0.9 OUTLIER -78.81 -23.68 45.0 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.34 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.505 ' CD2' HE22 ' A' ' 51' ' ' GLN . 28.6 mt -84.82 -25.82 27.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.709 -1.244 . . . . 0.0 108.859 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -67.79 -19.19 65.07 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.582 -0.699 . . . . 0.0 111.189 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 15.7 p30 -88.32 -8.35 55.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.917 -1.114 . . . . 0.0 108.014 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.508 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 4.6 m-85 -85.3 -27.14 26.15 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.7 0.762 . . . . 0.0 109.201 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.456 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 3.2 m -67.99 110.92 4.12 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.432 -0.792 . . . . 0.0 110.115 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.456 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 5.4 m120 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.983 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.831 ' CG ' ' O ' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.436 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.408 ' O ' ' CG ' ' A' ' 3' ' ' ASN . 7.1 p -79.91 -42.35 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.341 -1.474 . . . . 0.0 108.48 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 4' ' ' GLN . 11.6 m120 -168.54 -98.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.542 ' O ' ' O ' ' A' ' 3' ' ' ASN . 5.1 pt20 32.22 -166.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 122.342 1.067 . . . . 0.0 112.992 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -98.14 146.47 25.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.0 109.01 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 1' ' ' PHE . 1.2 tp -132.8 108.92 9.29 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 t -117.14 145.75 43.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.516 -0.74 . . . . 0.0 109.057 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 10' ' ' HIS . . . 82.01 177.39 51.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 10' ' ' HIS . 2.6 p -54.16 -10.55 0.37 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.556 -1.555 . . . . 0.0 109.14 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 8' ' ' GLY . 40.2 m80 -52.24 -29.38 22.52 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 177.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.407 ' N ' ' C ' ' A' ' 9' ' ' SER . 10.9 tp -74.74 -49.36 21.28 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 13' ' ' GLU . 5.0 t -49.89 -41.43 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 20.6 tt0 -47.69 -59.25 3.42 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.608 -177.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.62 -61.11 1.84 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.62 ' O ' ' N ' ' A' ' 19' ' ' CYS . 7.1 mt -46.32 -44.97 17.2 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.556 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.96 -50.9 69.51 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.691 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 19.5 mt -52.02 -62.75 1.44 Allowed 'General case' 0 C--N 1.291 -1.96 0 O-C-N 120.998 -1.064 . . . . 0.0 109.866 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -58.21 6.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.578 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.62 ' N ' ' O ' ' A' ' 15' ' ' LEU . 82.7 m -86.26 34.18 0.63 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.977 -1.077 . . . . 0.0 110.526 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . -54.7 -111.98 0.01 OUTLIER Glycine 0 N--CA 1.499 2.851 0 O-C-N 120.889 -1.132 . . . . 0.0 111.329 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -43.86 -15.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -1.053 . . . . 0.0 110.582 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 20' ' ' GLY . 3.9 mmp_? -74.58 -40.13 61.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.987 -1.07 . . . . 0.0 109.73 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.07 137.37 9.78 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -138.81 -173.33 3.53 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -154.43 118.54 4.73 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 119.928 -1.733 . . . . 0.0 112.607 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 27' ' ' THR . 32.4 m-85 -146.53 108.84 4.45 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.627 ' HG1' ' N ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -55.35 -166.12 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.148 -0.97 . . . . 0.0 109.799 -179.095 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.682 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -48.38 -172.04 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 28' ' ' ASP . 28.3 Cg_endo -85.89 -5.96 8.69 Favored 'Trans proline' 0 C--N 1.295 -2.256 0 C-N-CA 124.161 3.241 . . . . 0.0 111.308 174.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.694 ' OG1' ' N ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -145.19 -140.72 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.694 ' N ' ' OG1' ' A' ' 30' ' ' THR . 1.2 mt-10 65.1 92.07 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.126 -1.609 . . . . 0.0 108.897 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 59.21 -69.83 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.934 -0.479 . . . . 0.0 110.675 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 36' ' ' ARG . . . 168.41 169.53 31.98 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 117.765 -2.159 . . . . 0.0 112.575 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.435 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 59.1 Cg_endo -79.13 -125.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 124.346 3.364 . . . . 0.0 113.234 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.435 ' H ' ' HB2' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -94.57 -16.52 23.18 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.891 0.853 . . . . 0.0 108.904 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.533 ' CZ ' ' HA3' ' A' ' 33' ' ' GLY . 1.8 mpt_? 61.29 45.63 8.58 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.73 -83.95 0.05 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 117.285 -2.388 . . . . 0.0 109.012 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 4.8 tt -48.7 -38.74 10.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.752 -0.852 . . . . 0.0 110.371 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.458 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 39.3 t -72.87 -61.16 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.436 0.636 . . . . 0.0 111.013 -178.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -52.25 -27.07 13.54 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -93.46 -34.95 13.21 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.055 -1.028 . . . . 0.0 109.525 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' SER . 50.1 t -83.28 -49.96 8.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.721 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 39' ' ' VAL . 44.2 t -64.29 -23.94 67.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 110.018 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -102.72 -29.18 11.66 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.168 -0.957 . . . . 0.0 110.068 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 t -134.3 -172.98 3.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.375 -0.828 . . . . 0.0 109.794 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.8 mm -65.95 175.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -137.21 141.65 42.1 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.027 -1.046 . . . . 0.0 110.063 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -93.43 151.08 19.97 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 tp -83.12 -42.08 17.79 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -55.84 -25.11 40.4 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 123.017 1.389 . . . . 0.0 107.925 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.486 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 7.6 tt0 -78.69 -23.35 45.66 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.102 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.1 mt -85.36 -36.36 20.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.454 -1.404 . . . . 0.0 108.497 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -58.11 -19.57 33.38 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.645 -0.66 . . . . 0.0 110.948 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -88.03 -7.97 56.27 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.072 -1.017 . . . . 0.0 108.792 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.486 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 5.7 m-85 -88.72 -25.59 22.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.529 -0.732 . . . . 0.0 110.636 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.8 110.61 0.37 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.07 -1.019 . . . . 0.0 109.629 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 t30 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.475 179.909 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.592 ' O ' ' N ' ' A' ' 3' ' ' ASN . 23.4 p90 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.4 p -53.25 89.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 119.936 -1.727 . . . . 0.0 108.97 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 1' ' ' PHE . 1.6 m120 47.0 -132.17 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.645 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.02 166.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 109.646 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -76.73 142.19 40.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.643 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.68 124.89 34.69 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.3 m -128.05 -176.84 3.91 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.541 -0.724 . . . . 0.0 109.085 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.6 -151.44 1.07 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.452 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -77.12 -13.32 59.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.039 -1.271 . . . . 0.0 109.151 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -51.73 -23.73 4.91 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.452 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.8 tp -81.74 -50.94 8.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 13' ' ' GLU . 22.5 t -46.26 -47.91 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.74 0.781 . . . . 0.0 108.979 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.483 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.5 tt0 -48.06 -59.71 3.17 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.579 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -44.72 -62.24 1.28 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 14.6 mt -44.94 -44.38 9.72 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -57.67 -49.71 75.6 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 29.1 mt -53.94 -62.84 1.39 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.117 0.96 . . . . 0.0 110.942 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 m -62.43 -37.17 78.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.955 -177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.1 t -81.23 -22.22 38.95 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.026 -1.046 . . . . 0.0 109.881 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 67.56 -146.66 47.49 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 23' ' ' GLY . 19.1 mt-10 -83.1 -1.72 53.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 0.0 109.363 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -61.92 1.69 0.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 110.033 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 64.73 120.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.47 ' CD2' ' N ' ' A' ' 24' ' ' PHE . 13.8 p90 -99.63 171.69 7.76 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.542 -0.975 . . . . 0.0 109.62 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -104.59 119.6 39.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.503 -0.748 . . . . 0.0 109.732 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.488 ' C ' ' HG1' ' A' ' 27' ' ' THR . 46.2 t80 -152.54 4.14 0.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.277 -0.89 . . . . 0.0 108.76 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.488 ' HG1' ' C ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER 60.53 175.28 0.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.507 -0.746 . . . . 0.0 109.787 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.67 165.63 0.29 Allowed Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.9 -15.04 45.98 Favored 'Trans proline' 0 C--N 1.288 -2.645 0 C-N-CA 122.214 1.942 . . . . 0.0 110.239 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 30' ' ' THR . 1.8 t -136.89 129.05 29.62 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.472 ' HG2' ' C ' ' A' ' 30' ' ' THR . 35.9 mm-40 -171.78 167.23 6.41 Favored 'General case' 0 CA--C 1.586 2.354 0 CA-C-O 123.101 1.429 . . . . 0.0 111.868 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.16 48.98 0.82 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.092 -1.63 . . . . 0.0 111.306 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.654 ' C ' ' H ' ' A' ' 35' ' ' ARG . . . 175.09 41.42 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.675 -1.726 . . . . 0.0 110.842 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 73.0 Cg_endo -66.74 29.31 0.11 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 123.168 2.578 . . . . 0.0 110.127 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.733 ' O ' ' N ' ' A' ' 37' ' ' GLY . 12.6 ttm-85 69.53 -8.6 0.73 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.639 ' H ' ' C ' ' A' ' 34' ' ' PRO . 11.0 mmt180 32.69 27.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.733 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -106.64 -67.56 0.67 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.532 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 9.2 tt -62.12 -41.24 90.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 122.118 0.961 . . . . 0.0 109.821 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.52 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 45.2 t -65.39 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 O-C-N 121.678 -0.639 . . . . 0.0 111.403 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 36' ' ' ARG . 20.1 mt-10 -60.93 -22.04 64.0 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.033 -1.042 . . . . 0.0 110.31 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -93.31 -37.84 11.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.852 -1.155 . . . . 0.0 110.345 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 28.9 m -88.59 -36.84 16.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.076 -1.015 . . . . 0.0 110.344 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.9 t -76.36 -37.16 57.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.863 -1.148 . . . . 0.0 109.98 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -91.71 -22.29 20.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.0 -1.063 . . . . 0.0 109.395 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 42' ' ' CYS . 2.7 m -140.37 -174.52 3.97 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.241 -0.912 . . . . 0.0 109.36 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.9 mm -83.53 174.14 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.864 . . . . 0.0 108.99 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 m -151.05 167.83 26.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.002 -1.061 . . . . 0.0 110.069 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.71 163.73 12.35 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.624 0.726 . . . . 0.0 109.352 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.04 -31.56 30.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.61 -27.3 68.3 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.676 1.227 . . . . 0.0 108.53 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.43 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 12.1 tt0 -71.55 -24.51 61.95 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.433 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.2 mt -84.78 -34.02 22.87 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -62.57 -18.85 62.95 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.495 -0.753 . . . . 0.0 109.911 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.2 m-20 -82.85 -8.93 59.54 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.4 m-85 -91.6 -28.74 17.33 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.61 0.719 . . . . 0.0 109.394 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 35.5 t -68.77 112.48 5.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.394 -0.816 . . . . 0.0 109.703 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 t30 . . . . . 0 C--N 1.291 -1.973 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.491 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.953 ' CE1' HD11 ' A' ' 17' ' ' LEU . 6.0 p90 . . . . . 0 C--O 1.206 -1.196 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 3' ' ' ASN . 87.1 t -145.94 91.2 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 118.524 0.602 . . . . 0.0 110.0 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 2' ' ' VAL . 1.7 m120 40.01 51.56 2.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.689 -0.632 . . . . 0.0 110.162 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.8 161.05 35.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.491 -0.756 . . . . 0.0 110.006 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 0.3 OUTLIER -50.43 124.93 11.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 110.334 -179.254 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.25 109.69 9.59 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.3 m -121.92 -177.88 3.7 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.32 -150.96 2.98 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.1 p -77.25 -12.64 59.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.952 -1.323 . . . . 0.0 109.135 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -51.63 -25.17 6.56 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.434 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.6 tp -81.31 -49.68 10.42 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 13' ' ' GLU . 19.4 t -46.53 -46.48 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.491 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 35.7 tt0 -47.83 -59.69 3.13 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.429 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.02 -61.39 1.65 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.1 mt -45.86 -45.05 14.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.553 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.79 -49.81 74.22 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.953 HD11 ' CE1' ' A' ' 1' ' ' PHE . 29.1 mt -54.19 -62.42 1.67 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.098 0.951 . . . . 0.0 110.821 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.36 -36.75 78.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.169 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 41.9 t -80.55 -22.57 40.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.844 -1.16 . . . . 0.0 110.002 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 68.29 -146.05 45.3 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 23' ' ' GLY . 1.8 mp0 -83.23 -17.13 43.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.16 -1.2 . . . . 0.0 109.211 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -45.56 -13.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.776 -0.577 . . . . 0.0 110.352 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 81.17 130.74 1.09 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -116.43 149.42 39.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.677 -0.896 . . . . 0.0 109.27 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -85.48 116.57 23.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.145 -0.972 . . . . 0.0 110.015 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -161.48 -11.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.445 ' CG2' ' H ' ' A' ' 28' ' ' ASP . 1.8 m 58.03 -140.43 0.78 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 109.69 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.445 ' H ' ' CG2' ' A' ' 27' ' ' THR . 0.4 OUTLIER -103.09 167.07 10.76 Favored Pre-proline 0 N--CA 1.487 1.412 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.44 -19.62 19.14 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 123.007 2.471 . . . . 0.0 110.285 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -111.19 -128.92 0.29 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.908 -179.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.41 ' H ' ' HB ' ' A' ' 30' ' ' THR . 1.4 mt-10 60.35 -80.76 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -159.03 155.42 27.42 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.425 -1.31 . . . . 0.0 112.058 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.485 ' HA2' ' HD2' ' A' ' 34' ' ' PRO . . . -37.36 109.1 0.08 OUTLIER Glycine 0 N--CA 1.492 2.408 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.114 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.872 ' O ' ' N ' ' A' ' 36' ' ' ARG . 15.0 Cg_endo -50.35 -176.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 124.084 3.189 . . . . 0.0 112.914 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 34' ' ' PRO . 1.3 ttm180 -19.07 -31.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.836 -0.54 . . . . 0.0 111.967 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.872 ' N ' ' O ' ' A' ' 34' ' ' PRO . 1.8 tpp180 72.17 31.72 1.88 Allowed 'General case' 0 N--CA 1.511 2.578 0 O-C-N 120.555 -1.34 . . . . 0.0 107.825 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.54 -63.01 0.01 OUTLIER Glycine 0 C--N 1.274 -2.915 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 5.4 tt -67.43 -39.3 82.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 122.106 0.955 . . . . 0.0 109.699 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.777 HG22 ' CG ' ' A' ' 34' ' ' PRO . 45.0 t -70.35 -61.87 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.74 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.87 -21.85 32.58 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.405 -0.81 . . . . 0.0 109.717 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -94.24 -49.22 5.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.158 -0.964 . . . . 0.0 110.699 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' SER . 3.0 t -80.03 -29.99 39.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.82 -1.175 . . . . 0.0 111.013 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.4 t -78.61 -49.67 12.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.658 -1.276 . . . . 0.0 109.708 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -80.94 -23.08 39.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.046 -1.034 . . . . 0.0 109.349 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 m -139.96 -173.04 3.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.305 -0.872 . . . . 0.0 108.951 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 mm -86.5 168.33 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.174 -0.954 . . . . 0.0 108.791 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 23.1 p -149.45 161.08 42.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.07 -1.019 . . . . 0.0 109.259 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.93 164.85 14.4 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.083 0.945 . . . . 0.0 111.079 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.74 -36.92 25.34 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.91 -26.3 62.01 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 122.757 1.265 . . . . 0.0 108.094 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.528 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 6.5 tt0 -76.49 -22.53 54.37 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.736 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.7 mt -85.28 -30.9 23.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.861 -1.15 . . . . 0.0 108.235 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -64.2 -19.29 65.24 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.564 -0.71 . . . . 0.0 111.049 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 14.8 p30 -87.51 -8.57 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.926 -1.109 . . . . 0.0 108.045 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.482 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 4.9 m-85 -84.78 -28.69 26.0 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.3 t -68.48 112.31 5.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.444 -0.785 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--N 1.29 -1.992 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.445 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.742 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.476 0.655 . . . . 0.0 109.815 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 4' ' ' GLN . 3.3 t 54.88 48.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.267 0.556 . . . . 0.0 110.021 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 4' ' ' GLN . 22.2 m-80 56.68 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.107 -0.996 . . . . 0.0 110.28 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 3' ' ' ASN . 5.8 pt20 35.43 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.69 -0.631 . . . . 0.0 111.498 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 51.8 p-80 -90.86 123.9 34.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.126 -0.984 . . . . 0.0 109.612 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.88 116.75 19.12 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.6 m -122.41 -176.91 3.48 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.542 -0.724 . . . . 0.0 109.123 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 44.02 -149.21 0.87 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.506 ' H ' ' HG ' ' A' ' 9' ' ' SER . 2.2 p -80.81 -9.48 59.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.942 -1.328 . . . . 0.0 108.865 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 9' ' ' SER . 50.6 m80 -52.29 -24.63 7.74 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.458 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.0 tp -77.76 -53.82 7.07 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 13' ' ' GLU . 5.0 t -46.55 -42.56 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.6 tt0 -46.84 -59.21 3.22 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.635 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.37 -61.42 1.68 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 19' ' ' CYS . 7.1 mt -46.14 -48.41 17.37 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -51.24 -48.47 62.13 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.626 HD12 ' CE1' ' A' ' 1' ' ' PHE . 19.6 mt -57.31 -63.66 1.15 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.168 -0.957 . . . . 0.0 110.532 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -64.55 -47.59 88.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.965 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.533 ' N ' ' O ' ' A' ' 15' ' ' LEU . 67.0 m -73.05 -20.81 60.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.908 -1.12 . . . . 0.0 109.756 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 42.55 -125.74 4.33 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -83.63 -15.2 49.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -1.015 . . . . 0.0 110.077 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -46.73 -29.12 1.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.103 -0.998 . . . . 0.0 109.481 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.45 127.54 4.29 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.705 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CD1' ' C ' ' A' ' 24' ' ' PHE . 29.1 p90 -132.83 176.29 8.6 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -154.01 125.75 7.66 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 119.589 -1.944 . . . . 0.0 112.527 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.421 ' CE2' ' CD1' ' A' ' 15' ' ' LEU . 20.3 m-85 -141.33 -179.93 6.41 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.588 HG22 ' CB ' ' A' ' 31' ' ' GLU . 1.4 m -152.35 171.88 17.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.001 -1.062 . . . . 0.0 109.629 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.454 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -74.64 164.77 59.02 Favored Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 121.493 -0.755 . . . . 0.0 108.969 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 28' ' ' ASP . 16.8 Cg_endo -53.93 -34.74 77.74 Favored 'Trans proline' 0 C--N 1.276 -3.27 0 C-N-CA 123.7 2.933 . . . . 0.0 111.559 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.896 ' C ' ' H ' ' A' ' 32' ' ' GLU . 14.3 t -102.54 -34.17 9.21 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.45 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.645 ' N ' HG23 ' A' ' 30' ' ' THR . 46.7 mm-40 -62.28 10.19 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.896 ' H ' ' C ' ' A' ' 30' ' ' THR . 0.4 OUTLIER 106.99 123.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.708 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 32' ' ' GLU . . . -48.01 156.46 1.04 Allowed Glycine 0 N--CA 1.478 1.481 0 N-CA-C 107.261 -2.335 . . . . 0.0 107.261 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 36' ' ' ARG . 42.7 Cg_endo -94.73 -147.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.288 -2.641 0 C-N-CA 123.34 2.694 . . . . 0.0 111.595 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.71 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.4 OUTLIER -63.07 84.06 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.5 -1.375 . . . . 0.0 109.004 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.574 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -47.22 110.73 0.33 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 158.2 -89.83 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -176.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.554 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 6.3 tt -46.9 -40.26 4.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 122.009 0.909 . . . . 0.0 109.982 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.498 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 47.1 t -69.45 -61.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 O-C-N 121.298 -0.876 . . . . 0.0 110.308 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.457 ' HG3' ' HD2' ' A' ' 36' ' ' ARG . 42.6 mt-10 -62.53 -19.42 63.62 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.141 -0.974 . . . . 0.0 109.724 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -94.18 -39.31 10.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.082 -1.011 . . . . 0.0 110.088 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 33.7 m -88.47 -40.43 13.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.967 -1.083 . . . . 0.0 110.365 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.0 t -71.02 -25.77 62.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.792 -1.192 . . . . 0.0 109.541 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -102.95 -25.88 13.3 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.334 -0.854 . . . . 0.0 109.195 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -137.41 -168.06 2.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.404 -0.81 . . . . 0.0 108.964 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.2 mm -94.98 169.95 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.131 -0.98 . . . . 0.0 109.499 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 98.3 m -149.21 167.85 24.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.088 -1.008 . . . . 0.0 110.104 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.21 165.24 12.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.831 . . . . 0.0 109.521 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.67 -35.24 27.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.17 -25.28 65.42 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.756 1.265 . . . . 0.0 108.238 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.474 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 14.1 tt0 -75.81 -22.41 56.36 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.545 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -84.42 -33.29 23.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.852 -1.155 . . . . 0.0 107.983 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -64.19 -17.88 63.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.624 -0.672 . . . . 0.0 110.319 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -86.48 -8.41 57.61 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 108.607 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.524 ' CE2' ' HD3' ' A' ' 35' ' ' ARG . 5.0 m-85 -88.12 -39.85 14.24 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.765 0.793 . . . . 0.0 109.606 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.99 110.15 0.36 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.549 -0.719 . . . . 0.0 109.636 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.7 t30 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.485 179.916 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.794 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 1.2 t80 . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.236 0.541 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER 39.65 -96.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.272 -1.517 . . . . 0.0 110.792 176.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.51 ' O ' ' O ' ' A' ' 4' ' ' GLN . 23.7 m-20 -139.06 -43.63 0.47 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.882 -1.136 . . . . 0.0 109.85 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.51 ' O ' ' O ' ' A' ' 3' ' ' ASN . 2.4 pt20 -18.28 143.55 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.674 ' H ' ' HD1' ' A' ' 5' ' ' HIS . 3.2 p-80 -46.21 141.98 3.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.692 . . . . 0.0 110.284 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.726 HD22 ' CE1' ' A' ' 1' ' ' PHE . 0.7 OUTLIER -131.1 109.96 10.84 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.8 m -114.87 146.1 41.47 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.32 -0.862 . . . . 0.0 109.106 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.61 -175.57 54.84 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.9 p -56.05 -15.07 3.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.984 -1.304 . . . . 0.0 109.115 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -52.12 -24.16 6.53 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' A' ' 9' ' ' SER . 15.0 tp -81.83 -47.64 12.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.419 HG11 ' CZ ' ' A' ' 24' ' ' PHE . 24.4 t -49.66 -46.66 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.8 tt0 -48.7 -59.97 3.11 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.484 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.794 ' HB1' ' CE2' ' A' ' 1' ' ' PHE . . . -44.45 -60.66 1.85 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.7 mt -45.81 -51.38 12.93 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -50.03 -50.95 45.88 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 27.0 mt -53.65 -62.33 1.72 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.179 0.99 . . . . 0.0 111.299 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.27 -40.71 83.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.662 -176.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.647 ' O ' ' NH2' ' A' ' 22' ' ' ARG . 95.4 m -78.31 -28.44 47.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.72 -1.238 . . . . 0.0 112.581 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.709 ' C ' HH22 ' A' ' 22' ' ' ARG . . . 86.89 -150.2 22.86 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.314 -1.422 . . . . 0.0 111.046 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 23' ' ' GLY . 30.6 tt0 -87.8 -18.72 28.72 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.63 -0.923 . . . . 0.0 113.338 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.715 ' NH1' ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -43.12 -15.07 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 O-C-N 120.798 -1.189 . . . . 0.0 110.932 -177.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.715 ' H ' ' NH1' ' A' ' 22' ' ' ARG . . . 85.8 93.43 0.83 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.683 ' N ' HH11 ' A' ' 22' ' ' ARG . 29.9 p90 -76.88 161.58 28.3 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.305 -1.115 . . . . 0.0 109.383 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.623 ' CB ' ' NH1' ' A' ' 35' ' ' ARG . 60.5 m-85 -89.9 132.69 35.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.303 -0.873 . . . . 0.0 110.631 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -173.16 -22.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.72 168.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.489 -0.757 . . . . 0.0 110.012 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -85.51 163.64 43.68 Favored Pre-proline 0 N--CA 1.485 1.316 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.829 ' O ' ' C ' ' A' ' 30' ' ' THR . 1.2 Cg_endo -48.24 -134.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 124.76 3.64 . . . . 0.0 113.099 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.829 ' C ' ' O ' ' A' ' 29' ' ' PRO . 69.2 p 9.95 -119.79 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.49 1.138 . . . . 0.0 108.278 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.743 ' C ' ' O ' ' A' ' 30' ' ' THR . 8.5 mt-10 3.07 90.11 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.215 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 2.4 mt-10 46.58 -129.61 1.4 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.535 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 32' ' ' GLU . . . -149.69 -173.16 19.9 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.169 -177.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.502 ' HG3' HG22 ' A' ' 39' ' ' VAL . 72.5 Cg_endo -67.84 -126.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 124.163 3.242 . . . . 0.0 111.124 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.766 ' O ' ' O ' ' A' ' 36' ' ' ARG . 12.5 ttm180 -110.91 14.7 22.05 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.766 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 45.37 110.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.86 -67.32 0.36 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 116.138 -2.934 . . . . 0.0 107.745 -176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.551 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 7.3 tt -67.78 -44.61 85.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.805 0.812 . . . . 0.0 109.348 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.551 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 44.4 t -65.53 -61.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.425 0.631 . . . . 0.0 111.078 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.537 ' OE2' ' HG3' ' A' ' 36' ' ' ARG . 3.0 mt-10 -51.7 -26.42 9.26 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.658 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 45' ' ' SER . 17.8 tt0 -93.96 -61.21 1.58 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.122 -0.986 . . . . 0.0 110.414 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 45' ' ' SER . 98.0 m -58.36 -37.0 74.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.139 -0.976 . . . . 0.0 110.652 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.19 -38.54 31.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.903 -1.123 . . . . 0.0 110.516 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -86.99 -17.31 33.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.838 -1.164 . . . . 0.0 109.249 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 41' ' ' GLN . 7.9 t -140.42 -164.89 1.81 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.432 -0.792 . . . . 0.0 109.071 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 47' ' ' CYS . 4.5 mm -76.46 167.4 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.082 -1.011 . . . . 0.0 109.328 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.421 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 4.5 t -121.15 139.14 53.76 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.451 -0.781 . . . . 0.0 110.381 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -101.15 150.88 22.48 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 tp -82.34 -38.52 24.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.479 1.133 . . . . 0.0 108.038 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.53 -24.24 60.15 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 123.005 1.383 . . . . 0.0 108.199 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.729 HE21 HD22 ' A' ' 54' ' ' ASN . 6.5 tp60 -79.8 -24.62 41.29 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.033 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.739 HD11 ' CZ ' ' A' ' 1' ' ' PHE . 33.9 mt -85.3 -30.99 23.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.494 -1.379 . . . . 0.0 109.107 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -62.32 -20.81 64.73 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.682 -0.637 . . . . 0.0 111.549 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.729 HD22 HE21 ' A' ' 51' ' ' GLN . 15.6 p30 -88.53 -7.79 55.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.823 -1.173 . . . . 0.0 108.838 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.493 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 5.1 m-85 -83.72 -9.79 58.59 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.671 0.748 . . . . 0.0 109.465 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.429 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -91.42 115.82 28.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.569 -0.707 . . . . 0.0 109.351 -179.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.429 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 55.9 t-20 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.026 -1.046 . . . . 0.0 109.282 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.686 ' C ' ' CD1' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.728 0.299 . . . . 0.0 110.687 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 4' ' ' GLN . 14.0 p -66.02 163.62 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 119.967 -1.708 . . . . 0.0 108.708 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -49.04 98.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.04 -1.038 . . . . 0.0 109.531 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 2' ' ' VAL . 1.8 pt20 -159.03 -163.94 1.32 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.841 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -89.86 131.2 35.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.743 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.93 109.65 11.79 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.5 m -118.58 152.59 35.73 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.523 -0.736 . . . . 0.0 109.248 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.57 -163.24 54.34 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.456 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -66.47 -14.63 62.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.864 -1.374 . . . . 0.0 109.261 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' SER . 4.5 m-70 -51.18 -24.67 4.43 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.456 ' N ' ' C ' ' A' ' 9' ' ' SER . 14.1 tp -81.86 -46.67 13.8 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' A' ' 9' ' ' SER . 18.7 t -50.15 -46.15 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 20.7 tt0 -49.16 -59.72 3.41 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.446 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 15' ' ' LEU . . . -44.43 -60.67 1.84 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.2 mt -45.38 -53.68 8.3 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.554 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -47.75 -49.62 27.8 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 26.4 mt -56.01 -62.59 1.6 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.106 0.955 . . . . 0.0 111.304 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.56 -48.12 77.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.643 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.501 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 30.9 m -73.86 -26.48 60.59 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.868 -1.145 . . . . 0.0 112.787 -175.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' C ' ' HE ' ' A' ' 22' ' ' ARG . . . 85.15 -161.21 35.71 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 119.473 -2.017 . . . . 0.0 111.156 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.57 ' C ' ' H ' ' A' ' 23' ' ' GLY . 11.8 mt-10 -86.85 -13.26 45.48 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -177.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.704 ' NE ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.66 0.1 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 119.513 -1.992 . . . . 0.0 110.712 -178.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.594 ' N ' ' CZ ' ' A' ' 22' ' ' ARG . . . 88.52 113.48 1.21 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.68 ' N ' HH12 ' A' ' 22' ' ' ARG . 26.9 p90 -98.45 141.83 30.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -1.024 . . . . 0.0 109.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.33 126.75 30.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.516 -0.74 . . . . 0.0 110.33 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 27' ' ' THR . 53.9 t80 -173.14 -22.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.595 -0.69 . . . . 0.0 109.164 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.615 ' CG2' ' H ' ' A' ' 28' ' ' ASP . 56.6 m 49.29 -176.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.179 -0.951 . . . . 0.0 109.548 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.615 ' H ' ' CG2' ' A' ' 27' ' ' THR . 0.3 OUTLIER -50.6 -171.91 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.338 -0.852 . . . . 0.0 108.94 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.551 ' CD ' ' H ' ' A' ' 30' ' ' THR . 76.9 Cg_endo -92.36 -34.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.261 2.64 . . . . 0.0 108.913 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.945 ' CG2' ' H ' ' A' ' 31' ' ' GLU . 3.8 t -66.6 -92.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.68 1.228 . . . . 0.0 109.539 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.945 ' H ' ' CG2' ' A' ' 30' ' ' THR . 9.5 tp10 57.76 5.39 0.34 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.338 -1.476 . . . . 0.0 108.394 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.62 ' HG2' ' C ' ' A' ' 31' ' ' GLU . 2.6 pt-20 43.13 35.87 0.88 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.197 -0.939 . . . . 0.0 108.696 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.12 98.87 2.56 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.464 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 30.2 Cg_endo -87.38 -117.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.683 2.922 . . . . 0.0 112.439 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.628 ' O ' ' C ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -82.09 -13.91 56.59 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.212 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.677 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER 34.66 70.22 0.14 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.88 -83.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 CA-C-N 113.482 -1.69 . . . . 0.0 109.008 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.536 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 6.3 tt -55.31 -42.4 66.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.721 -0.87 . . . . 0.0 110.145 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.536 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 42.2 t -63.93 -60.68 2.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.306 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.677 ' OE2' ' HD2' ' A' ' 36' ' ' ARG . 38.7 mt-10 -59.23 -20.11 51.33 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.215 -0.928 . . . . 0.0 109.872 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -94.58 -36.18 11.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.042 -1.037 . . . . 0.0 110.021 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 45' ' ' SER . 92.2 m -88.46 -38.17 15.22 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.232 -0.917 . . . . 0.0 110.537 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.5 t -77.86 -44.92 25.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -0.996 . . . . 0.0 110.597 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -82.76 -20.35 36.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.992 -1.068 . . . . 0.0 109.822 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.8 m -140.38 -171.85 3.3 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.271 -0.893 . . . . 0.0 109.61 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.5 mm -64.85 170.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 108.97 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.3 t -128.19 122.51 32.02 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.459 -0.775 . . . . 0.0 110.157 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.5 m -79.75 146.72 32.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 108.728 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 tp -82.34 -40.5 21.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -57.15 -25.62 59.21 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.979 1.371 . . . . 0.0 108.147 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.477 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 7.0 tt0 -77.62 -24.12 49.66 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.933 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.3 mt -84.68 -29.48 25.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.777 -1.202 . . . . 0.0 108.487 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -64.6 -19.35 65.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.756 -0.59 . . . . 0.0 111.058 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -88.31 -7.24 57.05 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.027 -1.046 . . . . 0.0 109.188 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.477 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 5.1 m-85 -86.6 -6.72 58.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.579 -0.701 . . . . 0.0 111.147 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.87 113.86 20.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.148 -0.97 . . . . 0.0 110.314 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.4 t30 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.842 -179.932 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.621 ' H1 ' ' NE2' ' A' ' 4' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.62 ' C ' ' O ' ' A' ' 1' ' ' PHE . 0.8 OUTLIER 32.23 -153.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 118.655 -2.528 . . . . 0.0 110.643 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.49 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 1.6 m120 -101.74 93.95 5.59 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.053 -1.03 . . . . 0.0 109.551 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.621 ' NE2' ' H1 ' ' A' ' 1' ' ' PHE . 16.4 pt20 -152.5 -178.81 7.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.217 -0.927 . . . . 0.0 109.26 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -75.54 133.2 41.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.999 -1.063 . . . . 0.0 109.378 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.95 120.01 24.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.7 m -127.18 -178.26 4.37 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.448 -0.782 . . . . 0.0 109.207 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.56 -149.05 2.29 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.439 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.4 p -77.97 -14.12 59.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.026 -1.279 . . . . 0.0 109.241 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -51.86 -24.07 5.69 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.439 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.7 tp -81.56 -51.14 8.56 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 13' ' ' GLU . 24.6 t -45.44 -46.77 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.697 0.761 . . . . 0.0 108.988 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.491 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 35.8 tt0 -47.89 -59.81 3.06 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.378 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.05 -61.5 1.61 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.7 mt -45.66 -46.84 14.94 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.554 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.54 -48.73 71.66 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 24.7 mt -55.91 -62.8 1.46 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.156 0.979 . . . . 0.0 110.827 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 m -64.94 -31.93 56.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.221 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.1 m -92.12 -7.38 48.68 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.999 -1.063 . . . . 0.0 110.096 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 47.4 -144.0 5.61 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 23' ' ' GLY . 14.3 tp10 -79.35 -19.29 50.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.594 -0.945 . . . . 0.0 109.996 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -42.58 -17.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.457 -0.777 . . . . 0.0 110.653 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 88.02 137.5 5.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -131.33 144.95 51.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.69 -0.888 . . . . 0.0 109.473 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -87.89 127.55 35.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.327 -0.858 . . . . 0.0 109.646 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' ' 27' ' ' THR . 85.9 t80 -163.14 -48.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 108.961 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.476 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 2.4 m 53.6 172.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.451 -0.781 . . . . 0.0 109.842 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.82 171.04 12.65 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 31' ' ' GLU . 19.2 Cg_endo -52.12 -83.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.515 2.745 0 C-N-CA 123.699 2.932 . . . . 0.0 114.546 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.573 ' H ' ' HG2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -43.65 4.09 0.0 OUTLIER 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 109.493 -3.503 . . . . 0.0 112.454 -176.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.921 ' O ' ' O ' ' A' ' 32' ' ' GLU . 1.1 tp10 -95.26 138.45 32.95 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 119.917 -1.74 . . . . 0.0 107.97 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.921 ' O ' ' O ' ' A' ' 31' ' ' GLU . 3.7 mp0 13.03 -140.93 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.396 -1.44 . . . . 0.0 109.161 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 35' ' ' ARG . . . -121.66 97.95 0.63 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.401 ' HD2' ' HA2' ' A' ' 33' ' ' GLY . 39.4 Cg_endo -62.98 30.06 0.07 OUTLIER 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.906 3.07 . . . . 0.0 113.751 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER 62.14 123.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.85 -1.156 . . . . 0.0 112.035 179.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' N ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -92.52 112.33 24.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.551 -0.718 . . . . 0.0 110.787 179.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.93 -48.49 0.06 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 13.3 tt -82.21 -42.47 18.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.541 -0.976 . . . . 0.0 110.332 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.522 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 54.1 t -69.42 -62.17 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 O-C-N 121.63 -0.669 . . . . 0.0 111.016 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -59.21 -22.01 60.39 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -94.31 -41.61 9.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.995 -1.065 . . . . 0.0 110.497 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 45' ' ' SER . 1.8 t -86.46 -29.73 22.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.867 -1.145 . . . . 0.0 110.737 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 51.8 t -81.58 -51.62 8.05 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.604 -1.31 . . . . 0.0 109.446 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -24.81 53.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.045 -1.034 . . . . 0.0 108.743 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' CYS . 5.1 m -140.52 -174.88 4.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.314 -0.866 . . . . 0.0 109.123 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.5 mt -90.64 148.92 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.233 -0.917 . . . . 0.0 109.216 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 20.6 p -128.88 167.39 17.45 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.378 -0.827 . . . . 0.0 109.775 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.82 165.3 13.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.303 -0.873 . . . . 0.0 110.79 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.68 -36.61 25.76 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.11 -25.27 61.15 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.862 1.315 . . . . 0.0 108.097 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.461 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 13.1 tt0 -77.8 -22.19 50.46 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.695 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.3 mt -84.5 -33.66 23.51 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.748 -1.22 . . . . 0.0 107.869 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -62.89 -18.72 63.38 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.554 -0.716 . . . . 0.0 110.162 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -84.84 -8.52 58.76 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -90.39 -37.33 14.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.695 -0.628 . . . . 0.0 109.643 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 m -49.8 110.94 0.44 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.507 -0.746 . . . . 0.0 109.718 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.1 t30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.464 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.618 ' CE1' HD22 ' A' ' 6' ' ' LEU . 1.9 t80 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 123.251 1.501 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.551 ' N ' HE21 ' A' ' 4' ' ' GLN . 6.1 p -90.23 84.55 2.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.335 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 2' ' ' VAL . 1.1 m120 41.29 70.25 0.28 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 110.567 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.551 HE21 ' N ' ' A' ' 2' ' ' VAL . 14.0 pt20 -141.69 169.86 16.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.057 -1.027 . . . . 0.0 109.639 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -63.16 126.63 28.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.895 . . . . 0.0 110.482 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.618 HD22 ' CE1' ' A' ' 1' ' ' PHE . 0.8 OUTLIER -129.89 123.75 31.52 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.3 m -130.77 179.47 5.95 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.344 -0.847 . . . . 0.0 108.929 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.51 -147.68 2.78 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.44 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -77.29 -14.38 59.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.026 -1.279 . . . . 0.0 109.328 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -52.53 -24.02 7.36 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.4 tp -81.29 -49.58 10.56 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.414 ' CG2' ' CD2' ' A' ' 26' ' ' TYR . 22.3 t -46.56 -45.73 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 14.8 tt0 -48.08 -60.03 2.93 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.244 -0.983 . . . . 0.0 109.476 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.0 -61.55 1.58 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.7 mt -45.65 -45.98 14.32 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.81 -51.52 67.19 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.0 mt -51.68 -62.38 1.66 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.113 0.959 . . . . 0.0 110.778 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 m -66.06 -36.7 78.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.23 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.8 m -87.09 -4.93 59.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.935 -1.103 . . . . 0.0 110.146 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 46.88 -146.75 3.47 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 23' ' ' GLY . 32.0 mt-10 -83.39 -0.11 48.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -1.176 . . . . 0.0 109.719 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -58.79 -0.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 109.939 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 73.5 131.58 0.19 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -126.4 148.61 49.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.589 -0.947 . . . . 0.0 109.347 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -82.51 123.53 29.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 0.0 110.042 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.47 ' CE2' ' O ' ' A' ' 27' ' ' THR . 36.4 t80 -172.27 160.44 5.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 109.21 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.47 ' O ' ' CE2' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -154.73 -156.16 0.64 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.322 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.505 ' CB ' ' OE1' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -91.86 172.17 6.82 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.603 ' O ' ' C ' ' A' ' 30' ' ' THR . 57.0 Cg_endo -68.66 -145.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 118.067 -1.596 . . . . 0.0 112.718 176.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.321 ' O ' ' N ' ' A' ' 32' ' ' GLU 0.255 36.8 m 14.14 -107.66 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.024 -1.443 . . . . 0.0 112.982 175.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.73 ' C ' ' O ' ' A' ' 30' ' ' THR . 18.9 mt-10 16.59 -56.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 123.622 1.677 . . . . 0.0 107.093 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 1.321 ' N ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -156.16 -179.13 7.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.109 -2.314 . . . . 0.0 107.024 178.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.403 ' HA3' ' HD2' ' A' ' 36' ' ' ARG . . . -112.42 122.03 5.81 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.287 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.86 ' C ' ' H ' ' A' ' 36' ' ' ARG . 80.1 Cg_endo -75.08 81.26 2.26 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 124.217 3.278 . . . . 0.0 110.837 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.862 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 57.49 -10.65 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.86 ' H ' ' C ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER 30.12 21.35 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.973 -0.454 . . . . 0.0 110.327 -179.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.862 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -104.1 -36.57 3.12 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 107.779 -2.128 . . . . 0.0 107.779 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 11.3 tt -81.83 -45.92 20.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.551 0.691 . . . . 0.0 110.344 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.553 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 55.8 t -64.62 -61.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.78 -0.575 . . . . 0.0 111.726 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.52 -23.59 64.67 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.223 -0.923 . . . . 0.0 110.126 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' NE2' HE22 ' A' ' 51' ' ' GLN . 29.5 tt0 -94.33 -33.96 12.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.982 -1.074 . . . . 0.0 109.954 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.47 ' N ' ' O ' ' A' ' 38' ' ' ILE . 51.0 t -88.51 -43.58 11.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.152 -0.967 . . . . 0.0 110.568 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.78 -24.22 62.55 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 110.73 -178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -104.82 -19.07 14.02 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.201 -0.937 . . . . 0.0 109.524 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -140.1 179.52 6.57 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.264 -0.898 . . . . 0.0 109.035 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.557 ' CG2' ' H ' ' A' ' 47' ' ' CYS . 5.0 mm -64.62 -177.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.996 . . . . 0.0 108.324 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.579 ' HB2' ' HZ ' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -146.03 150.45 36.01 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.897 -1.127 . . . . 0.0 110.222 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -97.16 151.74 19.51 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.57 -40.46 20.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -57.67 -24.79 58.54 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 122.841 1.305 . . . . 0.0 107.943 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.454 HE22 ' NE2' ' A' ' 41' ' ' GLN . 7.7 tt0 -78.44 -23.03 46.78 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.802 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.595 HD11 ' HE2' ' A' ' 1' ' ' PHE . 46.1 mt -84.8 -36.89 21.36 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.69 -20.66 50.47 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.507 -0.746 . . . . 0.0 110.002 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -82.99 -8.94 59.51 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.7 m-85 -90.34 -36.72 14.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.551 -0.718 . . . . 0.0 109.316 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -51.51 110.49 0.46 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.376 -0.827 . . . . 0.0 109.565 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.6 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.505 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.851 ' CD1' ' O ' ' A' ' 1' ' ' PHE . 48.8 p90 . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 9.1 p -55.27 167.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 116.145 -2.222 . . . . 0.0 108.976 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.409 ' N ' ' CG2' ' A' ' 2' ' ' VAL . 2.6 m120 -52.78 105.77 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.002 -1.061 . . . . 0.0 109.952 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -164.49 -160.77 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.172 -0.955 . . . . 0.0 109.77 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -95.45 132.66 40.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.247 -0.908 . . . . 0.0 109.609 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.1 113.71 15.45 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.01 148.72 50.54 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.42 -169.99 53.05 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.412 ' C ' ' N ' ' A' ' 11' ' ' LEU . 4.3 p -60.95 -14.8 25.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.612 -1.523 . . . . 0.0 109.202 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -52.81 -25.74 12.33 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.412 ' N ' ' C ' ' A' ' 9' ' ' SER . 13.0 tp -81.11 -47.9 12.88 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 13' ' ' GLU . 27.2 t -48.08 -47.35 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.1 tt0 -47.51 -59.91 2.9 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.561 -176.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.717 ' HB2' ' CE2' ' A' ' 1' ' ' PHE . . . -45.23 -61.38 1.68 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 19' ' ' CYS . 13.0 mt -45.76 -45.94 14.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.75 -52.46 63.86 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.7 mt -50.59 -62.32 1.67 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.079 0.942 . . . . 0.0 110.614 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.25 -31.92 55.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.036 -177.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 15' ' ' LEU . 47.7 m -91.72 0.51 57.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.045 -1.034 . . . . 0.0 109.995 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 45.86 -158.7 0.29 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.32 -2.94 43.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -1.152 . . . . 0.0 109.354 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -46.62 -58.63 3.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.865 . . . . 0.0 109.487 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.58 131.18 2.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -131.4 143.72 50.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.68 -0.894 . . . . 0.0 108.846 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -86.29 134.35 33.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.324 -0.86 . . . . 0.0 110.266 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' THR . 86.3 t80 -172.9 -24.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.44 -0.788 . . . . 0.0 109.399 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' TYR . 3.1 p 47.62 -175.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.734 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.84 ' O ' ' N ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -98.84 162.53 21.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.751 ' C ' HG22 ' A' ' 30' ' ' THR . 53.2 Cg_exo -42.51 32.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 124.212 3.275 . . . . 0.0 113.593 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.84 ' N ' ' O ' ' A' ' 28' ' ' ASP . 3.6 p -158.39 -101.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.708 -1.245 . . . . 0.0 111.437 -177.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.67 ' C ' ' O ' ' A' ' 30' ' ' THR . 14.5 mt-10 0.9 69.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.095 -1.003 . . . . 0.0 111.017 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.947 ' OE2' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER 62.49 -40.63 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.736 -1.227 . . . . 0.0 110.415 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 85.05 178.12 50.94 Favored Glycine 0 N--CA 1.503 3.113 0 O-C-N 119.824 -1.797 . . . . 0.0 109.23 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.418 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 94.3 Cg_endo -77.82 -148.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.893 3.062 . . . . 0.0 112.292 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.857 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -120.12 85.71 2.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.722 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -15.11 104.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.668 1.223 . . . . 0.0 109.368 -178.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.12 -54.25 0.02 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 8.4 tt -81.9 -45.34 20.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.664 -0.904 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.538 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 40.3 t -64.69 -62.24 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.625 -0.672 . . . . 0.0 111.962 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.514 ' CG ' ' HG3' ' A' ' 36' ' ' ARG . 25.3 mt-10 -47.77 -33.63 7.4 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.284 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.2 mt-30 -93.52 -59.54 1.99 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.003 -1.06 . . . . 0.0 109.415 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.484 ' N ' ' O ' ' A' ' 38' ' ' ILE . 17.6 t -52.8 -34.07 51.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.108 -0.995 . . . . 0.0 110.738 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.7 t -85.28 -53.03 5.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.863 -1.148 . . . . 0.0 110.831 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.446 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 2.3 m-70 -86.17 -5.06 59.27 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.966 -1.084 . . . . 0.0 110.511 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.0 m -140.39 -177.82 5.21 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.054 -1.029 . . . . 0.0 109.362 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.598 ' CG2' ' H ' ' A' ' 47' ' ' CYS . 6.0 mm -64.66 -178.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.173 -0.954 . . . . 0.0 108.524 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.598 ' H ' ' CG2' ' A' ' 46' ' ' ILE . 1.3 t -134.91 130.46 35.93 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.162 -0.961 . . . . 0.0 110.543 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.7 m -95.03 145.97 24.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 tp -82.5 -40.33 21.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -56.41 -24.97 48.4 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 122.945 1.355 . . . . 0.0 108.147 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.472 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 9.3 tt0 -79.39 -22.83 43.79 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.142 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.658 HD11 ' CZ ' ' A' ' 1' ' ' PHE . 38.8 mt -85.46 -38.33 18.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.597 -1.314 . . . . 0.0 108.223 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.31 -20.17 26.82 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.487 -0.758 . . . . 0.0 110.368 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -83.87 -8.69 59.14 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.472 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 3.6 m-85 -90.55 -39.18 12.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.6 -0.688 . . . . 0.0 109.758 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -49.67 110.65 0.4 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.353 -0.842 . . . . 0.0 109.546 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.6 t30 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.509 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.72 ' CD2' HD13 ' A' ' 17' ' ' LEU . 33.3 p90 . . . . . 0 CA--C 1.56 1.364 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 1' ' ' PHE . 60.1 t 42.55 -99.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.409 -1.432 . . . . 0.0 109.23 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.519 ' O ' ' O ' ' A' ' 4' ' ' GLN . 1.9 m-20 -147.46 -30.77 0.32 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.07 -1.019 . . . . 0.0 109.89 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.519 ' O ' ' O ' ' A' ' 3' ' ' ASN . 4.3 pt20 -25.44 152.92 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.959 0.885 . . . . 0.0 112.98 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -45.77 136.07 6.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.327 -0.858 . . . . 0.0 109.603 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tp -134.38 109.38 8.75 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' GLY . 59.5 m -106.64 -176.39 3.06 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.153 -0.967 . . . . 0.0 109.685 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 7' ' ' CYS . . . 43.26 -164.43 0.03 OUTLIER Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.467 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.0 p -69.0 -8.65 46.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.985 -1.303 . . . . 0.0 109.23 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -53.33 -22.84 7.95 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.467 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.0 tp -78.99 -52.33 8.39 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 13' ' ' GLU . 4.4 t -48.11 -40.72 9.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.494 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.2 tt0 -48.36 -59.39 3.49 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.534 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.45 -61.28 1.74 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 19' ' ' CYS . 6.6 mt -45.74 -49.17 15.06 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.553 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -50.45 -48.71 56.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.72 HD13 ' CD2' ' A' ' 1' ' ' PHE . 19.2 mt -56.96 -63.87 1.06 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.962 0.887 . . . . 0.0 110.464 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -64.12 -51.46 68.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.601 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' LEU . 78.6 m -72.88 -1.57 17.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.028 -1.045 . . . . 0.0 109.346 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 40.2 -142.74 0.63 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.36 -6.89 59.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.608 -0.937 . . . . 0.0 109.793 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.0 mtp85 -42.48 -59.11 1.98 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.844 -0.535 . . . . 0.0 109.767 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.4 102.85 0.81 Allowed Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -103.68 -170.48 1.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 63.4 t80 -154.33 120.58 5.37 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 119.638 -1.914 . . . . 0.0 112.9 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 32.4 m-85 -150.25 92.8 1.91 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.652 ' HG1' ' H ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -54.3 -171.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 -179.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.652 ' H ' ' HG1' ' A' ' 27' ' ' THR . 0.1 OUTLIER -85.58 168.34 20.42 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' O ' ' C ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -54.26 -125.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.196 0 C-N-CA 123.829 3.019 . . . . 0.0 113.724 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.05 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER 27.91 -132.17 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.042 0 O-C-N 121.329 -0.857 . . . . 0.0 110.808 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 1.135 ' O ' ' N ' ' A' ' 33' ' ' GLY . 2.7 mt-10 -12.62 168.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.147 0.498 . . . . 0.0 111.204 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.669 ' C ' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -17.69 58.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.563 0.697 . . . . 0.0 109.938 178.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 1.135 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 10.37 -138.48 0.0 OUTLIER Glycine 0 N--CA 1.499 2.897 0 CA-C-O 122.14 0.856 . . . . 0.0 112.892 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.602 ' HG2' ' H ' ' A' ' 35' ' ' ARG . 69.5 Cg_endo -80.22 -89.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 123.538 2.826 . . . . 0.0 113.183 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.79 ' O ' ' CB ' ' A' ' 36' ' ' ARG . 62.8 ttt180 -127.56 -46.74 1.44 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.347 -0.846 . . . . 0.0 108.929 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.79 ' CB ' ' O ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER 101.4 73.31 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.803 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.06 -79.32 0.14 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 5.0 tt -56.04 -44.05 77.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.816 -0.814 . . . . 0.0 109.491 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 46.6 t -65.29 -61.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.622 -0.674 . . . . 0.0 110.39 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.506 ' OE2' ' HG3' ' A' ' 36' ' ' ARG . 2.4 mt-10 -57.56 -18.47 19.65 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.141 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' SER . 44.8 tt0 -94.08 -51.92 4.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.224 -0.922 . . . . 0.0 110.755 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -75.69 -54.06 7.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.745 -1.222 . . . . 0.0 110.091 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 48.6 t -52.73 -23.45 6.77 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.025 -1.047 . . . . 0.0 110.406 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -111.82 -29.13 7.79 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.062 -1.024 . . . . 0.0 110.122 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -132.83 -163.96 1.41 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.365 -0.834 . . . . 0.0 109.232 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.5 mm -106.46 159.64 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.269 -0.894 . . . . 0.0 109.233 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 m -145.61 168.82 19.74 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.951 -1.093 . . . . 0.0 109.943 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.43 165.76 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.908 0.861 . . . . 0.0 110.182 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.59 -33.33 28.03 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.29 -25.88 68.1 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.794 1.283 . . . . 0.0 108.177 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.528 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 8.5 tt0 -73.11 -23.07 60.46 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.33 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.9 mt -84.62 -28.98 26.13 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.59 -18.19 64.9 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.602 -0.686 . . . . 0.0 110.856 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 13.7 p30 -88.19 -8.84 54.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.818 -1.176 . . . . 0.0 108.368 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.604 ' CE2' ' NH2' ' A' ' 35' ' ' ARG . 6.4 m-85 -82.88 -38.12 23.37 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.576 0.703 . . . . 0.0 109.318 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 m -49.81 110.5 0.39 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.741 -0.599 . . . . 0.0 109.816 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.551 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.885 ' CG ' ' O ' ' A' ' 1' ' ' PHE . 1.6 p90 . . . . . 0 C--O 1.195 -1.784 0 CA-C-O 122.333 1.063 . . . . 0.0 108.613 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.598 ' C ' ' H ' ' A' ' 4' ' ' GLN . 3.9 t -92.56 50.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.294 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.989 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 4' ' ' GLN . 0.6 OUTLIER 69.86 -33.95 0.27 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.389 -0.819 . . . . 0.0 109.57 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.598 ' H ' ' C ' ' A' ' 2' ' ' VAL . 8.5 pt20 -28.81 157.99 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.921 0.867 . . . . 0.0 112.338 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -44.35 125.71 4.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.382 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.75 109.2 10.43 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.6 m -114.91 -176.49 2.91 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.433 -0.792 . . . . 0.0 109.403 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.79 -152.95 0.85 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.47 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.1 p -79.16 -9.24 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.895 -1.356 . . . . 0.0 108.888 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 9' ' ' SER . 14.9 m-70 -52.0 -24.39 6.53 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.47 ' N ' ' C ' ' A' ' 9' ' ' SER . 8.7 tp -78.22 -54.02 6.69 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 13' ' ' GLU . 4.7 t -46.4 -41.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 19.4 tt0 -47.24 -58.94 3.54 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.939 -1.104 . . . . 0.0 108.385 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.53 -61.4 1.7 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 19' ' ' CYS . 7.6 mt -46.01 -48.01 16.73 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -51.75 -49.01 63.43 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 19.5 mt -56.58 -63.64 1.13 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.002 0.906 . . . . 0.0 110.651 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 m -64.7 -48.27 85.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.761 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' LEU . 60.9 m -73.26 -15.24 61.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.045 -1.034 . . . . 0.0 109.852 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 43.01 -133.09 5.17 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -83.75 -9.7 58.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -1.044 . . . . 0.0 110.016 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -47.12 -25.53 0.89 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 109.613 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.7 117.95 2.26 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.273 -0.965 . . . . 0.0 110.73 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.488 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 32.8 p90 -122.06 -178.91 3.98 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.509 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 64.3 m-85 -150.72 125.92 9.98 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 119.552 -1.968 . . . . 0.0 112.783 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.509 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 29.7 m-85 -151.47 114.78 4.8 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -57.35 -163.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.068 -1.02 . . . . 0.0 108.8 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.68 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -49.17 -178.54 0.02 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 108.625 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.68 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 29.5 Cg_endo -66.85 -114.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.676 2.251 . . . . 0.0 111.235 177.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.036 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -61.65 -15.12 37.04 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.504 -0.747 . . . . 0.0 111.844 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 1.036 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.2 pp20? -6.78 -146.78 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 122.157 0.98 . . . . 0.0 112.541 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.435 ' H ' ' HB2' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -71.08 -125.01 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.251 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.434 ' H ' ' HB3' ' A' ' 32' ' ' GLU . . . -100.48 135.54 12.2 Favored Glycine 0 N--CA 1.504 3.23 0 C-N-CA 119.681 -1.247 . . . . 0.0 111.649 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.927 ' O ' ' HG2' ' A' ' 36' ' ' ARG . 18.5 Cg_endo -94.97 173.42 1.28 Allowed 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 124.872 3.714 . . . . 0.0 112.446 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.752 ' O ' ' O ' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -54.03 -5.11 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.927 ' HG2' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 48.82 164.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.54 -77.53 0.43 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 118.797 -1.668 . . . . 0.0 109.553 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.548 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 8.8 tt -65.34 -45.99 91.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.403 -1.057 . . . . 0.0 111.188 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.548 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 55.7 t -65.88 -61.03 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.72 -0.612 . . . . 0.0 110.946 -177.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -57.23 -22.42 40.95 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 109.228 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.66 ' NE2' HE22 ' A' ' 51' ' ' GLN . 26.2 tt0 -94.22 -32.79 13.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.16 -0.963 . . . . 0.0 109.569 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.52 ' N ' ' O ' ' A' ' 38' ' ' ILE . 99.7 m -89.7 -47.75 7.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.034 -1.041 . . . . 0.0 109.992 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' VAL . 44.9 t -66.89 -52.52 42.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 110.855 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -85.89 -18.04 33.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.923 -1.111 . . . . 0.0 110.47 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' CYS . 13.1 m -140.59 179.84 6.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.078 -1.013 . . . . 0.0 109.613 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 mm -95.92 139.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.317 -0.864 . . . . 0.0 108.802 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.65 168.22 14.03 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.309 -0.87 . . . . 0.0 109.978 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.1 166.89 14.1 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.071 0.939 . . . . 0.0 111.044 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.4 ' HB2' ' HZ ' ' A' ' 1' ' ' PHE . 0.3 OUTLIER -82.93 -36.88 24.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -57.98 -25.37 60.95 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 122.898 1.332 . . . . 0.0 108.172 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.66 HE22 ' NE2' ' A' ' 41' ' ' GLN . 6.9 tt0 -76.28 -21.82 55.82 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.559 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.3 mt -84.49 -35.46 22.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.856 -1.153 . . . . 0.0 107.941 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -62.29 -18.29 60.91 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.63 -0.669 . . . . 0.0 110.148 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 2.3 m-20 -85.43 -8.67 58.28 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 51' ' ' GLN . 4.6 m-85 -89.23 -40.67 12.69 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.818 0.818 . . . . 0.0 109.316 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.5 m -49.77 110.28 0.37 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.739 -0.601 . . . . 0.0 109.993 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.0 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.491 179.699 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 1.045 ' CZ ' ' CD1' ' A' ' 17' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.65 76.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.538 -0.726 . . . . 0.0 109.132 167.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 4' ' ' GLN . 3.8 m120 53.63 -102.06 0.13 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.219 -0.925 . . . . 0.0 109.37 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ASN . 14.6 pt20 37.8 -162.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.541 0.686 . . . . 0.0 111.392 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -93.19 137.12 32.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.351 -0.843 . . . . 0.0 109.639 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.701 HD13 ' H1 ' ' A' ' 1' ' ' PHE . 1.3 mp -133.72 109.63 9.28 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 m -118.78 -176.95 3.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.501 -0.749 . . . . 0.0 109.186 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.67 -145.97 3.66 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.2 p -81.66 -12.89 58.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.061 -1.258 . . . . 0.0 109.471 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -51.22 -24.54 4.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.2 tp -81.83 -49.86 9.88 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 13' ' ' GLU . 22.1 t -46.84 -48.3 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.494 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.6 tt0 -47.42 -59.7 3.04 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.528 -176.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -44.89 -61.65 1.53 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ALA . 14.6 mt -45.77 -45.46 14.65 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.554 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.12 -49.44 73.89 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 1.045 ' CD1' ' CZ ' ' A' ' 1' ' ' PHE . 27.5 mt -54.85 -62.85 1.39 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.101 0.953 . . . . 0.0 110.909 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -64.23 -37.69 80.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.943 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 42.5 t -80.25 -22.41 41.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.977 -1.077 . . . . 0.0 110.039 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 68.87 -146.73 45.4 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.6 tt0 -83.16 -15.26 51.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.333 -1.098 . . . . 0.0 109.656 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -47.45 -9.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.665 -0.647 . . . . 0.0 110.529 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 78.6 131.42 0.68 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -116.91 157.0 26.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.642 -0.916 . . . . 0.0 109.925 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -85.52 122.1 29.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.388 -0.82 . . . . 0.0 110.113 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.4 ' O ' ' O ' ' A' ' 27' ' ' THR . 39.2 t80 -170.42 71.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.841 . . . . 0.0 108.911 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.507 HG21 ' HB3' ' A' ' 31' ' ' GLU . 1.3 m -47.65 171.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.74 . . . . 0.0 109.717 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.9 168.94 23.32 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.764 ' O ' ' CG2' ' A' ' 30' ' ' THR . 57.1 Cg_endo -71.76 90.18 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.635 2.223 . . . . 0.0 111.439 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.822 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.9 OUTLIER 145.65 -55.67 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.452 0.644 . . . . 0.0 109.898 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.524 ' C ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -35.44 78.3 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.185 -178.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.822 ' N ' ' O ' ' A' ' 30' ' ' THR . 2.6 mt-10 51.47 19.21 0.78 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.52 ' N ' ' C ' ' A' ' 31' ' ' GLU . . . 58.73 176.3 0.71 Allowed Glycine 0 N--CA 1.479 1.555 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.567 ' HG2' ' H ' ' A' ' 35' ' ' ARG . 40.0 Cg_endo -83.25 -97.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 123.49 2.794 . . . . 0.0 109.828 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.794 ' O ' ' O ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -158.0 9.27 0.16 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.985 -1.072 . . . . 0.0 108.233 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.794 ' O ' ' O ' ' A' ' 35' ' ' ARG . 1.2 mpt_? 43.81 133.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.429 1.109 . . . . 0.0 108.434 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.16 -63.77 0.36 Allowed Glycine 0 C--N 1.275 -2.826 0 C-N-CA 117.493 -2.289 . . . . 0.0 108.402 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 8.1 tt -80.61 -41.12 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.618 -0.93 . . . . 0.0 109.712 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.524 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 55.0 t -70.75 -61.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.317 0.58 . . . . 0.0 110.876 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -59.15 -18.9 40.21 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.3 -0.875 . . . . 0.0 110.01 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.465 ' NE2' HE22 ' A' ' 51' ' ' GLN . 13.3 tt0 -94.29 -43.59 8.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.047 -1.033 . . . . 0.0 110.439 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' SER . 1.8 t -88.1 -31.46 19.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.89 -1.131 . . . . 0.0 110.82 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.6 t -76.91 -48.97 16.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.815 -1.178 . . . . 0.0 109.841 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -83.15 -22.94 33.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.063 -1.023 . . . . 0.0 109.47 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' CYS . 4.5 m -140.14 -170.04 2.88 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.374 -0.829 . . . . 0.0 108.917 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.01 168.32 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.032 -1.043 . . . . 0.0 108.831 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.7 p -150.7 167.27 27.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.138 -0.976 . . . . 0.0 109.728 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.18 164.94 12.28 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 122.047 0.927 . . . . 0.0 111.153 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.53 -36.94 25.89 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.82 -25.95 61.34 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.843 1.306 . . . . 0.0 108.282 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.465 HE22 ' NE2' ' A' ' 41' ' ' GLN . 6.5 tt0 -76.72 -22.08 54.39 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.577 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 mt -84.82 -33.39 22.92 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.941 -1.099 . . . . 0.0 108.036 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -62.81 -18.78 63.3 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 110.34 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -84.51 -8.72 58.84 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.55 ' CE2' ' NH1' ' A' ' 35' ' ' ARG . 3.7 m-85 -90.11 -27.59 19.54 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.62 -0.675 . . . . 0.0 109.648 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.9 t -66.97 112.04 4.13 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.845 0.831 . . . . 0.0 109.793 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 . . . . . 0 C--N 1.291 -1.972 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.429 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.772 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.896 0.855 . . . . 0.0 108.758 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 3' ' ' ASN . 4.0 p -55.97 -20.31 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -177.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 2' ' ' VAL . 13.4 m-20 154.82 71.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -151.04 170.72 18.69 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.593 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 5.2 p80 -61.2 136.59 58.11 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.012 -1.055 . . . . 0.0 109.252 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.496 ' CD2' ' HB2' ' A' ' 1' ' ' PHE . 1.0 OUTLIER -134.07 110.06 9.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.39 -0.819 . . . . 0.0 108.883 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 m -122.61 -176.89 3.49 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 47.2 -149.54 2.6 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.433 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.2 p -79.49 -12.75 59.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.912 -1.346 . . . . 0.0 109.291 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -52.39 -24.04 7.05 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.433 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.5 tp -80.59 -52.43 7.6 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 13' ' ' GLU . 22.6 t -44.13 -47.66 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.626 0.727 . . . . 0.0 109.225 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.482 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 28.3 tt0 -46.62 -59.52 2.96 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.471 -176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.15 -61.81 1.5 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.8 mt -45.97 -43.96 14.53 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.558 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -57.58 -50.45 73.08 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 29.6 mt -52.68 -62.68 1.49 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.211 1.005 . . . . 0.0 110.789 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 m -65.14 -42.36 94.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.432 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.0 t -75.15 -22.45 58.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.779 -1.201 . . . . 0.0 110.118 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 69.33 -151.57 51.12 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 23' ' ' GLY . 22.5 mt-10 -83.24 0.53 45.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -1.209 . . . . 0.0 109.694 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -62.42 1.36 0.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.173 -0.954 . . . . 0.0 109.988 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 68.65 121.05 0.03 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.405 ' CD2' ' N ' ' A' ' 24' ' ' PHE . 16.1 p90 -105.34 170.25 7.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.569 -0.959 . . . . 0.0 109.58 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -98.54 123.67 42.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.33 -0.856 . . . . 0.0 110.135 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' THR . 49.5 t80 -172.45 86.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.503 -0.748 . . . . 0.0 109.141 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -53.12 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.294 -0.879 . . . . 0.0 109.296 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.52 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -83.62 177.18 3.15 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.52 ' HD2' ' CB ' ' A' ' 28' ' ' ASP . 51.0 Cg_endo -60.12 -6.06 4.62 Favored 'Trans proline' 0 N--CA 1.525 3.355 0 C-N-CA 124.267 3.311 . . . . 0.0 116.523 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.106 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -121.84 -168.63 1.73 Allowed 'General case' 0 C--N 1.284 -2.267 0 O-C-N 120.051 -1.656 . . . . 0.0 111.36 -178.354 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 1.106 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.3 OUTLIER 33.12 134.64 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 1.17 ' O ' ' O ' ' A' ' 33' ' ' GLY . 25.0 mp0 13.01 48.92 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.35 -0.844 . . . . 0.0 111.243 -177.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 1.17 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -25.49 -139.16 0.0 OUTLIER Glycine 0 N--CA 1.506 3.365 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.829 ' HG2' HG23 ' A' ' 39' ' ' VAL . 32.5 Cg_exo -61.94 148.25 93.51 Favored 'Trans proline' 0 N--CA 1.51 2.453 0 C-N-CA 122.698 2.265 . . . . 0.0 112.282 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.842 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -55.63 7.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 119.544 -1.973 . . . . 0.0 108.355 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.842 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 75.9 92.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.732 -1.23 . . . . 0.0 110.351 -179.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.19 -53.86 0.21 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 117.005 -2.522 . . . . 0.0 109.371 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.539 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 7.1 tt -75.58 -42.16 41.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.705 -0.88 . . . . 0.0 110.487 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.829 HG23 ' HG2' ' A' ' 34' ' ' PRO . 49.0 t -65.75 -60.62 2.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.268 0.556 . . . . 0.0 111.029 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -58.5 -21.34 51.63 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.671 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.525 ' NE2' ' OE1' ' A' ' 51' ' ' GLN . 8.8 tt0 -94.08 -36.32 12.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.237 -0.914 . . . . 0.0 109.85 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 38' ' ' ILE . 96.6 m -88.35 -50.42 6.34 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.112 -0.993 . . . . 0.0 109.96 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.3 t -62.51 -50.43 71.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.292 -0.88 . . . . 0.0 110.882 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -83.84 -26.24 29.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.86 -1.15 . . . . 0.0 110.752 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 41' ' ' GLN . 37.2 m -140.6 -179.43 6.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.969 -1.082 . . . . 0.0 110.249 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mm -84.55 157.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 p -143.16 167.22 22.62 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.893 -1.13 . . . . 0.0 109.474 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.28 161.86 21.33 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.078 0.942 . . . . 0.0 110.682 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.04 -35.14 26.0 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -59.62 -25.95 65.08 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.674 1.226 . . . . 0.0 108.203 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.531 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 6.8 tt0 -74.45 -23.33 58.89 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.41 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.9 mt -84.64 -27.41 27.16 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.039 -1.038 . . . . 0.0 108.303 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -68.08 -18.65 64.73 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.564 -0.71 . . . . 0.0 110.887 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 15.7 p30 -87.27 -9.03 56.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.499 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 5.0 m-85 -84.32 -32.26 24.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.8 t -60.88 112.28 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.873 0.844 . . . . 0.0 109.932 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 t30 . . . . . 0 C--N 1.292 -1.902 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.533 179.866 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.521 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 2.6 p90 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 1' ' ' PHE . 87.7 t -158.71 87.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 O-C-N 120.532 -1.355 . . . . 0.0 109.252 -171.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 2' ' ' VAL . 1.2 m120 42.49 51.1 4.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.639 -0.663 . . . . 0.0 110.069 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -128.79 165.05 21.7 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.484 -0.76 . . . . 0.0 109.812 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.459 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 31.8 p80 -60.05 130.07 44.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.38 -0.825 . . . . 0.0 110.35 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -135.12 118.92 17.22 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.0 t -123.28 -176.82 3.53 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.459 -0.776 . . . . 0.0 109.408 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.23 -152.82 0.69 Allowed Glycine 0 N--CA 1.499 2.898 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.453 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.0 p -77.93 -10.18 59.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.73 -1.453 . . . . 0.0 108.734 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' SER . 68.7 m80 -53.01 -22.96 6.4 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.453 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.4 tp -79.82 -50.99 9.71 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 13' ' ' GLU . 4.0 t -47.36 -40.06 6.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.489 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.0 tt0 -48.68 -59.36 3.6 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.661 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.53 -60.64 2.07 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 19' ' ' CYS . 7.3 mt -46.37 -47.54 18.69 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.55 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -52.49 -48.34 66.0 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 20.1 mt -56.8 -63.34 1.24 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.01 0.909 . . . . 0.0 110.542 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.3 m -65.56 -46.16 90.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.014 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 15' ' ' LEU . 58.6 m -72.97 -22.51 60.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.96 -1.088 . . . . 0.0 109.596 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 39.67 -120.92 1.4 Allowed Glycine 0 N--CA 1.496 2.662 0 O-C-N 121.284 -0.885 . . . . 0.0 111.131 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -81.67 -20.75 38.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.547 -0.972 . . . . 0.0 110.001 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -46.26 -34.04 4.15 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.343 -0.848 . . . . 0.0 109.402 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.36 137.04 8.53 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 24' ' ' PHE . 28.1 p90 -140.99 174.83 10.13 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 7.2 p90 -154.37 125.92 7.51 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.69 -1.881 . . . . 0.0 112.439 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 27' ' ' THR . 18.7 m-85 -139.38 3.26 2.12 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 26' ' ' TYR . 1.8 p 45.88 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.807 0.813 . . . . 0.0 110.28 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.518 ' O ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -69.02 167.53 20.03 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.518 ' C ' ' O ' ' A' ' 28' ' ' ASP . 2.5 Cg_endo -33.89 -45.06 0.37 Allowed 'Trans proline' 0 C--N 1.278 -3.148 0 C-N-CA 121.706 1.604 . . . . 0.0 111.604 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.821 ' OG1' ' N ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -114.82 -144.88 0.39 Allowed 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.527 0.679 . . . . 0.0 109.656 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 1.066 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 5.3 mt-10 72.99 65.94 0.11 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.113 -0.992 . . . . 0.0 112.334 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 1.066 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER 103.21 -57.17 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 O-C-N 120.789 -1.194 . . . . 0.0 112.553 177.458 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.678 ' C ' ' H ' ' A' ' 35' ' ' ARG . . . 152.85 122.73 0.94 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 117.435 -2.317 . . . . 0.0 113.22 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.517 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 5.4 Cg_exo -56.91 11.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.92 2.413 . . . . 0.0 111.376 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.823 ' NH2' ' CE2' ' A' ' 55' ' ' TYR . 9.1 ttt-85 84.88 -16.57 0.49 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.471 HH21 ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER 53.07 -173.79 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.095 -1.003 . . . . 0.0 110.671 179.087 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.49 -81.45 0.08 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 4.5 tt -52.0 -40.36 28.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.856 -0.791 . . . . 0.0 110.757 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.479 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 40.3 t -71.63 -61.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.724 -0.61 . . . . 0.0 110.565 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -55.7 -23.47 28.92 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.369 -0.832 . . . . 0.0 109.135 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -94.53 -34.45 12.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.277 -0.889 . . . . 0.0 109.852 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 38' ' ' ILE . 42.0 t -88.35 -46.29 9.3 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.052 -1.03 . . . . 0.0 110.233 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.8 t -63.59 -34.24 77.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 110.643 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -103.34 -15.4 15.95 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.167 -0.958 . . . . 0.0 110.28 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER -140.07 -179.14 5.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.109 -0.994 . . . . 0.0 109.19 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.606 ' CG2' ' H ' ' A' ' 47' ' ' CYS . 5.3 mm -66.2 -179.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 0.0 109.305 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.606 ' H ' ' CG2' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -146.93 134.49 20.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.042 -1.037 . . . . 0.0 109.365 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 m -87.68 155.27 20.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.438 -0.789 . . . . 0.0 109.182 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 tp -82.83 -39.83 21.16 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -57.95 -23.34 53.24 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 123.179 1.466 . . . . 0.0 107.826 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.506 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 10.5 tp-100 -80.69 -23.28 39.67 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.109 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.05 -38.52 19.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.399 -1.438 . . . . 0.0 108.213 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -58.24 -19.61 35.39 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.646 -0.659 . . . . 0.0 110.293 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -85.15 -8.57 58.55 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 108.634 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.823 ' CE2' ' NH2' ' A' ' 35' ' ' ARG . 4.4 m-85 -90.54 -40.29 12.05 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.937 0.875 . . . . 0.0 109.212 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.2 m -49.74 110.67 0.41 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.259 0.552 . . . . 0.0 110.03 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.55 179.829 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 1.085 ' CE1' ' HA ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 122.304 1.05 . . . . 0.0 110.072 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.5 m -73.37 55.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 120.778 -1.201 . . . . 0.0 109.114 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 1.085 ' HA ' ' CE1' ' A' ' 1' ' ' PHE . 0.8 OUTLIER 67.42 -88.4 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.365 -0.834 . . . . 0.0 109.096 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 3' ' ' ASN . 28.4 pt20 31.46 -151.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.463 -0.773 . . . . 0.0 111.787 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.512 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 7.6 p80 -98.92 132.59 44.14 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.367 -0.833 . . . . 0.0 109.236 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.796 HD22 ' CD1' ' A' ' 1' ' ' PHE . 1.4 mp -133.81 111.12 10.26 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.6 m -123.36 -177.57 3.74 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.84 -148.19 5.0 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.432 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -80.31 -13.38 59.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.947 -1.325 . . . . 0.0 109.425 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -52.01 -24.45 6.65 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.432 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.0 tp -81.67 -49.01 10.98 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 13' ' ' GLU . 20.9 t -47.41 -46.61 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.491 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 27.5 tt0 -47.9 -59.76 3.1 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.499 -176.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.06 -61.49 1.61 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 19' ' ' CYS . 13.4 mt -45.61 -46.8 14.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.555 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.83 -50.18 69.24 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 27.9 mt -53.75 -62.69 1.49 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 122.111 0.958 . . . . 0.0 110.727 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.38 -31.83 55.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.006 -177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 15' ' ' LEU . 54.6 m -93.11 -0.52 56.99 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.08 -1.013 . . . . 0.0 109.936 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 47.9 -148.79 3.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 2.0 mp0 -83.21 -15.18 51.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -1.084 . . . . 0.0 109.328 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -42.73 -18.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.8 -0.562 . . . . 0.0 110.568 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 92.74 138.19 8.46 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -129.82 155.84 45.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.591 -0.946 . . . . 0.0 109.71 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' HD1' ' HE ' ' A' ' 35' ' ' ARG . 48.1 t80 -84.51 124.05 30.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 0.0 110.193 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 27' ' ' THR . 44.4 t80 -172.47 77.97 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 109.324 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -52.33 -176.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.08 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.51 154.52 68.75 Favored Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 121.133 -0.979 . . . . 0.0 108.606 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.561 ' O ' ' CG2' ' A' ' 30' ' ' THR . 59.2 Cg_endo -75.07 57.42 4.61 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.307 2.671 . . . . 0.0 111.766 -175.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.561 ' CG2' ' O ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -162.6 -61.7 0.04 OUTLIER 'General case' 0 C--N 1.262 -3.234 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 33' ' ' GLY . 4.9 mm-40 -54.98 122.53 11.09 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 117.778 -1.569 . . . . 0.0 108.703 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 1.1 pt-20 39.67 7.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.43 -0.794 . . . . 0.0 110.531 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.786 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 82.86 168.06 42.12 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 118.356 -1.878 . . . . 0.0 109.246 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.95 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 28.5 Cg_endo -63.84 -28.41 67.58 Favored 'Trans proline' 0 C--N 1.285 -2.781 0 C-N-CA 122.804 2.336 . . . . 0.0 117.421 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.95 ' HB2' ' O ' ' A' ' 34' ' ' PRO . 9.2 ttt-85 151.71 7.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 119.79 -1.819 . . . . 0.0 107.119 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.592 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER 29.4 102.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.747 0.784 . . . . 0.0 109.924 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.47 -68.79 0.3 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 6.4 tt -73.83 -41.28 53.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.594 -0.945 . . . . 0.0 109.74 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.613 HG22 ' CG ' ' A' ' 34' ' ' PRO . 44.9 t -68.99 -61.05 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.329 0.585 . . . . 0.0 110.774 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -57.28 -22.0 38.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.343 -0.848 . . . . 0.0 109.802 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -94.57 -43.15 8.44 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.025 -1.047 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 45' ' ' SER . 0.9 OUTLIER -85.44 -29.22 24.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.88 -1.137 . . . . 0.0 110.642 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.7 t -80.9 -54.16 5.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.798 -1.189 . . . . 0.0 109.802 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -76.12 -24.53 54.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.996 -1.065 . . . . 0.0 109.121 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' CYS . 9.9 m -140.23 -173.99 3.81 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.2 mt -93.9 146.13 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.024 -1.048 . . . . 0.0 109.445 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p -122.04 165.37 16.15 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.606 -0.684 . . . . 0.0 109.263 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.74 166.74 13.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.242 -0.911 . . . . 0.0 110.52 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.31 -36.65 26.77 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -58.77 -25.54 63.15 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.837 1.303 . . . . 0.0 108.199 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.429 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 6.4 tt0 -77.31 -22.19 52.32 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.694 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.3 mt -84.63 -34.53 23.06 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -61.58 -19.28 62.02 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 110.209 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -84.02 -8.72 59.06 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -89.91 -37.79 14.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.689 -0.632 . . . . 0.0 109.529 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.3 m -50.64 110.61 0.43 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.316 -0.865 . . . . 0.0 109.477 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.469 -179.815 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.859 ' C ' ' CD1' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 120.685 0.279 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 4' ' ' GLN . 11.7 p -69.66 167.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 170.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -49.18 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 0.0 109.485 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 2' ' ' VAL . 1.7 pt20 -157.64 -177.81 6.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 110.119 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -78.09 135.33 37.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.316 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.6 109.82 8.91 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -118.11 174.65 6.09 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.71 -153.07 29.95 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 10' ' ' HIS . 3.3 p -78.41 -11.12 59.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.026 -1.279 . . . . 0.0 109.671 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 9' ' ' SER . 1.8 t-80 -53.24 -30.56 38.81 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.91 -48.18 25.98 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.5 t -48.81 -46.3 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.483 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.8 tt0 -49.05 -60.19 2.99 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.492 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.03 -60.96 1.82 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 19' ' ' CYS . 13.5 mt -45.81 -46.84 15.71 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.72 -51.02 66.9 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.2 mt -52.84 -62.49 1.62 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.101 0.953 . . . . 0.0 110.718 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.09 -30.86 50.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.209 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.461 ' N ' ' O ' ' A' ' 15' ' ' LEU . 56.4 m -90.4 -10.85 42.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.002 -1.061 . . . . 0.0 110.325 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 43.71 -131.42 6.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 23' ' ' GLY . 1.9 mp0 -83.91 -19.08 35.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.492 -1.005 . . . . 0.0 110.354 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -46.0 -12.84 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.348 -0.845 . . . . 0.0 110.174 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 76.04 133.54 0.45 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -124.36 142.34 51.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.841 -0.8 . . . . 0.0 109.374 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -83.34 138.13 33.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.428 -0.795 . . . . 0.0 109.776 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 27' ' ' THR . 39.0 t80 -171.86 -39.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.356 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 26' ' ' TYR . 1.6 m 53.93 172.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 109.359 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.18 158.61 69.41 Favored Pre-proline 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 108.715 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 1.256 ' O ' HG22 ' A' ' 30' ' ' THR . 87.7 Cg_endo -82.98 96.19 0.83 Allowed 'Trans proline' 1 C--N 1.253 -4.487 0 N-CA-C 114.932 1.089 . . . . 0.0 114.932 -172.151 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.256 HG22 ' O ' ' A' ' 29' ' ' PRO . 13.9 p 157.45 -54.17 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.646 0 CA-C-O 122.762 1.268 . . . . 0.0 108.951 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 30' ' ' THR . 79.2 mm-40 -31.9 -76.03 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.749 -1.219 . . . . 0.0 112.285 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.36 -26.15 4.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.898 -1.126 . . . . 0.0 109.379 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.01 148.98 5.36 Favored Glycine 0 N--CA 1.513 3.794 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.647 ' O ' ' CB ' ' A' ' 35' ' ' ARG . 80.2 Cg_endo -78.79 26.13 0.54 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 CA-C-N 119.741 1.77 . . . . 0.0 111.524 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.647 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER 83.42 -20.46 0.33 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -178.372 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 38' ' ' ILE . 43.6 mtt-85 52.48 -159.32 0.12 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.406 ' C ' HE21 ' A' ' 41' ' ' GLN . . . 62.44 -81.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' ARG . 6.2 tt -55.6 -41.83 66.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.736 -0.861 . . . . 0.0 109.973 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.51 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 41.8 t -72.41 -60.68 2.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.546 0.689 . . . . 0.0 111.214 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -49.42 -31.84 10.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.604 -0.685 . . . . 0.0 110.771 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.9 pt20 -93.58 -37.11 12.06 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.842 -1.161 . . . . 0.0 110.068 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.3 t -78.14 -55.29 5.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.04 -1.038 . . . . 0.0 109.69 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.8 t -54.89 -27.84 45.94 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.432 -0.792 . . . . 0.0 110.516 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -111.35 -15.53 13.57 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.235 -0.916 . . . . 0.0 110.451 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -140.43 -173.83 3.79 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.934 -1.104 . . . . 0.0 109.78 -179.513 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.469 ' CG2' ' H ' ' A' ' 47' ' ' CYS . 6.5 mm -64.94 178.73 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.469 ' H ' ' CG2' ' A' ' 46' ' ' ILE . 0.7 OUTLIER -143.99 127.77 17.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.957 -1.09 . . . . 0.0 109.866 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 m -80.79 149.32 29.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.333 -0.854 . . . . 0.0 109.171 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 tp -82.83 -41.59 18.88 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -55.79 -25.72 42.68 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 123.02 1.39 . . . . 0.0 108.128 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.533 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 18.6 tt0 -77.98 -22.34 49.54 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.029 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.0 mt -85.38 -28.17 25.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.661 -1.274 . . . . 0.0 108.584 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -65.49 -19.73 66.05 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.631 -0.668 . . . . 0.0 111.354 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 15.2 p30 -88.01 -8.37 55.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.813 -1.179 . . . . 0.0 108.123 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.522 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 4.7 m-85 -86.74 -26.01 24.42 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.681 0.753 . . . . 0.0 109.163 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 57' ' ' ASN . 4.2 m -67.36 95.91 0.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.705 -0.622 . . . . 0.0 111.088 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 56' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 117.923 -1.037 . . . . 0.0 108.38 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 1.267 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.151 0.501 . . . . 0.0 110.162 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p -82.4 164.27 2.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.739 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -47.87 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.991 -1.068 . . . . 0.0 109.493 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -158.66 -160.39 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.419 ' O ' ' CG ' ' A' ' 5' ' ' HIS . 44.8 p-80 -97.95 110.6 23.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.87 139.34 41.45 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.0 t -149.46 -178.47 6.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.282 -0.886 . . . . 0.0 108.792 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.96 -141.68 10.02 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.759 -1.737 . . . . 0.0 108.759 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' VAL . 3.3 p -84.07 -13.35 53.31 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.853 -1.381 . . . . 0.0 109.194 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -52.02 -27.68 14.44 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.455 ' CD2' ' OH ' ' A' ' 26' ' ' TYR . 22.4 tp -81.67 -37.25 27.74 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' SER . 13.8 t -58.73 -48.47 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.494 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 36.0 tt0 -47.74 -59.69 3.12 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.432 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 1.267 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -44.65 -61.76 1.45 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 mt -46.05 -45.55 16.14 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.552 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.22 -48.25 76.82 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.806 HD12 ' CD2' ' A' ' 1' ' ' PHE . 30.1 mt -55.75 -62.81 1.44 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 122.089 0.947 . . . . 0.0 110.836 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -64.18 -36.32 76.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.436 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.7 t -84.4 -22.68 30.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.929 -1.107 . . . . 0.0 110.559 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 70.76 -153.06 51.13 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 23' ' ' GLY . 14.7 mt-10 -83.66 3.61 32.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.244 . . . . 0.0 109.776 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.47 1.8 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 71.93 124.81 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.431 ' CZ ' HG13 ' A' ' 12' ' ' VAL . 13.2 p90 -111.52 170.42 8.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -1.034 . . . . 0.0 110.845 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -98.5 134.85 40.89 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.579 0.704 . . . . 0.0 110.034 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.464 ' CE2' HG23 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -175.92 -149.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.491 ' OG1' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 170.3 166.28 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.152 -0.967 . . . . 0.0 109.227 178.025 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.582 ' HB2' ' HG3' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -96.76 161.47 26.44 Favored Pre-proline 0 N--CA 1.487 1.397 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.56 -7.1 20.12 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 123.856 3.037 . . . . 0.0 110.493 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.449 HG21 ' N ' ' A' ' 31' ' ' GLU . 10.1 t -103.2 -28.28 12.01 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.752 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -76.85 -9.27 58.57 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 176.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 1.032 ' O ' ' O ' ' A' ' 33' ' ' GLY . 53.3 mt-10 107.89 119.9 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.574 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 1.032 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -6.14 147.86 0.0 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.962 ' HG3' HG23 ' A' ' 39' ' ' VAL . 86.0 Cg_endo -84.49 59.14 5.69 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 123.767 2.978 . . . . 0.0 115.774 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.57 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER 80.43 -37.04 0.14 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 111.187 177.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.57 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 81.93 114.55 0.06 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.082 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.5 -60.64 0.42 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.528 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 3.3 tt -82.09 -44.63 19.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.733 -0.863 . . . . 0.0 110.065 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.962 HG23 ' HG3' ' A' ' 34' ' ' PRO . 43.7 t -70.47 -61.29 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 O-C-N 121.308 -0.87 . . . . 0.0 111.37 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.28 -24.55 28.98 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.089 -1.007 . . . . 0.0 110.156 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.509 ' NE2' HE22 ' A' ' 51' ' ' GLN . 20.2 tt0 -94.42 -47.76 6.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.914 -1.116 . . . . 0.0 110.284 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 31.3 m -76.85 -33.28 57.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.069 -1.019 . . . . 0.0 110.535 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.7 t -78.65 -29.26 45.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.851 -1.156 . . . . 0.0 109.874 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -102.42 -21.5 14.24 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.301 -0.874 . . . . 0.0 109.915 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 t -140.03 -171.33 3.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.225 -0.922 . . . . 0.0 109.858 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.3 mm -82.88 174.97 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.9 m -152.08 167.16 29.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.992 -1.068 . . . . 0.0 109.701 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.75 163.44 12.26 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.634 0.73 . . . . 0.0 109.246 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.95 -32.5 30.74 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.58 -28.06 69.67 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.648 1.213 . . . . 0.0 108.569 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.528 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 6.3 tt0 -71.55 -26.3 62.58 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.517 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.657 ' CD1' ' HZ ' ' A' ' 1' ' ' PHE . 47.7 mt -85.78 -23.75 27.11 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.116 -0.99 . . . . 0.0 108.501 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -71.73 -18.37 62.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.333 -0.855 . . . . 0.0 110.89 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 16.8 p30 -86.33 -9.19 56.89 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.526 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 5.7 m-85 -84.24 -28.14 27.46 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.4 t -67.33 112.46 4.58 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.843 0.83 . . . . 0.0 110.106 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.1 m120 . . . . . 0 C--N 1.292 -1.918 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.579 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 1.468 ' CE2' ' HB3' ' A' ' 14' ' ' ALA . 8.2 p90 . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.38 169.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 119.101 -2.249 . . . . 0.0 108.902 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.38 110.02 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.057 -1.027 . . . . 0.0 109.412 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -169.33 -165.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.06 -1.025 . . . . 0.0 110.018 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 30.9 p80 -93.71 132.15 38.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.373 -0.829 . . . . 0.0 109.723 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.5 127.8 41.55 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.4 m -136.15 -177.3 4.64 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.27 -0.894 . . . . 0.0 108.758 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.62 -147.78 2.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.45 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.5 p -79.9 -14.1 58.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.326 . . . . 0.0 109.133 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -51.94 -24.25 6.17 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.45 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.1 tp -81.22 -51.34 8.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 13' ' ' GLU . 25.3 t -46.16 -46.7 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 121.908 0.861 . . . . 0.0 108.98 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.491 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.8 tt0 -47.78 -59.92 2.95 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.51 -176.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 1.468 ' HB3' ' CE2' ' A' ' 1' ' ' PHE . . . -44.99 -62.0 1.41 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.8 mt -45.53 -45.68 13.53 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.558 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.92 -52.01 65.6 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.8 mt -51.03 -62.33 1.68 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.028 0.918 . . . . 0.0 110.753 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.1 m -66.39 -34.92 73.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.409 -177.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.0 m -88.53 -6.87 57.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.949 -1.095 . . . . 0.0 110.305 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 45.87 -142.58 4.46 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 23' ' ' GLY . 19.9 mt-10 -83.13 -3.26 57.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -1.116 . . . . 0.0 109.6 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -55.64 -4.82 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.772 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 72.8 127.83 0.1 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -122.29 145.9 47.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.627 -0.925 . . . . 0.0 108.971 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -83.17 133.11 35.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.189 -0.944 . . . . 0.0 109.891 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.528 ' CE2' ' O ' ' A' ' 27' ' ' THR . 43.6 t80 -172.82 174.24 3.65 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.559 HG21 ' HB3' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -153.18 -178.01 6.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.028 -1.045 . . . . 0.0 109.494 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.06 159.93 64.28 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.268 -0.895 . . . . 0.0 108.857 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.52 -24.43 9.13 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 124.188 3.259 . . . . 0.0 113.258 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.6 p -115.07 -27.49 7.31 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.57 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 32' ' ' GLU . 4.1 mm-40 -54.22 138.07 39.49 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.892 -1.13 . . . . 0.0 109.643 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.597 ' C ' ' O ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER 24.74 -105.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.51 ' H ' ' HB2' ' A' ' 32' ' ' GLU . . . -175.2 100.37 0.15 Allowed Glycine 0 C--N 1.29 -2.014 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.675 ' O ' ' C ' ' A' ' 35' ' ' ARG . 12.0 Cg_endo -51.23 120.41 6.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.407 2.738 . . . . 0.0 113.493 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.675 ' C ' ' O ' ' A' ' 34' ' ' PRO . 0.4 OUTLIER 11.0 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 122.041 -0.412 . . . . 0.0 111.349 177.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.435 ' HD3' ' CD ' ' A' ' 40' ' ' GLU . 8.5 mmt-85 -59.6 102.18 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.5 -49.36 0.28 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 9.6 tt -82.52 -44.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.608 -0.937 . . . . 0.0 110.894 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.538 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 46.1 t -67.76 -62.61 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.379 -0.825 . . . . 0.0 111.448 -177.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.435 ' CD ' ' HD3' ' A' ' 36' ' ' ARG . 15.2 mt-10 -55.29 -25.92 37.03 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.084 -1.01 . . . . 0.0 110.369 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' SER . 16.1 tt0 -93.92 -55.92 3.06 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.05 -1.031 . . . . 0.0 110.493 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 14.4 m -67.88 -33.93 75.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.053 -1.029 . . . . 0.0 111.238 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.6 t -77.95 -32.23 51.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.726 -1.234 . . . . 0.0 110.355 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -101.97 -18.33 15.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.059 -1.026 . . . . 0.0 109.781 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLN . 3.2 m -140.17 -179.38 5.95 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.221 -0.925 . . . . 0.0 109.235 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.5 mm -78.16 173.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 108.921 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.5 m -152.11 167.45 28.46 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.197 -0.94 . . . . 0.0 109.559 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.97 163.42 12.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 109.338 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.42 -35.07 27.95 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.29 -26.26 66.37 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.729 1.252 . . . . 0.0 108.27 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.444 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 6.5 tt0 -74.69 -23.01 58.56 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.452 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.885 ' CD1' ' CZ ' ' A' ' 1' ' ' PHE . 57.4 mt -84.93 -36.75 21.23 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.75 -19.31 49.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.548 -0.72 . . . . 0.0 110.156 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -84.02 -8.51 59.12 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -90.03 -37.79 14.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.514 -0.741 . . . . 0.0 109.744 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.421 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 3.2 m -49.92 109.24 0.27 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.413 -0.804 . . . . 0.0 109.587 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.421 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 33.3 t-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.576 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 1.106 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 1.5 t80 . . . . . 0 C--O 1.174 -2.92 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.678 ' CG1' ' O ' ' A' ' 1' ' ' PHE . 16.7 m -166.79 -30.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 118.95 -2.344 . . . . 0.0 107.715 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 2' ' ' VAL . 22.4 m-80 -175.22 -102.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.586 HE22 ' CG2' ' A' ' 2' ' ' VAL . 0.1 OUTLIER 33.81 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.265 1.031 . . . . 0.0 112.879 179.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 16.8 p-80 -101.37 110.96 23.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.764 -0.585 . . . . 0.0 109.778 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.533 ' C ' ' CE1' ' A' ' 10' ' ' HIS . 0.3 OUTLIER -102.02 104.02 14.66 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.729 ' N ' ' CE1' ' A' ' 10' ' ' HIS . 17.0 m -122.0 115.35 22.37 Favored 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.59 -141.16 15.86 Favored Glycine 0 N--CA 1.507 3.426 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 12' ' ' VAL . 7.4 p -87.23 -27.32 23.03 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 120.712 -1.463 . . . . 0.0 113.783 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 1.119 ' HD1' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -45.34 -22.66 0.14 Allowed 'General case' 0 N--CA 1.527 3.395 0 CA-C-N 121.525 1.966 . . . . 0.0 106.453 178.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 1.119 ' N ' ' HD1' ' A' ' 10' ' ' HIS . 32.9 tp -79.46 -51.34 9.48 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 9' ' ' SER . 41.4 t -49.77 -53.39 10.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.3 tt0 -49.78 -59.4 3.86 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -44.53 -61.6 1.49 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.466 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 14.6 mt -46.43 -47.95 18.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.57 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.37 -55.15 31.52 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.452 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.89 HD11 ' CE1' ' A' ' 1' ' ' PHE . 31.7 mt -47.41 -62.17 1.56 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.156 0.979 . . . . 0.0 110.64 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.17 -26.6 34.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.88 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 58.6 m -97.75 1.47 48.47 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.229 -0.919 . . . . 0.0 110.723 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 48.47 -152.2 2.57 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' GLY . 43.5 tt0 -83.58 -15.05 50.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -1.138 . . . . 0.0 109.915 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.523 ' H ' ' CD ' ' A' ' 22' ' ' ARG . 7.7 mpt_? -42.84 -18.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.679 -0.638 . . . . 0.0 110.438 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 95.04 138.54 9.59 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.438 ' CZ ' HG12 ' A' ' 12' ' ' VAL . 26.6 p90 -129.29 178.0 6.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.65 -0.912 . . . . 0.0 109.047 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 55' ' ' TYR . 51.9 m-85 -104.71 132.53 50.85 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.064 -1.022 . . . . 0.0 111.244 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -175.91 -143.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 10.2 t -172.49 -151.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.06 -1.025 . . . . 0.0 109.776 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.439 ' N ' ' OG1' ' A' ' 27' ' ' THR . 0.4 OUTLIER -112.45 165.24 13.43 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 31' ' ' GLU . 10.8 Cg_endo -73.85 -75.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.291 -2.485 0 C-N-CA 122.457 2.105 . . . . 0.0 111.087 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.35 -25.93 0.16 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' PRO . 4.1 mm-40 -94.43 86.11 4.77 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.12 96.89 0.1 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.155 -0.966 . . . . 0.0 111.369 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.664 ' N ' ' CD ' ' A' ' 34' ' ' PRO . . . -151.24 45.06 0.65 Allowed Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.508 -1.806 . . . . 0.0 111.218 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 30.9 Cg_endo -61.8 170.35 5.99 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 124.833 3.688 . . . . 0.0 112.757 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.432 ' HD3' HH21 ' A' ' 35' ' ' ARG . 3.6 ttm180 -86.52 -16.11 37.95 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.605 ' HE ' ' HG2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 69.02 53.67 0.47 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.546 -0.721 . . . . 0.0 110.026 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.4 -60.02 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 18.2 tt -69.99 -47.54 68.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.72 -0.871 . . . . 0.0 110.117 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.552 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 43.9 t -62.7 -61.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 121.723 -0.61 . . . . 0.0 111.101 -177.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.584 ' OE2' ' NH2' ' A' ' 36' ' ' ARG . 18.1 mt-10 -49.61 -26.54 3.69 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.393 -0.817 . . . . 0.0 110.11 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -94.56 -61.44 1.51 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.956 -1.09 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.435 ' O ' ' O ' ' A' ' 45' ' ' SER . 59.6 m -59.31 -28.74 67.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.31 -0.869 . . . . 0.0 110.466 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.9 t -85.61 -54.51 4.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.767 -1.208 . . . . 0.0 110.499 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.535 ' H ' ' HD1' ' A' ' 44' ' ' HIS . 3.1 m80 -71.37 -15.68 62.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.816 -1.177 . . . . 0.0 109.413 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 t -140.37 178.88 6.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.4 mm -64.6 163.74 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 9.0 t -108.55 140.43 41.91 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.237 -0.914 . . . . 0.0 111.169 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 m -98.65 145.37 26.94 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 tp -82.22 -40.97 20.91 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -54.09 -26.59 27.91 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 122.796 1.284 . . . . 0.0 108.478 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.526 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 0.9 OUTLIER -78.81 -23.68 45.0 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.34 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.505 ' CD2' HE22 ' A' ' 51' ' ' GLN . 28.6 mt -84.82 -25.82 27.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.709 -1.244 . . . . 0.0 108.859 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -67.79 -19.19 65.07 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.582 -0.699 . . . . 0.0 111.189 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 15.7 p30 -88.32 -8.35 55.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.917 -1.114 . . . . 0.0 108.014 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.508 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 4.6 m-85 -85.3 -27.14 26.15 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.7 0.762 . . . . 0.0 109.201 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.456 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 3.2 m -67.99 110.92 4.12 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.432 -0.792 . . . . 0.0 110.115 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.456 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 5.4 m120 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.983 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.831 ' CG ' ' O ' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.436 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.408 ' O ' ' CG ' ' A' ' 3' ' ' ASN . 7.1 p -79.91 -42.35 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.341 -1.474 . . . . 0.0 108.48 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 4' ' ' GLN . 11.6 m120 -168.54 -98.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.542 ' O ' ' O ' ' A' ' 3' ' ' ASN . 5.1 pt20 32.22 -166.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 122.342 1.067 . . . . 0.0 112.992 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -98.14 146.47 25.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.0 109.01 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 1' ' ' PHE . 1.2 tp -132.8 108.92 9.29 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 t -117.14 145.75 43.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.516 -0.74 . . . . 0.0 109.057 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 10' ' ' HIS . . . 82.01 177.39 51.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 10' ' ' HIS . 2.6 p -54.16 -10.55 0.37 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.556 -1.555 . . . . 0.0 109.14 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 8' ' ' GLY . 40.2 m80 -52.24 -29.38 22.52 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 177.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.407 ' N ' ' C ' ' A' ' 9' ' ' SER . 10.9 tp -74.74 -49.36 21.28 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 13' ' ' GLU . 5.0 t -49.89 -41.43 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 20.6 tt0 -47.69 -59.25 3.42 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.608 -177.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.62 -61.11 1.84 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.62 ' O ' ' N ' ' A' ' 19' ' ' CYS . 7.1 mt -46.32 -44.97 17.2 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.556 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.96 -50.9 69.51 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.691 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 19.5 mt -52.02 -62.75 1.44 Allowed 'General case' 0 C--N 1.291 -1.96 0 O-C-N 120.998 -1.064 . . . . 0.0 109.866 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -69.08 -58.21 6.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.578 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.62 ' N ' ' O ' ' A' ' 15' ' ' LEU . 82.7 m -86.26 34.18 0.63 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.977 -1.077 . . . . 0.0 110.526 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . -54.7 -111.98 0.01 OUTLIER Glycine 0 N--CA 1.499 2.851 0 O-C-N 120.889 -1.132 . . . . 0.0 111.329 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -43.86 -15.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -1.053 . . . . 0.0 110.582 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 20' ' ' GLY . 3.9 mmp_? -74.58 -40.13 61.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.987 -1.07 . . . . 0.0 109.73 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.07 137.37 9.78 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -138.81 -173.33 3.53 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -154.43 118.54 4.73 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 119.928 -1.733 . . . . 0.0 112.607 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 27' ' ' THR . 32.4 m-85 -146.53 108.84 4.45 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.627 ' HG1' ' N ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -55.35 -166.12 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.148 -0.97 . . . . 0.0 109.799 -179.095 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.682 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -48.38 -172.04 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 28' ' ' ASP . 28.3 Cg_endo -85.89 -5.96 8.69 Favored 'Trans proline' 0 C--N 1.295 -2.256 0 C-N-CA 124.161 3.241 . . . . 0.0 111.308 174.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.694 ' OG1' ' N ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -145.19 -140.72 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.694 ' N ' ' OG1' ' A' ' 30' ' ' THR . 1.2 mt-10 65.1 92.07 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.126 -1.609 . . . . 0.0 108.897 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 59.21 -69.83 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.934 -0.479 . . . . 0.0 110.675 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 36' ' ' ARG . . . 168.41 169.53 31.98 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 117.765 -2.159 . . . . 0.0 112.575 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.435 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 59.1 Cg_endo -79.13 -125.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 124.346 3.364 . . . . 0.0 113.234 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.435 ' H ' ' HB2' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -94.57 -16.52 23.18 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.891 0.853 . . . . 0.0 108.904 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.533 ' CZ ' ' HA3' ' A' ' 33' ' ' GLY . 1.8 mpt_? 61.29 45.63 8.58 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.73 -83.95 0.05 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 117.285 -2.388 . . . . 0.0 109.012 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 4.8 tt -48.7 -38.74 10.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.752 -0.852 . . . . 0.0 110.371 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.458 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 39.3 t -72.87 -61.16 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.436 0.636 . . . . 0.0 111.013 -178.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -52.25 -27.07 13.54 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -93.46 -34.95 13.21 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.055 -1.028 . . . . 0.0 109.525 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' SER . 50.1 t -83.28 -49.96 8.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.721 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 39' ' ' VAL . 44.2 t -64.29 -23.94 67.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 110.018 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -102.72 -29.18 11.66 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.168 -0.957 . . . . 0.0 110.068 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 t -134.3 -172.98 3.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.375 -0.828 . . . . 0.0 109.794 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.8 mm -65.95 175.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -137.21 141.65 42.1 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.027 -1.046 . . . . 0.0 110.063 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -93.43 151.08 19.97 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 tp -83.12 -42.08 17.79 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -55.84 -25.11 40.4 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 123.017 1.389 . . . . 0.0 107.925 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.486 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 7.6 tt0 -78.69 -23.35 45.66 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.102 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.1 mt -85.36 -36.36 20.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.454 -1.404 . . . . 0.0 108.497 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -58.11 -19.57 33.38 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.645 -0.66 . . . . 0.0 110.948 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -88.03 -7.97 56.27 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.072 -1.017 . . . . 0.0 108.792 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.486 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 5.7 m-85 -88.72 -25.59 22.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.529 -0.732 . . . . 0.0 110.636 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.8 110.61 0.37 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.07 -1.019 . . . . 0.0 109.629 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 t30 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.475 179.909 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.592 ' O ' ' N ' ' A' ' 3' ' ' ASN . 23.4 p90 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.4 p -53.25 89.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 119.936 -1.727 . . . . 0.0 108.97 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 1' ' ' PHE . 1.6 m120 47.0 -132.17 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.645 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.02 166.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 109.646 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -76.73 142.19 40.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.643 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.68 124.89 34.69 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.3 m -128.05 -176.84 3.91 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.541 -0.724 . . . . 0.0 109.085 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.6 -151.44 1.07 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.452 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -77.12 -13.32 59.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.039 -1.271 . . . . 0.0 109.151 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -51.73 -23.73 4.91 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.452 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.8 tp -81.74 -50.94 8.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.411 ' O ' ' C ' ' A' ' 13' ' ' GLU . 22.5 t -46.26 -47.91 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.74 0.781 . . . . 0.0 108.979 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.483 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.5 tt0 -48.06 -59.71 3.17 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.579 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -44.72 -62.24 1.28 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 14.6 mt -44.94 -44.38 9.72 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -57.67 -49.71 75.6 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 29.1 mt -53.94 -62.84 1.39 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.117 0.96 . . . . 0.0 110.942 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 m -62.43 -37.17 78.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.955 -177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.1 t -81.23 -22.22 38.95 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.026 -1.046 . . . . 0.0 109.881 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 67.56 -146.66 47.49 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 23' ' ' GLY . 19.1 mt-10 -83.1 -1.72 53.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 0.0 109.363 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -61.92 1.69 0.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 110.033 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 64.73 120.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.47 ' CD2' ' N ' ' A' ' 24' ' ' PHE . 13.8 p90 -99.63 171.69 7.76 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.542 -0.975 . . . . 0.0 109.62 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -104.59 119.6 39.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.503 -0.748 . . . . 0.0 109.732 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.488 ' C ' ' HG1' ' A' ' 27' ' ' THR . 46.2 t80 -152.54 4.14 0.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.277 -0.89 . . . . 0.0 108.76 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.488 ' HG1' ' C ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER 60.53 175.28 0.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.507 -0.746 . . . . 0.0 109.787 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.67 165.63 0.29 Allowed Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.9 -15.04 45.98 Favored 'Trans proline' 0 C--N 1.288 -2.645 0 C-N-CA 122.214 1.942 . . . . 0.0 110.239 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 30' ' ' THR . 1.8 t -136.89 129.05 29.62 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.472 ' HG2' ' C ' ' A' ' 30' ' ' THR . 35.9 mm-40 -171.78 167.23 6.41 Favored 'General case' 0 CA--C 1.586 2.354 0 CA-C-O 123.101 1.429 . . . . 0.0 111.868 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.16 48.98 0.82 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.092 -1.63 . . . . 0.0 111.306 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.654 ' C ' ' H ' ' A' ' 35' ' ' ARG . . . 175.09 41.42 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.675 -1.726 . . . . 0.0 110.842 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 73.0 Cg_endo -66.74 29.31 0.11 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 123.168 2.578 . . . . 0.0 110.127 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.733 ' O ' ' N ' ' A' ' 37' ' ' GLY . 12.6 ttm-85 69.53 -8.6 0.73 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.639 ' H ' ' C ' ' A' ' 34' ' ' PRO . 11.0 mmt180 32.69 27.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.733 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -106.64 -67.56 0.67 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.532 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 9.2 tt -62.12 -41.24 90.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 122.118 0.961 . . . . 0.0 109.821 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.52 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 45.2 t -65.39 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 O-C-N 121.678 -0.639 . . . . 0.0 111.403 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 36' ' ' ARG . 20.1 mt-10 -60.93 -22.04 64.0 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.033 -1.042 . . . . 0.0 110.31 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -93.31 -37.84 11.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.852 -1.155 . . . . 0.0 110.345 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 28.9 m -88.59 -36.84 16.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.076 -1.015 . . . . 0.0 110.344 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.9 t -76.36 -37.16 57.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.863 -1.148 . . . . 0.0 109.98 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -91.71 -22.29 20.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.0 -1.063 . . . . 0.0 109.395 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 42' ' ' CYS . 2.7 m -140.37 -174.52 3.97 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.241 -0.912 . . . . 0.0 109.36 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.9 mm -83.53 174.14 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.864 . . . . 0.0 108.99 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 m -151.05 167.83 26.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.002 -1.061 . . . . 0.0 110.069 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.71 163.73 12.35 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.624 0.726 . . . . 0.0 109.352 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.04 -31.56 30.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.61 -27.3 68.3 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.676 1.227 . . . . 0.0 108.53 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.43 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 12.1 tt0 -71.55 -24.51 61.95 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.433 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.2 mt -84.78 -34.02 22.87 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -62.57 -18.85 62.95 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.495 -0.753 . . . . 0.0 109.911 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.2 m-20 -82.85 -8.93 59.54 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.4 m-85 -91.6 -28.74 17.33 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.61 0.719 . . . . 0.0 109.394 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 35.5 t -68.77 112.48 5.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.394 -0.816 . . . . 0.0 109.703 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 t30 . . . . . 0 C--N 1.291 -1.973 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.491 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.726 ' CD1' HD12 ' A' ' 17' ' ' LEU . 6.0 p90 . . . . . 0 C--O 1.206 -1.196 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 3' ' ' ASN . 87.1 t -145.94 91.2 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 118.524 0.602 . . . . 0.0 110.0 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.482 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.7 m120 40.01 51.56 2.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.689 -0.632 . . . . 0.0 110.162 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -132.8 161.05 35.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.491 -0.756 . . . . 0.0 110.006 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.425 ' O ' ' CG ' ' A' ' 5' ' ' HIS . 0.6 OUTLIER -50.43 124.93 11.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 110.334 -179.254 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.25 109.69 9.59 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.3 m -121.92 -177.88 3.7 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.32 -150.96 2.98 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.1 p -77.25 -12.64 59.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.952 -1.323 . . . . 0.0 109.135 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -51.63 -25.17 6.56 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.434 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.6 tp -81.31 -49.68 10.42 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.662 HG13 ' CE1' ' A' ' 24' ' ' PHE . 19.4 t -46.53 -46.48 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.521 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 35.7 tt0 -47.83 -59.69 3.13 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.429 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.516 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.02 -61.39 1.65 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.1 mt -45.86 -45.05 14.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.553 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.79 -49.81 74.22 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.726 HD12 ' CD1' ' A' ' 1' ' ' PHE . 29.1 mt -54.19 -62.42 1.67 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.098 0.951 . . . . 0.0 110.821 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.1 m -65.36 -36.75 78.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.169 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 41.9 t -80.55 -22.57 40.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.844 -1.16 . . . . 0.0 110.002 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 68.29 -146.05 45.3 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.589 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.8 mp0 -83.23 -17.13 43.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.16 -1.2 . . . . 0.0 109.211 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -45.56 -13.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.776 -0.577 . . . . 0.0 110.352 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 81.17 130.74 1.09 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.662 ' CE1' HG13 ' A' ' 12' ' ' VAL . 27.0 p90 -116.43 149.42 39.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.677 -0.896 . . . . 0.0 109.27 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -85.48 116.57 23.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.145 -0.972 . . . . 0.0 110.015 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -161.48 -11.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 28' ' ' ASP . 1.8 m 58.03 -140.43 0.78 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 109.69 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -103.09 167.07 10.76 Favored Pre-proline 0 N--CA 1.487 1.412 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.44 -19.62 19.14 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 123.007 2.471 . . . . 0.0 110.285 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -111.19 -128.92 0.29 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.908 -179.104 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.487 ' H ' ' HB ' ' A' ' 30' ' ' THR . 1.4 mt-10 60.35 -80.76 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -159.03 155.42 27.42 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.425 -1.31 . . . . 0.0 112.058 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.503 ' HA2' ' HD2' ' A' ' 34' ' ' PRO . . . -37.36 109.1 0.08 OUTLIER Glycine 0 N--CA 1.492 2.408 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.114 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.883 ' CG ' HG21 ' A' ' 39' ' ' VAL . 15.0 Cg_endo -50.35 -176.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 124.084 3.189 . . . . 0.0 112.914 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 34' ' ' PRO . 1.3 ttm180 -19.07 -31.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.836 -0.54 . . . . 0.0 111.967 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.872 ' N ' ' O ' ' A' ' 34' ' ' PRO . 1.8 tpp180 72.17 31.72 1.88 Allowed 'General case' 0 N--CA 1.511 2.578 0 O-C-N 120.555 -1.34 . . . . 0.0 107.825 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.54 -63.01 0.01 OUTLIER Glycine 0 C--N 1.274 -2.915 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.553 HG23 ' N ' ' A' ' 39' ' ' VAL . 5.4 tt -67.43 -39.3 82.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 122.106 0.955 . . . . 0.0 109.699 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.883 HG21 ' CG ' ' A' ' 34' ' ' PRO . 45.0 t -70.35 -61.87 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.74 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.87 -21.85 32.58 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.405 -0.81 . . . . 0.0 109.717 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -94.24 -49.22 5.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.158 -0.964 . . . . 0.0 110.699 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' SER . 3.0 t -80.03 -29.99 39.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.82 -1.175 . . . . 0.0 111.013 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.4 t -78.61 -49.67 12.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.658 -1.276 . . . . 0.0 109.708 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -80.94 -23.08 39.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.046 -1.034 . . . . 0.0 109.349 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 m -139.96 -173.04 3.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.305 -0.872 . . . . 0.0 108.951 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 47' ' ' CYS . 1.9 mm -86.5 168.33 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.174 -0.954 . . . . 0.0 108.791 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.508 ' N ' HG22 ' A' ' 46' ' ' ILE . 23.1 p -149.45 161.08 42.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.07 -1.019 . . . . 0.0 109.259 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.93 164.85 14.4 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.083 0.945 . . . . 0.0 111.079 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.569 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.74 -36.92 25.34 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.91 -26.3 62.01 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 122.757 1.265 . . . . 0.0 108.094 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.44 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 40.8 tt0 -76.49 -22.53 54.37 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.736 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.7 mt -85.28 -30.9 23.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.861 -1.15 . . . . 0.0 108.235 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -64.2 -19.29 65.24 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.564 -0.71 . . . . 0.0 111.049 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.631 ' ND2' ' CD1' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -87.51 -8.57 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.926 -1.109 . . . . 0.0 108.045 178.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.631 ' CD1' ' ND2' ' A' ' 54' ' ' ASN . 4.9 m-85 -84.78 -28.69 26.0 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.3 t -68.48 112.31 5.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.444 -0.785 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--N 1.29 -1.992 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.445 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.742 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.476 0.655 . . . . 0.0 109.815 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 4' ' ' GLN . 3.3 t 54.88 48.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.267 0.556 . . . . 0.0 110.021 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 4' ' ' GLN . 22.2 m-80 56.68 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.107 -0.996 . . . . 0.0 110.28 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 3' ' ' ASN . 5.8 pt20 35.43 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.69 -0.631 . . . . 0.0 111.498 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 51.8 p-80 -90.86 123.9 34.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.126 -0.984 . . . . 0.0 109.612 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -129.88 116.75 19.12 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.6 m -122.41 -176.91 3.48 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.542 -0.724 . . . . 0.0 109.123 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 44.02 -149.21 0.87 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.458 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.2 p -80.81 -9.48 59.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.942 -1.328 . . . . 0.0 108.865 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 9' ' ' SER . 50.6 m80 -52.29 -24.63 7.74 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.458 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.0 tp -77.76 -53.82 7.07 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.64 HG13 ' CE1' ' A' ' 24' ' ' PHE . 5.0 t -46.55 -42.56 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.531 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.6 tt0 -46.84 -59.21 3.22 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.635 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.49 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.37 -61.42 1.68 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.763 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.1 mt -46.14 -48.41 17.37 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -51.24 -48.47 62.13 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.357 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.61 HD12 ' CE1' ' A' ' 1' ' ' PHE . 19.6 mt -57.31 -63.66 1.15 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.168 -0.957 . . . . 0.0 110.532 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -64.55 -47.59 88.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.965 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.473 ' N ' ' O ' ' A' ' 15' ' ' LEU . 67.0 m -73.05 -20.81 60.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.908 -1.12 . . . . 0.0 109.756 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 42.55 -125.74 4.33 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -83.63 -15.2 49.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -1.015 . . . . 0.0 110.077 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -46.73 -29.12 1.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.103 -0.998 . . . . 0.0 109.481 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.45 127.54 4.29 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.705 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.64 ' CE1' HG13 ' A' ' 12' ' ' VAL . 29.1 p90 -132.83 176.29 8.6 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -154.01 125.75 7.66 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 119.589 -1.944 . . . . 0.0 112.527 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.763 ' CE2' HD13 ' A' ' 15' ' ' LEU . 20.3 m-85 -141.33 -179.93 6.41 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.572 HG22 ' CB ' ' A' ' 31' ' ' GLU . 1.4 m -152.35 171.88 17.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.001 -1.062 . . . . 0.0 109.629 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.449 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -74.64 164.77 59.02 Favored Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 121.493 -0.755 . . . . 0.0 108.969 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 28' ' ' ASP . 16.8 Cg_endo -53.93 -34.74 77.74 Favored 'Trans proline' 0 C--N 1.276 -3.27 0 C-N-CA 123.7 2.933 . . . . 0.0 111.559 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.895 ' C ' ' H ' ' A' ' 32' ' ' GLU . 14.3 t -102.54 -34.17 9.21 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.45 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.572 ' CB ' HG22 ' A' ' 27' ' ' THR . 46.7 mm-40 -62.28 10.19 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.895 ' H ' ' C ' ' A' ' 30' ' ' THR . 0.4 OUTLIER 106.99 123.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.708 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 32' ' ' GLU . . . -48.01 156.46 1.04 Allowed Glycine 0 N--CA 1.478 1.481 0 N-CA-C 107.261 -2.335 . . . . 0.0 107.261 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.58 ' HG2' HG21 ' A' ' 39' ' ' VAL . 42.7 Cg_endo -94.73 -147.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.288 -2.641 0 C-N-CA 123.34 2.694 . . . . 0.0 111.595 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.726 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.4 OUTLIER -63.07 84.06 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.5 -1.375 . . . . 0.0 109.004 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.574 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -47.22 110.73 0.33 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 158.2 -89.83 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -176.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.557 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.3 tt -46.9 -40.26 4.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 122.009 0.909 . . . . 0.0 109.982 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.58 HG21 ' HG2' ' A' ' 34' ' ' PRO . 47.1 t -69.45 -61.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 O-C-N 121.298 -0.876 . . . . 0.0 110.308 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.47 ' HG3' ' HD2' ' A' ' 36' ' ' ARG . 42.6 mt-10 -62.53 -19.42 63.62 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.141 -0.974 . . . . 0.0 109.724 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -94.18 -39.31 10.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.082 -1.011 . . . . 0.0 110.088 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 33.7 m -88.47 -40.43 13.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.967 -1.083 . . . . 0.0 110.365 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.0 t -71.02 -25.77 62.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.792 -1.192 . . . . 0.0 109.541 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -102.95 -25.88 13.3 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.334 -0.854 . . . . 0.0 109.195 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -137.41 -168.06 2.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.404 -0.81 . . . . 0.0 108.964 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 47' ' ' CYS . 4.2 mm -94.98 169.95 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.131 -0.98 . . . . 0.0 109.499 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.577 ' N ' HG22 ' A' ' 46' ' ' ILE . 98.3 m -149.21 167.85 24.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.088 -1.008 . . . . 0.0 110.104 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.21 165.24 12.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.831 . . . . 0.0 109.521 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -82.67 -35.24 27.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 178.167 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.17 -25.28 65.42 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.756 1.265 . . . . 0.0 108.238 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.474 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 14.1 tt0 -75.81 -22.41 56.36 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.545 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -84.42 -33.29 23.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.852 -1.155 . . . . 0.0 107.983 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -64.19 -17.88 63.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.624 -0.672 . . . . 0.0 110.319 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -86.48 -8.41 57.61 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 108.607 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.554 ' CE2' ' HD3' ' A' ' 35' ' ' ARG . 5.0 m-85 -88.12 -39.85 14.24 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.765 0.793 . . . . 0.0 109.606 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.99 110.15 0.36 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.549 -0.719 . . . . 0.0 109.636 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.7 t30 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.485 179.916 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.842 ' CZ ' HD11 ' A' ' 52' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.236 0.541 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.753 HG22 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER 39.65 -96.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.272 -1.517 . . . . 0.0 110.792 176.489 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.753 ' N ' HG22 ' A' ' 2' ' ' VAL . 23.7 m-20 -139.06 -43.63 0.47 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.882 -1.136 . . . . 0.0 109.85 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.51 ' O ' ' O ' ' A' ' 3' ' ' ASN . 2.4 pt20 -18.28 143.55 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.56 ' N ' ' ND1' ' A' ' 5' ' ' HIS . 3.2 p-80 -46.21 141.98 3.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.692 . . . . 0.0 110.284 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.69 HD22 ' CE1' ' A' ' 1' ' ' PHE . 0.7 OUTLIER -131.1 109.96 10.84 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.8 m -114.87 146.1 41.47 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.32 -0.862 . . . . 0.0 109.106 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.61 -175.57 54.84 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.9 p -56.05 -15.07 3.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.984 -1.304 . . . . 0.0 109.115 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -52.12 -24.16 6.53 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' A' ' 9' ' ' SER . 15.0 tp -81.83 -47.64 12.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.583 HG13 ' CE1' ' A' ' 24' ' ' PHE . 24.4 t -49.66 -46.66 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.53 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.8 tt0 -48.7 -59.97 3.11 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.484 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.721 ' HB1' ' CE2' ' A' ' 1' ' ' PHE . . . -44.45 -60.66 1.85 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.7 mt -45.81 -51.38 12.93 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -50.03 -50.95 45.88 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.545 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 27.0 mt -53.65 -62.33 1.72 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.179 0.99 . . . . 0.0 111.299 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -68.27 -40.71 83.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.662 -176.207 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.647 ' O ' ' NH2' ' A' ' 22' ' ' ARG . 95.4 m -78.31 -28.44 47.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.72 -1.238 . . . . 0.0 112.581 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.743 ' C ' HH22 ' A' ' 22' ' ' ARG . . . 86.89 -150.2 22.86 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.314 -1.422 . . . . 0.0 111.046 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 23' ' ' GLY . 30.6 tt0 -87.8 -18.72 28.72 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.63 -0.923 . . . . 0.0 113.338 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.747 ' NH1' ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -43.12 -15.07 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 O-C-N 120.798 -1.189 . . . . 0.0 110.932 -177.467 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.747 ' H ' ' NH1' ' A' ' 22' ' ' ARG . . . 85.8 93.43 0.83 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.703 ' N ' HH11 ' A' ' 22' ' ' ARG . 29.9 p90 -76.88 161.58 28.3 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.305 -1.115 . . . . 0.0 109.383 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.623 ' CB ' ' NH1' ' A' ' 35' ' ' ARG . 60.5 m-85 -89.9 132.69 35.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.303 -0.873 . . . . 0.0 110.631 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -173.16 -22.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.72 168.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.489 -0.757 . . . . 0.0 110.012 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -85.51 163.64 43.68 Favored Pre-proline 0 N--CA 1.485 1.316 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.829 ' O ' ' C ' ' A' ' 30' ' ' THR . 1.2 Cg_endo -48.24 -134.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 124.76 3.64 . . . . 0.0 113.099 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.829 ' C ' ' O ' ' A' ' 29' ' ' PRO . 69.2 p 9.95 -119.79 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.49 1.138 . . . . 0.0 108.278 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.743 ' C ' ' O ' ' A' ' 30' ' ' THR . 8.5 mt-10 3.07 90.11 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.215 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 46.58 -129.61 1.4 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.535 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.69 -173.16 19.9 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.169 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.754 ' HG3' HG21 ' A' ' 39' ' ' VAL . 72.5 Cg_endo -67.84 -126.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 124.163 3.242 . . . . 0.0 111.124 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.766 ' O ' ' O ' ' A' ' 36' ' ' ARG . 12.5 ttm180 -110.91 14.7 22.05 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.766 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 45.37 110.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.86 -67.32 0.36 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 116.138 -2.934 . . . . 0.0 107.745 -176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.612 HG23 ' N ' ' A' ' 39' ' ' VAL . 7.3 tt -67.78 -44.61 85.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.805 0.812 . . . . 0.0 109.348 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.754 HG21 ' HG3' ' A' ' 34' ' ' PRO . 44.4 t -65.53 -61.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.425 0.631 . . . . 0.0 111.078 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.56 ' OE2' ' HG3' ' A' ' 36' ' ' ARG . 3.0 mt-10 -51.7 -26.42 9.26 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.658 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 45' ' ' SER . 17.8 tt0 -93.96 -61.21 1.58 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.122 -0.986 . . . . 0.0 110.414 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 45' ' ' SER . 98.0 m -58.36 -37.0 74.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.139 -0.976 . . . . 0.0 110.652 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.19 -38.54 31.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.903 -1.123 . . . . 0.0 110.516 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -86.99 -17.31 33.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.838 -1.164 . . . . 0.0 109.249 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 41' ' ' GLN . 7.9 t -140.42 -164.89 1.81 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.432 -0.792 . . . . 0.0 109.071 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 47' ' ' CYS . 4.5 mm -76.46 167.4 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.082 -1.011 . . . . 0.0 109.328 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.589 ' N ' HG22 ' A' ' 46' ' ' ILE . 4.5 t -121.15 139.14 53.76 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.451 -0.781 . . . . 0.0 110.381 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -101.15 150.88 22.48 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.451 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.5 tp -82.34 -38.52 24.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.479 1.133 . . . . 0.0 108.038 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.53 -24.24 60.15 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 123.005 1.383 . . . . 0.0 108.199 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.474 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 6.5 tp60 -79.8 -24.62 41.29 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.033 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.842 HD11 ' CZ ' ' A' ' 1' ' ' PHE . 33.9 mt -85.3 -30.99 23.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.494 -1.379 . . . . 0.0 109.107 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -62.32 -20.81 64.73 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.682 -0.637 . . . . 0.0 111.549 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.643 ' ND2' ' CD1' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -88.53 -7.79 55.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.823 -1.173 . . . . 0.0 108.838 179.424 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.643 ' CD1' ' ND2' ' A' ' 54' ' ' ASN . 5.1 m-85 -83.72 -9.79 58.59 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.671 0.748 . . . . 0.0 109.465 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.429 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -91.42 115.82 28.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.569 -0.707 . . . . 0.0 109.351 -179.43 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.429 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 55.9 t-20 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.026 -1.046 . . . . 0.0 109.282 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.686 ' C ' ' CD1' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.728 0.299 . . . . 0.0 110.687 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 3' ' ' ASN . 14.0 p -66.02 163.62 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 119.967 -1.708 . . . . 0.0 108.708 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.506 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.1 m120 -49.04 98.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.04 -1.038 . . . . 0.0 109.531 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 2' ' ' VAL . 14.9 pt20 -159.03 -163.94 1.32 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.841 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -89.86 131.2 35.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.743 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.93 109.65 11.79 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.5 m -118.58 152.59 35.73 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.523 -0.736 . . . . 0.0 109.248 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.57 -163.24 54.34 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.456 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -66.47 -14.63 62.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.864 -1.374 . . . . 0.0 109.261 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' SER . 4.5 m-70 -51.18 -24.67 4.43 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.456 ' N ' ' C ' ' A' ' 9' ' ' SER . 14.1 tp -81.86 -46.67 13.8 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.636 HG13 ' CE1' ' A' ' 24' ' ' PHE . 18.7 t -50.15 -46.15 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.538 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 20.7 tt0 -49.16 -59.72 3.41 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.446 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.481 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.43 -60.67 1.84 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.2 mt -45.38 -53.68 8.3 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.554 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -47.75 -49.62 27.8 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.346 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 26.4 mt -56.01 -62.59 1.6 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.106 0.955 . . . . 0.0 111.304 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.9 OUTLIER -67.56 -48.12 77.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.643 -176.292 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.501 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 30.9 m -73.86 -26.48 60.59 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.868 -1.145 . . . . 0.0 112.787 -175.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.499 ' C ' ' HE ' ' A' ' 22' ' ' ARG . . . 85.15 -161.21 35.71 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 119.473 -2.017 . . . . 0.0 111.156 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 23' ' ' GLY . 11.8 mt-10 -86.85 -13.26 45.48 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -177.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.704 ' NE ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.66 0.1 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 119.513 -1.992 . . . . 0.0 110.712 -178.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.594 ' N ' ' CZ ' ' A' ' 22' ' ' ARG . . . 88.52 113.48 1.21 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.696 ' N ' HH12 ' A' ' 22' ' ' ARG . 26.9 p90 -98.45 141.83 30.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -1.024 . . . . 0.0 109.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.33 126.75 30.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.516 -0.74 . . . . 0.0 110.33 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 27' ' ' THR . 53.9 t80 -173.14 -22.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.595 -0.69 . . . . 0.0 109.164 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.917 HG21 ' OE2' ' A' ' 31' ' ' GLU . 56.6 m 49.29 -176.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.179 -0.951 . . . . 0.0 109.548 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.854 ' H ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -50.6 -171.91 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.338 -0.852 . . . . 0.0 108.94 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 28' ' ' ASP . 76.9 Cg_endo -92.36 -34.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.261 2.64 . . . . 0.0 108.913 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.99 HG23 ' N ' ' A' ' 31' ' ' GLU . 3.8 t -66.6 -92.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.68 1.228 . . . . 0.0 109.539 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.99 ' N ' HG23 ' A' ' 30' ' ' THR . 9.5 tp10 57.76 5.39 0.34 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.338 -1.476 . . . . 0.0 108.394 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.647 ' HG2' ' C ' ' A' ' 31' ' ' GLU . 2.6 pt-20 43.13 35.87 0.88 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.197 -0.939 . . . . 0.0 108.696 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.12 98.87 2.56 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 30.2 Cg_endo -87.38 -117.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.683 2.922 . . . . 0.0 112.439 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.628 ' O ' ' C ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -82.09 -13.91 56.59 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.212 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.709 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER 34.66 70.22 0.14 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.88 -83.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 CA-C-N 113.482 -1.69 . . . . 0.0 109.008 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.586 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.3 tt -55.31 -42.4 66.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.721 -0.87 . . . . 0.0 110.145 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.586 ' N ' HG23 ' A' ' 38' ' ' ILE . 42.2 t -63.93 -60.68 2.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.306 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.709 ' OE2' ' HD2' ' A' ' 36' ' ' ARG . 38.7 mt-10 -59.23 -20.11 51.33 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.215 -0.928 . . . . 0.0 109.872 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -94.58 -36.18 11.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.042 -1.037 . . . . 0.0 110.021 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 45' ' ' SER . 92.2 m -88.46 -38.17 15.22 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.232 -0.917 . . . . 0.0 110.537 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.5 t -77.86 -44.92 25.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -0.996 . . . . 0.0 110.597 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -82.76 -20.35 36.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.992 -1.068 . . . . 0.0 109.822 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.8 m -140.38 -171.85 3.3 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.271 -0.893 . . . . 0.0 109.61 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 47' ' ' CYS . 6.5 mm -64.85 170.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 108.97 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.576 ' N ' HG22 ' A' ' 46' ' ' ILE . 8.3 t -128.19 122.51 32.02 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.459 -0.775 . . . . 0.0 110.157 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.5 m -79.75 146.72 32.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 108.728 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.1 tp -82.34 -40.5 21.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -57.15 -25.62 59.21 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.979 1.371 . . . . 0.0 108.147 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.477 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 7.0 tt0 -77.62 -24.12 49.66 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.933 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.3 mt -84.68 -29.48 25.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.777 -1.202 . . . . 0.0 108.487 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -64.6 -19.35 65.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.756 -0.59 . . . . 0.0 111.058 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -88.31 -7.24 57.05 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.027 -1.046 . . . . 0.0 109.188 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.477 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 5.1 m-85 -86.6 -6.72 58.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.579 -0.701 . . . . 0.0 111.147 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.87 113.86 20.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.148 -0.97 . . . . 0.0 110.314 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.4 t30 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.842 -179.932 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.62 ' O ' ' C ' ' A' ' 2' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.732 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.8 OUTLIER 32.23 -153.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 118.655 -2.528 . . . . 0.0 110.643 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.732 ' N ' HG13 ' A' ' 2' ' ' VAL . 1.6 m120 -101.74 93.95 5.59 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.053 -1.03 . . . . 0.0 109.551 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -152.5 -178.81 7.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.217 -0.927 . . . . 0.0 109.26 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 5' ' ' HIS . 1.2 m-70 -75.54 133.2 41.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.999 -1.063 . . . . 0.0 109.378 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.95 120.01 24.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.7 m -127.18 -178.26 4.37 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.448 -0.782 . . . . 0.0 109.207 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.56 -149.05 2.29 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.439 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.4 p -77.97 -14.12 59.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.026 -1.279 . . . . 0.0 109.241 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -51.86 -24.07 5.69 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.439 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.7 tp -81.56 -51.14 8.56 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.618 HG13 ' CE1' ' A' ' 24' ' ' PHE . 24.6 t -45.44 -46.77 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.697 0.761 . . . . 0.0 108.988 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 35.8 tt0 -47.89 -59.81 3.06 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.378 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.05 -61.5 1.61 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.7 mt -45.66 -46.84 14.94 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.554 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.54 -48.73 71.66 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 24.7 mt -55.91 -62.8 1.46 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.156 0.979 . . . . 0.0 110.827 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -64.94 -31.93 56.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.221 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.1 m -92.12 -7.38 48.68 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.999 -1.063 . . . . 0.0 110.096 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 47.4 -144.0 5.61 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 23' ' ' GLY . 14.3 tp10 -79.35 -19.29 50.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.594 -0.945 . . . . 0.0 109.996 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -42.58 -17.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.457 -0.777 . . . . 0.0 110.653 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 88.02 137.5 5.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CE1' HG13 ' A' ' 12' ' ' VAL . 34.1 p90 -131.33 144.95 51.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.69 -0.888 . . . . 0.0 109.473 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -87.89 127.55 35.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.327 -0.858 . . . . 0.0 109.646 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' ' 27' ' ' THR . 85.9 t80 -163.14 -48.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 108.961 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 28' ' ' ASP . 2.4 m 53.6 172.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.451 -0.781 . . . . 0.0 109.842 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.5 ' H ' HG22 ' A' ' 27' ' ' THR . 0.2 OUTLIER -82.82 171.04 12.65 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 31' ' ' GLU . 19.2 Cg_endo -52.12 -83.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.515 2.745 0 C-N-CA 123.699 2.932 . . . . 0.0 114.546 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.561 ' H ' ' HG2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -43.65 4.09 0.0 OUTLIER 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 109.493 -3.503 . . . . 0.0 112.454 -176.566 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.921 ' O ' ' O ' ' A' ' 32' ' ' GLU . 1.1 tp10 -95.26 138.45 32.95 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 119.917 -1.74 . . . . 0.0 107.97 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.921 ' O ' ' O ' ' A' ' 31' ' ' GLU . 3.7 mp0 13.03 -140.93 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.396 -1.44 . . . . 0.0 109.161 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.41 ' HA2' ' HD2' ' A' ' 34' ' ' PRO . . . -121.66 97.95 0.63 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.41 ' HD2' ' HA2' ' A' ' 33' ' ' GLY . 39.4 Cg_endo -62.98 30.06 0.07 OUTLIER 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.906 3.07 . . . . 0.0 113.751 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.14 123.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.85 -1.156 . . . . 0.0 112.035 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.425 ' N ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -92.52 112.33 24.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.551 -0.718 . . . . 0.0 110.787 179.311 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.93 -48.49 0.06 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 39' ' ' VAL . 13.3 tt -82.21 -42.47 18.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.541 -0.976 . . . . 0.0 110.332 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.595 ' N ' HG23 ' A' ' 38' ' ' ILE . 54.1 t -69.42 -62.17 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 O-C-N 121.63 -0.669 . . . . 0.0 111.016 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -59.21 -22.01 60.39 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -94.31 -41.61 9.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.995 -1.065 . . . . 0.0 110.497 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 45' ' ' SER . 1.8 t -86.46 -29.73 22.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.867 -1.145 . . . . 0.0 110.737 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 51.8 t -81.58 -51.62 8.05 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.604 -1.31 . . . . 0.0 109.446 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -24.81 53.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.045 -1.034 . . . . 0.0 108.743 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' CYS . 5.1 m -140.52 -174.88 4.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.314 -0.866 . . . . 0.0 109.123 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.5 mt -90.64 148.92 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.233 -0.917 . . . . 0.0 109.216 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 20.6 p -128.88 167.39 17.45 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.378 -0.827 . . . . 0.0 109.775 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.82 165.3 13.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.303 -0.873 . . . . 0.0 110.79 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.68 -36.61 25.76 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.054 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.11 -25.27 61.15 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.862 1.315 . . . . 0.0 108.097 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.461 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 13.1 tt0 -77.8 -22.19 50.46 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.695 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.3 mt -84.5 -33.66 23.51 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.748 -1.22 . . . . 0.0 107.869 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -62.89 -18.72 63.38 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.554 -0.716 . . . . 0.0 110.162 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -84.84 -8.52 58.76 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -90.39 -37.33 14.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.695 -0.628 . . . . 0.0 109.643 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 m -49.8 110.94 0.44 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.507 -0.746 . . . . 0.0 109.718 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.464 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.63 ' HE2' HD11 ' A' ' 52' ' ' LEU . 1.9 t80 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 123.251 1.501 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 2' ' ' VAL . 6.1 p -90.23 84.55 2.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.335 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 2' ' ' VAL . 1.6 m-20 41.29 70.25 0.28 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 110.567 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.584 ' H ' ' HE1' ' A' ' 1' ' ' PHE . 15.2 pt20 -141.69 169.86 16.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.057 -1.027 . . . . 0.0 109.639 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -63.16 126.63 28.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.895 . . . . 0.0 110.482 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 1' ' ' PHE . 0.8 OUTLIER -129.89 123.75 31.52 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.3 m -130.77 179.47 5.95 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.344 -0.847 . . . . 0.0 108.929 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.51 -147.68 2.78 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.44 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -77.29 -14.38 59.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.026 -1.279 . . . . 0.0 109.328 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -52.53 -24.02 7.36 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.4 tp -81.29 -49.58 10.56 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.638 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.3 t -46.56 -45.73 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.514 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 14.8 tt0 -48.08 -60.03 2.93 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.244 -0.983 . . . . 0.0 109.476 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.526 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.0 -61.55 1.58 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.7 mt -45.65 -45.98 14.32 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.81 -51.52 67.19 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.0 mt -51.68 -62.38 1.66 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.113 0.959 . . . . 0.0 110.778 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -66.06 -36.7 78.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.23 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.8 m -87.09 -4.93 59.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.935 -1.103 . . . . 0.0 110.146 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 46.88 -146.75 3.47 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 23' ' ' GLY . 32.0 mt-10 -83.39 -0.11 48.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -1.176 . . . . 0.0 109.719 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -58.79 -0.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 109.939 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 73.5 131.58 0.19 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.638 ' CE1' HG13 ' A' ' 12' ' ' VAL . 28.6 p90 -126.4 148.61 49.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.589 -0.947 . . . . 0.0 109.347 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -82.51 123.53 29.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 0.0 110.042 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.47 ' CE2' ' O ' ' A' ' 27' ' ' THR . 36.4 t80 -172.27 160.44 5.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 109.21 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -154.73 -156.16 0.64 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.322 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.554 ' H ' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -91.86 172.17 6.82 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.603 ' O ' ' C ' ' A' ' 30' ' ' THR . 57.0 Cg_endo -68.66 -145.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 118.067 -1.596 . . . . 0.0 112.718 176.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.321 ' O ' ' N ' ' A' ' 32' ' ' GLU 0.255 36.8 m 14.14 -107.66 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.024 -1.443 . . . . 0.0 112.982 175.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.73 ' C ' ' O ' ' A' ' 30' ' ' THR . 18.9 mt-10 16.59 -56.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 123.622 1.677 . . . . 0.0 107.093 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 1.321 ' N ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -156.16 -179.13 7.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.109 -2.314 . . . . 0.0 107.024 178.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.463 ' HA3' ' HD2' ' A' ' 36' ' ' ARG . . . -112.42 122.03 5.81 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.287 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.827 ' C ' ' H ' ' A' ' 36' ' ' ARG . 80.1 Cg_endo -75.08 81.26 2.26 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 124.217 3.278 . . . . 0.0 110.837 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.862 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 57.49 -10.65 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.827 ' H ' ' C ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER 30.12 21.35 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.973 -0.454 . . . . 0.0 110.327 -179.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.862 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -104.1 -36.57 3.12 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 107.779 -2.128 . . . . 0.0 107.779 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 39' ' ' VAL . 11.3 tt -81.83 -45.92 20.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.551 0.691 . . . . 0.0 110.344 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.618 ' N ' HG23 ' A' ' 38' ' ' ILE . 55.8 t -64.62 -61.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.78 -0.575 . . . . 0.0 111.726 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.52 -23.59 64.67 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.223 -0.923 . . . . 0.0 110.126 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -94.33 -33.96 12.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.982 -1.074 . . . . 0.0 109.954 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 38' ' ' ILE . 51.0 t -88.51 -43.58 11.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.152 -0.967 . . . . 0.0 110.568 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.78 -24.22 62.55 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 110.73 -178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -104.82 -19.07 14.02 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.201 -0.937 . . . . 0.0 109.524 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -140.1 179.52 6.57 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.264 -0.898 . . . . 0.0 109.035 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.821 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.0 mm -64.62 -177.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.996 . . . . 0.0 108.324 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.821 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -146.03 150.45 36.01 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.897 -1.127 . . . . 0.0 110.222 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -97.16 151.74 19.51 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -82.57 -40.46 20.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -57.67 -24.79 58.54 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 122.841 1.305 . . . . 0.0 107.943 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.443 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 7.7 tt0 -78.44 -23.03 46.78 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.802 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.63 HD11 ' HE2' ' A' ' 1' ' ' PHE . 46.1 mt -84.8 -36.89 21.36 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.69 -20.66 50.47 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.507 -0.746 . . . . 0.0 110.002 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -82.99 -8.94 59.51 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.7 m-85 -90.34 -36.72 14.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.551 -0.718 . . . . 0.0 109.316 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -51.51 110.49 0.46 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.376 -0.827 . . . . 0.0 109.565 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.6 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.505 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.851 ' CD1' ' O ' ' A' ' 1' ' ' PHE . 48.8 p90 . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 3' ' ' ASN . 9.1 p -55.27 167.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 116.145 -2.222 . . . . 0.0 108.976 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.585 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.6 m120 -52.78 105.77 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.002 -1.061 . . . . 0.0 109.952 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -164.49 -160.77 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.172 -0.955 . . . . 0.0 109.77 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -95.45 132.66 40.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.247 -0.908 . . . . 0.0 109.609 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.1 113.71 15.45 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.01 148.72 50.54 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.42 -169.99 53.05 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.412 ' C ' ' N ' ' A' ' 11' ' ' LEU . 4.3 p -60.95 -14.8 25.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.612 -1.523 . . . . 0.0 109.202 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -52.81 -25.74 12.33 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.501 HD13 ' SG ' ' A' ' 42' ' ' CYS . 13.0 tp -81.11 -47.9 12.88 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.618 HG13 ' CE1' ' A' ' 24' ' ' PHE . 27.2 t -48.08 -47.35 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.513 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.1 tt0 -47.51 -59.91 2.9 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.561 -176.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.627 ' HB1' ' CE2' ' A' ' 1' ' ' PHE . . . -45.23 -61.38 1.68 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.429 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 13.0 mt -45.76 -45.94 14.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.75 -52.46 63.86 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.472 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.7 mt -50.59 -62.32 1.67 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.079 0.942 . . . . 0.0 110.614 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -67.25 -31.92 55.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.036 -177.207 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 47.7 m -91.72 0.51 57.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.045 -1.034 . . . . 0.0 109.995 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 45.86 -158.7 0.29 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.32 -2.94 43.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -1.152 . . . . 0.0 109.354 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -46.62 -58.63 3.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.865 . . . . 0.0 109.487 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.58 131.18 2.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CE1' HG13 ' A' ' 12' ' ' VAL . 34.3 p90 -131.4 143.72 50.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.68 -0.894 . . . . 0.0 108.846 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -86.29 134.35 33.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.324 -0.86 . . . . 0.0 110.266 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' THR . 86.3 t80 -172.9 -24.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.44 -0.788 . . . . 0.0 109.399 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' TYR . 3.1 p 47.62 -175.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.734 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.84 ' O ' ' N ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -98.84 162.53 21.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.72 ' O ' HG22 ' A' ' 30' ' ' THR . 53.2 Cg_exo -42.51 32.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 124.212 3.275 . . . . 0.0 113.593 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.84 ' N ' ' O ' ' A' ' 28' ' ' ASP . 3.6 p -158.39 -101.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.708 -1.245 . . . . 0.0 111.437 -177.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.67 ' C ' ' O ' ' A' ' 30' ' ' THR . 14.5 mt-10 0.9 69.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.095 -1.003 . . . . 0.0 111.017 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.947 ' OE2' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER 62.49 -40.63 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.736 -1.227 . . . . 0.0 110.415 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 85.05 178.12 50.94 Favored Glycine 0 N--CA 1.503 3.113 0 O-C-N 119.824 -1.797 . . . . 0.0 109.23 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 94.3 Cg_endo -77.82 -148.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.893 3.062 . . . . 0.0 112.292 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.872 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -120.12 85.71 2.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.722 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -15.11 104.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.668 1.223 . . . . 0.0 109.368 -178.833 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.12 -54.25 0.02 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.584 HG23 ' N ' ' A' ' 39' ' ' VAL . 8.4 tt -81.9 -45.34 20.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.664 -0.904 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 38' ' ' ILE . 40.3 t -64.69 -62.24 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.625 -0.672 . . . . 0.0 111.962 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.53 ' CG ' ' HG3' ' A' ' 36' ' ' ARG . 25.3 mt-10 -47.77 -33.63 7.4 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.284 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.2 mt-30 -93.52 -59.54 1.99 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.003 -1.06 . . . . 0.0 109.415 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.501 ' SG ' HD13 ' A' ' 11' ' ' LEU . 17.6 t -52.8 -34.07 51.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.108 -0.995 . . . . 0.0 110.738 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.7 t -85.28 -53.03 5.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.863 -1.148 . . . . 0.0 110.831 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.446 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 2.3 m-70 -86.17 -5.06 59.27 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.966 -1.084 . . . . 0.0 110.511 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.0 m -140.39 -177.82 5.21 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.054 -1.029 . . . . 0.0 109.362 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.0 mm -64.66 -178.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.173 -0.954 . . . . 0.0 108.524 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.804 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.3 t -134.91 130.46 35.93 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.162 -0.961 . . . . 0.0 110.543 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.7 m -95.03 145.97 24.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.5 tp -82.5 -40.33 21.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -56.41 -24.97 48.4 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 122.945 1.355 . . . . 0.0 108.147 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.472 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 9.3 tt0 -79.39 -22.83 43.79 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.142 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.542 HD12 ' CZ ' ' A' ' 1' ' ' PHE . 38.8 mt -85.46 -38.33 18.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.597 -1.314 . . . . 0.0 108.223 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.31 -20.17 26.82 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.487 -0.758 . . . . 0.0 110.368 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -83.87 -8.69 59.14 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.472 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 3.6 m-85 -90.55 -39.18 12.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.6 -0.688 . . . . 0.0 109.758 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -49.67 110.65 0.4 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.353 -0.842 . . . . 0.0 109.546 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.6 t30 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.509 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.828 ' CD2' HD12 ' A' ' 17' ' ' LEU . 33.3 p90 . . . . . 0 CA--C 1.56 1.364 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.507 HG12 ' ND2' ' A' ' 3' ' ' ASN . 60.1 t 42.55 -99.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.409 -1.432 . . . . 0.0 109.23 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.519 ' O ' ' O ' ' A' ' 4' ' ' GLN . 1.9 m-20 -147.46 -30.77 0.32 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.07 -1.019 . . . . 0.0 109.89 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.519 ' O ' ' O ' ' A' ' 3' ' ' ASN . 4.3 pt20 -25.44 152.92 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.959 0.885 . . . . 0.0 112.98 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -45.77 136.07 6.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.327 -0.858 . . . . 0.0 109.603 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 1' ' ' PHE . 1.1 tp -134.38 109.38 8.75 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' GLY . 59.5 m -106.64 -176.39 3.06 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.153 -0.967 . . . . 0.0 109.685 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 7' ' ' CYS . . . 43.26 -164.43 0.03 OUTLIER Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.467 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.0 p -69.0 -8.65 46.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.985 -1.303 . . . . 0.0 109.23 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -53.33 -22.84 7.95 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.283 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.467 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.0 tp -78.99 -52.33 8.39 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.628 HG13 ' CE1' ' A' ' 24' ' ' PHE . 4.4 t -48.11 -40.72 9.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.528 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.2 tt0 -48.36 -59.39 3.49 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.534 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.49 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.45 -61.28 1.74 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.794 HD13 ' CE2' ' A' ' 26' ' ' TYR . 6.6 mt -45.74 -49.17 15.06 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.553 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -50.45 -48.71 56.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.828 HD12 ' CD2' ' A' ' 1' ' ' PHE . 19.2 mt -56.96 -63.87 1.06 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.962 0.887 . . . . 0.0 110.464 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.4 m -64.12 -51.46 68.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.601 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' LEU . 78.6 m -72.88 -1.57 17.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.028 -1.045 . . . . 0.0 109.346 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 40.2 -142.74 0.63 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.36 -6.89 59.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.608 -0.937 . . . . 0.0 109.793 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 22' ' ' ARG . 44.0 mtp85 -42.48 -59.11 1.98 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.844 -0.535 . . . . 0.0 109.767 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.4 102.85 0.81 Allowed Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.628 ' CE1' HG13 ' A' ' 12' ' ' VAL . 35.6 p90 -103.68 -170.48 1.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 63.4 t80 -154.33 120.58 5.37 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 119.638 -1.914 . . . . 0.0 112.9 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.794 ' CE2' HD13 ' A' ' 15' ' ' LEU . 32.4 m-85 -150.25 92.8 1.91 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -54.3 -171.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 -179.527 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.578 ' N ' ' OG1' ' A' ' 27' ' ' THR . 0.1 OUTLIER -85.58 168.34 20.42 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HB2' ' H ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -54.26 -125.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.196 0 C-N-CA 123.829 3.019 . . . . 0.0 113.724 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.05 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER 27.91 -132.17 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.042 0 O-C-N 121.329 -0.857 . . . . 0.0 110.808 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 1.135 ' O ' ' N ' ' A' ' 33' ' ' GLY . 2.7 mt-10 -12.62 168.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.147 0.498 . . . . 0.0 111.204 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.669 ' C ' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -17.69 58.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.563 0.697 . . . . 0.0 109.938 178.171 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 1.135 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 10.37 -138.48 0.0 OUTLIER Glycine 0 N--CA 1.499 2.897 0 CA-C-O 122.14 0.856 . . . . 0.0 112.892 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.587 ' HG2' ' H ' ' A' ' 35' ' ' ARG . 69.5 Cg_endo -80.22 -89.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 123.538 2.826 . . . . 0.0 113.183 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.79 ' O ' ' CB ' ' A' ' 36' ' ' ARG . 62.8 ttt180 -127.56 -46.74 1.44 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.347 -0.846 . . . . 0.0 108.929 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.79 ' CB ' ' O ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER 101.4 73.31 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.803 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.06 -79.32 0.14 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.61 HG23 ' N ' ' A' ' 39' ' ' VAL . 5.0 tt -56.04 -44.05 77.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.816 -0.814 . . . . 0.0 109.491 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.61 ' N ' HG23 ' A' ' 38' ' ' ILE . 46.6 t -65.29 -61.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.622 -0.674 . . . . 0.0 110.39 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.513 ' OE2' ' HG3' ' A' ' 36' ' ' ARG . 2.4 mt-10 -57.56 -18.47 19.65 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.141 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' SER . 44.8 tt0 -94.08 -51.92 4.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.224 -0.922 . . . . 0.0 110.755 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -75.69 -54.06 7.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.745 -1.222 . . . . 0.0 110.091 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 48.6 t -52.73 -23.45 6.77 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.025 -1.047 . . . . 0.0 110.406 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -111.82 -29.13 7.79 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.062 -1.024 . . . . 0.0 110.122 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -132.83 -163.96 1.41 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.365 -0.834 . . . . 0.0 109.232 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.5 mm -106.46 159.64 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.269 -0.894 . . . . 0.0 109.233 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 m -145.61 168.82 19.74 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.951 -1.093 . . . . 0.0 109.943 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.43 165.76 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.908 0.861 . . . . 0.0 110.182 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.783 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -82.59 -33.33 28.03 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.088 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.29 -25.88 68.1 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.794 1.283 . . . . 0.0 108.177 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.444 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 33.5 tt0 -73.11 -23.07 60.46 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.33 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.9 mt -84.62 -28.98 26.13 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.59 -18.19 64.9 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.602 -0.686 . . . . 0.0 110.856 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.621 ' ND2' ' CD1' ' A' ' 55' ' ' TYR . 0.4 OUTLIER -88.19 -8.84 54.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.818 -1.176 . . . . 0.0 108.368 179.256 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.621 ' CD1' ' ND2' ' A' ' 54' ' ' ASN . 6.4 m-85 -82.88 -38.12 23.37 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.576 0.703 . . . . 0.0 109.318 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 m -49.81 110.5 0.39 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.741 -0.599 . . . . 0.0 109.816 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.551 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.885 ' CG ' ' O ' ' A' ' 1' ' ' PHE . 1.6 p90 . . . . . 0 C--O 1.195 -1.784 0 CA-C-O 122.333 1.063 . . . . 0.0 108.613 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.578 ' C ' ' H ' ' A' ' 4' ' ' GLN . 3.9 t -92.56 50.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.294 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.989 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 4' ' ' GLN . 0.6 OUTLIER 69.86 -33.95 0.27 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.389 -0.819 . . . . 0.0 109.57 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.578 ' H ' ' C ' ' A' ' 2' ' ' VAL . 17.9 pt20 -28.81 157.99 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.921 0.867 . . . . 0.0 112.338 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -44.35 125.71 4.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.382 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -130.75 109.2 10.43 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.6 m -114.91 -176.49 2.91 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.433 -0.792 . . . . 0.0 109.403 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.79 -152.95 0.85 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.47 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.1 p -79.16 -9.24 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.895 -1.356 . . . . 0.0 108.888 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 9' ' ' SER . 14.9 m-70 -52.0 -24.39 6.53 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.47 ' N ' ' C ' ' A' ' 9' ' ' SER . 8.7 tp -78.22 -54.02 6.69 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.616 HG13 ' CE1' ' A' ' 24' ' ' PHE . 4.7 t -46.4 -41.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.525 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 19.4 tt0 -47.24 -58.94 3.54 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.939 -1.104 . . . . 0.0 108.385 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.486 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.53 -61.4 1.7 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.794 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.6 mt -46.01 -48.01 16.73 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -51.75 -49.01 63.43 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 19.5 mt -56.58 -63.64 1.13 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.002 0.906 . . . . 0.0 110.651 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -64.7 -48.27 85.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.761 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' LEU . 60.9 m -73.26 -15.24 61.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.045 -1.034 . . . . 0.0 109.852 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 43.01 -133.09 5.17 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -83.75 -9.7 58.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -1.044 . . . . 0.0 110.016 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -47.12 -25.53 0.89 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 109.613 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.7 117.95 2.26 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.273 -0.965 . . . . 0.0 110.73 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.616 ' CE1' HG13 ' A' ' 12' ' ' VAL . 32.8 p90 -122.06 -178.91 3.98 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.509 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 64.3 m-85 -150.72 125.92 9.98 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 119.552 -1.968 . . . . 0.0 112.783 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.794 ' CE2' HD13 ' A' ' 15' ' ' LEU . 29.7 m-85 -151.47 114.78 4.8 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -57.35 -163.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.068 -1.02 . . . . 0.0 108.8 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.718 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -49.17 -178.54 0.02 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 108.625 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.718 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 29.5 Cg_endo -66.85 -114.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.676 2.251 . . . . 0.0 111.235 177.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.036 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -61.65 -15.12 37.04 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.504 -0.747 . . . . 0.0 111.844 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 1.036 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.2 pp20? -6.78 -146.78 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 122.157 0.98 . . . . 0.0 112.541 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.466 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -71.08 -125.01 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.251 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 32' ' ' GLU . . . -100.48 135.54 12.2 Favored Glycine 0 N--CA 1.504 3.23 0 C-N-CA 119.681 -1.247 . . . . 0.0 111.649 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.937 ' O ' ' HG2' ' A' ' 36' ' ' ARG . 18.5 Cg_endo -94.97 173.42 1.28 Allowed 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 124.872 3.714 . . . . 0.0 112.446 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.752 ' O ' ' O ' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -54.03 -5.11 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.682 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.937 ' HG2' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 48.82 164.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.54 -77.53 0.43 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 118.797 -1.668 . . . . 0.0 109.553 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 39' ' ' VAL . 8.8 tt -65.34 -45.99 91.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.403 -1.057 . . . . 0.0 111.188 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.634 ' N ' HG23 ' A' ' 38' ' ' ILE . 55.7 t -65.88 -61.03 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.72 -0.612 . . . . 0.0 110.946 -177.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 40' ' ' GLU . 14.7 mt-10 -57.23 -22.42 40.95 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 109.228 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 45' ' ' SER . 35.1 tt0 -94.22 -32.79 13.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.16 -0.963 . . . . 0.0 109.569 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 38' ' ' ILE . 99.7 m -89.7 -47.75 7.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.034 -1.041 . . . . 0.0 109.992 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' VAL . 44.9 t -66.89 -52.52 42.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 110.855 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -85.89 -18.04 33.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.923 -1.111 . . . . 0.0 110.47 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' CYS . 13.1 m -140.59 179.84 6.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.078 -1.013 . . . . 0.0 109.613 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 mm -95.92 139.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.317 -0.864 . . . . 0.0 108.802 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.65 168.22 14.03 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.309 -0.87 . . . . 0.0 109.978 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.1 166.89 14.1 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.071 0.939 . . . . 0.0 111.044 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -82.93 -36.88 24.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -57.98 -25.37 60.95 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 122.898 1.332 . . . . 0.0 108.172 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.453 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 40.2 tt0 -76.28 -21.82 55.82 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.559 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.3 mt -84.49 -35.46 22.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.856 -1.153 . . . . 0.0 107.941 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -62.29 -18.29 60.91 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.63 -0.669 . . . . 0.0 110.148 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 2.3 m-20 -85.43 -8.67 58.28 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.485 ' HE2' ' HD2' ' A' ' 35' ' ' ARG . 4.6 m-85 -89.23 -40.67 12.69 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.818 0.818 . . . . 0.0 109.316 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.5 m -49.77 110.28 0.37 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.739 -0.601 . . . . 0.0 109.993 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.0 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.491 179.699 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 1.083 ' CZ ' HD13 ' A' ' 17' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.65 76.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.538 -0.726 . . . . 0.0 109.132 167.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 4' ' ' GLN . 15.5 m-20 53.63 -102.06 0.13 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.219 -0.925 . . . . 0.0 109.37 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ASN . 14.6 pt20 37.8 -162.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.541 0.686 . . . . 0.0 111.392 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.568 ' O ' HD12 ' A' ' 6' ' ' LEU . 30.6 p-80 -93.19 137.12 32.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.351 -0.843 . . . . 0.0 109.639 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 5' ' ' HIS . 1.3 mp -133.72 109.63 9.28 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 m -118.78 -176.95 3.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.501 -0.749 . . . . 0.0 109.186 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.67 -145.97 3.66 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.2 p -81.66 -12.89 58.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.061 -1.258 . . . . 0.0 109.471 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -51.22 -24.54 4.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.2 tp -81.83 -49.86 9.88 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.657 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.1 t -46.84 -48.3 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.6 tt0 -47.42 -59.7 3.04 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.528 -176.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.89 -61.65 1.53 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ALA . 14.6 mt -45.77 -45.46 14.65 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.554 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.12 -49.44 73.89 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.802 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.083 HD13 ' CZ ' ' A' ' 1' ' ' PHE . 27.5 mt -54.85 -62.85 1.39 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.101 0.953 . . . . 0.0 110.909 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -64.23 -37.69 80.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.943 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 42.5 t -80.25 -22.41 41.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.977 -1.077 . . . . 0.0 110.039 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 68.87 -146.73 45.4 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.6 tt0 -83.16 -15.26 51.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.333 -1.098 . . . . 0.0 109.656 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -47.45 -9.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.665 -0.647 . . . . 0.0 110.529 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 78.6 131.42 0.68 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.657 ' CE1' HG13 ' A' ' 12' ' ' VAL . 23.0 p90 -116.91 157.0 26.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.642 -0.916 . . . . 0.0 109.925 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -85.52 122.1 29.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.388 -0.82 . . . . 0.0 110.113 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.4 ' CD2' HG22 ' A' ' 12' ' ' VAL . 39.2 t80 -170.42 71.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.841 . . . . 0.0 108.911 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.607 HG21 ' HB3' ' A' ' 31' ' ' GLU . 1.3 m -47.65 171.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.74 . . . . 0.0 109.717 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -75.9 168.94 23.32 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.942 ' O ' HG23 ' A' ' 30' ' ' THR . 57.1 Cg_endo -71.76 90.18 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.635 2.223 . . . . 0.0 111.439 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.942 HG23 ' O ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER 145.65 -55.67 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.452 0.644 . . . . 0.0 109.898 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.607 ' HB3' HG21 ' A' ' 27' ' ' THR . 0.1 OUTLIER -35.44 78.3 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.185 -178.625 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.822 ' N ' ' O ' ' A' ' 30' ' ' THR . 2.6 mt-10 51.47 19.21 0.78 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.52 ' N ' ' C ' ' A' ' 31' ' ' GLU . . . 58.73 176.3 0.71 Allowed Glycine 0 N--CA 1.479 1.555 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.537 ' HG2' ' H ' ' A' ' 36' ' ' ARG . 40.0 Cg_endo -83.25 -97.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 123.49 2.794 . . . . 0.0 109.828 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.794 ' O ' ' O ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -158.0 9.27 0.16 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.985 -1.072 . . . . 0.0 108.233 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.794 ' O ' ' O ' ' A' ' 35' ' ' ARG . 1.2 mpt_? 43.81 133.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.429 1.109 . . . . 0.0 108.434 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.16 -63.77 0.36 Allowed Glycine 0 C--N 1.275 -2.826 0 C-N-CA 117.493 -2.289 . . . . 0.0 108.402 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 39' ' ' VAL . 8.1 tt -80.61 -41.12 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.618 -0.93 . . . . 0.0 109.712 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.605 ' N ' HG23 ' A' ' 38' ' ' ILE . 55.0 t -70.75 -61.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.317 0.58 . . . . 0.0 110.876 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -59.15 -18.9 40.21 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.3 -0.875 . . . . 0.0 110.01 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -94.29 -43.59 8.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.047 -1.033 . . . . 0.0 110.439 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' SER . 1.8 t -88.1 -31.46 19.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.89 -1.131 . . . . 0.0 110.82 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.6 t -76.91 -48.97 16.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.815 -1.178 . . . . 0.0 109.841 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -83.15 -22.94 33.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.063 -1.023 . . . . 0.0 109.47 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' CYS . 4.5 m -140.14 -170.04 2.88 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.374 -0.829 . . . . 0.0 108.917 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 47' ' ' CYS . 4.0 mm -89.01 168.32 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.032 -1.043 . . . . 0.0 108.831 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.481 ' N ' HG22 ' A' ' 46' ' ' ILE . 19.7 p -150.7 167.27 27.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.138 -0.976 . . . . 0.0 109.728 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.18 164.94 12.28 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 122.047 0.927 . . . . 0.0 111.153 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.53 -36.94 25.89 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.046 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.82 -25.95 61.34 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.843 1.306 . . . . 0.0 108.282 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.452 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 34.1 tt0 -76.72 -22.08 54.39 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.577 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 mt -84.82 -33.39 22.92 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.941 -1.099 . . . . 0.0 108.036 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -62.81 -18.78 63.3 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 110.34 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -84.51 -8.72 58.84 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.55 ' CE2' ' NH1' ' A' ' 35' ' ' ARG . 3.7 m-85 -90.11 -27.59 19.54 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.62 -0.675 . . . . 0.0 109.648 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.9 t -66.97 112.04 4.13 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.845 0.831 . . . . 0.0 109.793 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 . . . . . 0 C--N 1.291 -1.972 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.429 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.781 ' HB2' HD21 ' A' ' 6' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.896 0.855 . . . . 0.0 108.758 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 3' ' ' ASN . 4.0 p -55.97 -20.31 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -177.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 2' ' ' VAL . 13.4 m-20 154.82 71.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -151.04 170.72 18.69 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.455 ' O ' HD12 ' A' ' 6' ' ' LEU . 10.6 p-80 -61.2 136.59 58.11 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.012 -1.055 . . . . 0.0 109.252 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.781 HD21 ' HB2' ' A' ' 1' ' ' PHE . 1.0 OUTLIER -134.07 110.06 9.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.39 -0.819 . . . . 0.0 108.883 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 m -122.61 -176.89 3.49 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 47.2 -149.54 2.6 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.433 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.2 p -79.49 -12.75 59.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.912 -1.346 . . . . 0.0 109.291 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -52.39 -24.04 7.05 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.477 ' HA ' HD23 ' A' ' 6' ' ' LEU . 9.5 tp -80.59 -52.43 7.6 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.686 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.6 t -44.13 -47.66 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.626 0.727 . . . . 0.0 109.225 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 28.3 tt0 -46.62 -59.52 2.96 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.471 -176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.15 -61.81 1.5 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.8 mt -45.97 -43.96 14.53 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.558 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -57.58 -50.45 73.08 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.421 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 29.6 mt -52.68 -62.68 1.49 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.211 1.005 . . . . 0.0 110.789 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -65.14 -42.36 94.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.432 -177.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.0 t -75.15 -22.45 58.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.779 -1.201 . . . . 0.0 110.118 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 69.33 -151.57 51.12 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 23' ' ' GLY . 22.5 mt-10 -83.24 0.53 45.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -1.209 . . . . 0.0 109.694 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -62.42 1.36 0.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.173 -0.954 . . . . 0.0 109.988 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 68.65 121.05 0.03 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.686 ' CE1' HG13 ' A' ' 12' ' ' VAL . 16.1 p90 -105.34 170.25 7.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.569 -0.959 . . . . 0.0 109.58 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -98.54 123.67 42.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.33 -0.856 . . . . 0.0 110.135 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' THR . 49.5 t80 -172.45 86.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.503 -0.748 . . . . 0.0 109.141 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -53.12 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.294 -0.879 . . . . 0.0 109.296 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.527 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -83.62 177.18 3.15 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 28' ' ' ASP . 51.0 Cg_endo -60.12 -6.06 4.62 Favored 'Trans proline' 0 N--CA 1.525 3.355 0 C-N-CA 124.267 3.311 . . . . 0.0 116.523 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.106 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -121.84 -168.63 1.73 Allowed 'General case' 0 C--N 1.284 -2.267 0 O-C-N 120.051 -1.656 . . . . 0.0 111.36 -178.354 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 1.106 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.3 OUTLIER 33.12 134.64 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 1.17 ' O ' ' O ' ' A' ' 33' ' ' GLY . 25.0 mp0 13.01 48.92 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.35 -0.844 . . . . 0.0 111.243 -177.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 1.17 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -25.49 -139.16 0.0 OUTLIER Glycine 0 N--CA 1.506 3.365 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.997 ' HG2' HG21 ' A' ' 39' ' ' VAL . 32.5 Cg_exo -61.94 148.25 93.51 Favored 'Trans proline' 0 N--CA 1.51 2.453 0 C-N-CA 122.698 2.265 . . . . 0.0 112.282 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.857 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -55.63 7.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 119.544 -1.973 . . . . 0.0 108.355 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.857 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 75.9 92.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.732 -1.23 . . . . 0.0 110.351 -179.712 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.19 -53.86 0.21 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 117.005 -2.522 . . . . 0.0 109.371 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 39' ' ' VAL . 7.1 tt -75.58 -42.16 41.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.705 -0.88 . . . . 0.0 110.487 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.997 HG21 ' HG2' ' A' ' 34' ' ' PRO . 49.0 t -65.75 -60.62 2.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.268 0.556 . . . . 0.0 111.029 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 40' ' ' GLU . 12.3 mt-10 -58.5 -21.34 51.63 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.671 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' O ' ' O ' ' A' ' 45' ' ' SER . 56.1 tt0 -94.08 -36.32 12.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.237 -0.914 . . . . 0.0 109.85 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.419 ' O ' ' O ' ' A' ' 45' ' ' SER . 96.6 m -88.35 -50.42 6.34 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.112 -0.993 . . . . 0.0 109.96 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.3 t -62.51 -50.43 71.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.292 -0.88 . . . . 0.0 110.882 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -83.84 -26.24 29.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.86 -1.15 . . . . 0.0 110.752 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 41' ' ' GLN . 37.2 m -140.6 -179.43 6.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.969 -1.082 . . . . 0.0 110.249 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mm -84.55 157.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 p -143.16 167.22 22.62 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.893 -1.13 . . . . 0.0 109.474 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.28 161.86 21.33 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.078 0.942 . . . . 0.0 110.682 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.7 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -83.04 -35.14 26.0 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.078 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -59.62 -25.95 65.08 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.674 1.226 . . . . 0.0 108.203 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.439 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 39.5 tt0 -74.45 -23.33 58.89 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.41 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 1' ' ' PHE . 66.9 mt -84.64 -27.41 27.16 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.039 -1.038 . . . . 0.0 108.303 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -68.08 -18.65 64.73 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.564 -0.71 . . . . 0.0 110.887 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.643 ' ND2' ' CD1' ' A' ' 55' ' ' TYR . 0.5 OUTLIER -87.27 -9.03 56.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.651 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.643 ' CD1' ' ND2' ' A' ' 54' ' ' ASN . 5.0 m-85 -84.32 -32.26 24.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.8 t -60.88 112.28 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.873 0.844 . . . . 0.0 109.932 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 t30 . . . . . 0 C--N 1.292 -1.902 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.533 179.866 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.521 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 2.6 p90 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 1' ' ' PHE . 87.7 t -158.71 87.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 O-C-N 120.532 -1.355 . . . . 0.0 109.252 -171.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.515 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.2 m120 42.49 51.1 4.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.639 -0.663 . . . . 0.0 110.069 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -128.79 165.05 21.7 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.484 -0.76 . . . . 0.0 109.812 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.459 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 31.8 p80 -60.05 130.07 44.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.38 -0.825 . . . . 0.0 110.35 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 11' ' ' LEU . 1.2 tp -135.12 118.92 17.22 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.0 t -123.28 -176.82 3.53 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.459 -0.776 . . . . 0.0 109.408 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.23 -152.82 0.69 Allowed Glycine 0 N--CA 1.499 2.898 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.453 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.0 p -77.93 -10.18 59.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.73 -1.453 . . . . 0.0 108.734 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' SER . 68.7 m80 -53.01 -22.96 6.4 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.592 ' HA ' HD23 ' A' ' 6' ' ' LEU . 9.4 tp -79.82 -50.99 9.71 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.644 HG13 ' CE1' ' A' ' 24' ' ' PHE . 4.0 t -47.36 -40.06 6.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.0 tt0 -48.68 -59.36 3.6 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.661 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.494 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.53 -60.64 2.07 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.751 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.3 mt -46.37 -47.54 18.69 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.55 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -52.49 -48.34 66.0 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.599 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 20.1 mt -56.8 -63.34 1.24 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.01 0.909 . . . . 0.0 110.542 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -65.56 -46.16 90.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.014 -177.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 15' ' ' LEU . 58.6 m -72.97 -22.51 60.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.96 -1.088 . . . . 0.0 109.596 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 39.67 -120.92 1.4 Allowed Glycine 0 N--CA 1.496 2.662 0 O-C-N 121.284 -0.885 . . . . 0.0 111.131 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -81.67 -20.75 38.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.547 -0.972 . . . . 0.0 110.001 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -46.26 -34.04 4.15 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.343 -0.848 . . . . 0.0 109.402 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.36 137.04 8.53 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.644 ' CE1' HG13 ' A' ' 12' ' ' VAL . 28.1 p90 -140.99 174.83 10.13 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 7.2 p90 -154.37 125.92 7.51 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.69 -1.881 . . . . 0.0 112.439 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.751 ' CE2' HD13 ' A' ' 15' ' ' LEU . 18.7 m-85 -139.38 3.26 2.12 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 26' ' ' TYR . 1.8 p 45.88 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.807 0.813 . . . . 0.0 110.28 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.518 ' O ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -69.02 167.53 20.03 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.518 ' C ' ' O ' ' A' ' 28' ' ' ASP . 2.5 Cg_endo -33.89 -45.06 0.37 Allowed 'Trans proline' 0 C--N 1.278 -3.148 0 C-N-CA 121.706 1.604 . . . . 0.0 111.604 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.821 ' OG1' ' N ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -114.82 -144.88 0.39 Allowed 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.527 0.679 . . . . 0.0 109.656 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 1.071 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 5.3 mt-10 72.99 65.94 0.11 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.113 -0.992 . . . . 0.0 112.334 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 1.071 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER 103.21 -57.17 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 O-C-N 120.789 -1.194 . . . . 0.0 112.553 177.458 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.649 ' C ' ' H ' ' A' ' 35' ' ' ARG . . . 152.85 122.73 0.94 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 117.435 -2.317 . . . . 0.0 113.22 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.536 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 5.4 Cg_exo -56.91 11.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.92 2.413 . . . . 0.0 111.376 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.823 ' NH2' ' CE2' ' A' ' 55' ' ' TYR . 9.1 ttt-85 84.88 -16.57 0.49 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.487 HH21 ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER 53.07 -173.79 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.095 -1.003 . . . . 0.0 110.671 179.087 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.49 -81.45 0.08 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 39' ' ' VAL . 4.5 tt -52.0 -40.36 28.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.856 -0.791 . . . . 0.0 110.757 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.52 ' N ' HG23 ' A' ' 38' ' ' ILE . 40.3 t -71.63 -61.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.724 -0.61 . . . . 0.0 110.565 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -55.7 -23.47 28.92 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.369 -0.832 . . . . 0.0 109.135 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -94.53 -34.45 12.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.277 -0.889 . . . . 0.0 109.852 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 38' ' ' ILE . 42.0 t -88.35 -46.29 9.3 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.052 -1.03 . . . . 0.0 110.233 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.8 t -63.59 -34.24 77.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 110.643 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -103.34 -15.4 15.95 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.167 -0.958 . . . . 0.0 110.28 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER -140.07 -179.14 5.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.109 -0.994 . . . . 0.0 109.19 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.803 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.3 mm -66.2 -179.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 0.0 109.305 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.803 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -146.93 134.49 20.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.042 -1.037 . . . . 0.0 109.365 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 m -87.68 155.27 20.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.438 -0.789 . . . . 0.0 109.182 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.4 tp -82.83 -39.83 21.16 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -57.95 -23.34 53.24 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 123.179 1.466 . . . . 0.0 107.826 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.506 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 10.5 tp-100 -80.69 -23.28 39.67 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.109 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.05 -38.52 19.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.399 -1.438 . . . . 0.0 108.213 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -58.24 -19.61 35.39 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.646 -0.659 . . . . 0.0 110.293 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -85.15 -8.57 58.55 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 108.634 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.823 ' CE2' ' NH2' ' A' ' 35' ' ' ARG . 4.4 m-85 -90.54 -40.29 12.05 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.937 0.875 . . . . 0.0 109.212 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.2 m -49.74 110.67 0.41 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.259 0.552 . . . . 0.0 110.03 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.55 179.829 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 1.067 ' CE1' ' HA ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 122.304 1.05 . . . . 0.0 110.072 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 2' ' ' VAL . 10.5 m -73.37 55.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 120.778 -1.201 . . . . 0.0 109.114 175.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 1.067 ' HA ' ' CE1' ' A' ' 1' ' ' PHE . 0.8 OUTLIER 67.42 -88.4 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.365 -0.834 . . . . 0.0 109.096 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 3' ' ' ASN . 28.4 pt20 31.46 -151.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.463 -0.773 . . . . 0.0 111.787 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.57 ' O ' HD12 ' A' ' 6' ' ' LEU . 25.5 p-80 -98.92 132.59 44.14 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.367 -0.833 . . . . 0.0 109.236 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 1' ' ' PHE . 1.4 mp -133.81 111.12 10.26 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.6 m -123.36 -177.57 3.74 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.84 -148.19 5.0 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.432 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -80.31 -13.38 59.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.947 -1.325 . . . . 0.0 109.425 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -52.01 -24.45 6.65 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.432 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.0 tp -81.67 -49.01 10.98 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.65 HG13 ' CE1' ' A' ' 24' ' ' PHE . 20.9 t -47.41 -46.61 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.522 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 27.5 tt0 -47.9 -59.76 3.1 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.499 -176.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.06 -61.49 1.61 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.4 mt -45.61 -46.8 14.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.555 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.83 -50.18 69.24 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 27.9 mt -53.75 -62.69 1.49 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 122.111 0.958 . . . . 0.0 110.727 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.1 m -65.38 -31.83 55.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.006 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.6 m -93.11 -0.52 56.99 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.08 -1.013 . . . . 0.0 109.936 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 47.9 -148.79 3.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.6 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 2.0 mp0 -83.21 -15.18 51.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -1.084 . . . . 0.0 109.328 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -42.73 -18.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.8 -0.562 . . . . 0.0 110.568 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 92.74 138.19 8.46 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.65 ' CE1' HG13 ' A' ' 12' ' ' VAL . 21.6 p90 -129.82 155.84 45.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.591 -0.946 . . . . 0.0 109.71 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' HD1' ' HE ' ' A' ' 35' ' ' ARG . 48.1 t80 -84.51 124.05 30.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 0.0 110.193 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 27' ' ' THR . 44.4 t80 -172.47 77.97 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 109.324 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -52.33 -176.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.08 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -82.51 154.52 68.75 Favored Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 121.133 -0.979 . . . . 0.0 108.606 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.899 ' O ' HG23 ' A' ' 30' ' ' THR . 59.2 Cg_endo -75.07 57.42 4.61 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.307 2.671 . . . . 0.0 111.766 -175.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.899 HG23 ' O ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -162.6 -61.7 0.04 OUTLIER 'General case' 0 C--N 1.262 -3.234 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.288 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 33' ' ' GLY . 4.9 mm-40 -54.98 122.53 11.09 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 117.778 -1.569 . . . . 0.0 108.703 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 1.1 pt-20 39.67 7.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.43 -0.794 . . . . 0.0 110.531 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.786 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 82.86 168.06 42.12 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 118.356 -1.878 . . . . 0.0 109.246 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.97 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 28.5 Cg_endo -63.84 -28.41 67.58 Favored 'Trans proline' 0 C--N 1.285 -2.781 0 C-N-CA 122.804 2.336 . . . . 0.0 117.421 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.97 ' HB2' ' O ' ' A' ' 34' ' ' PRO . 9.2 ttt-85 151.71 7.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 119.79 -1.819 . . . . 0.0 107.119 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.592 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER 29.4 102.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.747 0.784 . . . . 0.0 109.924 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.47 -68.79 0.3 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.4 tt -73.83 -41.28 53.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.594 -0.945 . . . . 0.0 109.74 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.738 HG21 ' CG ' ' A' ' 34' ' ' PRO . 44.9 t -68.99 -61.05 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.329 0.585 . . . . 0.0 110.774 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -57.28 -22.0 38.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.343 -0.848 . . . . 0.0 109.802 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -94.57 -43.15 8.44 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.025 -1.047 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 45' ' ' SER . 0.9 OUTLIER -85.44 -29.22 24.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.88 -1.137 . . . . 0.0 110.642 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.7 t -80.9 -54.16 5.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.798 -1.189 . . . . 0.0 109.802 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -76.12 -24.53 54.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.996 -1.065 . . . . 0.0 109.121 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' CYS . 9.9 m -140.23 -173.99 3.81 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.2 mt -93.9 146.13 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.024 -1.048 . . . . 0.0 109.445 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p -122.04 165.37 16.15 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.606 -0.684 . . . . 0.0 109.263 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.74 166.74 13.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.242 -0.911 . . . . 0.0 110.52 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.31 -36.65 26.77 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -58.77 -25.54 63.15 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.837 1.303 . . . . 0.0 108.199 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.429 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 35.3 tt0 -77.31 -22.19 52.32 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.694 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.3 mt -84.63 -34.53 23.06 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -61.58 -19.28 62.02 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 110.209 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -84.02 -8.72 59.06 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -89.91 -37.79 14.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.689 -0.632 . . . . 0.0 109.529 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.3 m -50.64 110.61 0.43 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.316 -0.865 . . . . 0.0 109.477 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.469 -179.815 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.859 ' C ' ' CD1' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 120.685 0.279 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 3' ' ' ASN . 11.7 p -69.66 167.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 170.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.513 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.3 m120 -49.18 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 0.0 109.485 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 2' ' ' VAL . 13.8 pt20 -157.64 -177.81 6.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 110.119 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -78.09 135.33 37.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.316 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.585 HD23 ' HA ' ' A' ' 11' ' ' LEU . 1.4 tp -134.6 109.82 8.91 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -118.11 174.65 6.09 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.71 -153.07 29.95 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 10' ' ' HIS . 3.3 p -78.41 -11.12 59.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.026 -1.279 . . . . 0.0 109.671 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 9' ' ' SER . 1.8 t-80 -53.24 -30.56 38.81 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.585 ' HA ' HD23 ' A' ' 6' ' ' LEU . 14.6 tp -74.91 -48.18 25.98 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.623 HG13 ' CE1' ' A' ' 24' ' ' PHE . 24.5 t -48.81 -46.3 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.513 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.8 tt0 -49.05 -60.19 2.99 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.492 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.508 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.03 -60.96 1.82 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.433 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 13.5 mt -45.81 -46.84 15.71 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.72 -51.02 66.9 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.2 mt -52.84 -62.49 1.62 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.101 0.953 . . . . 0.0 110.718 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -67.09 -30.86 50.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.209 -177.068 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 56.4 m -90.4 -10.85 42.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.002 -1.061 . . . . 0.0 110.325 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 43.71 -131.42 6.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.605 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.9 mp0 -83.91 -19.08 35.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.492 -1.005 . . . . 0.0 110.354 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -46.0 -12.84 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.348 -0.845 . . . . 0.0 110.174 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 76.04 133.54 0.45 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.623 ' CE1' HG13 ' A' ' 12' ' ' VAL . 38.3 p90 -124.36 142.34 51.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.841 -0.8 . . . . 0.0 109.374 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -83.34 138.13 33.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.428 -0.795 . . . . 0.0 109.776 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 27' ' ' THR . 39.0 t80 -171.86 -39.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.356 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 28' ' ' ASP . 1.6 m 53.93 172.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 109.359 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.452 ' H ' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -81.18 158.61 69.41 Favored Pre-proline 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 108.715 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 1.245 ' O ' HG23 ' A' ' 30' ' ' THR . 87.7 Cg_endo -82.98 96.19 0.83 Allowed 'Trans proline' 1 C--N 1.253 -4.487 0 N-CA-C 114.932 1.089 . . . . 0.0 114.932 -172.151 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.245 HG23 ' O ' ' A' ' 29' ' ' PRO . 13.9 p 157.45 -54.17 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.646 0 CA-C-O 122.762 1.268 . . . . 0.0 108.951 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 30' ' ' THR . 79.2 mm-40 -31.9 -76.03 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.749 -1.219 . . . . 0.0 112.285 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.36 -26.15 4.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.898 -1.126 . . . . 0.0 109.379 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.01 148.98 5.36 Favored Glycine 0 N--CA 1.513 3.794 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.647 ' O ' ' CB ' ' A' ' 35' ' ' ARG . 80.2 Cg_endo -78.79 26.13 0.54 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 CA-C-N 119.741 1.77 . . . . 0.0 111.524 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.647 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER 83.42 -20.46 0.33 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -178.372 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 38' ' ' ILE . 43.6 mtt-85 52.48 -159.32 0.12 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.437 ' C ' HE21 ' A' ' 41' ' ' GLN . . . 62.44 -81.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.535 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.2 tt -55.6 -41.83 66.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.736 -0.861 . . . . 0.0 109.973 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.535 ' N ' HG23 ' A' ' 38' ' ' ILE . 41.8 t -72.41 -60.68 2.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.546 0.689 . . . . 0.0 111.214 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -49.42 -31.84 10.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.604 -0.685 . . . . 0.0 110.771 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.9 pt20 -93.58 -37.11 12.06 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.842 -1.161 . . . . 0.0 110.068 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.3 t -78.14 -55.29 5.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.04 -1.038 . . . . 0.0 109.69 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.8 t -54.89 -27.84 45.94 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.432 -0.792 . . . . 0.0 110.516 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -111.35 -15.53 13.57 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.235 -0.916 . . . . 0.0 110.451 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -140.43 -173.83 3.79 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.934 -1.104 . . . . 0.0 109.78 -179.513 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.716 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.5 mm -64.94 178.73 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.716 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -143.99 127.77 17.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.957 -1.09 . . . . 0.0 109.866 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 m -80.79 149.32 29.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.333 -0.854 . . . . 0.0 109.171 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.2 tp -82.83 -41.59 18.88 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -55.79 -25.72 42.68 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 123.02 1.39 . . . . 0.0 108.128 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.472 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 21.6 tt0 -77.98 -22.34 49.54 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.029 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.0 mt -85.38 -28.17 25.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.661 -1.274 . . . . 0.0 108.584 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -65.49 -19.73 66.05 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.631 -0.668 . . . . 0.0 111.354 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.672 ' ND2' ' CD1' ' A' ' 55' ' ' TYR . 1.1 p-10 -88.01 -8.37 55.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.813 -1.179 . . . . 0.0 108.123 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.672 ' CD1' ' ND2' ' A' ' 54' ' ' ASN . 4.7 m-85 -86.74 -26.01 24.42 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.681 0.753 . . . . 0.0 109.163 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 57' ' ' ASN . 4.2 m -67.36 95.91 0.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.705 -0.622 . . . . 0.0 111.088 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 56' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 117.923 -1.037 . . . . 0.0 108.38 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 1.189 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.151 0.501 . . . . 0.0 110.162 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 3' ' ' ASN . 14.3 p -82.4 164.27 2.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.739 -176.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.505 ' N ' HG22 ' A' ' 2' ' ' VAL . 1.3 m120 -47.87 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.991 -1.068 . . . . 0.0 109.493 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -158.66 -160.39 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.419 ' O ' ' CG ' ' A' ' 5' ' ' HIS . 44.8 p-80 -97.95 110.6 23.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.87 139.34 41.45 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.0 t -149.46 -178.47 6.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.282 -0.886 . . . . 0.0 108.792 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.96 -141.68 10.02 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.759 -1.737 . . . . 0.0 108.759 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' VAL . 3.3 p -84.07 -13.35 53.31 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.853 -1.381 . . . . 0.0 109.194 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -52.02 -27.68 14.44 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.935 HD23 ' OH ' ' A' ' 26' ' ' TYR . 22.4 tp -81.67 -37.25 27.74 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.614 HG13 ' CE1' ' A' ' 24' ' ' PHE . 13.8 t -58.73 -48.47 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 36.0 tt0 -47.74 -59.69 3.12 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.432 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.189 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -44.65 -61.76 1.45 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 mt -46.05 -45.55 16.14 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.552 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.22 -48.25 76.82 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.774 HD12 ' CD2' ' A' ' 1' ' ' PHE . 30.1 mt -55.75 -62.81 1.44 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 122.089 0.947 . . . . 0.0 110.836 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.4 m -64.18 -36.32 76.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.436 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.7 t -84.4 -22.68 30.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.929 -1.107 . . . . 0.0 110.559 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 70.76 -153.06 51.13 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 23' ' ' GLY . 14.7 mt-10 -83.66 3.61 32.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.244 . . . . 0.0 109.776 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.47 1.8 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 71.93 124.81 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.614 ' CE1' HG13 ' A' ' 12' ' ' VAL . 13.2 p90 -111.52 170.42 8.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -1.034 . . . . 0.0 110.845 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -98.5 134.85 40.89 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.579 0.704 . . . . 0.0 110.034 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.935 ' OH ' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -175.92 -149.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER 170.3 166.28 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.152 -0.967 . . . . 0.0 109.227 178.025 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.636 ' HB2' ' HG3' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -96.76 161.47 26.44 Favored Pre-proline 0 N--CA 1.487 1.397 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.56 -7.1 20.12 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 123.856 3.037 . . . . 0.0 110.493 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 28' ' ' ASP . 10.1 t -103.2 -28.28 12.01 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.749 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -76.85 -9.27 58.57 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 176.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 1.032 ' O ' ' O ' ' A' ' 33' ' ' GLY . 53.3 mt-10 107.89 119.9 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.574 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 1.032 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -6.14 147.86 0.0 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.993 ' HG3' HG21 ' A' ' 39' ' ' VAL . 86.0 Cg_endo -84.49 59.14 5.69 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 123.767 2.978 . . . . 0.0 115.774 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER 80.43 -37.04 0.14 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 111.187 177.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.564 ' CB ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 81.93 114.55 0.06 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.082 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.5 -60.64 0.42 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.528 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 3.3 tt -82.09 -44.63 19.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.733 -0.863 . . . . 0.0 110.065 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.993 HG21 ' HG3' ' A' ' 34' ' ' PRO . 43.7 t -70.47 -61.29 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 O-C-N 121.308 -0.87 . . . . 0.0 111.37 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.28 -24.55 28.98 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.089 -1.007 . . . . 0.0 110.156 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -94.42 -47.76 6.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.914 -1.116 . . . . 0.0 110.284 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 31.3 m -76.85 -33.28 57.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.069 -1.019 . . . . 0.0 110.535 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.7 t -78.65 -29.26 45.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.851 -1.156 . . . . 0.0 109.874 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -102.42 -21.5 14.24 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.301 -0.874 . . . . 0.0 109.915 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 t -140.03 -171.33 3.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.225 -0.922 . . . . 0.0 109.858 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.3 mm -82.88 174.97 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.595 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.9 m -152.08 167.16 29.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.992 -1.068 . . . . 0.0 109.701 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.75 163.44 12.26 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.634 0.73 . . . . 0.0 109.246 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.675 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -81.95 -32.5 30.74 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.514 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.58 -28.06 69.67 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.648 1.213 . . . . 0.0 108.569 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.417 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 38.1 tt0 -71.55 -26.3 62.58 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.517 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.669 ' CD1' ' HZ ' ' A' ' 1' ' ' PHE . 47.7 mt -85.78 -23.75 27.11 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.116 -0.99 . . . . 0.0 108.501 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -71.73 -18.37 62.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.333 -0.855 . . . . 0.0 110.89 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.676 ' ND2' ' CD1' ' A' ' 55' ' ' TYR . 0.7 OUTLIER -86.33 -9.19 56.89 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.463 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.676 ' CD1' ' ND2' ' A' ' 54' ' ' ASN . 5.7 m-85 -84.24 -28.14 27.46 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.4 t -67.33 112.46 4.58 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.843 0.83 . . . . 0.0 110.106 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.1 m120 . . . . . 0 C--N 1.292 -1.918 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.579 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 1.386 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 8.2 p90 . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 3' ' ' ASN . 11.2 p -56.38 169.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 119.101 -2.249 . . . . 0.0 108.902 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.543 ' N ' HG22 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -49.38 110.02 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.057 -1.027 . . . . 0.0 109.412 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -169.33 -165.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.06 -1.025 . . . . 0.0 110.018 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 30.9 p80 -93.71 132.15 38.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.373 -0.829 . . . . 0.0 109.723 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 1' ' ' PHE . 0.9 OUTLIER -129.5 127.8 41.55 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.4 m -136.15 -177.3 4.64 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.27 -0.894 . . . . 0.0 108.758 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.62 -147.78 2.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.45 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.5 p -79.9 -14.1 58.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.326 . . . . 0.0 109.133 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -51.94 -24.25 6.17 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.45 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.1 tp -81.22 -51.34 8.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.626 HG13 ' CE1' ' A' ' 24' ' ' PHE . 25.3 t -46.16 -46.7 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 121.908 0.861 . . . . 0.0 108.98 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.521 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.8 tt0 -47.78 -59.92 2.95 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.51 -176.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.386 ' HB1' ' CE2' ' A' ' 1' ' ' PHE . . . -44.99 -62.0 1.41 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.8 mt -45.53 -45.68 13.53 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.558 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.92 -52.01 65.6 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.8 mt -51.03 -62.33 1.68 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.028 0.918 . . . . 0.0 110.753 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.1 m -66.39 -34.92 73.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.409 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.0 m -88.53 -6.87 57.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.949 -1.095 . . . . 0.0 110.305 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 45.87 -142.58 4.46 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 23' ' ' GLY . 19.9 mt-10 -83.13 -3.26 57.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -1.116 . . . . 0.0 109.6 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -55.64 -4.82 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.772 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 72.8 127.83 0.1 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CE1' HG13 ' A' ' 12' ' ' VAL . 32.9 p90 -122.29 145.9 47.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.627 -0.925 . . . . 0.0 108.971 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -83.17 133.11 35.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.189 -0.944 . . . . 0.0 109.891 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.528 ' CE2' ' O ' ' A' ' 27' ' ' THR . 43.6 t80 -172.82 174.24 3.65 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.528 ' O ' ' CE2' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -153.18 -178.01 6.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.028 -1.045 . . . . 0.0 109.494 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.409 ' H ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -82.06 159.93 64.28 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.268 -0.895 . . . . 0.0 108.857 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.52 -24.43 9.13 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 124.188 3.259 . . . . 0.0 113.258 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.6 p -115.07 -27.49 7.31 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.57 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 32' ' ' GLU . 4.1 mm-40 -54.22 138.07 39.49 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.892 -1.13 . . . . 0.0 109.643 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.597 ' C ' ' O ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER 24.74 -105.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.443 ' H ' ' HB2' ' A' ' 32' ' ' GLU . . . -175.2 100.37 0.15 Allowed Glycine 0 C--N 1.29 -2.014 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.675 ' O ' ' C ' ' A' ' 35' ' ' ARG . 12.0 Cg_endo -51.23 120.41 6.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.407 2.738 . . . . 0.0 113.493 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.675 ' C ' ' O ' ' A' ' 34' ' ' PRO . 0.4 OUTLIER 11.0 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 122.041 -0.412 . . . . 0.0 111.349 177.521 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 40' ' ' GLU . 8.5 mmt-85 -59.6 102.18 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.5 -49.36 0.28 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 39' ' ' VAL . 9.6 tt -82.52 -44.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.608 -0.937 . . . . 0.0 110.894 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.568 ' N ' HG23 ' A' ' 38' ' ' ILE . 46.1 t -67.76 -62.61 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.379 -0.825 . . . . 0.0 111.448 -177.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 36' ' ' ARG . 15.2 mt-10 -55.29 -25.92 37.03 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.084 -1.01 . . . . 0.0 110.369 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' SER . 44.7 tt0 -93.92 -55.92 3.06 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.05 -1.031 . . . . 0.0 110.493 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 14.4 m -67.88 -33.93 75.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.053 -1.029 . . . . 0.0 111.238 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.6 t -77.95 -32.23 51.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.726 -1.234 . . . . 0.0 110.355 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -101.97 -18.33 15.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.059 -1.026 . . . . 0.0 109.781 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLN . 3.2 m -140.17 -179.38 5.95 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.221 -0.925 . . . . 0.0 109.235 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 47' ' ' CYS . 4.5 mm -78.16 173.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 108.921 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.579 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.5 m -152.11 167.45 28.46 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.197 -0.94 . . . . 0.0 109.559 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.97 163.42 12.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 109.338 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.42 -35.07 27.95 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.3 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.29 -26.26 66.37 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.729 1.252 . . . . 0.0 108.27 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.444 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 37.8 tt0 -74.69 -23.01 58.56 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.452 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.885 ' CD1' ' CZ ' ' A' ' 1' ' ' PHE . 57.4 mt -84.93 -36.75 21.23 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.75 -19.31 49.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.548 -0.72 . . . . 0.0 110.156 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -84.02 -8.51 59.12 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -90.03 -37.79 14.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.514 -0.741 . . . . 0.0 109.744 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.421 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 3.2 m -49.92 109.24 0.27 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.413 -0.804 . . . . 0.0 109.587 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.421 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 33.3 t-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.576 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 1.106 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 1.5 t80 . . . . . 0 C--O 1.174 -2.92 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 1' ' ' PHE . 16.7 m -166.79 -30.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 118.95 -2.344 . . . . 0.0 107.715 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 4' ' ' GLN . 6.8 m120 -175.22 -102.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.652 HE22 HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER 33.81 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.265 1.031 . . . . 0.0 112.879 179.297 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 16.8 p-80 -101.37 110.96 23.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.764 -0.585 . . . . 0.0 109.778 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.533 ' C ' ' CE1' ' A' ' 10' ' ' HIS . 0.3 OUTLIER -102.02 104.02 14.66 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.729 ' N ' ' CE1' ' A' ' 10' ' ' HIS . 17.0 m -122.0 115.35 22.37 Favored 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.59 -141.16 15.86 Favored Glycine 0 N--CA 1.507 3.426 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 12' ' ' VAL . 7.4 p -87.23 -27.32 23.03 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 120.712 -1.463 . . . . 0.0 113.783 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.752 ' ND1' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -45.34 -22.66 0.14 Allowed 'General case' 0 N--CA 1.527 3.395 0 CA-C-N 121.525 1.966 . . . . 0.0 106.453 178.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.752 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 32.9 tp -79.46 -51.34 9.48 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.556 HG13 ' CE1' ' A' ' 24' ' ' PHE . 41.4 t -49.77 -53.39 10.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.517 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.3 tt0 -49.78 -59.4 3.86 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.557 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.53 -61.6 1.49 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.466 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 14.6 mt -46.43 -47.95 18.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.57 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.37 -55.15 31.52 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.452 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.89 HD12 ' CD1' ' A' ' 1' ' ' PHE . 31.7 mt -47.41 -62.17 1.56 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.156 0.979 . . . . 0.0 110.64 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -68.17 -26.6 34.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.88 -177.097 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 58.6 m -97.75 1.47 48.47 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.229 -0.919 . . . . 0.0 110.723 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 48.47 -152.2 2.57 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' GLY . 43.5 tt0 -83.58 -15.05 50.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -1.138 . . . . 0.0 109.915 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.6 ' H ' ' CD ' ' A' ' 22' ' ' ARG . 7.7 mpt_? -42.84 -18.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.679 -0.638 . . . . 0.0 110.438 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 95.04 138.54 9.59 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.556 ' CE1' HG13 ' A' ' 12' ' ' VAL . 26.6 p90 -129.29 178.0 6.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.65 -0.912 . . . . 0.0 109.047 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 55' ' ' TYR . 51.9 m-85 -104.71 132.53 50.85 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.064 -1.022 . . . . 0.0 111.244 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CD2' HG22 ' A' ' 12' ' ' VAL . 10.8 t80 -175.91 -143.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 10.2 t -172.49 -151.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.06 -1.025 . . . . 0.0 109.776 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.468 ' N ' ' OG1' ' A' ' 27' ' ' THR . 0.4 OUTLIER -112.45 165.24 13.43 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 31' ' ' GLU . 10.8 Cg_endo -73.85 -75.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.291 -2.485 0 C-N-CA 122.457 2.105 . . . . 0.0 111.087 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.35 -25.93 0.16 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' PRO . 4.1 mm-40 -94.43 86.11 4.77 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.12 96.89 0.1 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.155 -0.966 . . . . 0.0 111.369 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.664 ' N ' ' CD ' ' A' ' 34' ' ' PRO . . . -151.24 45.06 0.65 Allowed Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.508 -1.806 . . . . 0.0 111.218 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 30.9 Cg_endo -61.8 170.35 5.99 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 124.833 3.688 . . . . 0.0 112.757 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.448 ' HD3' HH21 ' A' ' 35' ' ' ARG . 3.6 ttm180 -86.52 -16.11 37.95 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.634 ' HE ' ' HG2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 69.02 53.67 0.47 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.546 -0.721 . . . . 0.0 110.026 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.4 -60.02 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.647 HG23 ' N ' ' A' ' 39' ' ' VAL . 18.2 tt -69.99 -47.54 68.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.72 -0.871 . . . . 0.0 110.117 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.647 ' N ' HG23 ' A' ' 38' ' ' ILE . 43.9 t -62.7 -61.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 121.723 -0.61 . . . . 0.0 111.101 -177.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.584 ' OE2' ' NH2' ' A' ' 36' ' ' ARG . 18.1 mt-10 -49.61 -26.54 3.69 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.393 -0.817 . . . . 0.0 110.11 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -94.56 -61.44 1.51 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.956 -1.09 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.435 ' O ' ' O ' ' A' ' 45' ' ' SER . 59.6 m -59.31 -28.74 67.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.31 -0.869 . . . . 0.0 110.466 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.9 t -85.61 -54.51 4.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.767 -1.208 . . . . 0.0 110.499 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.448 ' ND1' ' N ' ' A' ' 44' ' ' HIS . 3.1 m80 -71.37 -15.68 62.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.816 -1.177 . . . . 0.0 109.413 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 t -140.37 178.88 6.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 47' ' ' CYS . 5.4 mm -64.6 163.74 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.458 ' N ' HG22 ' A' ' 46' ' ' ILE . 9.0 t -108.55 140.43 41.91 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.237 -0.914 . . . . 0.0 111.169 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 m -98.65 145.37 26.94 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.4 tp -82.22 -40.97 20.91 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -54.09 -26.59 27.91 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 122.796 1.284 . . . . 0.0 108.478 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.539 HE22 ' CD2' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -78.81 -23.68 45.0 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.34 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.539 ' CD2' HE22 ' A' ' 51' ' ' GLN . 28.6 mt -84.82 -25.82 27.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.709 -1.244 . . . . 0.0 108.859 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -67.79 -19.19 65.07 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.582 -0.699 . . . . 0.0 111.189 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 15.7 p30 -88.32 -8.35 55.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.917 -1.114 . . . . 0.0 108.014 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.508 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 4.6 m-85 -85.3 -27.14 26.15 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.7 0.762 . . . . 0.0 109.201 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.456 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 3.2 m -67.99 110.92 4.12 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.432 -0.792 . . . . 0.0 110.115 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.456 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 5.4 m120 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.983 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.831 ' CG ' ' O ' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.436 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 3' ' ' ASN . 7.1 p -79.91 -42.35 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.341 -1.474 . . . . 0.0 108.48 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 4' ' ' GLN . 11.6 m120 -168.54 -98.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.542 ' O ' ' O ' ' A' ' 3' ' ' ASN . 5.1 pt20 32.22 -166.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 122.342 1.067 . . . . 0.0 112.992 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -98.14 146.47 25.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.0 109.01 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.662 HD23 ' HA ' ' A' ' 11' ' ' LEU . 1.2 tp -132.8 108.92 9.29 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 t -117.14 145.75 43.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.516 -0.74 . . . . 0.0 109.057 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.424 ' C ' ' N ' ' A' ' 10' ' ' HIS . . . 82.01 177.39 51.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 10' ' ' HIS . 2.6 p -54.16 -10.55 0.37 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.556 -1.555 . . . . 0.0 109.14 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.424 ' N ' ' C ' ' A' ' 8' ' ' GLY . 40.2 m80 -52.24 -29.38 22.52 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 177.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.662 ' HA ' HD23 ' A' ' 6' ' ' LEU . 10.9 tp -74.74 -49.36 21.28 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.603 HG13 ' CE1' ' A' ' 24' ' ' PHE . 5.0 t -49.89 -41.43 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 20.6 tt0 -47.69 -59.25 3.42 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.608 -177.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.488 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.62 -61.11 1.84 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.756 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.1 mt -46.32 -44.97 17.2 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.556 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.96 -50.9 69.51 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.691 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 19.5 mt -52.02 -62.75 1.44 Allowed 'General case' 0 C--N 1.291 -1.96 0 O-C-N 120.998 -1.064 . . . . 0.0 109.866 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -69.08 -58.21 6.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.578 -178.302 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.62 ' N ' ' O ' ' A' ' 15' ' ' LEU . 82.7 m -86.26 34.18 0.63 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.977 -1.077 . . . . 0.0 110.526 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . -54.7 -111.98 0.01 OUTLIER Glycine 0 N--CA 1.499 2.851 0 O-C-N 120.889 -1.132 . . . . 0.0 111.329 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -43.86 -15.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -1.053 . . . . 0.0 110.582 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 20' ' ' GLY . 3.9 mmp_? -74.58 -40.13 61.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.987 -1.07 . . . . 0.0 109.73 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.07 137.37 9.78 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.603 ' CE1' HG13 ' A' ' 12' ' ' VAL . 37.1 p90 -138.81 -173.33 3.53 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -154.43 118.54 4.73 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 119.928 -1.733 . . . . 0.0 112.607 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.756 ' CE2' HD13 ' A' ' 15' ' ' LEU . 32.4 m-85 -146.53 108.84 4.45 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -55.35 -166.12 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.148 -0.97 . . . . 0.0 109.799 -179.095 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.705 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -48.38 -172.04 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 28' ' ' ASP . 28.3 Cg_endo -85.89 -5.96 8.69 Favored 'Trans proline' 0 C--N 1.295 -2.256 0 C-N-CA 124.161 3.241 . . . . 0.0 111.308 174.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.694 ' OG1' ' N ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -145.19 -140.72 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.549 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.705 ' OE2' ' HB2' ' A' ' 28' ' ' ASP . 1.2 mt-10 65.1 92.07 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.126 -1.609 . . . . 0.0 108.897 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 59.21 -69.83 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.934 -0.479 . . . . 0.0 110.675 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.543 ' HA3' ' CZ ' ' A' ' 36' ' ' ARG . . . 168.41 169.53 31.98 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 117.765 -2.159 . . . . 0.0 112.575 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 59.1 Cg_endo -79.13 -125.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 124.346 3.364 . . . . 0.0 113.234 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.432 ' H ' ' HB2' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -94.57 -16.52 23.18 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.891 0.853 . . . . 0.0 108.904 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' CZ ' ' HA3' ' A' ' 33' ' ' GLY . 1.8 mpt_? 61.29 45.63 8.58 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.73 -83.95 0.05 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 117.285 -2.388 . . . . 0.0 109.012 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 39' ' ' VAL . 4.8 tt -48.7 -38.74 10.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.752 -0.852 . . . . 0.0 110.371 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.499 ' N ' HG23 ' A' ' 38' ' ' ILE . 39.3 t -72.87 -61.16 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.436 0.636 . . . . 0.0 111.013 -178.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -52.25 -27.07 13.54 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -93.46 -34.95 13.21 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.055 -1.028 . . . . 0.0 109.525 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' SER . 50.1 t -83.28 -49.96 8.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.721 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 39' ' ' VAL . 44.2 t -64.29 -23.94 67.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 110.018 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -102.72 -29.18 11.66 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.168 -0.957 . . . . 0.0 110.068 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 t -134.3 -172.98 3.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.375 -0.828 . . . . 0.0 109.794 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.8 mm -65.95 175.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.6 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -137.21 141.65 42.1 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.027 -1.046 . . . . 0.0 110.063 -178.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -93.43 151.08 19.97 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.2 tp -83.12 -42.08 17.79 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -55.84 -25.11 40.4 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 123.017 1.389 . . . . 0.0 107.925 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.486 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 7.6 tt0 -78.69 -23.35 45.66 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.102 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.1 mt -85.36 -36.36 20.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.454 -1.404 . . . . 0.0 108.497 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -58.11 -19.57 33.38 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.645 -0.66 . . . . 0.0 110.948 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -88.03 -7.97 56.27 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.072 -1.017 . . . . 0.0 108.792 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.486 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 5.7 m-85 -88.72 -25.59 22.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.529 -0.732 . . . . 0.0 110.636 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.8 110.61 0.37 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.07 -1.019 . . . . 0.0 109.629 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 t30 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.475 179.909 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.592 ' O ' ' N ' ' A' ' 3' ' ' ASN . 23.4 p90 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 2' ' ' VAL . 1.4 p -53.25 89.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 119.936 -1.727 . . . . 0.0 108.97 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 1' ' ' PHE . 1.6 m120 47.0 -132.17 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.645 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.02 166.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 109.646 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -76.73 142.19 40.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.643 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.68 124.89 34.69 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.3 m -128.05 -176.84 3.91 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.541 -0.724 . . . . 0.0 109.085 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.6 -151.44 1.07 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.452 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -77.12 -13.32 59.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.039 -1.271 . . . . 0.0 109.151 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -51.73 -23.73 4.91 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.452 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.8 tp -81.74 -50.94 8.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.641 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.5 t -46.26 -47.91 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.74 0.781 . . . . 0.0 108.979 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.514 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.5 tt0 -48.06 -59.71 3.17 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.579 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.539 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.72 -62.24 1.28 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 14.6 mt -44.94 -44.38 9.72 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -57.67 -49.71 75.6 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 29.1 mt -53.94 -62.84 1.39 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.117 0.96 . . . . 0.0 110.942 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.6 m -62.43 -37.17 78.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.955 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.1 t -81.23 -22.22 38.95 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.026 -1.046 . . . . 0.0 109.881 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 67.56 -146.66 47.49 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 23' ' ' GLY . 19.1 mt-10 -83.1 -1.72 53.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 0.0 109.363 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -61.92 1.69 0.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 110.033 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 64.73 120.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.641 ' CE1' HG13 ' A' ' 12' ' ' VAL . 13.8 p90 -99.63 171.69 7.76 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.542 -0.975 . . . . 0.0 109.62 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -104.59 119.6 39.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.503 -0.748 . . . . 0.0 109.732 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -152.54 4.14 0.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.277 -0.89 . . . . 0.0 108.76 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 31' ' ' GLU . 0.2 OUTLIER 60.53 175.28 0.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.507 -0.746 . . . . 0.0 109.787 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.67 165.63 0.29 Allowed Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.9 -15.04 45.98 Favored 'Trans proline' 0 C--N 1.288 -2.645 0 C-N-CA 122.214 1.942 . . . . 0.0 110.239 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 30' ' ' THR . 1.8 t -136.89 129.05 29.62 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' OE2' HG23 ' A' ' 30' ' ' THR . 35.9 mm-40 -171.78 167.23 6.41 Favored 'General case' 0 CA--C 1.586 2.354 0 CA-C-O 123.101 1.429 . . . . 0.0 111.868 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.16 48.98 0.82 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.092 -1.63 . . . . 0.0 111.306 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.682 ' H ' ' HD3' ' A' ' 34' ' ' PRO . . . 175.09 41.42 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.675 -1.726 . . . . 0.0 110.842 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.682 ' HD3' ' H ' ' A' ' 33' ' ' GLY . 73.0 Cg_endo -66.74 29.31 0.11 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 123.168 2.578 . . . . 0.0 110.127 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.733 ' O ' ' N ' ' A' ' 37' ' ' GLY . 12.6 ttm-85 69.53 -8.6 0.73 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.591 ' H ' ' C ' ' A' ' 34' ' ' PRO . 11.0 mmt180 32.69 27.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.733 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -106.64 -67.56 0.67 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 39' ' ' VAL . 9.2 tt -62.12 -41.24 90.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 122.118 0.961 . . . . 0.0 109.821 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.575 ' N ' HG23 ' A' ' 38' ' ' ILE . 45.2 t -65.39 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 O-C-N 121.678 -0.639 . . . . 0.0 111.403 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 36' ' ' ARG . 20.1 mt-10 -60.93 -22.04 64.0 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.033 -1.042 . . . . 0.0 110.31 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -93.31 -37.84 11.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.852 -1.155 . . . . 0.0 110.345 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 28.9 m -88.59 -36.84 16.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.076 -1.015 . . . . 0.0 110.344 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.9 t -76.36 -37.16 57.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.863 -1.148 . . . . 0.0 109.98 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -91.71 -22.29 20.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.0 -1.063 . . . . 0.0 109.395 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 42' ' ' CYS . 2.7 m -140.37 -174.52 3.97 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.241 -0.912 . . . . 0.0 109.36 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.602 HG22 ' H ' ' A' ' 47' ' ' CYS . 4.9 mm -83.53 174.14 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.864 . . . . 0.0 108.99 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.602 ' H ' HG22 ' A' ' 46' ' ' ILE . 2.0 m -151.05 167.83 26.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.002 -1.061 . . . . 0.0 110.069 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.71 163.73 12.35 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.624 0.726 . . . . 0.0 109.352 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.04 -31.56 30.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.64 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.61 -27.3 68.3 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.676 1.227 . . . . 0.0 108.53 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.43 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 12.1 tt0 -71.55 -24.51 61.95 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.433 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.2 mt -84.78 -34.02 22.87 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -62.57 -18.85 62.95 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.495 -0.753 . . . . 0.0 109.911 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.2 m-20 -82.85 -8.93 59.54 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.4 m-85 -91.6 -28.74 17.33 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.61 0.719 . . . . 0.0 109.394 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 35.5 t -68.77 112.48 5.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.394 -0.816 . . . . 0.0 109.703 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 t30 . . . . . 0 C--N 1.291 -1.973 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.491 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.726 ' CD1' HD12 ' A' ' 17' ' ' LEU . 6.0 p90 . . . . . 0 C--O 1.206 -1.196 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 3' ' ' ASN . 87.1 t -145.94 91.2 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 118.524 0.602 . . . . 0.0 110.0 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.482 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.7 m120 40.01 51.56 2.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.689 -0.632 . . . . 0.0 110.162 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -132.8 161.05 35.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.491 -0.756 . . . . 0.0 110.006 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.425 ' O ' ' CG ' ' A' ' 5' ' ' HIS . 0.6 OUTLIER -50.43 124.93 11.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 110.334 -179.254 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.25 109.69 9.59 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.3 m -121.92 -177.88 3.7 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.32 -150.96 2.98 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.1 p -77.25 -12.64 59.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.952 -1.323 . . . . 0.0 109.135 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -51.63 -25.17 6.56 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.434 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.6 tp -81.31 -49.68 10.42 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.662 HG13 ' CE1' ' A' ' 24' ' ' PHE . 19.4 t -46.53 -46.48 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.521 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 35.7 tt0 -47.83 -59.69 3.13 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.429 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.516 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.02 -61.39 1.65 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.1 mt -45.86 -45.05 14.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.553 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.79 -49.81 74.22 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.726 HD12 ' CD1' ' A' ' 1' ' ' PHE . 29.1 mt -54.19 -62.42 1.67 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.098 0.951 . . . . 0.0 110.821 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.1 m -65.36 -36.75 78.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.169 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 41.9 t -80.55 -22.57 40.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.844 -1.16 . . . . 0.0 110.002 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 68.29 -146.05 45.3 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.589 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.8 mp0 -83.23 -17.13 43.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.16 -1.2 . . . . 0.0 109.211 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -45.56 -13.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.776 -0.577 . . . . 0.0 110.352 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 81.17 130.74 1.09 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.662 ' CE1' HG13 ' A' ' 12' ' ' VAL . 27.0 p90 -116.43 149.42 39.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.677 -0.896 . . . . 0.0 109.27 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -85.48 116.57 23.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.145 -0.972 . . . . 0.0 110.015 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -161.48 -11.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 28' ' ' ASP . 1.8 m 58.03 -140.43 0.78 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 109.69 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -103.09 167.07 10.76 Favored Pre-proline 0 N--CA 1.487 1.412 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.44 -19.62 19.14 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 123.007 2.471 . . . . 0.0 110.285 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -111.19 -128.92 0.29 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.908 -179.104 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.487 ' H ' ' HB ' ' A' ' 30' ' ' THR . 1.4 mt-10 60.35 -80.76 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -159.03 155.42 27.42 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.425 -1.31 . . . . 0.0 112.058 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.503 ' HA2' ' HD2' ' A' ' 34' ' ' PRO . . . -37.36 109.1 0.08 OUTLIER Glycine 0 N--CA 1.492 2.408 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.114 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.883 ' CG ' HG21 ' A' ' 39' ' ' VAL . 15.0 Cg_endo -50.35 -176.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 124.084 3.189 . . . . 0.0 112.914 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 34' ' ' PRO . 1.3 ttm180 -19.07 -31.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.836 -0.54 . . . . 0.0 111.967 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.872 ' N ' ' O ' ' A' ' 34' ' ' PRO . 1.8 tpp180 72.17 31.72 1.88 Allowed 'General case' 0 N--CA 1.511 2.578 0 O-C-N 120.555 -1.34 . . . . 0.0 107.825 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.54 -63.01 0.01 OUTLIER Glycine 0 C--N 1.274 -2.915 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.553 HG23 ' N ' ' A' ' 39' ' ' VAL . 5.4 tt -67.43 -39.3 82.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 122.106 0.955 . . . . 0.0 109.699 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.883 HG21 ' CG ' ' A' ' 34' ' ' PRO . 45.0 t -70.35 -61.87 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.74 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.87 -21.85 32.58 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.405 -0.81 . . . . 0.0 109.717 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -94.24 -49.22 5.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.158 -0.964 . . . . 0.0 110.699 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' SER . 3.0 t -80.03 -29.99 39.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.82 -1.175 . . . . 0.0 111.013 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.4 t -78.61 -49.67 12.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.658 -1.276 . . . . 0.0 109.708 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -80.94 -23.08 39.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.046 -1.034 . . . . 0.0 109.349 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 m -139.96 -173.04 3.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.305 -0.872 . . . . 0.0 108.951 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 47' ' ' CYS . 1.9 mm -86.5 168.33 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.174 -0.954 . . . . 0.0 108.791 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.508 ' N ' HG22 ' A' ' 46' ' ' ILE . 23.1 p -149.45 161.08 42.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.07 -1.019 . . . . 0.0 109.259 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.93 164.85 14.4 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.083 0.945 . . . . 0.0 111.079 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.569 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.74 -36.92 25.34 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.91 -26.3 62.01 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 122.757 1.265 . . . . 0.0 108.094 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.44 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 40.8 tt0 -76.49 -22.53 54.37 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.736 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.7 mt -85.28 -30.9 23.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.861 -1.15 . . . . 0.0 108.235 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -64.2 -19.29 65.24 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.564 -0.71 . . . . 0.0 111.049 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.631 ' ND2' ' CD1' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -87.51 -8.57 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.926 -1.109 . . . . 0.0 108.045 178.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.631 ' CD1' ' ND2' ' A' ' 54' ' ' ASN . 4.9 m-85 -84.78 -28.69 26.0 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.3 t -68.48 112.31 5.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.444 -0.785 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--N 1.29 -1.992 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.445 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.742 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.476 0.655 . . . . 0.0 109.815 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 4' ' ' GLN . 3.3 t 54.88 48.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.267 0.556 . . . . 0.0 110.021 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 4' ' ' GLN . 22.2 m-80 56.68 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.107 -0.996 . . . . 0.0 110.28 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 3' ' ' ASN . 5.8 pt20 35.43 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.69 -0.631 . . . . 0.0 111.498 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 51.8 p-80 -90.86 123.9 34.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.126 -0.984 . . . . 0.0 109.612 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -129.88 116.75 19.12 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.6 m -122.41 -176.91 3.48 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.542 -0.724 . . . . 0.0 109.123 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 44.02 -149.21 0.87 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.458 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.2 p -80.81 -9.48 59.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.942 -1.328 . . . . 0.0 108.865 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 9' ' ' SER . 50.6 m80 -52.29 -24.63 7.74 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.458 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.0 tp -77.76 -53.82 7.07 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.64 HG13 ' CE1' ' A' ' 24' ' ' PHE . 5.0 t -46.55 -42.56 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.531 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.6 tt0 -46.84 -59.21 3.22 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.635 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.49 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.37 -61.42 1.68 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.763 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.1 mt -46.14 -48.41 17.37 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -51.24 -48.47 62.13 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.357 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.61 HD12 ' CE1' ' A' ' 1' ' ' PHE . 19.6 mt -57.31 -63.66 1.15 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.168 -0.957 . . . . 0.0 110.532 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -64.55 -47.59 88.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.965 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.473 ' N ' ' O ' ' A' ' 15' ' ' LEU . 67.0 m -73.05 -20.81 60.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.908 -1.12 . . . . 0.0 109.756 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 42.55 -125.74 4.33 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -83.63 -15.2 49.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -1.015 . . . . 0.0 110.077 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -46.73 -29.12 1.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.103 -0.998 . . . . 0.0 109.481 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.45 127.54 4.29 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.705 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.64 ' CE1' HG13 ' A' ' 12' ' ' VAL . 29.1 p90 -132.83 176.29 8.6 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -154.01 125.75 7.66 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 119.589 -1.944 . . . . 0.0 112.527 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.763 ' CE2' HD13 ' A' ' 15' ' ' LEU . 20.3 m-85 -141.33 -179.93 6.41 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.572 HG22 ' CB ' ' A' ' 31' ' ' GLU . 1.4 m -152.35 171.88 17.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.001 -1.062 . . . . 0.0 109.629 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.449 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -74.64 164.77 59.02 Favored Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 121.493 -0.755 . . . . 0.0 108.969 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 28' ' ' ASP . 16.8 Cg_endo -53.93 -34.74 77.74 Favored 'Trans proline' 0 C--N 1.276 -3.27 0 C-N-CA 123.7 2.933 . . . . 0.0 111.559 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.895 ' C ' ' H ' ' A' ' 32' ' ' GLU . 14.3 t -102.54 -34.17 9.21 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.45 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.572 ' CB ' HG22 ' A' ' 27' ' ' THR . 46.7 mm-40 -62.28 10.19 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.895 ' H ' ' C ' ' A' ' 30' ' ' THR . 0.4 OUTLIER 106.99 123.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.708 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 32' ' ' GLU . . . -48.01 156.46 1.04 Allowed Glycine 0 N--CA 1.478 1.481 0 N-CA-C 107.261 -2.335 . . . . 0.0 107.261 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.58 ' HG2' HG21 ' A' ' 39' ' ' VAL . 42.7 Cg_endo -94.73 -147.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.288 -2.641 0 C-N-CA 123.34 2.694 . . . . 0.0 111.595 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.726 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.4 OUTLIER -63.07 84.06 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.5 -1.375 . . . . 0.0 109.004 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.574 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -47.22 110.73 0.33 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 158.2 -89.83 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -176.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.557 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.3 tt -46.9 -40.26 4.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 122.009 0.909 . . . . 0.0 109.982 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.58 HG21 ' HG2' ' A' ' 34' ' ' PRO . 47.1 t -69.45 -61.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 O-C-N 121.298 -0.876 . . . . 0.0 110.308 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.47 ' HG3' ' HD2' ' A' ' 36' ' ' ARG . 42.6 mt-10 -62.53 -19.42 63.62 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.141 -0.974 . . . . 0.0 109.724 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -94.18 -39.31 10.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.082 -1.011 . . . . 0.0 110.088 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 33.7 m -88.47 -40.43 13.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.967 -1.083 . . . . 0.0 110.365 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.0 t -71.02 -25.77 62.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.792 -1.192 . . . . 0.0 109.541 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -102.95 -25.88 13.3 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.334 -0.854 . . . . 0.0 109.195 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -137.41 -168.06 2.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.404 -0.81 . . . . 0.0 108.964 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 47' ' ' CYS . 4.2 mm -94.98 169.95 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.131 -0.98 . . . . 0.0 109.499 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.577 ' N ' HG22 ' A' ' 46' ' ' ILE . 98.3 m -149.21 167.85 24.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.088 -1.008 . . . . 0.0 110.104 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.21 165.24 12.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.831 . . . . 0.0 109.521 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -82.67 -35.24 27.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 178.167 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.17 -25.28 65.42 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.756 1.265 . . . . 0.0 108.238 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.474 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 14.1 tt0 -75.81 -22.41 56.36 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.545 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -84.42 -33.29 23.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.852 -1.155 . . . . 0.0 107.983 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -64.19 -17.88 63.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.624 -0.672 . . . . 0.0 110.319 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -86.48 -8.41 57.61 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 108.607 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.554 ' CE2' ' HD3' ' A' ' 35' ' ' ARG . 5.0 m-85 -88.12 -39.85 14.24 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.765 0.793 . . . . 0.0 109.606 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.99 110.15 0.36 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.549 -0.719 . . . . 0.0 109.636 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.7 t30 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.485 179.916 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.842 ' CZ ' HD11 ' A' ' 52' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.236 0.541 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.753 HG22 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER 39.65 -96.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.272 -1.517 . . . . 0.0 110.792 176.489 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.753 ' N ' HG22 ' A' ' 2' ' ' VAL . 23.7 m-20 -139.06 -43.63 0.47 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.882 -1.136 . . . . 0.0 109.85 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.51 ' O ' ' O ' ' A' ' 3' ' ' ASN . 2.4 pt20 -18.28 143.55 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.56 ' N ' ' ND1' ' A' ' 5' ' ' HIS . 3.2 p-80 -46.21 141.98 3.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.692 . . . . 0.0 110.284 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.69 HD22 ' CE1' ' A' ' 1' ' ' PHE . 0.7 OUTLIER -131.1 109.96 10.84 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.8 m -114.87 146.1 41.47 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.32 -0.862 . . . . 0.0 109.106 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.61 -175.57 54.84 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.9 p -56.05 -15.07 3.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.984 -1.304 . . . . 0.0 109.115 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -52.12 -24.16 6.53 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' A' ' 9' ' ' SER . 15.0 tp -81.83 -47.64 12.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.583 HG13 ' CE1' ' A' ' 24' ' ' PHE . 24.4 t -49.66 -46.66 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.53 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.8 tt0 -48.7 -59.97 3.11 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.484 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.721 ' HB1' ' CE2' ' A' ' 1' ' ' PHE . . . -44.45 -60.66 1.85 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.7 mt -45.81 -51.38 12.93 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -50.03 -50.95 45.88 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.545 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 27.0 mt -53.65 -62.33 1.72 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.179 0.99 . . . . 0.0 111.299 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -68.27 -40.71 83.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.662 -176.207 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.647 ' O ' ' NH2' ' A' ' 22' ' ' ARG . 95.4 m -78.31 -28.44 47.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.72 -1.238 . . . . 0.0 112.581 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.743 ' C ' HH22 ' A' ' 22' ' ' ARG . . . 86.89 -150.2 22.86 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.314 -1.422 . . . . 0.0 111.046 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 23' ' ' GLY . 30.6 tt0 -87.8 -18.72 28.72 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.63 -0.923 . . . . 0.0 113.338 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.747 ' NH1' ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -43.12 -15.07 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 O-C-N 120.798 -1.189 . . . . 0.0 110.932 -177.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.747 ' H ' ' NH1' ' A' ' 22' ' ' ARG . . . 85.8 93.43 0.83 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.703 ' N ' HH11 ' A' ' 22' ' ' ARG . 29.9 p90 -76.88 161.58 28.3 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.305 -1.115 . . . . 0.0 109.383 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.623 ' CB ' ' NH1' ' A' ' 35' ' ' ARG . 60.5 m-85 -89.9 132.69 35.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.303 -0.873 . . . . 0.0 110.631 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -173.16 -22.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.72 168.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.489 -0.757 . . . . 0.0 110.012 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -85.51 163.64 43.68 Favored Pre-proline 0 N--CA 1.485 1.316 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.829 ' O ' ' C ' ' A' ' 30' ' ' THR . 1.2 Cg_endo -48.24 -134.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 124.76 3.64 . . . . 0.0 113.099 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.829 ' C ' ' O ' ' A' ' 29' ' ' PRO . 69.2 p 9.95 -119.79 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.49 1.138 . . . . 0.0 108.278 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.743 ' C ' ' O ' ' A' ' 30' ' ' THR . 8.5 mt-10 3.07 90.11 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.215 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 46.58 -129.61 1.4 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.535 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.69 -173.16 19.9 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.169 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.754 ' HG3' HG21 ' A' ' 39' ' ' VAL . 72.5 Cg_endo -67.84 -126.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 124.163 3.242 . . . . 0.0 111.124 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.766 ' O ' ' O ' ' A' ' 36' ' ' ARG . 12.5 ttm180 -110.91 14.7 22.05 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.766 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 45.37 110.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.86 -67.32 0.36 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 116.138 -2.934 . . . . 0.0 107.745 -176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.612 HG23 ' N ' ' A' ' 39' ' ' VAL . 7.3 tt -67.78 -44.61 85.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.805 0.812 . . . . 0.0 109.348 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.754 HG21 ' HG3' ' A' ' 34' ' ' PRO . 44.4 t -65.53 -61.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.425 0.631 . . . . 0.0 111.078 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.56 ' OE2' ' HG3' ' A' ' 36' ' ' ARG . 3.0 mt-10 -51.7 -26.42 9.26 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.658 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 45' ' ' SER . 17.8 tt0 -93.96 -61.21 1.58 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.122 -0.986 . . . . 0.0 110.414 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 45' ' ' SER . 98.0 m -58.36 -37.0 74.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.139 -0.976 . . . . 0.0 110.652 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.19 -38.54 31.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.903 -1.123 . . . . 0.0 110.516 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -86.99 -17.31 33.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.838 -1.164 . . . . 0.0 109.249 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 41' ' ' GLN . 7.9 t -140.42 -164.89 1.81 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.432 -0.792 . . . . 0.0 109.071 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 47' ' ' CYS . 4.5 mm -76.46 167.4 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.082 -1.011 . . . . 0.0 109.328 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.589 ' N ' HG22 ' A' ' 46' ' ' ILE . 4.5 t -121.15 139.14 53.76 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.451 -0.781 . . . . 0.0 110.381 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -101.15 150.88 22.48 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.451 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.5 tp -82.34 -38.52 24.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.479 1.133 . . . . 0.0 108.038 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.53 -24.24 60.15 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 123.005 1.383 . . . . 0.0 108.199 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.474 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 6.5 tp60 -79.8 -24.62 41.29 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.033 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.842 HD11 ' CZ ' ' A' ' 1' ' ' PHE . 33.9 mt -85.3 -30.99 23.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.494 -1.379 . . . . 0.0 109.107 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -62.32 -20.81 64.73 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.682 -0.637 . . . . 0.0 111.549 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.643 ' ND2' ' CD1' ' A' ' 55' ' ' TYR . 0.8 OUTLIER -88.53 -7.79 55.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.823 -1.173 . . . . 0.0 108.838 179.424 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.643 ' CD1' ' ND2' ' A' ' 54' ' ' ASN . 5.1 m-85 -83.72 -9.79 58.59 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.671 0.748 . . . . 0.0 109.465 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.429 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -91.42 115.82 28.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.569 -0.707 . . . . 0.0 109.351 -179.43 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.429 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 55.9 t-20 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.026 -1.046 . . . . 0.0 109.282 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.686 ' C ' ' CD1' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.728 0.299 . . . . 0.0 110.687 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 3' ' ' ASN . 14.0 p -66.02 163.62 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 119.967 -1.708 . . . . 0.0 108.708 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.506 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.1 m120 -49.04 98.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.04 -1.038 . . . . 0.0 109.531 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 2' ' ' VAL . 14.9 pt20 -159.03 -163.94 1.32 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.841 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -89.86 131.2 35.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.743 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.93 109.65 11.79 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.5 m -118.58 152.59 35.73 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.523 -0.736 . . . . 0.0 109.248 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.57 -163.24 54.34 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.456 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -66.47 -14.63 62.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.864 -1.374 . . . . 0.0 109.261 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' SER . 4.5 m-70 -51.18 -24.67 4.43 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.456 ' N ' ' C ' ' A' ' 9' ' ' SER . 14.1 tp -81.86 -46.67 13.8 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.636 HG13 ' CE1' ' A' ' 24' ' ' PHE . 18.7 t -50.15 -46.15 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.538 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 20.7 tt0 -49.16 -59.72 3.41 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.446 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.481 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.43 -60.67 1.84 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.2 mt -45.38 -53.68 8.3 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.554 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -47.75 -49.62 27.8 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.346 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 26.4 mt -56.01 -62.59 1.6 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.106 0.955 . . . . 0.0 111.304 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.9 OUTLIER -67.56 -48.12 77.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.643 -176.292 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.501 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 30.9 m -73.86 -26.48 60.59 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.868 -1.145 . . . . 0.0 112.787 -175.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.499 ' C ' ' HE ' ' A' ' 22' ' ' ARG . . . 85.15 -161.21 35.71 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 119.473 -2.017 . . . . 0.0 111.156 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 23' ' ' GLY . 11.8 mt-10 -86.85 -13.26 45.48 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -177.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.704 ' NE ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.66 0.1 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 119.513 -1.992 . . . . 0.0 110.712 -178.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.594 ' N ' ' CZ ' ' A' ' 22' ' ' ARG . . . 88.52 113.48 1.21 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.696 ' N ' HH12 ' A' ' 22' ' ' ARG . 26.9 p90 -98.45 141.83 30.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -1.024 . . . . 0.0 109.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.33 126.75 30.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.516 -0.74 . . . . 0.0 110.33 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 27' ' ' THR . 53.9 t80 -173.14 -22.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.595 -0.69 . . . . 0.0 109.164 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.917 HG21 ' OE2' ' A' ' 31' ' ' GLU . 56.6 m 49.29 -176.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.179 -0.951 . . . . 0.0 109.548 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.854 ' H ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -50.6 -171.91 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.338 -0.852 . . . . 0.0 108.94 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 28' ' ' ASP . 76.9 Cg_endo -92.36 -34.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.261 2.64 . . . . 0.0 108.913 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.99 HG23 ' N ' ' A' ' 31' ' ' GLU . 3.8 t -66.6 -92.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.68 1.228 . . . . 0.0 109.539 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.99 ' N ' HG23 ' A' ' 30' ' ' THR . 9.5 tp10 57.76 5.39 0.34 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.338 -1.476 . . . . 0.0 108.394 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.647 ' HG2' ' C ' ' A' ' 31' ' ' GLU . 2.6 pt-20 43.13 35.87 0.88 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.197 -0.939 . . . . 0.0 108.696 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.12 98.87 2.56 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 30.2 Cg_endo -87.38 -117.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.683 2.922 . . . . 0.0 112.439 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.628 ' O ' ' C ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -82.09 -13.91 56.59 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.212 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.709 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER 34.66 70.22 0.14 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.88 -83.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 CA-C-N 113.482 -1.69 . . . . 0.0 109.008 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.586 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.3 tt -55.31 -42.4 66.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.721 -0.87 . . . . 0.0 110.145 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.586 ' N ' HG23 ' A' ' 38' ' ' ILE . 42.2 t -63.93 -60.68 2.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.306 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.709 ' OE2' ' HD2' ' A' ' 36' ' ' ARG . 38.7 mt-10 -59.23 -20.11 51.33 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.215 -0.928 . . . . 0.0 109.872 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -94.58 -36.18 11.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.042 -1.037 . . . . 0.0 110.021 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 45' ' ' SER . 92.2 m -88.46 -38.17 15.22 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.232 -0.917 . . . . 0.0 110.537 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.5 t -77.86 -44.92 25.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -0.996 . . . . 0.0 110.597 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -82.76 -20.35 36.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.992 -1.068 . . . . 0.0 109.822 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.8 m -140.38 -171.85 3.3 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.271 -0.893 . . . . 0.0 109.61 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 47' ' ' CYS . 6.5 mm -64.85 170.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 108.97 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.576 ' N ' HG22 ' A' ' 46' ' ' ILE . 8.3 t -128.19 122.51 32.02 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.459 -0.775 . . . . 0.0 110.157 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.5 m -79.75 146.72 32.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 108.728 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.1 tp -82.34 -40.5 21.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -57.15 -25.62 59.21 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.979 1.371 . . . . 0.0 108.147 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.477 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 7.0 tt0 -77.62 -24.12 49.66 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.933 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.3 mt -84.68 -29.48 25.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.777 -1.202 . . . . 0.0 108.487 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -64.6 -19.35 65.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.756 -0.59 . . . . 0.0 111.058 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -88.31 -7.24 57.05 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.027 -1.046 . . . . 0.0 109.188 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.477 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 5.1 m-85 -86.6 -6.72 58.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.579 -0.701 . . . . 0.0 111.147 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.87 113.86 20.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.148 -0.97 . . . . 0.0 110.314 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.4 t30 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.842 -179.932 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.62 ' O ' ' C ' ' A' ' 2' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.732 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.8 OUTLIER 32.23 -153.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 118.655 -2.528 . . . . 0.0 110.643 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.732 ' N ' HG13 ' A' ' 2' ' ' VAL . 1.6 m120 -101.74 93.95 5.59 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.053 -1.03 . . . . 0.0 109.551 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -152.5 -178.81 7.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.217 -0.927 . . . . 0.0 109.26 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 5' ' ' HIS . 1.2 m-70 -75.54 133.2 41.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.999 -1.063 . . . . 0.0 109.378 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.95 120.01 24.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.7 m -127.18 -178.26 4.37 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.448 -0.782 . . . . 0.0 109.207 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.56 -149.05 2.29 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.439 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.4 p -77.97 -14.12 59.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.026 -1.279 . . . . 0.0 109.241 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -51.86 -24.07 5.69 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.439 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.7 tp -81.56 -51.14 8.56 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.618 HG13 ' CE1' ' A' ' 24' ' ' PHE . 24.6 t -45.44 -46.77 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.697 0.761 . . . . 0.0 108.988 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 35.8 tt0 -47.89 -59.81 3.06 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.378 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.05 -61.5 1.61 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.7 mt -45.66 -46.84 14.94 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.554 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.54 -48.73 71.66 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 24.7 mt -55.91 -62.8 1.46 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.156 0.979 . . . . 0.0 110.827 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -64.94 -31.93 56.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.221 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.1 m -92.12 -7.38 48.68 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.999 -1.063 . . . . 0.0 110.096 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 47.4 -144.0 5.61 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 23' ' ' GLY . 14.3 tp10 -79.35 -19.29 50.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.594 -0.945 . . . . 0.0 109.996 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -42.58 -17.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.457 -0.777 . . . . 0.0 110.653 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 88.02 137.5 5.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CE1' HG13 ' A' ' 12' ' ' VAL . 34.1 p90 -131.33 144.95 51.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.69 -0.888 . . . . 0.0 109.473 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -87.89 127.55 35.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.327 -0.858 . . . . 0.0 109.646 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' ' 27' ' ' THR . 85.9 t80 -163.14 -48.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 108.961 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 28' ' ' ASP . 2.4 m 53.6 172.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.451 -0.781 . . . . 0.0 109.842 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.5 ' H ' HG22 ' A' ' 27' ' ' THR . 0.2 OUTLIER -82.82 171.04 12.65 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 31' ' ' GLU . 19.2 Cg_endo -52.12 -83.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.515 2.745 0 C-N-CA 123.699 2.932 . . . . 0.0 114.546 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.561 ' H ' ' HG2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -43.65 4.09 0.0 OUTLIER 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 109.493 -3.503 . . . . 0.0 112.454 -176.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.921 ' O ' ' O ' ' A' ' 32' ' ' GLU . 1.1 tp10 -95.26 138.45 32.95 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 119.917 -1.74 . . . . 0.0 107.97 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.921 ' O ' ' O ' ' A' ' 31' ' ' GLU . 3.7 mp0 13.03 -140.93 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.396 -1.44 . . . . 0.0 109.161 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.41 ' HA2' ' HD2' ' A' ' 34' ' ' PRO . . . -121.66 97.95 0.63 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.41 ' HD2' ' HA2' ' A' ' 33' ' ' GLY . 39.4 Cg_endo -62.98 30.06 0.07 OUTLIER 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.906 3.07 . . . . 0.0 113.751 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.14 123.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.85 -1.156 . . . . 0.0 112.035 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.425 ' N ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -92.52 112.33 24.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.551 -0.718 . . . . 0.0 110.787 179.311 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.93 -48.49 0.06 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 39' ' ' VAL . 13.3 tt -82.21 -42.47 18.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.541 -0.976 . . . . 0.0 110.332 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.595 ' N ' HG23 ' A' ' 38' ' ' ILE . 54.1 t -69.42 -62.17 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 O-C-N 121.63 -0.669 . . . . 0.0 111.016 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -59.21 -22.01 60.39 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -94.31 -41.61 9.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.995 -1.065 . . . . 0.0 110.497 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 45' ' ' SER . 1.8 t -86.46 -29.73 22.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.867 -1.145 . . . . 0.0 110.737 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 51.8 t -81.58 -51.62 8.05 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.604 -1.31 . . . . 0.0 109.446 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -24.81 53.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.045 -1.034 . . . . 0.0 108.743 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' CYS . 5.1 m -140.52 -174.88 4.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.314 -0.866 . . . . 0.0 109.123 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.5 mt -90.64 148.92 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.233 -0.917 . . . . 0.0 109.216 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 20.6 p -128.88 167.39 17.45 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.378 -0.827 . . . . 0.0 109.775 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.82 165.3 13.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.303 -0.873 . . . . 0.0 110.79 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.68 -36.61 25.76 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.054 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.11 -25.27 61.15 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.862 1.315 . . . . 0.0 108.097 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.461 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 13.1 tt0 -77.8 -22.19 50.46 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.695 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.3 mt -84.5 -33.66 23.51 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.748 -1.22 . . . . 0.0 107.869 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -62.89 -18.72 63.38 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.554 -0.716 . . . . 0.0 110.162 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -84.84 -8.52 58.76 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -90.39 -37.33 14.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.695 -0.628 . . . . 0.0 109.643 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 m -49.8 110.94 0.44 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.507 -0.746 . . . . 0.0 109.718 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.464 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.63 ' HE2' HD11 ' A' ' 52' ' ' LEU . 1.9 t80 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 123.251 1.501 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 2' ' ' VAL . 6.1 p -90.23 84.55 2.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.335 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 2' ' ' VAL . 1.6 m-20 41.29 70.25 0.28 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 110.567 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.584 ' H ' ' HE1' ' A' ' 1' ' ' PHE . 15.2 pt20 -141.69 169.86 16.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.057 -1.027 . . . . 0.0 109.639 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -63.16 126.63 28.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.895 . . . . 0.0 110.482 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 1' ' ' PHE . 0.8 OUTLIER -129.89 123.75 31.52 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.3 m -130.77 179.47 5.95 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.344 -0.847 . . . . 0.0 108.929 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.51 -147.68 2.78 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.44 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -77.29 -14.38 59.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.026 -1.279 . . . . 0.0 109.328 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -52.53 -24.02 7.36 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.4 tp -81.29 -49.58 10.56 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.638 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.3 t -46.56 -45.73 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.514 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 14.8 tt0 -48.08 -60.03 2.93 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.244 -0.983 . . . . 0.0 109.476 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.526 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.0 -61.55 1.58 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.7 mt -45.65 -45.98 14.32 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.81 -51.52 67.19 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.0 mt -51.68 -62.38 1.66 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.113 0.959 . . . . 0.0 110.778 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -66.06 -36.7 78.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.23 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.8 m -87.09 -4.93 59.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.935 -1.103 . . . . 0.0 110.146 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 46.88 -146.75 3.47 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 23' ' ' GLY . 32.0 mt-10 -83.39 -0.11 48.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -1.176 . . . . 0.0 109.719 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -58.79 -0.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 109.939 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 73.5 131.58 0.19 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.638 ' CE1' HG13 ' A' ' 12' ' ' VAL . 28.6 p90 -126.4 148.61 49.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.589 -0.947 . . . . 0.0 109.347 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -82.51 123.53 29.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 0.0 110.042 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.47 ' CE2' ' O ' ' A' ' 27' ' ' THR . 36.4 t80 -172.27 160.44 5.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 109.21 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -154.73 -156.16 0.64 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.322 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.554 ' H ' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -91.86 172.17 6.82 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.603 ' O ' ' C ' ' A' ' 30' ' ' THR . 57.0 Cg_endo -68.66 -145.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 118.067 -1.596 . . . . 0.0 112.718 176.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.321 ' O ' ' N ' ' A' ' 32' ' ' GLU 0.255 36.8 m 14.14 -107.66 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.024 -1.443 . . . . 0.0 112.982 175.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.73 ' C ' ' O ' ' A' ' 30' ' ' THR . 18.9 mt-10 16.59 -56.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 123.622 1.677 . . . . 0.0 107.093 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 1.321 ' N ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -156.16 -179.13 7.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.109 -2.314 . . . . 0.0 107.024 178.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.463 ' HA3' ' HD2' ' A' ' 36' ' ' ARG . . . -112.42 122.03 5.81 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.287 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.827 ' C ' ' H ' ' A' ' 36' ' ' ARG . 80.1 Cg_endo -75.08 81.26 2.26 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 124.217 3.278 . . . . 0.0 110.837 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.862 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 57.49 -10.65 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.827 ' H ' ' C ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER 30.12 21.35 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.973 -0.454 . . . . 0.0 110.327 -179.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.862 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -104.1 -36.57 3.12 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 107.779 -2.128 . . . . 0.0 107.779 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 39' ' ' VAL . 11.3 tt -81.83 -45.92 20.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.551 0.691 . . . . 0.0 110.344 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.618 ' N ' HG23 ' A' ' 38' ' ' ILE . 55.8 t -64.62 -61.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.78 -0.575 . . . . 0.0 111.726 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.52 -23.59 64.67 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.223 -0.923 . . . . 0.0 110.126 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -94.33 -33.96 12.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.982 -1.074 . . . . 0.0 109.954 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 38' ' ' ILE . 51.0 t -88.51 -43.58 11.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.152 -0.967 . . . . 0.0 110.568 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.78 -24.22 62.55 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 110.73 -178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -104.82 -19.07 14.02 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.201 -0.937 . . . . 0.0 109.524 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -140.1 179.52 6.57 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.264 -0.898 . . . . 0.0 109.035 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.821 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.0 mm -64.62 -177.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.996 . . . . 0.0 108.324 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.821 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -146.03 150.45 36.01 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.897 -1.127 . . . . 0.0 110.222 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -97.16 151.74 19.51 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -82.57 -40.46 20.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -57.67 -24.79 58.54 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 122.841 1.305 . . . . 0.0 107.943 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.443 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 7.7 tt0 -78.44 -23.03 46.78 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.802 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.63 HD11 ' HE2' ' A' ' 1' ' ' PHE . 46.1 mt -84.8 -36.89 21.36 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.69 -20.66 50.47 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.507 -0.746 . . . . 0.0 110.002 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -82.99 -8.94 59.51 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.7 m-85 -90.34 -36.72 14.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.551 -0.718 . . . . 0.0 109.316 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -51.51 110.49 0.46 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.376 -0.827 . . . . 0.0 109.565 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.6 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.505 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.851 ' CD1' ' O ' ' A' ' 1' ' ' PHE . 48.8 p90 . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 3' ' ' ASN . 9.1 p -55.27 167.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 116.145 -2.222 . . . . 0.0 108.976 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.585 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.6 m120 -52.78 105.77 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.002 -1.061 . . . . 0.0 109.952 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -164.49 -160.77 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.172 -0.955 . . . . 0.0 109.77 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -95.45 132.66 40.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.247 -0.908 . . . . 0.0 109.609 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.1 113.71 15.45 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.01 148.72 50.54 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.42 -169.99 53.05 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.412 ' C ' ' N ' ' A' ' 11' ' ' LEU . 4.3 p -60.95 -14.8 25.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.612 -1.523 . . . . 0.0 109.202 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -52.81 -25.74 12.33 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.501 HD13 ' SG ' ' A' ' 42' ' ' CYS . 13.0 tp -81.11 -47.9 12.88 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.618 HG13 ' CE1' ' A' ' 24' ' ' PHE . 27.2 t -48.08 -47.35 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.513 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.1 tt0 -47.51 -59.91 2.9 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.561 -176.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.627 ' HB1' ' CE2' ' A' ' 1' ' ' PHE . . . -45.23 -61.38 1.68 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.429 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 13.0 mt -45.76 -45.94 14.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.75 -52.46 63.86 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.472 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.7 mt -50.59 -62.32 1.67 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.079 0.942 . . . . 0.0 110.614 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -67.25 -31.92 55.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.036 -177.207 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 47.7 m -91.72 0.51 57.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.045 -1.034 . . . . 0.0 109.995 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 45.86 -158.7 0.29 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.32 -2.94 43.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -1.152 . . . . 0.0 109.354 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -46.62 -58.63 3.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.865 . . . . 0.0 109.487 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.58 131.18 2.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CE1' HG13 ' A' ' 12' ' ' VAL . 34.3 p90 -131.4 143.72 50.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.68 -0.894 . . . . 0.0 108.846 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -86.29 134.35 33.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.324 -0.86 . . . . 0.0 110.266 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' THR . 86.3 t80 -172.9 -24.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.44 -0.788 . . . . 0.0 109.399 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' TYR . 3.1 p 47.62 -175.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.734 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.84 ' O ' ' N ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -98.84 162.53 21.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.72 ' O ' HG22 ' A' ' 30' ' ' THR . 53.2 Cg_exo -42.51 32.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 124.212 3.275 . . . . 0.0 113.593 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.84 ' N ' ' O ' ' A' ' 28' ' ' ASP . 3.6 p -158.39 -101.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.708 -1.245 . . . . 0.0 111.437 -177.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.67 ' C ' ' O ' ' A' ' 30' ' ' THR . 14.5 mt-10 0.9 69.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.095 -1.003 . . . . 0.0 111.017 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.947 ' OE2' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER 62.49 -40.63 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.736 -1.227 . . . . 0.0 110.415 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 85.05 178.12 50.94 Favored Glycine 0 N--CA 1.503 3.113 0 O-C-N 119.824 -1.797 . . . . 0.0 109.23 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 94.3 Cg_endo -77.82 -148.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.893 3.062 . . . . 0.0 112.292 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.872 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -120.12 85.71 2.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.722 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -15.11 104.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.668 1.223 . . . . 0.0 109.368 -178.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.12 -54.25 0.02 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.584 HG23 ' N ' ' A' ' 39' ' ' VAL . 8.4 tt -81.9 -45.34 20.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.664 -0.904 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 38' ' ' ILE . 40.3 t -64.69 -62.24 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.625 -0.672 . . . . 0.0 111.962 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' CG ' ' HG3' ' A' ' 36' ' ' ARG . 25.3 mt-10 -47.77 -33.63 7.4 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.284 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.2 mt-30 -93.52 -59.54 1.99 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.003 -1.06 . . . . 0.0 109.415 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.501 ' SG ' HD13 ' A' ' 11' ' ' LEU . 17.6 t -52.8 -34.07 51.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.108 -0.995 . . . . 0.0 110.738 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.7 t -85.28 -53.03 5.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.863 -1.148 . . . . 0.0 110.831 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.446 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 2.3 m-70 -86.17 -5.06 59.27 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.966 -1.084 . . . . 0.0 110.511 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.0 m -140.39 -177.82 5.21 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.054 -1.029 . . . . 0.0 109.362 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.0 mm -64.66 -178.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.173 -0.954 . . . . 0.0 108.524 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.804 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.3 t -134.91 130.46 35.93 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.162 -0.961 . . . . 0.0 110.543 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.7 m -95.03 145.97 24.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.5 tp -82.5 -40.33 21.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -56.41 -24.97 48.4 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 122.945 1.355 . . . . 0.0 108.147 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.472 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 9.3 tt0 -79.39 -22.83 43.79 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.142 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.542 HD12 ' CZ ' ' A' ' 1' ' ' PHE . 38.8 mt -85.46 -38.33 18.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.597 -1.314 . . . . 0.0 108.223 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.31 -20.17 26.82 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.487 -0.758 . . . . 0.0 110.368 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -83.87 -8.69 59.14 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.472 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 3.6 m-85 -90.55 -39.18 12.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.6 -0.688 . . . . 0.0 109.758 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -49.67 110.65 0.4 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.353 -0.842 . . . . 0.0 109.546 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.6 t30 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.509 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.828 ' CD2' HD12 ' A' ' 17' ' ' LEU . 33.3 p90 . . . . . 0 CA--C 1.56 1.364 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.507 HG12 ' ND2' ' A' ' 3' ' ' ASN . 60.1 t 42.55 -99.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.409 -1.432 . . . . 0.0 109.23 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.519 ' O ' ' O ' ' A' ' 4' ' ' GLN . 1.9 m-20 -147.46 -30.77 0.32 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.07 -1.019 . . . . 0.0 109.89 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.519 ' O ' ' O ' ' A' ' 3' ' ' ASN . 4.3 pt20 -25.44 152.92 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.959 0.885 . . . . 0.0 112.98 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -45.77 136.07 6.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.327 -0.858 . . . . 0.0 109.603 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 1' ' ' PHE . 1.1 tp -134.38 109.38 8.75 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' GLY . 59.5 m -106.64 -176.39 3.06 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.153 -0.967 . . . . 0.0 109.685 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 7' ' ' CYS . . . 43.26 -164.43 0.03 OUTLIER Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.467 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.0 p -69.0 -8.65 46.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.985 -1.303 . . . . 0.0 109.23 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -53.33 -22.84 7.95 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.283 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.467 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.0 tp -78.99 -52.33 8.39 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.628 HG13 ' CE1' ' A' ' 24' ' ' PHE . 4.4 t -48.11 -40.72 9.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.528 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.2 tt0 -48.36 -59.39 3.49 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.534 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.49 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.45 -61.28 1.74 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.794 HD13 ' CE2' ' A' ' 26' ' ' TYR . 6.6 mt -45.74 -49.17 15.06 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.553 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -50.45 -48.71 56.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.828 HD12 ' CD2' ' A' ' 1' ' ' PHE . 19.2 mt -56.96 -63.87 1.06 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.962 0.887 . . . . 0.0 110.464 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.4 m -64.12 -51.46 68.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.601 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' LEU . 78.6 m -72.88 -1.57 17.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.028 -1.045 . . . . 0.0 109.346 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 40.2 -142.74 0.63 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.36 -6.89 59.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.608 -0.937 . . . . 0.0 109.793 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 22' ' ' ARG . 44.0 mtp85 -42.48 -59.11 1.98 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.844 -0.535 . . . . 0.0 109.767 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.4 102.85 0.81 Allowed Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.628 ' CE1' HG13 ' A' ' 12' ' ' VAL . 35.6 p90 -103.68 -170.48 1.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 63.4 t80 -154.33 120.58 5.37 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 119.638 -1.914 . . . . 0.0 112.9 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.794 ' CE2' HD13 ' A' ' 15' ' ' LEU . 32.4 m-85 -150.25 92.8 1.91 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -54.3 -171.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 -179.527 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.578 ' N ' ' OG1' ' A' ' 27' ' ' THR . 0.1 OUTLIER -85.58 168.34 20.42 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HB2' ' H ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -54.26 -125.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.196 0 C-N-CA 123.829 3.019 . . . . 0.0 113.724 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.05 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER 27.91 -132.17 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.042 0 O-C-N 121.329 -0.857 . . . . 0.0 110.808 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 1.135 ' O ' ' N ' ' A' ' 33' ' ' GLY . 2.7 mt-10 -12.62 168.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.147 0.498 . . . . 0.0 111.204 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.669 ' C ' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -17.69 58.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.563 0.697 . . . . 0.0 109.938 178.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 1.135 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 10.37 -138.48 0.0 OUTLIER Glycine 0 N--CA 1.499 2.897 0 CA-C-O 122.14 0.856 . . . . 0.0 112.892 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.587 ' HG2' ' H ' ' A' ' 35' ' ' ARG . 69.5 Cg_endo -80.22 -89.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 123.538 2.826 . . . . 0.0 113.183 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.79 ' O ' ' CB ' ' A' ' 36' ' ' ARG . 62.8 ttt180 -127.56 -46.74 1.44 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.347 -0.846 . . . . 0.0 108.929 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.79 ' CB ' ' O ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER 101.4 73.31 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.803 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.06 -79.32 0.14 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.61 HG23 ' N ' ' A' ' 39' ' ' VAL . 5.0 tt -56.04 -44.05 77.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.816 -0.814 . . . . 0.0 109.491 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.61 ' N ' HG23 ' A' ' 38' ' ' ILE . 46.6 t -65.29 -61.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.622 -0.674 . . . . 0.0 110.39 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.513 ' OE2' ' HG3' ' A' ' 36' ' ' ARG . 2.4 mt-10 -57.56 -18.47 19.65 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.141 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' SER . 44.8 tt0 -94.08 -51.92 4.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.224 -0.922 . . . . 0.0 110.755 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -75.69 -54.06 7.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.745 -1.222 . . . . 0.0 110.091 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 48.6 t -52.73 -23.45 6.77 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.025 -1.047 . . . . 0.0 110.406 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -111.82 -29.13 7.79 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.062 -1.024 . . . . 0.0 110.122 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -132.83 -163.96 1.41 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.365 -0.834 . . . . 0.0 109.232 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.5 mm -106.46 159.64 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.269 -0.894 . . . . 0.0 109.233 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 m -145.61 168.82 19.74 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.951 -1.093 . . . . 0.0 109.943 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.43 165.76 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.908 0.861 . . . . 0.0 110.182 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.783 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -82.59 -33.33 28.03 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.088 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.29 -25.88 68.1 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.794 1.283 . . . . 0.0 108.177 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.444 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 33.5 tt0 -73.11 -23.07 60.46 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.33 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.9 mt -84.62 -28.98 26.13 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.59 -18.19 64.9 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.602 -0.686 . . . . 0.0 110.856 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.621 ' ND2' ' CD1' ' A' ' 55' ' ' TYR . 0.4 OUTLIER -88.19 -8.84 54.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.818 -1.176 . . . . 0.0 108.368 179.256 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.621 ' CD1' ' ND2' ' A' ' 54' ' ' ASN . 6.4 m-85 -82.88 -38.12 23.37 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.576 0.703 . . . . 0.0 109.318 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 m -49.81 110.5 0.39 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.741 -0.599 . . . . 0.0 109.816 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.551 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.885 ' CG ' ' O ' ' A' ' 1' ' ' PHE . 1.6 p90 . . . . . 0 C--O 1.195 -1.784 0 CA-C-O 122.333 1.063 . . . . 0.0 108.613 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.578 ' C ' ' H ' ' A' ' 4' ' ' GLN . 3.9 t -92.56 50.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.294 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.989 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 4' ' ' GLN . 0.6 OUTLIER 69.86 -33.95 0.27 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.389 -0.819 . . . . 0.0 109.57 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.578 ' H ' ' C ' ' A' ' 2' ' ' VAL . 17.9 pt20 -28.81 157.99 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.921 0.867 . . . . 0.0 112.338 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -44.35 125.71 4.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.382 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -130.75 109.2 10.43 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.6 m -114.91 -176.49 2.91 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.433 -0.792 . . . . 0.0 109.403 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.79 -152.95 0.85 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.47 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.1 p -79.16 -9.24 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.895 -1.356 . . . . 0.0 108.888 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 9' ' ' SER . 14.9 m-70 -52.0 -24.39 6.53 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.47 ' N ' ' C ' ' A' ' 9' ' ' SER . 8.7 tp -78.22 -54.02 6.69 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.616 HG13 ' CE1' ' A' ' 24' ' ' PHE . 4.7 t -46.4 -41.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.525 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 19.4 tt0 -47.24 -58.94 3.54 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.939 -1.104 . . . . 0.0 108.385 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.486 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.53 -61.4 1.7 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.794 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.6 mt -46.01 -48.01 16.73 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -51.75 -49.01 63.43 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 19.5 mt -56.58 -63.64 1.13 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.002 0.906 . . . . 0.0 110.651 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -64.7 -48.27 85.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.761 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' LEU . 60.9 m -73.26 -15.24 61.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.045 -1.034 . . . . 0.0 109.852 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 43.01 -133.09 5.17 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -83.75 -9.7 58.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -1.044 . . . . 0.0 110.016 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -47.12 -25.53 0.89 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 109.613 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.7 117.95 2.26 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.273 -0.965 . . . . 0.0 110.73 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.616 ' CE1' HG13 ' A' ' 12' ' ' VAL . 32.8 p90 -122.06 -178.91 3.98 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.509 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 64.3 m-85 -150.72 125.92 9.98 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 119.552 -1.968 . . . . 0.0 112.783 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.794 ' CE2' HD13 ' A' ' 15' ' ' LEU . 29.7 m-85 -151.47 114.78 4.8 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -57.35 -163.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.068 -1.02 . . . . 0.0 108.8 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.718 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -49.17 -178.54 0.02 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 108.625 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.718 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 29.5 Cg_endo -66.85 -114.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.676 2.251 . . . . 0.0 111.235 177.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.036 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -61.65 -15.12 37.04 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.504 -0.747 . . . . 0.0 111.844 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 1.036 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.2 pp20? -6.78 -146.78 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 122.157 0.98 . . . . 0.0 112.541 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.466 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -71.08 -125.01 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.251 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 32' ' ' GLU . . . -100.48 135.54 12.2 Favored Glycine 0 N--CA 1.504 3.23 0 C-N-CA 119.681 -1.247 . . . . 0.0 111.649 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.937 ' O ' ' HG2' ' A' ' 36' ' ' ARG . 18.5 Cg_endo -94.97 173.42 1.28 Allowed 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 124.872 3.714 . . . . 0.0 112.446 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.752 ' O ' ' O ' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -54.03 -5.11 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.937 ' HG2' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 48.82 164.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.54 -77.53 0.43 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 118.797 -1.668 . . . . 0.0 109.553 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 39' ' ' VAL . 8.8 tt -65.34 -45.99 91.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.403 -1.057 . . . . 0.0 111.188 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.634 ' N ' HG23 ' A' ' 38' ' ' ILE . 55.7 t -65.88 -61.03 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.72 -0.612 . . . . 0.0 110.946 -177.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 40' ' ' GLU . 14.7 mt-10 -57.23 -22.42 40.95 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 109.228 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 45' ' ' SER . 35.1 tt0 -94.22 -32.79 13.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.16 -0.963 . . . . 0.0 109.569 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 38' ' ' ILE . 99.7 m -89.7 -47.75 7.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.034 -1.041 . . . . 0.0 109.992 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' VAL . 44.9 t -66.89 -52.52 42.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 110.855 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -85.89 -18.04 33.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.923 -1.111 . . . . 0.0 110.47 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' CYS . 13.1 m -140.59 179.84 6.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.078 -1.013 . . . . 0.0 109.613 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 mm -95.92 139.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.317 -0.864 . . . . 0.0 108.802 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.65 168.22 14.03 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.309 -0.87 . . . . 0.0 109.978 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.1 166.89 14.1 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.071 0.939 . . . . 0.0 111.044 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -82.93 -36.88 24.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -57.98 -25.37 60.95 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 122.898 1.332 . . . . 0.0 108.172 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.453 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 40.2 tt0 -76.28 -21.82 55.82 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.559 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.3 mt -84.49 -35.46 22.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.856 -1.153 . . . . 0.0 107.941 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -62.29 -18.29 60.91 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.63 -0.669 . . . . 0.0 110.148 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 2.3 m-20 -85.43 -8.67 58.28 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.485 ' HE2' ' HD2' ' A' ' 35' ' ' ARG . 4.6 m-85 -89.23 -40.67 12.69 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.818 0.818 . . . . 0.0 109.316 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.5 m -49.77 110.28 0.37 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.739 -0.601 . . . . 0.0 109.993 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.0 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.491 179.699 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 1.083 ' CZ ' HD13 ' A' ' 17' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.65 76.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.538 -0.726 . . . . 0.0 109.132 167.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 4' ' ' GLN . 15.5 m-20 53.63 -102.06 0.13 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.219 -0.925 . . . . 0.0 109.37 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ASN . 14.6 pt20 37.8 -162.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.541 0.686 . . . . 0.0 111.392 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.568 ' O ' HD12 ' A' ' 6' ' ' LEU . 30.6 p-80 -93.19 137.12 32.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.351 -0.843 . . . . 0.0 109.639 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 5' ' ' HIS . 1.3 mp -133.72 109.63 9.28 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 m -118.78 -176.95 3.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.501 -0.749 . . . . 0.0 109.186 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.67 -145.97 3.66 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.2 p -81.66 -12.89 58.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.061 -1.258 . . . . 0.0 109.471 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -51.22 -24.54 4.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.2 tp -81.83 -49.86 9.88 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.657 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.1 t -46.84 -48.3 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.6 tt0 -47.42 -59.7 3.04 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.528 -176.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.89 -61.65 1.53 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ALA . 14.6 mt -45.77 -45.46 14.65 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.554 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.12 -49.44 73.89 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.083 HD13 ' CZ ' ' A' ' 1' ' ' PHE . 27.5 mt -54.85 -62.85 1.39 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.101 0.953 . . . . 0.0 110.909 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -64.23 -37.69 80.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.943 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 42.5 t -80.25 -22.41 41.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.977 -1.077 . . . . 0.0 110.039 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 68.87 -146.73 45.4 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.6 tt0 -83.16 -15.26 51.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.333 -1.098 . . . . 0.0 109.656 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -47.45 -9.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.665 -0.647 . . . . 0.0 110.529 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 78.6 131.42 0.68 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.657 ' CE1' HG13 ' A' ' 12' ' ' VAL . 23.0 p90 -116.91 157.0 26.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.642 -0.916 . . . . 0.0 109.925 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -85.52 122.1 29.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.388 -0.82 . . . . 0.0 110.113 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.4 ' CD2' HG22 ' A' ' 12' ' ' VAL . 39.2 t80 -170.42 71.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.841 . . . . 0.0 108.911 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.607 HG21 ' HB3' ' A' ' 31' ' ' GLU . 1.3 m -47.65 171.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.74 . . . . 0.0 109.717 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -75.9 168.94 23.32 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.942 ' O ' HG23 ' A' ' 30' ' ' THR . 57.1 Cg_endo -71.76 90.18 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.635 2.223 . . . . 0.0 111.439 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.942 HG23 ' O ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER 145.65 -55.67 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.452 0.644 . . . . 0.0 109.898 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.607 ' HB3' HG21 ' A' ' 27' ' ' THR . 0.1 OUTLIER -35.44 78.3 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.185 -178.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.822 ' N ' ' O ' ' A' ' 30' ' ' THR . 2.6 mt-10 51.47 19.21 0.78 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.52 ' N ' ' C ' ' A' ' 31' ' ' GLU . . . 58.73 176.3 0.71 Allowed Glycine 0 N--CA 1.479 1.555 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' HG2' ' H ' ' A' ' 36' ' ' ARG . 40.0 Cg_endo -83.25 -97.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 123.49 2.794 . . . . 0.0 109.828 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.794 ' O ' ' O ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -158.0 9.27 0.16 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.985 -1.072 . . . . 0.0 108.233 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.794 ' O ' ' O ' ' A' ' 35' ' ' ARG . 1.2 mpt_? 43.81 133.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.429 1.109 . . . . 0.0 108.434 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.16 -63.77 0.36 Allowed Glycine 0 C--N 1.275 -2.826 0 C-N-CA 117.493 -2.289 . . . . 0.0 108.402 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 39' ' ' VAL . 8.1 tt -80.61 -41.12 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.618 -0.93 . . . . 0.0 109.712 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.605 ' N ' HG23 ' A' ' 38' ' ' ILE . 55.0 t -70.75 -61.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.317 0.58 . . . . 0.0 110.876 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -59.15 -18.9 40.21 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.3 -0.875 . . . . 0.0 110.01 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -94.29 -43.59 8.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.047 -1.033 . . . . 0.0 110.439 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' SER . 1.8 t -88.1 -31.46 19.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.89 -1.131 . . . . 0.0 110.82 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.6 t -76.91 -48.97 16.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.815 -1.178 . . . . 0.0 109.841 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -83.15 -22.94 33.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.063 -1.023 . . . . 0.0 109.47 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' CYS . 4.5 m -140.14 -170.04 2.88 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.374 -0.829 . . . . 0.0 108.917 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 47' ' ' CYS . 4.0 mm -89.01 168.32 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.032 -1.043 . . . . 0.0 108.831 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.481 ' N ' HG22 ' A' ' 46' ' ' ILE . 19.7 p -150.7 167.27 27.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.138 -0.976 . . . . 0.0 109.728 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.18 164.94 12.28 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 122.047 0.927 . . . . 0.0 111.153 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.53 -36.94 25.89 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.82 -25.95 61.34 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.843 1.306 . . . . 0.0 108.282 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.452 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 34.1 tt0 -76.72 -22.08 54.39 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.577 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 mt -84.82 -33.39 22.92 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.941 -1.099 . . . . 0.0 108.036 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -62.81 -18.78 63.3 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 110.34 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -84.51 -8.72 58.84 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.55 ' CE2' ' NH1' ' A' ' 35' ' ' ARG . 3.7 m-85 -90.11 -27.59 19.54 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.62 -0.675 . . . . 0.0 109.648 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.9 t -66.97 112.04 4.13 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.845 0.831 . . . . 0.0 109.793 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 . . . . . 0 C--N 1.291 -1.972 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.429 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.781 ' HB2' HD21 ' A' ' 6' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.896 0.855 . . . . 0.0 108.758 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 3' ' ' ASN . 4.0 p -55.97 -20.31 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -177.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 2' ' ' VAL . 13.4 m-20 154.82 71.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -151.04 170.72 18.69 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.455 ' O ' HD12 ' A' ' 6' ' ' LEU . 10.6 p-80 -61.2 136.59 58.11 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.012 -1.055 . . . . 0.0 109.252 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.781 HD21 ' HB2' ' A' ' 1' ' ' PHE . 1.0 OUTLIER -134.07 110.06 9.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.39 -0.819 . . . . 0.0 108.883 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 m -122.61 -176.89 3.49 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 47.2 -149.54 2.6 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.433 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.2 p -79.49 -12.75 59.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.912 -1.346 . . . . 0.0 109.291 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -52.39 -24.04 7.05 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.477 ' HA ' HD23 ' A' ' 6' ' ' LEU . 9.5 tp -80.59 -52.43 7.6 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.686 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.6 t -44.13 -47.66 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.626 0.727 . . . . 0.0 109.225 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 28.3 tt0 -46.62 -59.52 2.96 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.471 -176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.15 -61.81 1.5 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.8 mt -45.97 -43.96 14.53 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.558 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -57.58 -50.45 73.08 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.421 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 29.6 mt -52.68 -62.68 1.49 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.211 1.005 . . . . 0.0 110.789 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -65.14 -42.36 94.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.432 -177.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.0 t -75.15 -22.45 58.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.779 -1.201 . . . . 0.0 110.118 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 69.33 -151.57 51.12 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 23' ' ' GLY . 22.5 mt-10 -83.24 0.53 45.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -1.209 . . . . 0.0 109.694 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -62.42 1.36 0.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.173 -0.954 . . . . 0.0 109.988 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 68.65 121.05 0.03 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.686 ' CE1' HG13 ' A' ' 12' ' ' VAL . 16.1 p90 -105.34 170.25 7.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.569 -0.959 . . . . 0.0 109.58 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -98.54 123.67 42.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.33 -0.856 . . . . 0.0 110.135 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' THR . 49.5 t80 -172.45 86.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.503 -0.748 . . . . 0.0 109.141 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -53.12 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.294 -0.879 . . . . 0.0 109.296 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.527 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -83.62 177.18 3.15 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 28' ' ' ASP . 51.0 Cg_endo -60.12 -6.06 4.62 Favored 'Trans proline' 0 N--CA 1.525 3.355 0 C-N-CA 124.267 3.311 . . . . 0.0 116.523 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.106 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -121.84 -168.63 1.73 Allowed 'General case' 0 C--N 1.284 -2.267 0 O-C-N 120.051 -1.656 . . . . 0.0 111.36 -178.354 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 1.106 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.3 OUTLIER 33.12 134.64 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 1.17 ' O ' ' O ' ' A' ' 33' ' ' GLY . 25.0 mp0 13.01 48.92 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.35 -0.844 . . . . 0.0 111.243 -177.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 1.17 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -25.49 -139.16 0.0 OUTLIER Glycine 0 N--CA 1.506 3.365 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.997 ' HG2' HG21 ' A' ' 39' ' ' VAL . 32.5 Cg_exo -61.94 148.25 93.51 Favored 'Trans proline' 0 N--CA 1.51 2.453 0 C-N-CA 122.698 2.265 . . . . 0.0 112.282 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.857 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -55.63 7.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 119.544 -1.973 . . . . 0.0 108.355 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.857 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 75.9 92.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.732 -1.23 . . . . 0.0 110.351 -179.712 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.19 -53.86 0.21 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 117.005 -2.522 . . . . 0.0 109.371 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 39' ' ' VAL . 7.1 tt -75.58 -42.16 41.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.705 -0.88 . . . . 0.0 110.487 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.997 HG21 ' HG2' ' A' ' 34' ' ' PRO . 49.0 t -65.75 -60.62 2.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.268 0.556 . . . . 0.0 111.029 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 40' ' ' GLU . 12.3 mt-10 -58.5 -21.34 51.63 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.671 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' O ' ' O ' ' A' ' 45' ' ' SER . 56.1 tt0 -94.08 -36.32 12.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.237 -0.914 . . . . 0.0 109.85 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.419 ' O ' ' O ' ' A' ' 45' ' ' SER . 96.6 m -88.35 -50.42 6.34 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.112 -0.993 . . . . 0.0 109.96 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.3 t -62.51 -50.43 71.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.292 -0.88 . . . . 0.0 110.882 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -83.84 -26.24 29.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.86 -1.15 . . . . 0.0 110.752 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 41' ' ' GLN . 37.2 m -140.6 -179.43 6.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.969 -1.082 . . . . 0.0 110.249 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mm -84.55 157.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 p -143.16 167.22 22.62 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.893 -1.13 . . . . 0.0 109.474 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.28 161.86 21.33 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.078 0.942 . . . . 0.0 110.682 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.7 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -83.04 -35.14 26.0 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.078 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -59.62 -25.95 65.08 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.674 1.226 . . . . 0.0 108.203 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.439 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 39.5 tt0 -74.45 -23.33 58.89 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.41 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 1' ' ' PHE . 66.9 mt -84.64 -27.41 27.16 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.039 -1.038 . . . . 0.0 108.303 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -68.08 -18.65 64.73 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.564 -0.71 . . . . 0.0 110.887 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.643 ' ND2' ' CD1' ' A' ' 55' ' ' TYR . 0.5 OUTLIER -87.27 -9.03 56.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.643 ' CD1' ' ND2' ' A' ' 54' ' ' ASN . 5.0 m-85 -84.32 -32.26 24.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.8 t -60.88 112.28 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.873 0.844 . . . . 0.0 109.932 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 t30 . . . . . 0 C--N 1.292 -1.902 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.533 179.866 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.521 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 2.6 p90 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 1' ' ' PHE . 87.7 t -158.71 87.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 O-C-N 120.532 -1.355 . . . . 0.0 109.252 -171.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.515 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.2 m120 42.49 51.1 4.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.639 -0.663 . . . . 0.0 110.069 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -128.79 165.05 21.7 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.484 -0.76 . . . . 0.0 109.812 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.459 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 31.8 p80 -60.05 130.07 44.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.38 -0.825 . . . . 0.0 110.35 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 11' ' ' LEU . 1.2 tp -135.12 118.92 17.22 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.0 t -123.28 -176.82 3.53 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.459 -0.776 . . . . 0.0 109.408 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.23 -152.82 0.69 Allowed Glycine 0 N--CA 1.499 2.898 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.453 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.0 p -77.93 -10.18 59.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.73 -1.453 . . . . 0.0 108.734 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' SER . 68.7 m80 -53.01 -22.96 6.4 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.592 ' HA ' HD23 ' A' ' 6' ' ' LEU . 9.4 tp -79.82 -50.99 9.71 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG13 ' CE1' ' A' ' 24' ' ' PHE . 4.0 t -47.36 -40.06 6.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.0 tt0 -48.68 -59.36 3.6 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.661 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.494 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.53 -60.64 2.07 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.751 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.3 mt -46.37 -47.54 18.69 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.55 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -52.49 -48.34 66.0 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 20.1 mt -56.8 -63.34 1.24 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.01 0.909 . . . . 0.0 110.542 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -65.56 -46.16 90.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.014 -177.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 15' ' ' LEU . 58.6 m -72.97 -22.51 60.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.96 -1.088 . . . . 0.0 109.596 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 39.67 -120.92 1.4 Allowed Glycine 0 N--CA 1.496 2.662 0 O-C-N 121.284 -0.885 . . . . 0.0 111.131 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -81.67 -20.75 38.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.547 -0.972 . . . . 0.0 110.001 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -46.26 -34.04 4.15 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.343 -0.848 . . . . 0.0 109.402 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.36 137.04 8.53 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.644 ' CE1' HG13 ' A' ' 12' ' ' VAL . 28.1 p90 -140.99 174.83 10.13 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 7.2 p90 -154.37 125.92 7.51 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.69 -1.881 . . . . 0.0 112.439 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.751 ' CE2' HD13 ' A' ' 15' ' ' LEU . 18.7 m-85 -139.38 3.26 2.12 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 26' ' ' TYR . 1.8 p 45.88 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.807 0.813 . . . . 0.0 110.28 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.518 ' O ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -69.02 167.53 20.03 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.518 ' C ' ' O ' ' A' ' 28' ' ' ASP . 2.5 Cg_endo -33.89 -45.06 0.37 Allowed 'Trans proline' 0 C--N 1.278 -3.148 0 C-N-CA 121.706 1.604 . . . . 0.0 111.604 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.821 ' OG1' ' N ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -114.82 -144.88 0.39 Allowed 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.527 0.679 . . . . 0.0 109.656 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 1.071 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 5.3 mt-10 72.99 65.94 0.11 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.113 -0.992 . . . . 0.0 112.334 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 1.071 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER 103.21 -57.17 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 O-C-N 120.789 -1.194 . . . . 0.0 112.553 177.458 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.649 ' C ' ' H ' ' A' ' 35' ' ' ARG . . . 152.85 122.73 0.94 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 117.435 -2.317 . . . . 0.0 113.22 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.536 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 5.4 Cg_exo -56.91 11.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.92 2.413 . . . . 0.0 111.376 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.823 ' NH2' ' CE2' ' A' ' 55' ' ' TYR . 9.1 ttt-85 84.88 -16.57 0.49 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.487 HH21 ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER 53.07 -173.79 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.095 -1.003 . . . . 0.0 110.671 179.087 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.49 -81.45 0.08 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 39' ' ' VAL . 4.5 tt -52.0 -40.36 28.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.856 -0.791 . . . . 0.0 110.757 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.52 ' N ' HG23 ' A' ' 38' ' ' ILE . 40.3 t -71.63 -61.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.724 -0.61 . . . . 0.0 110.565 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -55.7 -23.47 28.92 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.369 -0.832 . . . . 0.0 109.135 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -94.53 -34.45 12.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.277 -0.889 . . . . 0.0 109.852 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 38' ' ' ILE . 42.0 t -88.35 -46.29 9.3 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.052 -1.03 . . . . 0.0 110.233 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.8 t -63.59 -34.24 77.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 110.643 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -103.34 -15.4 15.95 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.167 -0.958 . . . . 0.0 110.28 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER -140.07 -179.14 5.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.109 -0.994 . . . . 0.0 109.19 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.803 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.3 mm -66.2 -179.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 0.0 109.305 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.803 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -146.93 134.49 20.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.042 -1.037 . . . . 0.0 109.365 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 m -87.68 155.27 20.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.438 -0.789 . . . . 0.0 109.182 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.4 tp -82.83 -39.83 21.16 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -57.95 -23.34 53.24 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 123.179 1.466 . . . . 0.0 107.826 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.506 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 10.5 tp-100 -80.69 -23.28 39.67 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.109 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.05 -38.52 19.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.399 -1.438 . . . . 0.0 108.213 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -58.24 -19.61 35.39 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.646 -0.659 . . . . 0.0 110.293 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -85.15 -8.57 58.55 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 108.634 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.823 ' CE2' ' NH2' ' A' ' 35' ' ' ARG . 4.4 m-85 -90.54 -40.29 12.05 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.937 0.875 . . . . 0.0 109.212 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.2 m -49.74 110.67 0.41 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.259 0.552 . . . . 0.0 110.03 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.55 179.829 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 1.067 ' CE1' ' HA ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 122.304 1.05 . . . . 0.0 110.072 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 2' ' ' VAL . 10.5 m -73.37 55.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 120.778 -1.201 . . . . 0.0 109.114 175.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 1.067 ' HA ' ' CE1' ' A' ' 1' ' ' PHE . 0.8 OUTLIER 67.42 -88.4 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.365 -0.834 . . . . 0.0 109.096 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 3' ' ' ASN . 28.4 pt20 31.46 -151.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.463 -0.773 . . . . 0.0 111.787 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.57 ' O ' HD12 ' A' ' 6' ' ' LEU . 25.5 p-80 -98.92 132.59 44.14 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.367 -0.833 . . . . 0.0 109.236 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 1' ' ' PHE . 1.4 mp -133.81 111.12 10.26 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.6 m -123.36 -177.57 3.74 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.84 -148.19 5.0 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.432 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -80.31 -13.38 59.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.947 -1.325 . . . . 0.0 109.425 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -52.01 -24.45 6.65 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.432 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.0 tp -81.67 -49.01 10.98 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.65 HG13 ' CE1' ' A' ' 24' ' ' PHE . 20.9 t -47.41 -46.61 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.522 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 27.5 tt0 -47.9 -59.76 3.1 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.499 -176.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.06 -61.49 1.61 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.4 mt -45.61 -46.8 14.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.555 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.83 -50.18 69.24 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 27.9 mt -53.75 -62.69 1.49 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 122.111 0.958 . . . . 0.0 110.727 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.1 m -65.38 -31.83 55.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.006 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.6 m -93.11 -0.52 56.99 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.08 -1.013 . . . . 0.0 109.936 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 47.9 -148.79 3.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.6 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 2.0 mp0 -83.21 -15.18 51.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -1.084 . . . . 0.0 109.328 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -42.73 -18.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.8 -0.562 . . . . 0.0 110.568 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 92.74 138.19 8.46 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.65 ' CE1' HG13 ' A' ' 12' ' ' VAL . 21.6 p90 -129.82 155.84 45.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.591 -0.946 . . . . 0.0 109.71 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' HD1' ' HE ' ' A' ' 35' ' ' ARG . 48.1 t80 -84.51 124.05 30.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 0.0 110.193 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 27' ' ' THR . 44.4 t80 -172.47 77.97 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 109.324 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -52.33 -176.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.08 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -82.51 154.52 68.75 Favored Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 121.133 -0.979 . . . . 0.0 108.606 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.899 ' O ' HG23 ' A' ' 30' ' ' THR . 59.2 Cg_endo -75.07 57.42 4.61 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.307 2.671 . . . . 0.0 111.766 -175.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.899 HG23 ' O ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -162.6 -61.7 0.04 OUTLIER 'General case' 0 C--N 1.262 -3.234 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.288 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 33' ' ' GLY . 4.9 mm-40 -54.98 122.53 11.09 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 117.778 -1.569 . . . . 0.0 108.703 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 1.1 pt-20 39.67 7.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.43 -0.794 . . . . 0.0 110.531 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.786 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 82.86 168.06 42.12 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 118.356 -1.878 . . . . 0.0 109.246 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.97 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 28.5 Cg_endo -63.84 -28.41 67.58 Favored 'Trans proline' 0 C--N 1.285 -2.781 0 C-N-CA 122.804 2.336 . . . . 0.0 117.421 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.97 ' HB2' ' O ' ' A' ' 34' ' ' PRO . 9.2 ttt-85 151.71 7.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 119.79 -1.819 . . . . 0.0 107.119 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.592 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER 29.4 102.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.747 0.784 . . . . 0.0 109.924 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.47 -68.79 0.3 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.4 tt -73.83 -41.28 53.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.594 -0.945 . . . . 0.0 109.74 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.738 HG21 ' CG ' ' A' ' 34' ' ' PRO . 44.9 t -68.99 -61.05 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.329 0.585 . . . . 0.0 110.774 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -57.28 -22.0 38.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.343 -0.848 . . . . 0.0 109.802 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -94.57 -43.15 8.44 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.025 -1.047 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 45' ' ' SER . 0.9 OUTLIER -85.44 -29.22 24.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.88 -1.137 . . . . 0.0 110.642 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.7 t -80.9 -54.16 5.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.798 -1.189 . . . . 0.0 109.802 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -76.12 -24.53 54.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.996 -1.065 . . . . 0.0 109.121 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' CYS . 9.9 m -140.23 -173.99 3.81 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.2 mt -93.9 146.13 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.024 -1.048 . . . . 0.0 109.445 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p -122.04 165.37 16.15 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.606 -0.684 . . . . 0.0 109.263 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.74 166.74 13.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.242 -0.911 . . . . 0.0 110.52 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.31 -36.65 26.77 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -58.77 -25.54 63.15 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.837 1.303 . . . . 0.0 108.199 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.429 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 35.3 tt0 -77.31 -22.19 52.32 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.694 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.3 mt -84.63 -34.53 23.06 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -61.58 -19.28 62.02 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 110.209 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -84.02 -8.72 59.06 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -89.91 -37.79 14.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.689 -0.632 . . . . 0.0 109.529 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.3 m -50.64 110.61 0.43 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.316 -0.865 . . . . 0.0 109.477 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.469 -179.815 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.859 ' C ' ' CD1' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 120.685 0.279 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 3' ' ' ASN . 11.7 p -69.66 167.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 170.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.513 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.3 m120 -49.18 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 0.0 109.485 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 2' ' ' VAL . 13.8 pt20 -157.64 -177.81 6.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 110.119 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -78.09 135.33 37.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.316 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.585 HD23 ' HA ' ' A' ' 11' ' ' LEU . 1.4 tp -134.6 109.82 8.91 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -118.11 174.65 6.09 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.71 -153.07 29.95 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 10' ' ' HIS . 3.3 p -78.41 -11.12 59.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.026 -1.279 . . . . 0.0 109.671 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 9' ' ' SER . 1.8 t-80 -53.24 -30.56 38.81 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.585 ' HA ' HD23 ' A' ' 6' ' ' LEU . 14.6 tp -74.91 -48.18 25.98 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.623 HG13 ' CE1' ' A' ' 24' ' ' PHE . 24.5 t -48.81 -46.3 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.513 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.8 tt0 -49.05 -60.19 2.99 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.492 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.508 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.03 -60.96 1.82 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.433 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 13.5 mt -45.81 -46.84 15.71 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.72 -51.02 66.9 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.2 mt -52.84 -62.49 1.62 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.101 0.953 . . . . 0.0 110.718 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -67.09 -30.86 50.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.209 -177.068 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 56.4 m -90.4 -10.85 42.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.002 -1.061 . . . . 0.0 110.325 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 43.71 -131.42 6.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.605 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.9 mp0 -83.91 -19.08 35.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.492 -1.005 . . . . 0.0 110.354 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -46.0 -12.84 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.348 -0.845 . . . . 0.0 110.174 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 76.04 133.54 0.45 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.623 ' CE1' HG13 ' A' ' 12' ' ' VAL . 38.3 p90 -124.36 142.34 51.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.841 -0.8 . . . . 0.0 109.374 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -83.34 138.13 33.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.428 -0.795 . . . . 0.0 109.776 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 27' ' ' THR . 39.0 t80 -171.86 -39.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.356 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 28' ' ' ASP . 1.6 m 53.93 172.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 109.359 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' H ' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -81.18 158.61 69.41 Favored Pre-proline 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 108.715 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 1.245 ' O ' HG23 ' A' ' 30' ' ' THR . 87.7 Cg_endo -82.98 96.19 0.83 Allowed 'Trans proline' 1 C--N 1.253 -4.487 0 N-CA-C 114.932 1.089 . . . . 0.0 114.932 -172.151 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.245 HG23 ' O ' ' A' ' 29' ' ' PRO . 13.9 p 157.45 -54.17 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.646 0 CA-C-O 122.762 1.268 . . . . 0.0 108.951 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 30' ' ' THR . 79.2 mm-40 -31.9 -76.03 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.749 -1.219 . . . . 0.0 112.285 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.36 -26.15 4.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.898 -1.126 . . . . 0.0 109.379 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.01 148.98 5.36 Favored Glycine 0 N--CA 1.513 3.794 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.647 ' O ' ' CB ' ' A' ' 35' ' ' ARG . 80.2 Cg_endo -78.79 26.13 0.54 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 CA-C-N 119.741 1.77 . . . . 0.0 111.524 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.647 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER 83.42 -20.46 0.33 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -178.372 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 38' ' ' ILE . 43.6 mtt-85 52.48 -159.32 0.12 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' C ' HE21 ' A' ' 41' ' ' GLN . . . 62.44 -81.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.535 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.2 tt -55.6 -41.83 66.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.736 -0.861 . . . . 0.0 109.973 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.535 ' N ' HG23 ' A' ' 38' ' ' ILE . 41.8 t -72.41 -60.68 2.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.546 0.689 . . . . 0.0 111.214 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -49.42 -31.84 10.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.604 -0.685 . . . . 0.0 110.771 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.9 pt20 -93.58 -37.11 12.06 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.842 -1.161 . . . . 0.0 110.068 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.3 t -78.14 -55.29 5.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.04 -1.038 . . . . 0.0 109.69 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.8 t -54.89 -27.84 45.94 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.432 -0.792 . . . . 0.0 110.516 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -111.35 -15.53 13.57 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.235 -0.916 . . . . 0.0 110.451 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -140.43 -173.83 3.79 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.934 -1.104 . . . . 0.0 109.78 -179.513 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.716 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.5 mm -64.94 178.73 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.716 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -143.99 127.77 17.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.957 -1.09 . . . . 0.0 109.866 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 m -80.79 149.32 29.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.333 -0.854 . . . . 0.0 109.171 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.2 tp -82.83 -41.59 18.88 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -55.79 -25.72 42.68 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 123.02 1.39 . . . . 0.0 108.128 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.472 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 21.6 tt0 -77.98 -22.34 49.54 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.029 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.0 mt -85.38 -28.17 25.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.661 -1.274 . . . . 0.0 108.584 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -65.49 -19.73 66.05 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.631 -0.668 . . . . 0.0 111.354 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.672 ' ND2' ' CD1' ' A' ' 55' ' ' TYR . 1.1 p-10 -88.01 -8.37 55.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.813 -1.179 . . . . 0.0 108.123 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.672 ' CD1' ' ND2' ' A' ' 54' ' ' ASN . 4.7 m-85 -86.74 -26.01 24.42 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.681 0.753 . . . . 0.0 109.163 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 57' ' ' ASN . 4.2 m -67.36 95.91 0.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.705 -0.622 . . . . 0.0 111.088 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 56' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 117.923 -1.037 . . . . 0.0 108.38 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 1.189 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.151 0.501 . . . . 0.0 110.162 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 3' ' ' ASN . 14.3 p -82.4 164.27 2.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.739 -176.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.505 ' N ' HG22 ' A' ' 2' ' ' VAL . 1.3 m120 -47.87 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.991 -1.068 . . . . 0.0 109.493 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -158.66 -160.39 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.419 ' O ' ' CG ' ' A' ' 5' ' ' HIS . 44.8 p-80 -97.95 110.6 23.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.87 139.34 41.45 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.0 t -149.46 -178.47 6.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.282 -0.886 . . . . 0.0 108.792 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.96 -141.68 10.02 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.759 -1.737 . . . . 0.0 108.759 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' VAL . 3.3 p -84.07 -13.35 53.31 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.853 -1.381 . . . . 0.0 109.194 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -52.02 -27.68 14.44 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.935 HD23 ' OH ' ' A' ' 26' ' ' TYR . 22.4 tp -81.67 -37.25 27.74 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.614 HG13 ' CE1' ' A' ' 24' ' ' PHE . 13.8 t -58.73 -48.47 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 36.0 tt0 -47.74 -59.69 3.12 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.432 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.189 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -44.65 -61.76 1.45 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 mt -46.05 -45.55 16.14 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.552 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.22 -48.25 76.82 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.774 HD12 ' CD2' ' A' ' 1' ' ' PHE . 30.1 mt -55.75 -62.81 1.44 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 122.089 0.947 . . . . 0.0 110.836 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.4 m -64.18 -36.32 76.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.436 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.7 t -84.4 -22.68 30.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.929 -1.107 . . . . 0.0 110.559 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 70.76 -153.06 51.13 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 23' ' ' GLY . 14.7 mt-10 -83.66 3.61 32.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.244 . . . . 0.0 109.776 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.47 1.8 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 71.93 124.81 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.614 ' CE1' HG13 ' A' ' 12' ' ' VAL . 13.2 p90 -111.52 170.42 8.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -1.034 . . . . 0.0 110.845 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -98.5 134.85 40.89 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.579 0.704 . . . . 0.0 110.034 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.935 ' OH ' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -175.92 -149.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER 170.3 166.28 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.152 -0.967 . . . . 0.0 109.227 178.025 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.636 ' HB2' ' HG3' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -96.76 161.47 26.44 Favored Pre-proline 0 N--CA 1.487 1.397 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.56 -7.1 20.12 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 123.856 3.037 . . . . 0.0 110.493 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 28' ' ' ASP . 10.1 t -103.2 -28.28 12.01 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.749 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -76.85 -9.27 58.57 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 176.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 1.032 ' O ' ' O ' ' A' ' 33' ' ' GLY . 53.3 mt-10 107.89 119.9 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.574 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 1.032 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -6.14 147.86 0.0 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.993 ' HG3' HG21 ' A' ' 39' ' ' VAL . 86.0 Cg_endo -84.49 59.14 5.69 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 123.767 2.978 . . . . 0.0 115.774 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER 80.43 -37.04 0.14 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 111.187 177.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.564 ' CB ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 81.93 114.55 0.06 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.082 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.5 -60.64 0.42 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.528 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 3.3 tt -82.09 -44.63 19.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.733 -0.863 . . . . 0.0 110.065 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.993 HG21 ' HG3' ' A' ' 34' ' ' PRO . 43.7 t -70.47 -61.29 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 O-C-N 121.308 -0.87 . . . . 0.0 111.37 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.28 -24.55 28.98 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.089 -1.007 . . . . 0.0 110.156 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -94.42 -47.76 6.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.914 -1.116 . . . . 0.0 110.284 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 31.3 m -76.85 -33.28 57.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.069 -1.019 . . . . 0.0 110.535 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.7 t -78.65 -29.26 45.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.851 -1.156 . . . . 0.0 109.874 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -102.42 -21.5 14.24 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.301 -0.874 . . . . 0.0 109.915 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 t -140.03 -171.33 3.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.225 -0.922 . . . . 0.0 109.858 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.3 mm -82.88 174.97 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.595 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.9 m -152.08 167.16 29.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.992 -1.068 . . . . 0.0 109.701 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.75 163.44 12.26 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.634 0.73 . . . . 0.0 109.246 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.675 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -81.95 -32.5 30.74 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.514 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.58 -28.06 69.67 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.648 1.213 . . . . 0.0 108.569 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.417 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 38.1 tt0 -71.55 -26.3 62.58 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.517 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.669 ' CD1' ' HZ ' ' A' ' 1' ' ' PHE . 47.7 mt -85.78 -23.75 27.11 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.116 -0.99 . . . . 0.0 108.501 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -71.73 -18.37 62.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.333 -0.855 . . . . 0.0 110.89 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.676 ' ND2' ' CD1' ' A' ' 55' ' ' TYR . 0.7 OUTLIER -86.33 -9.19 56.89 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.463 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.676 ' CD1' ' ND2' ' A' ' 54' ' ' ASN . 5.7 m-85 -84.24 -28.14 27.46 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.4 t -67.33 112.46 4.58 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.843 0.83 . . . . 0.0 110.106 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.1 m120 . . . . . 0 C--N 1.292 -1.918 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.579 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 1.386 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 8.2 p90 . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 3' ' ' ASN . 11.2 p -56.38 169.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 119.101 -2.249 . . . . 0.0 108.902 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.543 ' N ' HG22 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -49.38 110.02 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.057 -1.027 . . . . 0.0 109.412 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -169.33 -165.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.06 -1.025 . . . . 0.0 110.018 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 30.9 p80 -93.71 132.15 38.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.373 -0.829 . . . . 0.0 109.723 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 1' ' ' PHE . 0.9 OUTLIER -129.5 127.8 41.55 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.4 m -136.15 -177.3 4.64 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.27 -0.894 . . . . 0.0 108.758 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.62 -147.78 2.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.45 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.5 p -79.9 -14.1 58.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.326 . . . . 0.0 109.133 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -51.94 -24.25 6.17 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.45 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.1 tp -81.22 -51.34 8.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.626 HG13 ' CE1' ' A' ' 24' ' ' PHE . 25.3 t -46.16 -46.7 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 121.908 0.861 . . . . 0.0 108.98 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.521 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.8 tt0 -47.78 -59.92 2.95 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.51 -176.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.386 ' HB1' ' CE2' ' A' ' 1' ' ' PHE . . . -44.99 -62.0 1.41 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.8 mt -45.53 -45.68 13.53 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.558 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.92 -52.01 65.6 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.8 mt -51.03 -62.33 1.68 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.028 0.918 . . . . 0.0 110.753 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.1 m -66.39 -34.92 73.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.409 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.0 m -88.53 -6.87 57.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.949 -1.095 . . . . 0.0 110.305 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 45.87 -142.58 4.46 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 23' ' ' GLY . 19.9 mt-10 -83.13 -3.26 57.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -1.116 . . . . 0.0 109.6 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -55.64 -4.82 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.772 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 72.8 127.83 0.1 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CE1' HG13 ' A' ' 12' ' ' VAL . 32.9 p90 -122.29 145.9 47.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.627 -0.925 . . . . 0.0 108.971 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -83.17 133.11 35.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.189 -0.944 . . . . 0.0 109.891 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.528 ' CE2' ' O ' ' A' ' 27' ' ' THR . 43.6 t80 -172.82 174.24 3.65 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.528 ' O ' ' CE2' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -153.18 -178.01 6.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.028 -1.045 . . . . 0.0 109.494 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.409 ' H ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -82.06 159.93 64.28 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.268 -0.895 . . . . 0.0 108.857 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.52 -24.43 9.13 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 124.188 3.259 . . . . 0.0 113.258 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.6 p -115.07 -27.49 7.31 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.57 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 32' ' ' GLU . 4.1 mm-40 -54.22 138.07 39.49 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.892 -1.13 . . . . 0.0 109.643 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.597 ' C ' ' O ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER 24.74 -105.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.443 ' H ' ' HB2' ' A' ' 32' ' ' GLU . . . -175.2 100.37 0.15 Allowed Glycine 0 C--N 1.29 -2.014 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.675 ' O ' ' C ' ' A' ' 35' ' ' ARG . 12.0 Cg_endo -51.23 120.41 6.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.407 2.738 . . . . 0.0 113.493 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.675 ' C ' ' O ' ' A' ' 34' ' ' PRO . 0.4 OUTLIER 11.0 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 122.041 -0.412 . . . . 0.0 111.349 177.521 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 40' ' ' GLU . 8.5 mmt-85 -59.6 102.18 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.5 -49.36 0.28 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 39' ' ' VAL . 9.6 tt -82.52 -44.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.608 -0.937 . . . . 0.0 110.894 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.568 ' N ' HG23 ' A' ' 38' ' ' ILE . 46.1 t -67.76 -62.61 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.379 -0.825 . . . . 0.0 111.448 -177.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 36' ' ' ARG . 15.2 mt-10 -55.29 -25.92 37.03 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.084 -1.01 . . . . 0.0 110.369 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' SER . 44.7 tt0 -93.92 -55.92 3.06 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.05 -1.031 . . . . 0.0 110.493 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 14.4 m -67.88 -33.93 75.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.053 -1.029 . . . . 0.0 111.238 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.6 t -77.95 -32.23 51.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.726 -1.234 . . . . 0.0 110.355 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -101.97 -18.33 15.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.059 -1.026 . . . . 0.0 109.781 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLN . 3.2 m -140.17 -179.38 5.95 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.221 -0.925 . . . . 0.0 109.235 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 47' ' ' CYS . 4.5 mm -78.16 173.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 108.921 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.579 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.5 m -152.11 167.45 28.46 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.197 -0.94 . . . . 0.0 109.559 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.97 163.42 12.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 109.338 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.42 -35.07 27.95 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.3 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.29 -26.26 66.37 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.729 1.252 . . . . 0.0 108.27 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.444 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 37.8 tt0 -74.69 -23.01 58.56 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.452 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.885 ' CD1' ' CZ ' ' A' ' 1' ' ' PHE . 57.4 mt -84.93 -36.75 21.23 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.75 -19.31 49.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.548 -0.72 . . . . 0.0 110.156 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -84.02 -8.51 59.12 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -90.03 -37.79 14.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.514 -0.741 . . . . 0.0 109.744 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.421 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 3.2 m -49.92 109.24 0.27 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.413 -0.804 . . . . 0.0 109.587 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.421 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 33.3 t-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.576 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 1.106 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 1.5 t80 . . . . . 0 C--O 1.174 -2.92 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 1' ' ' PHE . 16.7 m -166.79 -30.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 118.95 -2.344 . . . . 0.0 107.715 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 4' ' ' GLN . 6.8 m120 -175.22 -102.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.652 HE22 HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER 33.81 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.265 1.031 . . . . 0.0 112.879 179.297 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 16.8 p-80 -101.37 110.96 23.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.764 -0.585 . . . . 0.0 109.778 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.533 ' C ' ' CE1' ' A' ' 10' ' ' HIS . 0.3 OUTLIER -102.02 104.02 14.66 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.729 ' N ' ' CE1' ' A' ' 10' ' ' HIS . 17.0 m -122.0 115.35 22.37 Favored 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.59 -141.16 15.86 Favored Glycine 0 N--CA 1.507 3.426 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 12' ' ' VAL . 7.4 p -87.23 -27.32 23.03 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 120.712 -1.463 . . . . 0.0 113.783 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.752 ' ND1' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -45.34 -22.66 0.14 Allowed 'General case' 0 N--CA 1.527 3.395 0 CA-C-N 121.525 1.966 . . . . 0.0 106.453 178.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.752 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 32.9 tp -79.46 -51.34 9.48 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.556 HG13 ' CE1' ' A' ' 24' ' ' PHE . 41.4 t -49.77 -53.39 10.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.517 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.3 tt0 -49.78 -59.4 3.86 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.557 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.53 -61.6 1.49 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.466 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 14.6 mt -46.43 -47.95 18.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.57 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.37 -55.15 31.52 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.452 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.89 HD12 ' CD1' ' A' ' 1' ' ' PHE . 31.7 mt -47.41 -62.17 1.56 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.156 0.979 . . . . 0.0 110.64 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -68.17 -26.6 34.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.88 -177.097 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 58.6 m -97.75 1.47 48.47 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.229 -0.919 . . . . 0.0 110.723 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 48.47 -152.2 2.57 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' GLY . 43.5 tt0 -83.58 -15.05 50.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -1.138 . . . . 0.0 109.915 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.6 ' H ' ' CD ' ' A' ' 22' ' ' ARG . 7.7 mpt_? -42.84 -18.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.679 -0.638 . . . . 0.0 110.438 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 95.04 138.54 9.59 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.556 ' CE1' HG13 ' A' ' 12' ' ' VAL . 26.6 p90 -129.29 178.0 6.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.65 -0.912 . . . . 0.0 109.047 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 55' ' ' TYR . 51.9 m-85 -104.71 132.53 50.85 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.064 -1.022 . . . . 0.0 111.244 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CD2' HG22 ' A' ' 12' ' ' VAL . 10.8 t80 -175.91 -143.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 10.2 t -172.49 -151.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.06 -1.025 . . . . 0.0 109.776 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.468 ' N ' ' OG1' ' A' ' 27' ' ' THR . 0.4 OUTLIER -112.45 165.24 13.43 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 31' ' ' GLU . 10.8 Cg_endo -73.85 -75.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.291 -2.485 0 C-N-CA 122.457 2.105 . . . . 0.0 111.087 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.35 -25.93 0.16 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' PRO . 4.1 mm-40 -94.43 86.11 4.77 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.12 96.89 0.1 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.155 -0.966 . . . . 0.0 111.369 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.664 ' N ' ' CD ' ' A' ' 34' ' ' PRO . . . -151.24 45.06 0.65 Allowed Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.508 -1.806 . . . . 0.0 111.218 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 30.9 Cg_endo -61.8 170.35 5.99 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 124.833 3.688 . . . . 0.0 112.757 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.448 ' HD3' HH21 ' A' ' 35' ' ' ARG . 3.6 ttm180 -86.52 -16.11 37.95 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.634 ' HE ' ' HG2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 69.02 53.67 0.47 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.546 -0.721 . . . . 0.0 110.026 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.4 -60.02 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.647 HG23 ' N ' ' A' ' 39' ' ' VAL . 18.2 tt -69.99 -47.54 68.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.72 -0.871 . . . . 0.0 110.117 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.647 ' N ' HG23 ' A' ' 38' ' ' ILE . 43.9 t -62.7 -61.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 121.723 -0.61 . . . . 0.0 111.101 -177.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.584 ' OE2' ' NH2' ' A' ' 36' ' ' ARG . 18.1 mt-10 -49.61 -26.54 3.69 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.393 -0.817 . . . . 0.0 110.11 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -94.56 -61.44 1.51 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.956 -1.09 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.435 ' O ' ' O ' ' A' ' 45' ' ' SER . 59.6 m -59.31 -28.74 67.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.31 -0.869 . . . . 0.0 110.466 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.9 t -85.61 -54.51 4.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.767 -1.208 . . . . 0.0 110.499 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.448 ' ND1' ' N ' ' A' ' 44' ' ' HIS . 3.1 m80 -71.37 -15.68 62.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.816 -1.177 . . . . 0.0 109.413 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 t -140.37 178.88 6.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 47' ' ' CYS . 5.4 mm -64.6 163.74 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.458 ' N ' HG22 ' A' ' 46' ' ' ILE . 9.0 t -108.55 140.43 41.91 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.237 -0.914 . . . . 0.0 111.169 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 m -98.65 145.37 26.94 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.4 tp -82.22 -40.97 20.91 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -54.09 -26.59 27.91 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 122.796 1.284 . . . . 0.0 108.478 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.539 HE22 ' CD2' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -78.81 -23.68 45.0 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.34 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.539 ' CD2' HE22 ' A' ' 51' ' ' GLN . 28.6 mt -84.82 -25.82 27.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.709 -1.244 . . . . 0.0 108.859 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -67.79 -19.19 65.07 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.582 -0.699 . . . . 0.0 111.189 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 15.7 p30 -88.32 -8.35 55.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.917 -1.114 . . . . 0.0 108.014 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.508 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 4.6 m-85 -85.3 -27.14 26.15 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.7 0.762 . . . . 0.0 109.201 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.456 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 3.2 m -67.99 110.92 4.12 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.432 -0.792 . . . . 0.0 110.115 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.456 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 5.4 m120 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.983 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.831 ' CG ' ' O ' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.436 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 3' ' ' ASN . 7.1 p -79.91 -42.35 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.341 -1.474 . . . . 0.0 108.48 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 4' ' ' GLN . 11.6 m120 -168.54 -98.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.542 ' O ' ' O ' ' A' ' 3' ' ' ASN . 5.1 pt20 32.22 -166.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 122.342 1.067 . . . . 0.0 112.992 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -98.14 146.47 25.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.0 109.01 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.662 HD23 ' HA ' ' A' ' 11' ' ' LEU . 1.2 tp -132.8 108.92 9.29 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 t -117.14 145.75 43.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.516 -0.74 . . . . 0.0 109.057 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.424 ' C ' ' N ' ' A' ' 10' ' ' HIS . . . 82.01 177.39 51.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 10' ' ' HIS . 2.6 p -54.16 -10.55 0.37 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.556 -1.555 . . . . 0.0 109.14 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.424 ' N ' ' C ' ' A' ' 8' ' ' GLY . 40.2 m80 -52.24 -29.38 22.52 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 177.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.662 ' HA ' HD23 ' A' ' 6' ' ' LEU . 10.9 tp -74.74 -49.36 21.28 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.603 HG13 ' CE1' ' A' ' 24' ' ' PHE . 5.0 t -49.89 -41.43 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 20.6 tt0 -47.69 -59.25 3.42 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.608 -177.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.488 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.62 -61.11 1.84 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.756 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.1 mt -46.32 -44.97 17.2 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.556 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.96 -50.9 69.51 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.691 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 19.5 mt -52.02 -62.75 1.44 Allowed 'General case' 0 C--N 1.291 -1.96 0 O-C-N 120.998 -1.064 . . . . 0.0 109.866 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -69.08 -58.21 6.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.578 -178.302 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.62 ' N ' ' O ' ' A' ' 15' ' ' LEU . 82.7 m -86.26 34.18 0.63 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.977 -1.077 . . . . 0.0 110.526 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . -54.7 -111.98 0.01 OUTLIER Glycine 0 N--CA 1.499 2.851 0 O-C-N 120.889 -1.132 . . . . 0.0 111.329 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -43.86 -15.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -1.053 . . . . 0.0 110.582 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 20' ' ' GLY . 3.9 mmp_? -74.58 -40.13 61.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.987 -1.07 . . . . 0.0 109.73 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.07 137.37 9.78 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.603 ' CE1' HG13 ' A' ' 12' ' ' VAL . 37.1 p90 -138.81 -173.33 3.53 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -154.43 118.54 4.73 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 119.928 -1.733 . . . . 0.0 112.607 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.756 ' CE2' HD13 ' A' ' 15' ' ' LEU . 32.4 m-85 -146.53 108.84 4.45 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -55.35 -166.12 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.148 -0.97 . . . . 0.0 109.799 -179.095 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.705 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -48.38 -172.04 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 28' ' ' ASP . 28.3 Cg_endo -85.89 -5.96 8.69 Favored 'Trans proline' 0 C--N 1.295 -2.256 0 C-N-CA 124.161 3.241 . . . . 0.0 111.308 174.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.694 ' OG1' ' N ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -145.19 -140.72 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.549 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.705 ' OE2' ' HB2' ' A' ' 28' ' ' ASP . 1.2 mt-10 65.1 92.07 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.126 -1.609 . . . . 0.0 108.897 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 59.21 -69.83 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.934 -0.479 . . . . 0.0 110.675 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.543 ' HA3' ' CZ ' ' A' ' 36' ' ' ARG . . . 168.41 169.53 31.98 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 117.765 -2.159 . . . . 0.0 112.575 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 59.1 Cg_endo -79.13 -125.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 124.346 3.364 . . . . 0.0 113.234 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.432 ' H ' ' HB2' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -94.57 -16.52 23.18 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.891 0.853 . . . . 0.0 108.904 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' CZ ' ' HA3' ' A' ' 33' ' ' GLY . 1.8 mpt_? 61.29 45.63 8.58 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.73 -83.95 0.05 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 117.285 -2.388 . . . . 0.0 109.012 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 39' ' ' VAL . 4.8 tt -48.7 -38.74 10.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.752 -0.852 . . . . 0.0 110.371 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.499 ' N ' HG23 ' A' ' 38' ' ' ILE . 39.3 t -72.87 -61.16 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.436 0.636 . . . . 0.0 111.013 -178.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -52.25 -27.07 13.54 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -93.46 -34.95 13.21 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.055 -1.028 . . . . 0.0 109.525 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' SER . 50.1 t -83.28 -49.96 8.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.721 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 39' ' ' VAL . 44.2 t -64.29 -23.94 67.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 110.018 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -102.72 -29.18 11.66 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.168 -0.957 . . . . 0.0 110.068 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 t -134.3 -172.98 3.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.375 -0.828 . . . . 0.0 109.794 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.8 mm -65.95 175.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.6 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -137.21 141.65 42.1 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.027 -1.046 . . . . 0.0 110.063 -178.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -93.43 151.08 19.97 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.2 tp -83.12 -42.08 17.79 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -55.84 -25.11 40.4 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 123.017 1.389 . . . . 0.0 107.925 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.486 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 7.6 tt0 -78.69 -23.35 45.66 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.102 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.1 mt -85.36 -36.36 20.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.454 -1.404 . . . . 0.0 108.497 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -58.11 -19.57 33.38 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.645 -0.66 . . . . 0.0 110.948 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -88.03 -7.97 56.27 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.072 -1.017 . . . . 0.0 108.792 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.486 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 5.7 m-85 -88.72 -25.59 22.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.529 -0.732 . . . . 0.0 110.636 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.8 110.61 0.37 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.07 -1.019 . . . . 0.0 109.629 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 t30 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.475 179.909 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.592 ' O ' ' N ' ' A' ' 3' ' ' ASN . 23.4 p90 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 2' ' ' VAL . 1.4 p -53.25 89.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 119.936 -1.727 . . . . 0.0 108.97 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 1' ' ' PHE . 1.6 m120 47.0 -132.17 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.645 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.02 166.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 109.646 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -76.73 142.19 40.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.643 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.68 124.89 34.69 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.3 m -128.05 -176.84 3.91 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.541 -0.724 . . . . 0.0 109.085 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.6 -151.44 1.07 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.452 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -77.12 -13.32 59.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.039 -1.271 . . . . 0.0 109.151 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -51.73 -23.73 4.91 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.452 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.8 tp -81.74 -50.94 8.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.641 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.5 t -46.26 -47.91 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.74 0.781 . . . . 0.0 108.979 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.514 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.5 tt0 -48.06 -59.71 3.17 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.579 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.539 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.72 -62.24 1.28 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 14.6 mt -44.94 -44.38 9.72 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -57.67 -49.71 75.6 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 29.1 mt -53.94 -62.84 1.39 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.117 0.96 . . . . 0.0 110.942 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.6 m -62.43 -37.17 78.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.955 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.1 t -81.23 -22.22 38.95 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.026 -1.046 . . . . 0.0 109.881 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 67.56 -146.66 47.49 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 23' ' ' GLY . 19.1 mt-10 -83.1 -1.72 53.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 0.0 109.363 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -61.92 1.69 0.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 110.033 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 64.73 120.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.641 ' CE1' HG13 ' A' ' 12' ' ' VAL . 13.8 p90 -99.63 171.69 7.76 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.542 -0.975 . . . . 0.0 109.62 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -104.59 119.6 39.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.503 -0.748 . . . . 0.0 109.732 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -152.54 4.14 0.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.277 -0.89 . . . . 0.0 108.76 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 31' ' ' GLU . 0.2 OUTLIER 60.53 175.28 0.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.507 -0.746 . . . . 0.0 109.787 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.67 165.63 0.29 Allowed Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.9 -15.04 45.98 Favored 'Trans proline' 0 C--N 1.288 -2.645 0 C-N-CA 122.214 1.942 . . . . 0.0 110.239 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 30' ' ' THR . 1.8 t -136.89 129.05 29.62 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' OE2' HG23 ' A' ' 30' ' ' THR . 35.9 mm-40 -171.78 167.23 6.41 Favored 'General case' 0 CA--C 1.586 2.354 0 CA-C-O 123.101 1.429 . . . . 0.0 111.868 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.16 48.98 0.82 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.092 -1.63 . . . . 0.0 111.306 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.682 ' H ' ' HD3' ' A' ' 34' ' ' PRO . . . 175.09 41.42 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.675 -1.726 . . . . 0.0 110.842 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.682 ' HD3' ' H ' ' A' ' 33' ' ' GLY . 73.0 Cg_endo -66.74 29.31 0.11 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 123.168 2.578 . . . . 0.0 110.127 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.733 ' O ' ' N ' ' A' ' 37' ' ' GLY . 12.6 ttm-85 69.53 -8.6 0.73 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.591 ' H ' ' C ' ' A' ' 34' ' ' PRO . 11.0 mmt180 32.69 27.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.733 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -106.64 -67.56 0.67 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 39' ' ' VAL . 9.2 tt -62.12 -41.24 90.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 122.118 0.961 . . . . 0.0 109.821 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.575 ' N ' HG23 ' A' ' 38' ' ' ILE . 45.2 t -65.39 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 O-C-N 121.678 -0.639 . . . . 0.0 111.403 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 36' ' ' ARG . 20.1 mt-10 -60.93 -22.04 64.0 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.033 -1.042 . . . . 0.0 110.31 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -93.31 -37.84 11.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.852 -1.155 . . . . 0.0 110.345 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 28.9 m -88.59 -36.84 16.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.076 -1.015 . . . . 0.0 110.344 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.9 t -76.36 -37.16 57.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.863 -1.148 . . . . 0.0 109.98 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -91.71 -22.29 20.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.0 -1.063 . . . . 0.0 109.395 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 42' ' ' CYS . 2.7 m -140.37 -174.52 3.97 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.241 -0.912 . . . . 0.0 109.36 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.602 HG22 ' H ' ' A' ' 47' ' ' CYS . 4.9 mm -83.53 174.14 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.864 . . . . 0.0 108.99 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.602 ' H ' HG22 ' A' ' 46' ' ' ILE . 2.0 m -151.05 167.83 26.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.002 -1.061 . . . . 0.0 110.069 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.71 163.73 12.35 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.624 0.726 . . . . 0.0 109.352 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.04 -31.56 30.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.64 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.61 -27.3 68.3 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.676 1.227 . . . . 0.0 108.53 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.43 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 12.1 tt0 -71.55 -24.51 61.95 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.433 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.2 mt -84.78 -34.02 22.87 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -62.57 -18.85 62.95 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.495 -0.753 . . . . 0.0 109.911 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.2 m-20 -82.85 -8.93 59.54 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.4 m-85 -91.6 -28.74 17.33 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.61 0.719 . . . . 0.0 109.394 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 35.5 t -68.77 112.48 5.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.394 -0.816 . . . . 0.0 109.703 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 t30 . . . . . 0 C--N 1.291 -1.973 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.491 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.726 ' CD1' HD12 ' A' ' 17' ' ' LEU . 6.0 p90 . . . . . 0 C--O 1.206 -1.196 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 3' ' ' ASN . 87.1 t -145.94 91.2 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 118.524 0.602 . . . . 0.0 110.0 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.482 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.7 m120 40.01 51.56 2.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.689 -0.632 . . . . 0.0 110.162 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.8 161.05 35.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.491 -0.756 . . . . 0.0 110.006 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 0.3 OUTLIER -50.43 124.93 11.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 110.334 -179.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.25 109.69 9.59 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.3 m -121.92 -177.88 3.7 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.32 -150.96 2.98 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.1 p -77.25 -12.64 59.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.952 -1.323 . . . . 0.0 109.135 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -51.63 -25.17 6.56 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.434 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.6 tp -81.31 -49.68 10.42 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.662 HG13 ' CE1' ' A' ' 24' ' ' PHE . 19.4 t -46.53 -46.48 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.521 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 35.7 tt0 -47.83 -59.69 3.13 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.429 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.516 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.02 -61.39 1.65 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.1 mt -45.86 -45.05 14.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.553 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.79 -49.81 74.22 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.726 HD12 ' CD1' ' A' ' 1' ' ' PHE . 29.1 mt -54.19 -62.42 1.67 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.098 0.951 . . . . 0.0 110.821 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.1 m -65.36 -36.75 78.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.169 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 41.9 t -80.55 -22.57 40.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.844 -1.16 . . . . 0.0 110.002 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 68.29 -146.05 45.3 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.589 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.8 mp0 -83.23 -17.13 43.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.16 -1.2 . . . . 0.0 109.211 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -45.56 -13.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.776 -0.577 . . . . 0.0 110.352 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 81.17 130.74 1.09 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.662 ' CE1' HG13 ' A' ' 12' ' ' VAL . 27.0 p90 -116.43 149.42 39.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.677 -0.896 . . . . 0.0 109.27 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -85.48 116.57 23.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.145 -0.972 . . . . 0.0 110.015 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -161.48 -11.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 28' ' ' ASP . 1.8 m 58.03 -140.43 0.78 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 109.69 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -103.09 167.07 10.76 Favored Pre-proline 0 N--CA 1.487 1.412 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.44 -19.62 19.14 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 123.007 2.471 . . . . 0.0 110.285 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -111.19 -128.92 0.29 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.908 -179.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.487 ' H ' ' HB ' ' A' ' 30' ' ' THR . 1.4 mt-10 60.35 -80.76 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -159.03 155.42 27.42 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.425 -1.31 . . . . 0.0 112.058 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.503 ' HA2' ' HD2' ' A' ' 34' ' ' PRO . . . -37.36 109.1 0.08 OUTLIER Glycine 0 N--CA 1.492 2.408 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.114 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.883 ' CG ' HG21 ' A' ' 39' ' ' VAL . 15.0 Cg_endo -50.35 -176.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 124.084 3.189 . . . . 0.0 112.914 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 34' ' ' PRO . 1.3 ttm180 -19.07 -31.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.836 -0.54 . . . . 0.0 111.967 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.872 ' N ' ' O ' ' A' ' 34' ' ' PRO . 1.8 tpp180 72.17 31.72 1.88 Allowed 'General case' 0 N--CA 1.511 2.578 0 O-C-N 120.555 -1.34 . . . . 0.0 107.825 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.54 -63.01 0.01 OUTLIER Glycine 0 C--N 1.274 -2.915 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.553 HG23 ' N ' ' A' ' 39' ' ' VAL . 5.4 tt -67.43 -39.3 82.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 122.106 0.955 . . . . 0.0 109.699 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.883 HG21 ' CG ' ' A' ' 34' ' ' PRO . 45.0 t -70.35 -61.87 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.74 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.87 -21.85 32.58 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.405 -0.81 . . . . 0.0 109.717 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -94.24 -49.22 5.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.158 -0.964 . . . . 0.0 110.699 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' SER . 3.0 t -80.03 -29.99 39.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.82 -1.175 . . . . 0.0 111.013 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.4 t -78.61 -49.67 12.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.658 -1.276 . . . . 0.0 109.708 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -80.94 -23.08 39.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.046 -1.034 . . . . 0.0 109.349 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 m -139.96 -173.04 3.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.305 -0.872 . . . . 0.0 108.951 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 47' ' ' CYS . 1.9 mm -86.5 168.33 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.174 -0.954 . . . . 0.0 108.791 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.508 ' N ' HG22 ' A' ' 46' ' ' ILE . 23.1 p -149.45 161.08 42.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.07 -1.019 . . . . 0.0 109.259 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.93 164.85 14.4 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.083 0.945 . . . . 0.0 111.079 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.569 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.74 -36.92 25.34 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.91 -26.3 62.01 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 122.757 1.265 . . . . 0.0 108.094 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.528 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 6.5 tt0 -76.49 -22.53 54.37 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.736 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.7 mt -85.28 -30.9 23.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.861 -1.15 . . . . 0.0 108.235 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -64.2 -19.29 65.24 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.564 -0.71 . . . . 0.0 111.049 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 14.8 p30 -87.51 -8.57 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.926 -1.109 . . . . 0.0 108.045 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.482 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 4.9 m-85 -84.78 -28.69 26.0 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.3 t -68.48 112.31 5.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.444 -0.785 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--N 1.29 -1.992 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.445 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.742 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.476 0.655 . . . . 0.0 109.815 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 4' ' ' GLN . 3.3 t 54.88 48.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.267 0.556 . . . . 0.0 110.021 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 4' ' ' GLN . 22.2 m-80 56.68 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.107 -0.996 . . . . 0.0 110.28 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 3' ' ' ASN . 5.8 pt20 35.43 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.69 -0.631 . . . . 0.0 111.498 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 51.8 p-80 -90.86 123.9 34.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.126 -0.984 . . . . 0.0 109.612 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -129.88 116.75 19.12 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.6 m -122.41 -176.91 3.48 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.542 -0.724 . . . . 0.0 109.123 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 44.02 -149.21 0.87 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.458 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.2 p -80.81 -9.48 59.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.942 -1.328 . . . . 0.0 108.865 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 9' ' ' SER . 50.6 m80 -52.29 -24.63 7.74 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.458 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.0 tp -77.76 -53.82 7.07 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.64 HG13 ' CE1' ' A' ' 24' ' ' PHE . 5.0 t -46.55 -42.56 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.531 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.6 tt0 -46.84 -59.21 3.22 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.635 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.49 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.37 -61.42 1.68 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.763 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.1 mt -46.14 -48.41 17.37 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -51.24 -48.47 62.13 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.61 HD12 ' CE1' ' A' ' 1' ' ' PHE . 19.6 mt -57.31 -63.66 1.15 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.168 -0.957 . . . . 0.0 110.532 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -64.55 -47.59 88.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.965 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.473 ' N ' ' O ' ' A' ' 15' ' ' LEU . 67.0 m -73.05 -20.81 60.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.908 -1.12 . . . . 0.0 109.756 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 42.55 -125.74 4.33 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -83.63 -15.2 49.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -1.015 . . . . 0.0 110.077 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -46.73 -29.12 1.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.103 -0.998 . . . . 0.0 109.481 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.45 127.54 4.29 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.705 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.64 ' CE1' HG13 ' A' ' 12' ' ' VAL . 29.1 p90 -132.83 176.29 8.6 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -154.01 125.75 7.66 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 119.589 -1.944 . . . . 0.0 112.527 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.763 ' CE2' HD13 ' A' ' 15' ' ' LEU . 20.3 m-85 -141.33 -179.93 6.41 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.572 HG22 ' CB ' ' A' ' 31' ' ' GLU . 1.4 m -152.35 171.88 17.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.001 -1.062 . . . . 0.0 109.629 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.449 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -74.64 164.77 59.02 Favored Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 121.493 -0.755 . . . . 0.0 108.969 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 28' ' ' ASP . 16.8 Cg_endo -53.93 -34.74 77.74 Favored 'Trans proline' 0 C--N 1.276 -3.27 0 C-N-CA 123.7 2.933 . . . . 0.0 111.559 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.895 ' C ' ' H ' ' A' ' 32' ' ' GLU . 14.3 t -102.54 -34.17 9.21 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.45 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.572 ' CB ' HG22 ' A' ' 27' ' ' THR . 46.7 mm-40 -62.28 10.19 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.895 ' H ' ' C ' ' A' ' 30' ' ' THR . 0.4 OUTLIER 106.99 123.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.708 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 32' ' ' GLU . . . -48.01 156.46 1.04 Allowed Glycine 0 N--CA 1.478 1.481 0 N-CA-C 107.261 -2.335 . . . . 0.0 107.261 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.58 ' HG2' HG21 ' A' ' 39' ' ' VAL . 42.7 Cg_endo -94.73 -147.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.288 -2.641 0 C-N-CA 123.34 2.694 . . . . 0.0 111.595 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.726 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.4 OUTLIER -63.07 84.06 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.5 -1.375 . . . . 0.0 109.004 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.574 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -47.22 110.73 0.33 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 158.2 -89.83 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -176.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.557 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.3 tt -46.9 -40.26 4.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 122.009 0.909 . . . . 0.0 109.982 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.58 HG21 ' HG2' ' A' ' 34' ' ' PRO . 47.1 t -69.45 -61.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 O-C-N 121.298 -0.876 . . . . 0.0 110.308 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.47 ' HG3' ' HD2' ' A' ' 36' ' ' ARG . 42.6 mt-10 -62.53 -19.42 63.62 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.141 -0.974 . . . . 0.0 109.724 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -94.18 -39.31 10.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.082 -1.011 . . . . 0.0 110.088 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 33.7 m -88.47 -40.43 13.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.967 -1.083 . . . . 0.0 110.365 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.0 t -71.02 -25.77 62.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.792 -1.192 . . . . 0.0 109.541 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -102.95 -25.88 13.3 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.334 -0.854 . . . . 0.0 109.195 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -137.41 -168.06 2.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.404 -0.81 . . . . 0.0 108.964 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 47' ' ' CYS . 4.2 mm -94.98 169.95 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.131 -0.98 . . . . 0.0 109.499 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.577 ' N ' HG22 ' A' ' 46' ' ' ILE . 98.3 m -149.21 167.85 24.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.088 -1.008 . . . . 0.0 110.104 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.21 165.24 12.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.831 . . . . 0.0 109.521 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -82.67 -35.24 27.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 178.167 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.17 -25.28 65.42 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.756 1.265 . . . . 0.0 108.238 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.474 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 14.1 tt0 -75.81 -22.41 56.36 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.545 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -84.42 -33.29 23.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.852 -1.155 . . . . 0.0 107.983 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -64.19 -17.88 63.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.624 -0.672 . . . . 0.0 110.319 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -86.48 -8.41 57.61 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 108.607 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.554 ' CE2' ' HD3' ' A' ' 35' ' ' ARG . 5.0 m-85 -88.12 -39.85 14.24 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.765 0.793 . . . . 0.0 109.606 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.99 110.15 0.36 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.549 -0.719 . . . . 0.0 109.636 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.7 t30 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.485 179.916 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.842 ' CZ ' HD11 ' A' ' 52' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.236 0.541 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.753 HG22 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER 39.65 -96.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.272 -1.517 . . . . 0.0 110.792 176.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.753 ' N ' HG22 ' A' ' 2' ' ' VAL . 23.7 m-20 -139.06 -43.63 0.47 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.882 -1.136 . . . . 0.0 109.85 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.51 ' O ' ' O ' ' A' ' 3' ' ' ASN . 2.4 pt20 -18.28 143.55 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.56 ' N ' ' ND1' ' A' ' 5' ' ' HIS . 3.2 p-80 -46.21 141.98 3.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.692 . . . . 0.0 110.284 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.69 HD22 ' CE1' ' A' ' 1' ' ' PHE . 0.7 OUTLIER -131.1 109.96 10.84 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.8 m -114.87 146.1 41.47 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.32 -0.862 . . . . 0.0 109.106 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.61 -175.57 54.84 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.9 p -56.05 -15.07 3.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.984 -1.304 . . . . 0.0 109.115 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -52.12 -24.16 6.53 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' A' ' 9' ' ' SER . 15.0 tp -81.83 -47.64 12.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.583 HG13 ' CE1' ' A' ' 24' ' ' PHE . 24.4 t -49.66 -46.66 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.53 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.8 tt0 -48.7 -59.97 3.11 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.484 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.721 ' HB1' ' CE2' ' A' ' 1' ' ' PHE . . . -44.45 -60.66 1.85 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.7 mt -45.81 -51.38 12.93 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -50.03 -50.95 45.88 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 27.0 mt -53.65 -62.33 1.72 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.179 0.99 . . . . 0.0 111.299 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -68.27 -40.71 83.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.662 -176.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.647 ' O ' ' NH2' ' A' ' 22' ' ' ARG . 95.4 m -78.31 -28.44 47.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.72 -1.238 . . . . 0.0 112.581 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.743 ' C ' HH22 ' A' ' 22' ' ' ARG . . . 86.89 -150.2 22.86 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.314 -1.422 . . . . 0.0 111.046 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 23' ' ' GLY . 30.6 tt0 -87.8 -18.72 28.72 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.63 -0.923 . . . . 0.0 113.338 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.747 ' NH1' ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -43.12 -15.07 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 O-C-N 120.798 -1.189 . . . . 0.0 110.932 -177.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.747 ' H ' ' NH1' ' A' ' 22' ' ' ARG . . . 85.8 93.43 0.83 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.703 ' N ' HH11 ' A' ' 22' ' ' ARG . 29.9 p90 -76.88 161.58 28.3 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.305 -1.115 . . . . 0.0 109.383 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.623 ' CB ' ' NH1' ' A' ' 35' ' ' ARG . 60.5 m-85 -89.9 132.69 35.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.303 -0.873 . . . . 0.0 110.631 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -173.16 -22.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.72 168.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.489 -0.757 . . . . 0.0 110.012 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -85.51 163.64 43.68 Favored Pre-proline 0 N--CA 1.485 1.316 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.829 ' O ' ' C ' ' A' ' 30' ' ' THR . 1.2 Cg_endo -48.24 -134.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 124.76 3.64 . . . . 0.0 113.099 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.829 ' C ' ' O ' ' A' ' 29' ' ' PRO . 69.2 p 9.95 -119.79 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.49 1.138 . . . . 0.0 108.278 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.743 ' C ' ' O ' ' A' ' 30' ' ' THR . 8.5 mt-10 3.07 90.11 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.215 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 46.58 -129.61 1.4 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.535 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.69 -173.16 19.9 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.169 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.754 ' HG3' HG21 ' A' ' 39' ' ' VAL . 72.5 Cg_endo -67.84 -126.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 124.163 3.242 . . . . 0.0 111.124 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.766 ' O ' ' O ' ' A' ' 36' ' ' ARG . 12.5 ttm180 -110.91 14.7 22.05 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.766 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 45.37 110.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.86 -67.32 0.36 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 116.138 -2.934 . . . . 0.0 107.745 -176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.612 HG23 ' N ' ' A' ' 39' ' ' VAL . 7.3 tt -67.78 -44.61 85.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.805 0.812 . . . . 0.0 109.348 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.754 HG21 ' HG3' ' A' ' 34' ' ' PRO . 44.4 t -65.53 -61.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.425 0.631 . . . . 0.0 111.078 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.56 ' OE2' ' HG3' ' A' ' 36' ' ' ARG . 3.0 mt-10 -51.7 -26.42 9.26 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.658 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 45' ' ' SER . 17.8 tt0 -93.96 -61.21 1.58 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.122 -0.986 . . . . 0.0 110.414 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 45' ' ' SER . 98.0 m -58.36 -37.0 74.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.139 -0.976 . . . . 0.0 110.652 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.19 -38.54 31.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.903 -1.123 . . . . 0.0 110.516 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -86.99 -17.31 33.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.838 -1.164 . . . . 0.0 109.249 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 41' ' ' GLN . 7.9 t -140.42 -164.89 1.81 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.432 -0.792 . . . . 0.0 109.071 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 47' ' ' CYS . 4.5 mm -76.46 167.4 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.082 -1.011 . . . . 0.0 109.328 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.589 ' N ' HG22 ' A' ' 46' ' ' ILE . 4.5 t -121.15 139.14 53.76 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.451 -0.781 . . . . 0.0 110.381 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -101.15 150.88 22.48 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.451 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.5 tp -82.34 -38.52 24.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.479 1.133 . . . . 0.0 108.038 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.53 -24.24 60.15 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 123.005 1.383 . . . . 0.0 108.199 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.76 HE21 HD21 ' A' ' 54' ' ' ASN . 6.5 tp60 -79.8 -24.62 41.29 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.033 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.842 HD11 ' CZ ' ' A' ' 1' ' ' PHE . 33.9 mt -85.3 -30.99 23.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.494 -1.379 . . . . 0.0 109.107 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -62.32 -20.81 64.73 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.682 -0.637 . . . . 0.0 111.549 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.76 HD21 HE21 ' A' ' 51' ' ' GLN . 15.6 p30 -88.53 -7.79 55.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.823 -1.173 . . . . 0.0 108.838 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.493 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 5.1 m-85 -83.72 -9.79 58.59 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.671 0.748 . . . . 0.0 109.465 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.429 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -91.42 115.82 28.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.569 -0.707 . . . . 0.0 109.351 -179.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.429 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 55.9 t-20 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.026 -1.046 . . . . 0.0 109.282 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.686 ' C ' ' CD1' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.728 0.299 . . . . 0.0 110.687 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 3' ' ' ASN . 14.0 p -66.02 163.62 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 119.967 -1.708 . . . . 0.0 108.708 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.506 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.1 m120 -49.04 98.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.04 -1.038 . . . . 0.0 109.531 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 2' ' ' VAL . 1.8 pt20 -159.03 -163.94 1.32 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.841 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -89.86 131.2 35.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.743 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.93 109.65 11.79 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.5 m -118.58 152.59 35.73 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.523 -0.736 . . . . 0.0 109.248 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.57 -163.24 54.34 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.456 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -66.47 -14.63 62.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.864 -1.374 . . . . 0.0 109.261 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' SER . 4.5 m-70 -51.18 -24.67 4.43 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.456 ' N ' ' C ' ' A' ' 9' ' ' SER . 14.1 tp -81.86 -46.67 13.8 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.636 HG13 ' CE1' ' A' ' 24' ' ' PHE . 18.7 t -50.15 -46.15 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.538 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 20.7 tt0 -49.16 -59.72 3.41 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.446 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.481 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.43 -60.67 1.84 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.2 mt -45.38 -53.68 8.3 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.554 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -47.75 -49.62 27.8 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 26.4 mt -56.01 -62.59 1.6 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.106 0.955 . . . . 0.0 111.304 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.9 OUTLIER -67.56 -48.12 77.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.643 -176.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.501 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 30.9 m -73.86 -26.48 60.59 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.868 -1.145 . . . . 0.0 112.787 -175.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.499 ' C ' ' HE ' ' A' ' 22' ' ' ARG . . . 85.15 -161.21 35.71 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 119.473 -2.017 . . . . 0.0 111.156 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 23' ' ' GLY . 11.8 mt-10 -86.85 -13.26 45.48 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -177.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.704 ' NE ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.66 0.1 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 119.513 -1.992 . . . . 0.0 110.712 -178.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.594 ' N ' ' CZ ' ' A' ' 22' ' ' ARG . . . 88.52 113.48 1.21 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.696 ' N ' HH12 ' A' ' 22' ' ' ARG . 26.9 p90 -98.45 141.83 30.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -1.024 . . . . 0.0 109.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.33 126.75 30.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.516 -0.74 . . . . 0.0 110.33 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 27' ' ' THR . 53.9 t80 -173.14 -22.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.595 -0.69 . . . . 0.0 109.164 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.917 HG21 ' OE2' ' A' ' 31' ' ' GLU . 56.6 m 49.29 -176.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.179 -0.951 . . . . 0.0 109.548 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.854 ' H ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -50.6 -171.91 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.338 -0.852 . . . . 0.0 108.94 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 28' ' ' ASP . 76.9 Cg_endo -92.36 -34.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.261 2.64 . . . . 0.0 108.913 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.99 HG23 ' N ' ' A' ' 31' ' ' GLU . 3.8 t -66.6 -92.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.68 1.228 . . . . 0.0 109.539 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.99 ' N ' HG23 ' A' ' 30' ' ' THR . 9.5 tp10 57.76 5.39 0.34 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.338 -1.476 . . . . 0.0 108.394 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.647 ' HG2' ' C ' ' A' ' 31' ' ' GLU . 2.6 pt-20 43.13 35.87 0.88 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.197 -0.939 . . . . 0.0 108.696 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.12 98.87 2.56 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 30.2 Cg_endo -87.38 -117.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.683 2.922 . . . . 0.0 112.439 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.628 ' O ' ' C ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -82.09 -13.91 56.59 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.212 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.709 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER 34.66 70.22 0.14 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.88 -83.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 CA-C-N 113.482 -1.69 . . . . 0.0 109.008 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.586 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.3 tt -55.31 -42.4 66.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.721 -0.87 . . . . 0.0 110.145 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.586 ' N ' HG23 ' A' ' 38' ' ' ILE . 42.2 t -63.93 -60.68 2.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.306 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.709 ' OE2' ' HD2' ' A' ' 36' ' ' ARG . 38.7 mt-10 -59.23 -20.11 51.33 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.215 -0.928 . . . . 0.0 109.872 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -94.58 -36.18 11.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.042 -1.037 . . . . 0.0 110.021 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 45' ' ' SER . 92.2 m -88.46 -38.17 15.22 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.232 -0.917 . . . . 0.0 110.537 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.5 t -77.86 -44.92 25.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -0.996 . . . . 0.0 110.597 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -82.76 -20.35 36.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.992 -1.068 . . . . 0.0 109.822 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.8 m -140.38 -171.85 3.3 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.271 -0.893 . . . . 0.0 109.61 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 47' ' ' CYS . 6.5 mm -64.85 170.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 108.97 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.576 ' N ' HG22 ' A' ' 46' ' ' ILE . 8.3 t -128.19 122.51 32.02 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.459 -0.775 . . . . 0.0 110.157 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.5 m -79.75 146.72 32.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 108.728 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.1 tp -82.34 -40.5 21.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -57.15 -25.62 59.21 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.979 1.371 . . . . 0.0 108.147 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.477 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 7.0 tt0 -77.62 -24.12 49.66 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.933 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.3 mt -84.68 -29.48 25.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.777 -1.202 . . . . 0.0 108.487 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -64.6 -19.35 65.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.756 -0.59 . . . . 0.0 111.058 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -88.31 -7.24 57.05 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.027 -1.046 . . . . 0.0 109.188 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.477 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 5.1 m-85 -86.6 -6.72 58.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.579 -0.701 . . . . 0.0 111.147 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.87 113.86 20.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.148 -0.97 . . . . 0.0 110.314 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.4 t30 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.842 -179.932 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.62 ' O ' ' C ' ' A' ' 2' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.732 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.8 OUTLIER 32.23 -153.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 118.655 -2.528 . . . . 0.0 110.643 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.732 ' N ' HG13 ' A' ' 2' ' ' VAL . 1.6 m120 -101.74 93.95 5.59 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.053 -1.03 . . . . 0.0 109.551 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.524 ' NE2' HG12 ' A' ' 2' ' ' VAL . 16.4 pt20 -152.5 -178.81 7.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.217 -0.927 . . . . 0.0 109.26 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 5' ' ' HIS . 1.2 m-70 -75.54 133.2 41.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.999 -1.063 . . . . 0.0 109.378 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.95 120.01 24.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.7 m -127.18 -178.26 4.37 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.448 -0.782 . . . . 0.0 109.207 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.56 -149.05 2.29 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.439 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.4 p -77.97 -14.12 59.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.026 -1.279 . . . . 0.0 109.241 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -51.86 -24.07 5.69 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.439 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.7 tp -81.56 -51.14 8.56 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.618 HG13 ' CE1' ' A' ' 24' ' ' PHE . 24.6 t -45.44 -46.77 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.697 0.761 . . . . 0.0 108.988 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 35.8 tt0 -47.89 -59.81 3.06 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.378 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.05 -61.5 1.61 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.7 mt -45.66 -46.84 14.94 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.554 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.54 -48.73 71.66 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 24.7 mt -55.91 -62.8 1.46 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.156 0.979 . . . . 0.0 110.827 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -64.94 -31.93 56.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.221 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.1 m -92.12 -7.38 48.68 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.999 -1.063 . . . . 0.0 110.096 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 47.4 -144.0 5.61 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 23' ' ' GLY . 14.3 tp10 -79.35 -19.29 50.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.594 -0.945 . . . . 0.0 109.996 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -42.58 -17.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.457 -0.777 . . . . 0.0 110.653 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 88.02 137.5 5.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CE1' HG13 ' A' ' 12' ' ' VAL . 34.1 p90 -131.33 144.95 51.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.69 -0.888 . . . . 0.0 109.473 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -87.89 127.55 35.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.327 -0.858 . . . . 0.0 109.646 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' ' 27' ' ' THR . 85.9 t80 -163.14 -48.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 108.961 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 28' ' ' ASP . 2.4 m 53.6 172.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.451 -0.781 . . . . 0.0 109.842 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.5 ' H ' HG22 ' A' ' 27' ' ' THR . 0.2 OUTLIER -82.82 171.04 12.65 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 31' ' ' GLU . 19.2 Cg_endo -52.12 -83.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.515 2.745 0 C-N-CA 123.699 2.932 . . . . 0.0 114.546 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.561 ' H ' ' HG2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -43.65 4.09 0.0 OUTLIER 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 109.493 -3.503 . . . . 0.0 112.454 -176.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.921 ' O ' ' O ' ' A' ' 32' ' ' GLU . 1.1 tp10 -95.26 138.45 32.95 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 119.917 -1.74 . . . . 0.0 107.97 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.921 ' O ' ' O ' ' A' ' 31' ' ' GLU . 3.7 mp0 13.03 -140.93 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.396 -1.44 . . . . 0.0 109.161 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.41 ' HA2' ' HD2' ' A' ' 34' ' ' PRO . . . -121.66 97.95 0.63 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.41 ' HD2' ' HA2' ' A' ' 33' ' ' GLY . 39.4 Cg_endo -62.98 30.06 0.07 OUTLIER 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.906 3.07 . . . . 0.0 113.751 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.14 123.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.85 -1.156 . . . . 0.0 112.035 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.425 ' N ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -92.52 112.33 24.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.551 -0.718 . . . . 0.0 110.787 179.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.93 -48.49 0.06 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 39' ' ' VAL . 13.3 tt -82.21 -42.47 18.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.541 -0.976 . . . . 0.0 110.332 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.595 ' N ' HG23 ' A' ' 38' ' ' ILE . 54.1 t -69.42 -62.17 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 O-C-N 121.63 -0.669 . . . . 0.0 111.016 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -59.21 -22.01 60.39 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -94.31 -41.61 9.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.995 -1.065 . . . . 0.0 110.497 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 45' ' ' SER . 1.8 t -86.46 -29.73 22.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.867 -1.145 . . . . 0.0 110.737 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 51.8 t -81.58 -51.62 8.05 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.604 -1.31 . . . . 0.0 109.446 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -24.81 53.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.045 -1.034 . . . . 0.0 108.743 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' CYS . 5.1 m -140.52 -174.88 4.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.314 -0.866 . . . . 0.0 109.123 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.5 mt -90.64 148.92 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.233 -0.917 . . . . 0.0 109.216 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 20.6 p -128.88 167.39 17.45 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.378 -0.827 . . . . 0.0 109.775 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.82 165.3 13.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.303 -0.873 . . . . 0.0 110.79 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.68 -36.61 25.76 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.11 -25.27 61.15 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.862 1.315 . . . . 0.0 108.097 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.461 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 13.1 tt0 -77.8 -22.19 50.46 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.695 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.3 mt -84.5 -33.66 23.51 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.748 -1.22 . . . . 0.0 107.869 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -62.89 -18.72 63.38 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.554 -0.716 . . . . 0.0 110.162 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -84.84 -8.52 58.76 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -90.39 -37.33 14.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.695 -0.628 . . . . 0.0 109.643 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 m -49.8 110.94 0.44 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.507 -0.746 . . . . 0.0 109.718 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.1 t30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.464 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.63 ' HE2' HD11 ' A' ' 52' ' ' LEU . 1.9 t80 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 123.251 1.501 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.611 ' H ' HE21 ' A' ' 4' ' ' GLN . 6.1 p -90.23 84.55 2.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.335 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 2' ' ' VAL . 1.1 m120 41.29 70.25 0.28 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 110.567 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.611 HE21 ' H ' ' A' ' 2' ' ' VAL . 14.0 pt20 -141.69 169.86 16.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.057 -1.027 . . . . 0.0 109.639 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -63.16 126.63 28.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.895 . . . . 0.0 110.482 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 1' ' ' PHE . 0.8 OUTLIER -129.89 123.75 31.52 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.3 m -130.77 179.47 5.95 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.344 -0.847 . . . . 0.0 108.929 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.51 -147.68 2.78 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.44 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -77.29 -14.38 59.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.026 -1.279 . . . . 0.0 109.328 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -52.53 -24.02 7.36 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.4 tp -81.29 -49.58 10.56 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.638 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.3 t -46.56 -45.73 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.514 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 14.8 tt0 -48.08 -60.03 2.93 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.244 -0.983 . . . . 0.0 109.476 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.526 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.0 -61.55 1.58 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.7 mt -45.65 -45.98 14.32 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.81 -51.52 67.19 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.0 mt -51.68 -62.38 1.66 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.113 0.959 . . . . 0.0 110.778 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -66.06 -36.7 78.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.23 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.8 m -87.09 -4.93 59.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.935 -1.103 . . . . 0.0 110.146 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 46.88 -146.75 3.47 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 23' ' ' GLY . 32.0 mt-10 -83.39 -0.11 48.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -1.176 . . . . 0.0 109.719 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -58.79 -0.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 109.939 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 73.5 131.58 0.19 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.638 ' CE1' HG13 ' A' ' 12' ' ' VAL . 28.6 p90 -126.4 148.61 49.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.589 -0.947 . . . . 0.0 109.347 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -82.51 123.53 29.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 0.0 110.042 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.47 ' CE2' ' O ' ' A' ' 27' ' ' THR . 36.4 t80 -172.27 160.44 5.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 109.21 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -154.73 -156.16 0.64 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.322 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.554 ' H ' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -91.86 172.17 6.82 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.603 ' O ' ' C ' ' A' ' 30' ' ' THR . 57.0 Cg_endo -68.66 -145.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 118.067 -1.596 . . . . 0.0 112.718 176.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.321 ' O ' ' N ' ' A' ' 32' ' ' GLU 0.255 36.8 m 14.14 -107.66 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.024 -1.443 . . . . 0.0 112.982 175.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.73 ' C ' ' O ' ' A' ' 30' ' ' THR . 18.9 mt-10 16.59 -56.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 123.622 1.677 . . . . 0.0 107.093 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 1.321 ' N ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -156.16 -179.13 7.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.109 -2.314 . . . . 0.0 107.024 178.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.463 ' HA3' ' HD2' ' A' ' 36' ' ' ARG . . . -112.42 122.03 5.81 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.287 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.827 ' C ' ' H ' ' A' ' 36' ' ' ARG . 80.1 Cg_endo -75.08 81.26 2.26 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 124.217 3.278 . . . . 0.0 110.837 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.862 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 57.49 -10.65 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.827 ' H ' ' C ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER 30.12 21.35 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.973 -0.454 . . . . 0.0 110.327 -179.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.862 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -104.1 -36.57 3.12 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 107.779 -2.128 . . . . 0.0 107.779 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 39' ' ' VAL . 11.3 tt -81.83 -45.92 20.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.551 0.691 . . . . 0.0 110.344 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.618 ' N ' HG23 ' A' ' 38' ' ' ILE . 55.8 t -64.62 -61.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.78 -0.575 . . . . 0.0 111.726 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.52 -23.59 64.67 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.223 -0.923 . . . . 0.0 110.126 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' NE2' HE22 ' A' ' 51' ' ' GLN . 29.5 tt0 -94.33 -33.96 12.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.982 -1.074 . . . . 0.0 109.954 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 38' ' ' ILE . 51.0 t -88.51 -43.58 11.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.152 -0.967 . . . . 0.0 110.568 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.78 -24.22 62.55 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 110.73 -178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -104.82 -19.07 14.02 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.201 -0.937 . . . . 0.0 109.524 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -140.1 179.52 6.57 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.264 -0.898 . . . . 0.0 109.035 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.821 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.0 mm -64.62 -177.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.996 . . . . 0.0 108.324 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.821 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -146.03 150.45 36.01 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.897 -1.127 . . . . 0.0 110.222 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -97.16 151.74 19.51 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -82.57 -40.46 20.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -57.67 -24.79 58.54 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 122.841 1.305 . . . . 0.0 107.943 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.489 HE22 ' NE2' ' A' ' 41' ' ' GLN . 7.7 tt0 -78.44 -23.03 46.78 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.802 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.63 HD11 ' HE2' ' A' ' 1' ' ' PHE . 46.1 mt -84.8 -36.89 21.36 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.69 -20.66 50.47 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.507 -0.746 . . . . 0.0 110.002 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -82.99 -8.94 59.51 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.7 m-85 -90.34 -36.72 14.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.551 -0.718 . . . . 0.0 109.316 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -51.51 110.49 0.46 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.376 -0.827 . . . . 0.0 109.565 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.6 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.505 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.851 ' CD1' ' O ' ' A' ' 1' ' ' PHE . 48.8 p90 . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 3' ' ' ASN . 9.1 p -55.27 167.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 116.145 -2.222 . . . . 0.0 108.976 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.585 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.6 m120 -52.78 105.77 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.002 -1.061 . . . . 0.0 109.952 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -164.49 -160.77 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.172 -0.955 . . . . 0.0 109.77 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -95.45 132.66 40.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.247 -0.908 . . . . 0.0 109.609 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.1 113.71 15.45 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.01 148.72 50.54 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.42 -169.99 53.05 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.412 ' C ' ' N ' ' A' ' 11' ' ' LEU . 4.3 p -60.95 -14.8 25.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.612 -1.523 . . . . 0.0 109.202 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -52.81 -25.74 12.33 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.501 HD13 ' SG ' ' A' ' 42' ' ' CYS . 13.0 tp -81.11 -47.9 12.88 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.618 HG13 ' CE1' ' A' ' 24' ' ' PHE . 27.2 t -48.08 -47.35 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.513 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.1 tt0 -47.51 -59.91 2.9 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.561 -176.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.627 ' HB1' ' CE2' ' A' ' 1' ' ' PHE . . . -45.23 -61.38 1.68 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.429 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 13.0 mt -45.76 -45.94 14.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.75 -52.46 63.86 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.7 mt -50.59 -62.32 1.67 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.079 0.942 . . . . 0.0 110.614 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -67.25 -31.92 55.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.036 -177.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 47.7 m -91.72 0.51 57.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.045 -1.034 . . . . 0.0 109.995 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 45.86 -158.7 0.29 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.32 -2.94 43.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -1.152 . . . . 0.0 109.354 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -46.62 -58.63 3.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.865 . . . . 0.0 109.487 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.58 131.18 2.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CE1' HG13 ' A' ' 12' ' ' VAL . 34.3 p90 -131.4 143.72 50.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.68 -0.894 . . . . 0.0 108.846 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -86.29 134.35 33.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.324 -0.86 . . . . 0.0 110.266 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' THR . 86.3 t80 -172.9 -24.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.44 -0.788 . . . . 0.0 109.399 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' TYR . 3.1 p 47.62 -175.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.734 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.84 ' O ' ' N ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -98.84 162.53 21.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.72 ' O ' HG22 ' A' ' 30' ' ' THR . 53.2 Cg_exo -42.51 32.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 124.212 3.275 . . . . 0.0 113.593 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.84 ' N ' ' O ' ' A' ' 28' ' ' ASP . 3.6 p -158.39 -101.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.708 -1.245 . . . . 0.0 111.437 -177.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.67 ' C ' ' O ' ' A' ' 30' ' ' THR . 14.5 mt-10 0.9 69.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.095 -1.003 . . . . 0.0 111.017 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.947 ' OE2' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER 62.49 -40.63 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.736 -1.227 . . . . 0.0 110.415 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 85.05 178.12 50.94 Favored Glycine 0 N--CA 1.503 3.113 0 O-C-N 119.824 -1.797 . . . . 0.0 109.23 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 94.3 Cg_endo -77.82 -148.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.893 3.062 . . . . 0.0 112.292 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.872 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -120.12 85.71 2.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.722 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -15.11 104.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.668 1.223 . . . . 0.0 109.368 -178.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.12 -54.25 0.02 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.584 HG23 ' N ' ' A' ' 39' ' ' VAL . 8.4 tt -81.9 -45.34 20.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.664 -0.904 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 38' ' ' ILE . 40.3 t -64.69 -62.24 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.625 -0.672 . . . . 0.0 111.962 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.53 ' CG ' ' HG3' ' A' ' 36' ' ' ARG . 25.3 mt-10 -47.77 -33.63 7.4 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.284 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.2 mt-30 -93.52 -59.54 1.99 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.003 -1.06 . . . . 0.0 109.415 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.501 ' SG ' HD13 ' A' ' 11' ' ' LEU . 17.6 t -52.8 -34.07 51.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.108 -0.995 . . . . 0.0 110.738 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.7 t -85.28 -53.03 5.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.863 -1.148 . . . . 0.0 110.831 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.446 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 2.3 m-70 -86.17 -5.06 59.27 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.966 -1.084 . . . . 0.0 110.511 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.0 m -140.39 -177.82 5.21 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.054 -1.029 . . . . 0.0 109.362 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.0 mm -64.66 -178.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.173 -0.954 . . . . 0.0 108.524 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.804 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.3 t -134.91 130.46 35.93 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.162 -0.961 . . . . 0.0 110.543 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.7 m -95.03 145.97 24.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.5 tp -82.5 -40.33 21.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -56.41 -24.97 48.4 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 122.945 1.355 . . . . 0.0 108.147 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.472 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 9.3 tt0 -79.39 -22.83 43.79 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.142 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.542 HD12 ' CZ ' ' A' ' 1' ' ' PHE . 38.8 mt -85.46 -38.33 18.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.597 -1.314 . . . . 0.0 108.223 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.31 -20.17 26.82 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.487 -0.758 . . . . 0.0 110.368 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -83.87 -8.69 59.14 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.472 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 3.6 m-85 -90.55 -39.18 12.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.6 -0.688 . . . . 0.0 109.758 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -49.67 110.65 0.4 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.353 -0.842 . . . . 0.0 109.546 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.6 t30 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.509 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.828 ' CD2' HD12 ' A' ' 17' ' ' LEU . 33.3 p90 . . . . . 0 CA--C 1.56 1.364 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.507 HG12 ' ND2' ' A' ' 3' ' ' ASN . 60.1 t 42.55 -99.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.409 -1.432 . . . . 0.0 109.23 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.519 ' O ' ' O ' ' A' ' 4' ' ' GLN . 1.9 m-20 -147.46 -30.77 0.32 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.07 -1.019 . . . . 0.0 109.89 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.519 ' O ' ' O ' ' A' ' 3' ' ' ASN . 4.3 pt20 -25.44 152.92 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.959 0.885 . . . . 0.0 112.98 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -45.77 136.07 6.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.327 -0.858 . . . . 0.0 109.603 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 1' ' ' PHE . 1.1 tp -134.38 109.38 8.75 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' GLY . 59.5 m -106.64 -176.39 3.06 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.153 -0.967 . . . . 0.0 109.685 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 7' ' ' CYS . . . 43.26 -164.43 0.03 OUTLIER Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.467 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.0 p -69.0 -8.65 46.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.985 -1.303 . . . . 0.0 109.23 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -53.33 -22.84 7.95 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.467 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.0 tp -78.99 -52.33 8.39 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.628 HG13 ' CE1' ' A' ' 24' ' ' PHE . 4.4 t -48.11 -40.72 9.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.528 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.2 tt0 -48.36 -59.39 3.49 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.534 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.49 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.45 -61.28 1.74 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.794 HD13 ' CE2' ' A' ' 26' ' ' TYR . 6.6 mt -45.74 -49.17 15.06 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.553 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -50.45 -48.71 56.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.828 HD12 ' CD2' ' A' ' 1' ' ' PHE . 19.2 mt -56.96 -63.87 1.06 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.962 0.887 . . . . 0.0 110.464 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.4 m -64.12 -51.46 68.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.601 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' LEU . 78.6 m -72.88 -1.57 17.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.028 -1.045 . . . . 0.0 109.346 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 40.2 -142.74 0.63 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.36 -6.89 59.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.608 -0.937 . . . . 0.0 109.793 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 22' ' ' ARG . 44.0 mtp85 -42.48 -59.11 1.98 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.844 -0.535 . . . . 0.0 109.767 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.4 102.85 0.81 Allowed Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.628 ' CE1' HG13 ' A' ' 12' ' ' VAL . 35.6 p90 -103.68 -170.48 1.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 63.4 t80 -154.33 120.58 5.37 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 119.638 -1.914 . . . . 0.0 112.9 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.794 ' CE2' HD13 ' A' ' 15' ' ' LEU . 32.4 m-85 -150.25 92.8 1.91 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -54.3 -171.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 -179.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.578 ' N ' ' OG1' ' A' ' 27' ' ' THR . 0.1 OUTLIER -85.58 168.34 20.42 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HB2' ' H ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -54.26 -125.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.196 0 C-N-CA 123.829 3.019 . . . . 0.0 113.724 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.05 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER 27.91 -132.17 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.042 0 O-C-N 121.329 -0.857 . . . . 0.0 110.808 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 1.135 ' O ' ' N ' ' A' ' 33' ' ' GLY . 2.7 mt-10 -12.62 168.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.147 0.498 . . . . 0.0 111.204 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.669 ' C ' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -17.69 58.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.563 0.697 . . . . 0.0 109.938 178.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 1.135 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 10.37 -138.48 0.0 OUTLIER Glycine 0 N--CA 1.499 2.897 0 CA-C-O 122.14 0.856 . . . . 0.0 112.892 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.587 ' HG2' ' H ' ' A' ' 35' ' ' ARG . 69.5 Cg_endo -80.22 -89.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 123.538 2.826 . . . . 0.0 113.183 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.79 ' O ' ' CB ' ' A' ' 36' ' ' ARG . 62.8 ttt180 -127.56 -46.74 1.44 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.347 -0.846 . . . . 0.0 108.929 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.79 ' CB ' ' O ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER 101.4 73.31 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.803 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.06 -79.32 0.14 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.61 HG23 ' N ' ' A' ' 39' ' ' VAL . 5.0 tt -56.04 -44.05 77.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.816 -0.814 . . . . 0.0 109.491 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.61 ' N ' HG23 ' A' ' 38' ' ' ILE . 46.6 t -65.29 -61.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.622 -0.674 . . . . 0.0 110.39 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.513 ' OE2' ' HG3' ' A' ' 36' ' ' ARG . 2.4 mt-10 -57.56 -18.47 19.65 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.141 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' SER . 44.8 tt0 -94.08 -51.92 4.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.224 -0.922 . . . . 0.0 110.755 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -75.69 -54.06 7.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.745 -1.222 . . . . 0.0 110.091 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 48.6 t -52.73 -23.45 6.77 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.025 -1.047 . . . . 0.0 110.406 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -111.82 -29.13 7.79 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.062 -1.024 . . . . 0.0 110.122 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -132.83 -163.96 1.41 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.365 -0.834 . . . . 0.0 109.232 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.5 mm -106.46 159.64 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.269 -0.894 . . . . 0.0 109.233 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 m -145.61 168.82 19.74 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.951 -1.093 . . . . 0.0 109.943 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.43 165.76 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.908 0.861 . . . . 0.0 110.182 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.783 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -82.59 -33.33 28.03 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.29 -25.88 68.1 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.794 1.283 . . . . 0.0 108.177 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.528 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 8.5 tt0 -73.11 -23.07 60.46 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.33 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.9 mt -84.62 -28.98 26.13 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.59 -18.19 64.9 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.602 -0.686 . . . . 0.0 110.856 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 13.7 p30 -88.19 -8.84 54.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.818 -1.176 . . . . 0.0 108.368 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.604 ' CE2' ' NH2' ' A' ' 35' ' ' ARG . 6.4 m-85 -82.88 -38.12 23.37 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.576 0.703 . . . . 0.0 109.318 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 m -49.81 110.5 0.39 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.741 -0.599 . . . . 0.0 109.816 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.551 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.885 ' CG ' ' O ' ' A' ' 1' ' ' PHE . 1.6 p90 . . . . . 0 C--O 1.195 -1.784 0 CA-C-O 122.333 1.063 . . . . 0.0 108.613 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.715 ' H ' HE21 ' A' ' 4' ' ' GLN . 3.9 t -92.56 50.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.294 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.989 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 4' ' ' GLN . 0.6 OUTLIER 69.86 -33.95 0.27 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.389 -0.819 . . . . 0.0 109.57 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.715 HE21 ' H ' ' A' ' 2' ' ' VAL . 8.5 pt20 -28.81 157.99 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.921 0.867 . . . . 0.0 112.338 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -44.35 125.71 4.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.382 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -130.75 109.2 10.43 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.6 m -114.91 -176.49 2.91 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.433 -0.792 . . . . 0.0 109.403 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.79 -152.95 0.85 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.47 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.1 p -79.16 -9.24 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.895 -1.356 . . . . 0.0 108.888 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 9' ' ' SER . 14.9 m-70 -52.0 -24.39 6.53 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.47 ' N ' ' C ' ' A' ' 9' ' ' SER . 8.7 tp -78.22 -54.02 6.69 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.616 HG13 ' CE1' ' A' ' 24' ' ' PHE . 4.7 t -46.4 -41.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.525 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 19.4 tt0 -47.24 -58.94 3.54 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.939 -1.104 . . . . 0.0 108.385 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.486 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.53 -61.4 1.7 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.794 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.6 mt -46.01 -48.01 16.73 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -51.75 -49.01 63.43 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 19.5 mt -56.58 -63.64 1.13 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.002 0.906 . . . . 0.0 110.651 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -64.7 -48.27 85.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.761 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' LEU . 60.9 m -73.26 -15.24 61.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.045 -1.034 . . . . 0.0 109.852 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 43.01 -133.09 5.17 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -83.75 -9.7 58.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -1.044 . . . . 0.0 110.016 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -47.12 -25.53 0.89 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 109.613 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.7 117.95 2.26 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.273 -0.965 . . . . 0.0 110.73 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.616 ' CE1' HG13 ' A' ' 12' ' ' VAL . 32.8 p90 -122.06 -178.91 3.98 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.509 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 64.3 m-85 -150.72 125.92 9.98 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 119.552 -1.968 . . . . 0.0 112.783 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.794 ' CE2' HD13 ' A' ' 15' ' ' LEU . 29.7 m-85 -151.47 114.78 4.8 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -57.35 -163.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.068 -1.02 . . . . 0.0 108.8 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.718 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -49.17 -178.54 0.02 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 108.625 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.718 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 29.5 Cg_endo -66.85 -114.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.676 2.251 . . . . 0.0 111.235 177.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.036 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -61.65 -15.12 37.04 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.504 -0.747 . . . . 0.0 111.844 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 1.036 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.2 pp20? -6.78 -146.78 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 122.157 0.98 . . . . 0.0 112.541 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.466 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -71.08 -125.01 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.251 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 32' ' ' GLU . . . -100.48 135.54 12.2 Favored Glycine 0 N--CA 1.504 3.23 0 C-N-CA 119.681 -1.247 . . . . 0.0 111.649 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.937 ' O ' ' HG2' ' A' ' 36' ' ' ARG . 18.5 Cg_endo -94.97 173.42 1.28 Allowed 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 124.872 3.714 . . . . 0.0 112.446 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.752 ' O ' ' O ' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -54.03 -5.11 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.937 ' HG2' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 48.82 164.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.54 -77.53 0.43 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 118.797 -1.668 . . . . 0.0 109.553 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 39' ' ' VAL . 8.8 tt -65.34 -45.99 91.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.403 -1.057 . . . . 0.0 111.188 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.634 ' N ' HG23 ' A' ' 38' ' ' ILE . 55.7 t -65.88 -61.03 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.72 -0.612 . . . . 0.0 110.946 -177.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 40' ' ' GLU . 14.7 mt-10 -57.23 -22.42 40.95 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 109.228 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.689 ' NE2' HE22 ' A' ' 51' ' ' GLN . 26.2 tt0 -94.22 -32.79 13.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.16 -0.963 . . . . 0.0 109.569 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 38' ' ' ILE . 99.7 m -89.7 -47.75 7.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.034 -1.041 . . . . 0.0 109.992 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' VAL . 44.9 t -66.89 -52.52 42.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 110.855 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -85.89 -18.04 33.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.923 -1.111 . . . . 0.0 110.47 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' CYS . 13.1 m -140.59 179.84 6.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.078 -1.013 . . . . 0.0 109.613 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 mm -95.92 139.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.317 -0.864 . . . . 0.0 108.802 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.65 168.22 14.03 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.309 -0.87 . . . . 0.0 109.978 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.1 166.89 14.1 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.071 0.939 . . . . 0.0 111.044 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -82.93 -36.88 24.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -57.98 -25.37 60.95 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 122.898 1.332 . . . . 0.0 108.172 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.689 HE22 ' NE2' ' A' ' 41' ' ' GLN . 6.9 tt0 -76.28 -21.82 55.82 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.559 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.3 mt -84.49 -35.46 22.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.856 -1.153 . . . . 0.0 107.941 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -62.29 -18.29 60.91 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.63 -0.669 . . . . 0.0 110.148 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 2.3 m-20 -85.43 -8.67 58.28 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.485 ' HE2' ' HD2' ' A' ' 35' ' ' ARG . 4.6 m-85 -89.23 -40.67 12.69 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.818 0.818 . . . . 0.0 109.316 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.5 m -49.77 110.28 0.37 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.739 -0.601 . . . . 0.0 109.993 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.0 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.491 179.699 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 1.083 ' CZ ' HD13 ' A' ' 17' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.65 76.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.538 -0.726 . . . . 0.0 109.132 167.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 4' ' ' GLN . 3.8 m120 53.63 -102.06 0.13 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.219 -0.925 . . . . 0.0 109.37 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ASN . 14.6 pt20 37.8 -162.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.541 0.686 . . . . 0.0 111.392 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.568 ' O ' HD12 ' A' ' 6' ' ' LEU . 6.4 p80 -93.19 137.12 32.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.351 -0.843 . . . . 0.0 109.639 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 5' ' ' HIS . 1.3 mp -133.72 109.63 9.28 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 m -118.78 -176.95 3.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.501 -0.749 . . . . 0.0 109.186 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.67 -145.97 3.66 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.2 p -81.66 -12.89 58.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.061 -1.258 . . . . 0.0 109.471 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -51.22 -24.54 4.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.2 tp -81.83 -49.86 9.88 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.657 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.1 t -46.84 -48.3 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.6 tt0 -47.42 -59.7 3.04 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.528 -176.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.89 -61.65 1.53 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ALA . 14.6 mt -45.77 -45.46 14.65 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.554 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.12 -49.44 73.89 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.083 HD13 ' CZ ' ' A' ' 1' ' ' PHE . 27.5 mt -54.85 -62.85 1.39 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.101 0.953 . . . . 0.0 110.909 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -64.23 -37.69 80.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.943 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 42.5 t -80.25 -22.41 41.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.977 -1.077 . . . . 0.0 110.039 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 68.87 -146.73 45.4 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.6 tt0 -83.16 -15.26 51.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.333 -1.098 . . . . 0.0 109.656 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -47.45 -9.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.665 -0.647 . . . . 0.0 110.529 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 78.6 131.42 0.68 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.657 ' CE1' HG13 ' A' ' 12' ' ' VAL . 23.0 p90 -116.91 157.0 26.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.642 -0.916 . . . . 0.0 109.925 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -85.52 122.1 29.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.388 -0.82 . . . . 0.0 110.113 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.4 ' CD2' HG22 ' A' ' 12' ' ' VAL . 39.2 t80 -170.42 71.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.841 . . . . 0.0 108.911 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.607 HG21 ' HB3' ' A' ' 31' ' ' GLU . 1.3 m -47.65 171.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.74 . . . . 0.0 109.717 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -75.9 168.94 23.32 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.942 ' O ' HG23 ' A' ' 30' ' ' THR . 57.1 Cg_endo -71.76 90.18 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.635 2.223 . . . . 0.0 111.439 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.942 HG23 ' O ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER 145.65 -55.67 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.452 0.644 . . . . 0.0 109.898 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.607 ' HB3' HG21 ' A' ' 27' ' ' THR . 0.1 OUTLIER -35.44 78.3 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.185 -178.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.822 ' N ' ' O ' ' A' ' 30' ' ' THR . 2.6 mt-10 51.47 19.21 0.78 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.52 ' N ' ' C ' ' A' ' 31' ' ' GLU . . . 58.73 176.3 0.71 Allowed Glycine 0 N--CA 1.479 1.555 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.537 ' HG2' ' H ' ' A' ' 36' ' ' ARG . 40.0 Cg_endo -83.25 -97.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 123.49 2.794 . . . . 0.0 109.828 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.794 ' O ' ' O ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -158.0 9.27 0.16 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.985 -1.072 . . . . 0.0 108.233 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.794 ' O ' ' O ' ' A' ' 35' ' ' ARG . 1.2 mpt_? 43.81 133.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.429 1.109 . . . . 0.0 108.434 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.16 -63.77 0.36 Allowed Glycine 0 C--N 1.275 -2.826 0 C-N-CA 117.493 -2.289 . . . . 0.0 108.402 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 39' ' ' VAL . 8.1 tt -80.61 -41.12 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.618 -0.93 . . . . 0.0 109.712 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.605 ' N ' HG23 ' A' ' 38' ' ' ILE . 55.0 t -70.75 -61.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.317 0.58 . . . . 0.0 110.876 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -59.15 -18.9 40.21 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.3 -0.875 . . . . 0.0 110.01 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.485 ' NE2' HE22 ' A' ' 51' ' ' GLN . 13.3 tt0 -94.29 -43.59 8.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.047 -1.033 . . . . 0.0 110.439 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' SER . 1.8 t -88.1 -31.46 19.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.89 -1.131 . . . . 0.0 110.82 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.6 t -76.91 -48.97 16.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.815 -1.178 . . . . 0.0 109.841 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -83.15 -22.94 33.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.063 -1.023 . . . . 0.0 109.47 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' CYS . 4.5 m -140.14 -170.04 2.88 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.374 -0.829 . . . . 0.0 108.917 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 47' ' ' CYS . 4.0 mm -89.01 168.32 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.032 -1.043 . . . . 0.0 108.831 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.481 ' N ' HG22 ' A' ' 46' ' ' ILE . 19.7 p -150.7 167.27 27.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.138 -0.976 . . . . 0.0 109.728 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.18 164.94 12.28 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 122.047 0.927 . . . . 0.0 111.153 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.53 -36.94 25.89 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.82 -25.95 61.34 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.843 1.306 . . . . 0.0 108.282 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.485 HE22 ' NE2' ' A' ' 41' ' ' GLN . 6.5 tt0 -76.72 -22.08 54.39 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.577 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 mt -84.82 -33.39 22.92 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.941 -1.099 . . . . 0.0 108.036 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -62.81 -18.78 63.3 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 110.34 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -84.51 -8.72 58.84 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.55 ' CE2' ' NH1' ' A' ' 35' ' ' ARG . 3.7 m-85 -90.11 -27.59 19.54 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.62 -0.675 . . . . 0.0 109.648 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.9 t -66.97 112.04 4.13 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.845 0.831 . . . . 0.0 109.793 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 . . . . . 0 C--N 1.291 -1.972 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.429 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.781 ' HB2' HD21 ' A' ' 6' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.896 0.855 . . . . 0.0 108.758 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 3' ' ' ASN . 4.0 p -55.97 -20.31 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -177.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 2' ' ' VAL . 13.4 m-20 154.82 71.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -151.04 170.72 18.69 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.673 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 5.2 p80 -61.2 136.59 58.11 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.012 -1.055 . . . . 0.0 109.252 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.781 HD21 ' HB2' ' A' ' 1' ' ' PHE . 1.0 OUTLIER -134.07 110.06 9.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.39 -0.819 . . . . 0.0 108.883 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 m -122.61 -176.89 3.49 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 47.2 -149.54 2.6 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.433 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.2 p -79.49 -12.75 59.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.912 -1.346 . . . . 0.0 109.291 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -52.39 -24.04 7.05 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.477 ' HA ' HD23 ' A' ' 6' ' ' LEU . 9.5 tp -80.59 -52.43 7.6 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.686 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.6 t -44.13 -47.66 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.626 0.727 . . . . 0.0 109.225 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 28.3 tt0 -46.62 -59.52 2.96 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.471 -176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.15 -61.81 1.5 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.8 mt -45.97 -43.96 14.53 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.558 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -57.58 -50.45 73.08 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 29.6 mt -52.68 -62.68 1.49 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.211 1.005 . . . . 0.0 110.789 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -65.14 -42.36 94.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.432 -177.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.0 t -75.15 -22.45 58.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.779 -1.201 . . . . 0.0 110.118 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 69.33 -151.57 51.12 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 23' ' ' GLY . 22.5 mt-10 -83.24 0.53 45.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -1.209 . . . . 0.0 109.694 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -62.42 1.36 0.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.173 -0.954 . . . . 0.0 109.988 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 68.65 121.05 0.03 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.686 ' CE1' HG13 ' A' ' 12' ' ' VAL . 16.1 p90 -105.34 170.25 7.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.569 -0.959 . . . . 0.0 109.58 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -98.54 123.67 42.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.33 -0.856 . . . . 0.0 110.135 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' THR . 49.5 t80 -172.45 86.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.503 -0.748 . . . . 0.0 109.141 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -53.12 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.294 -0.879 . . . . 0.0 109.296 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.527 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -83.62 177.18 3.15 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 28' ' ' ASP . 51.0 Cg_endo -60.12 -6.06 4.62 Favored 'Trans proline' 0 N--CA 1.525 3.355 0 C-N-CA 124.267 3.311 . . . . 0.0 116.523 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.106 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -121.84 -168.63 1.73 Allowed 'General case' 0 C--N 1.284 -2.267 0 O-C-N 120.051 -1.656 . . . . 0.0 111.36 -178.354 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 1.106 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.3 OUTLIER 33.12 134.64 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 1.17 ' O ' ' O ' ' A' ' 33' ' ' GLY . 25.0 mp0 13.01 48.92 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.35 -0.844 . . . . 0.0 111.243 -177.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 1.17 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -25.49 -139.16 0.0 OUTLIER Glycine 0 N--CA 1.506 3.365 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.997 ' HG2' HG21 ' A' ' 39' ' ' VAL . 32.5 Cg_exo -61.94 148.25 93.51 Favored 'Trans proline' 0 N--CA 1.51 2.453 0 C-N-CA 122.698 2.265 . . . . 0.0 112.282 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.857 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -55.63 7.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 119.544 -1.973 . . . . 0.0 108.355 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.857 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 75.9 92.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.732 -1.23 . . . . 0.0 110.351 -179.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.19 -53.86 0.21 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 117.005 -2.522 . . . . 0.0 109.371 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 39' ' ' VAL . 7.1 tt -75.58 -42.16 41.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.705 -0.88 . . . . 0.0 110.487 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.997 HG21 ' HG2' ' A' ' 34' ' ' PRO . 49.0 t -65.75 -60.62 2.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.268 0.556 . . . . 0.0 111.029 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 40' ' ' GLU . 12.3 mt-10 -58.5 -21.34 51.63 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.671 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.525 ' NE2' ' OE1' ' A' ' 51' ' ' GLN . 8.8 tt0 -94.08 -36.32 12.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.237 -0.914 . . . . 0.0 109.85 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.419 ' O ' ' O ' ' A' ' 45' ' ' SER . 96.6 m -88.35 -50.42 6.34 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.112 -0.993 . . . . 0.0 109.96 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.3 t -62.51 -50.43 71.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.292 -0.88 . . . . 0.0 110.882 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -83.84 -26.24 29.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.86 -1.15 . . . . 0.0 110.752 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 41' ' ' GLN . 37.2 m -140.6 -179.43 6.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.969 -1.082 . . . . 0.0 110.249 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mm -84.55 157.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 p -143.16 167.22 22.62 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.893 -1.13 . . . . 0.0 109.474 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.28 161.86 21.33 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.078 0.942 . . . . 0.0 110.682 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.7 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -83.04 -35.14 26.0 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -59.62 -25.95 65.08 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.674 1.226 . . . . 0.0 108.203 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.531 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 6.8 tt0 -74.45 -23.33 58.89 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.41 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 1' ' ' PHE . 66.9 mt -84.64 -27.41 27.16 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.039 -1.038 . . . . 0.0 108.303 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -68.08 -18.65 64.73 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.564 -0.71 . . . . 0.0 110.887 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 15.7 p30 -87.27 -9.03 56.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.499 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 5.0 m-85 -84.32 -32.26 24.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.8 t -60.88 112.28 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.873 0.844 . . . . 0.0 109.932 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 t30 . . . . . 0 C--N 1.292 -1.902 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.533 179.866 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.521 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 2.6 p90 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 1' ' ' PHE . 87.7 t -158.71 87.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 O-C-N 120.532 -1.355 . . . . 0.0 109.252 -171.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.515 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.2 m120 42.49 51.1 4.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.639 -0.663 . . . . 0.0 110.069 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -128.79 165.05 21.7 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.484 -0.76 . . . . 0.0 109.812 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.459 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 31.8 p80 -60.05 130.07 44.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.38 -0.825 . . . . 0.0 110.35 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 11' ' ' LEU . 1.2 tp -135.12 118.92 17.22 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.0 t -123.28 -176.82 3.53 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.459 -0.776 . . . . 0.0 109.408 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.23 -152.82 0.69 Allowed Glycine 0 N--CA 1.499 2.898 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.453 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.0 p -77.93 -10.18 59.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.73 -1.453 . . . . 0.0 108.734 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' SER . 68.7 m80 -53.01 -22.96 6.4 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.592 ' HA ' HD23 ' A' ' 6' ' ' LEU . 9.4 tp -79.82 -50.99 9.71 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.644 HG13 ' CE1' ' A' ' 24' ' ' PHE . 4.0 t -47.36 -40.06 6.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.0 tt0 -48.68 -59.36 3.6 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.661 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.494 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.53 -60.64 2.07 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.751 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.3 mt -46.37 -47.54 18.69 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.55 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -52.49 -48.34 66.0 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 20.1 mt -56.8 -63.34 1.24 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.01 0.909 . . . . 0.0 110.542 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -65.56 -46.16 90.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.014 -177.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 15' ' ' LEU . 58.6 m -72.97 -22.51 60.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.96 -1.088 . . . . 0.0 109.596 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 39.67 -120.92 1.4 Allowed Glycine 0 N--CA 1.496 2.662 0 O-C-N 121.284 -0.885 . . . . 0.0 111.131 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -81.67 -20.75 38.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.547 -0.972 . . . . 0.0 110.001 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -46.26 -34.04 4.15 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.343 -0.848 . . . . 0.0 109.402 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.36 137.04 8.53 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.644 ' CE1' HG13 ' A' ' 12' ' ' VAL . 28.1 p90 -140.99 174.83 10.13 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 7.2 p90 -154.37 125.92 7.51 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.69 -1.881 . . . . 0.0 112.439 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.751 ' CE2' HD13 ' A' ' 15' ' ' LEU . 18.7 m-85 -139.38 3.26 2.12 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 26' ' ' TYR . 1.8 p 45.88 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.807 0.813 . . . . 0.0 110.28 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.518 ' O ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -69.02 167.53 20.03 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.518 ' C ' ' O ' ' A' ' 28' ' ' ASP . 2.5 Cg_endo -33.89 -45.06 0.37 Allowed 'Trans proline' 0 C--N 1.278 -3.148 0 C-N-CA 121.706 1.604 . . . . 0.0 111.604 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.821 ' OG1' ' N ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -114.82 -144.88 0.39 Allowed 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.527 0.679 . . . . 0.0 109.656 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 1.071 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 5.3 mt-10 72.99 65.94 0.11 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.113 -0.992 . . . . 0.0 112.334 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 1.071 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER 103.21 -57.17 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 O-C-N 120.789 -1.194 . . . . 0.0 112.553 177.458 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.649 ' C ' ' H ' ' A' ' 35' ' ' ARG . . . 152.85 122.73 0.94 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 117.435 -2.317 . . . . 0.0 113.22 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.536 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 5.4 Cg_exo -56.91 11.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.92 2.413 . . . . 0.0 111.376 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.823 ' NH2' ' CE2' ' A' ' 55' ' ' TYR . 9.1 ttt-85 84.88 -16.57 0.49 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.487 HH21 ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER 53.07 -173.79 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.095 -1.003 . . . . 0.0 110.671 179.087 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.49 -81.45 0.08 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 39' ' ' VAL . 4.5 tt -52.0 -40.36 28.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.856 -0.791 . . . . 0.0 110.757 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.52 ' N ' HG23 ' A' ' 38' ' ' ILE . 40.3 t -71.63 -61.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.724 -0.61 . . . . 0.0 110.565 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -55.7 -23.47 28.92 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.369 -0.832 . . . . 0.0 109.135 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -94.53 -34.45 12.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.277 -0.889 . . . . 0.0 109.852 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 38' ' ' ILE . 42.0 t -88.35 -46.29 9.3 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.052 -1.03 . . . . 0.0 110.233 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.8 t -63.59 -34.24 77.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 110.643 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -103.34 -15.4 15.95 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.167 -0.958 . . . . 0.0 110.28 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER -140.07 -179.14 5.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.109 -0.994 . . . . 0.0 109.19 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.803 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.3 mm -66.2 -179.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 0.0 109.305 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.803 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -146.93 134.49 20.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.042 -1.037 . . . . 0.0 109.365 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 m -87.68 155.27 20.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.438 -0.789 . . . . 0.0 109.182 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.4 tp -82.83 -39.83 21.16 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -57.95 -23.34 53.24 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 123.179 1.466 . . . . 0.0 107.826 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.506 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 10.5 tp-100 -80.69 -23.28 39.67 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.109 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.05 -38.52 19.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.399 -1.438 . . . . 0.0 108.213 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -58.24 -19.61 35.39 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.646 -0.659 . . . . 0.0 110.293 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -85.15 -8.57 58.55 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 108.634 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.823 ' CE2' ' NH2' ' A' ' 35' ' ' ARG . 4.4 m-85 -90.54 -40.29 12.05 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.937 0.875 . . . . 0.0 109.212 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.2 m -49.74 110.67 0.41 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.259 0.552 . . . . 0.0 110.03 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.55 179.829 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 1.067 ' CE1' ' HA ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 122.304 1.05 . . . . 0.0 110.072 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 2' ' ' VAL . 10.5 m -73.37 55.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 120.778 -1.201 . . . . 0.0 109.114 175.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 1.067 ' HA ' ' CE1' ' A' ' 1' ' ' PHE . 0.8 OUTLIER 67.42 -88.4 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.365 -0.834 . . . . 0.0 109.096 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 3' ' ' ASN . 28.4 pt20 31.46 -151.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.463 -0.773 . . . . 0.0 111.787 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.582 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 7.6 p80 -98.92 132.59 44.14 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.367 -0.833 . . . . 0.0 109.236 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 1' ' ' PHE . 1.4 mp -133.81 111.12 10.26 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.6 m -123.36 -177.57 3.74 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.84 -148.19 5.0 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.432 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -80.31 -13.38 59.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.947 -1.325 . . . . 0.0 109.425 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -52.01 -24.45 6.65 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.432 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.0 tp -81.67 -49.01 10.98 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.65 HG13 ' CE1' ' A' ' 24' ' ' PHE . 20.9 t -47.41 -46.61 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.522 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 27.5 tt0 -47.9 -59.76 3.1 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.499 -176.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.06 -61.49 1.61 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.4 mt -45.61 -46.8 14.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.555 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.83 -50.18 69.24 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 27.9 mt -53.75 -62.69 1.49 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 122.111 0.958 . . . . 0.0 110.727 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.1 m -65.38 -31.83 55.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.006 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.6 m -93.11 -0.52 56.99 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.08 -1.013 . . . . 0.0 109.936 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 47.9 -148.79 3.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.6 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 2.0 mp0 -83.21 -15.18 51.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -1.084 . . . . 0.0 109.328 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -42.73 -18.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.8 -0.562 . . . . 0.0 110.568 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 92.74 138.19 8.46 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.65 ' CE1' HG13 ' A' ' 12' ' ' VAL . 21.6 p90 -129.82 155.84 45.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.591 -0.946 . . . . 0.0 109.71 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' HD1' ' HE ' ' A' ' 35' ' ' ARG . 48.1 t80 -84.51 124.05 30.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 0.0 110.193 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 27' ' ' THR . 44.4 t80 -172.47 77.97 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 109.324 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -52.33 -176.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.08 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -82.51 154.52 68.75 Favored Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 121.133 -0.979 . . . . 0.0 108.606 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.899 ' O ' HG23 ' A' ' 30' ' ' THR . 59.2 Cg_endo -75.07 57.42 4.61 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.307 2.671 . . . . 0.0 111.766 -175.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.899 HG23 ' O ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -162.6 -61.7 0.04 OUTLIER 'General case' 0 C--N 1.262 -3.234 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 33' ' ' GLY . 4.9 mm-40 -54.98 122.53 11.09 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 117.778 -1.569 . . . . 0.0 108.703 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 1.1 pt-20 39.67 7.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.43 -0.794 . . . . 0.0 110.531 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.786 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 82.86 168.06 42.12 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 118.356 -1.878 . . . . 0.0 109.246 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.97 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 28.5 Cg_endo -63.84 -28.41 67.58 Favored 'Trans proline' 0 C--N 1.285 -2.781 0 C-N-CA 122.804 2.336 . . . . 0.0 117.421 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.97 ' HB2' ' O ' ' A' ' 34' ' ' PRO . 9.2 ttt-85 151.71 7.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 119.79 -1.819 . . . . 0.0 107.119 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.592 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER 29.4 102.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.747 0.784 . . . . 0.0 109.924 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.47 -68.79 0.3 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.4 tt -73.83 -41.28 53.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.594 -0.945 . . . . 0.0 109.74 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.738 HG21 ' CG ' ' A' ' 34' ' ' PRO . 44.9 t -68.99 -61.05 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.329 0.585 . . . . 0.0 110.774 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -57.28 -22.0 38.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.343 -0.848 . . . . 0.0 109.802 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -94.57 -43.15 8.44 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.025 -1.047 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 45' ' ' SER . 0.9 OUTLIER -85.44 -29.22 24.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.88 -1.137 . . . . 0.0 110.642 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.7 t -80.9 -54.16 5.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.798 -1.189 . . . . 0.0 109.802 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -76.12 -24.53 54.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.996 -1.065 . . . . 0.0 109.121 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' CYS . 9.9 m -140.23 -173.99 3.81 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.2 mt -93.9 146.13 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.024 -1.048 . . . . 0.0 109.445 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p -122.04 165.37 16.15 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.606 -0.684 . . . . 0.0 109.263 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.74 166.74 13.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.242 -0.911 . . . . 0.0 110.52 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.31 -36.65 26.77 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -58.77 -25.54 63.15 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.837 1.303 . . . . 0.0 108.199 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.429 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 6.4 tt0 -77.31 -22.19 52.32 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.694 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.3 mt -84.63 -34.53 23.06 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -61.58 -19.28 62.02 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 110.209 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -84.02 -8.72 59.06 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -89.91 -37.79 14.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.689 -0.632 . . . . 0.0 109.529 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.3 m -50.64 110.61 0.43 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.316 -0.865 . . . . 0.0 109.477 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.469 -179.815 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.859 ' C ' ' CD1' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 120.685 0.279 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 3' ' ' ASN . 11.7 p -69.66 167.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 170.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.513 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.3 m120 -49.18 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 0.0 109.485 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 2' ' ' VAL . 1.7 pt20 -157.64 -177.81 6.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 110.119 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -78.09 135.33 37.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.316 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.585 HD23 ' HA ' ' A' ' 11' ' ' LEU . 1.4 tp -134.6 109.82 8.91 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -118.11 174.65 6.09 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.71 -153.07 29.95 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 10' ' ' HIS . 3.3 p -78.41 -11.12 59.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.026 -1.279 . . . . 0.0 109.671 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 9' ' ' SER . 1.8 t-80 -53.24 -30.56 38.81 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.585 ' HA ' HD23 ' A' ' 6' ' ' LEU . 14.6 tp -74.91 -48.18 25.98 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.623 HG13 ' CE1' ' A' ' 24' ' ' PHE . 24.5 t -48.81 -46.3 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.513 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.8 tt0 -49.05 -60.19 2.99 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.492 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.508 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.03 -60.96 1.82 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.433 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 13.5 mt -45.81 -46.84 15.71 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.72 -51.02 66.9 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.2 mt -52.84 -62.49 1.62 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.101 0.953 . . . . 0.0 110.718 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -67.09 -30.86 50.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.209 -177.068 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 56.4 m -90.4 -10.85 42.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.002 -1.061 . . . . 0.0 110.325 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 43.71 -131.42 6.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.605 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.9 mp0 -83.91 -19.08 35.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.492 -1.005 . . . . 0.0 110.354 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -46.0 -12.84 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.348 -0.845 . . . . 0.0 110.174 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 76.04 133.54 0.45 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.623 ' CE1' HG13 ' A' ' 12' ' ' VAL . 38.3 p90 -124.36 142.34 51.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.841 -0.8 . . . . 0.0 109.374 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -83.34 138.13 33.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.428 -0.795 . . . . 0.0 109.776 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 27' ' ' THR . 39.0 t80 -171.86 -39.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.356 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 28' ' ' ASP . 1.6 m 53.93 172.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 109.359 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.452 ' H ' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -81.18 158.61 69.41 Favored Pre-proline 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 108.715 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 1.245 ' O ' HG23 ' A' ' 30' ' ' THR . 87.7 Cg_endo -82.98 96.19 0.83 Allowed 'Trans proline' 1 C--N 1.253 -4.487 0 N-CA-C 114.932 1.089 . . . . 0.0 114.932 -172.151 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.245 HG23 ' O ' ' A' ' 29' ' ' PRO . 13.9 p 157.45 -54.17 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.646 0 CA-C-O 122.762 1.268 . . . . 0.0 108.951 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 30' ' ' THR . 79.2 mm-40 -31.9 -76.03 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.749 -1.219 . . . . 0.0 112.285 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.36 -26.15 4.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.898 -1.126 . . . . 0.0 109.379 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.01 148.98 5.36 Favored Glycine 0 N--CA 1.513 3.794 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.647 ' O ' ' CB ' ' A' ' 35' ' ' ARG . 80.2 Cg_endo -78.79 26.13 0.54 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 CA-C-N 119.741 1.77 . . . . 0.0 111.524 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.647 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER 83.42 -20.46 0.33 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -178.372 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 38' ' ' ILE . 43.6 mtt-85 52.48 -159.32 0.12 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.437 ' C ' HE21 ' A' ' 41' ' ' GLN . . . 62.44 -81.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.535 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.2 tt -55.6 -41.83 66.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.736 -0.861 . . . . 0.0 109.973 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.535 ' N ' HG23 ' A' ' 38' ' ' ILE . 41.8 t -72.41 -60.68 2.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.546 0.689 . . . . 0.0 111.214 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -49.42 -31.84 10.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.604 -0.685 . . . . 0.0 110.771 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.9 pt20 -93.58 -37.11 12.06 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.842 -1.161 . . . . 0.0 110.068 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.3 t -78.14 -55.29 5.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.04 -1.038 . . . . 0.0 109.69 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.8 t -54.89 -27.84 45.94 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.432 -0.792 . . . . 0.0 110.516 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -111.35 -15.53 13.57 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.235 -0.916 . . . . 0.0 110.451 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -140.43 -173.83 3.79 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.934 -1.104 . . . . 0.0 109.78 -179.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.716 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.5 mm -64.94 178.73 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.716 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -143.99 127.77 17.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.957 -1.09 . . . . 0.0 109.866 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 m -80.79 149.32 29.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.333 -0.854 . . . . 0.0 109.171 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.2 tp -82.83 -41.59 18.88 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -55.79 -25.72 42.68 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 123.02 1.39 . . . . 0.0 108.128 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.533 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 18.6 tt0 -77.98 -22.34 49.54 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.029 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.0 mt -85.38 -28.17 25.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.661 -1.274 . . . . 0.0 108.584 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -65.49 -19.73 66.05 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.631 -0.668 . . . . 0.0 111.354 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 15.2 p30 -88.01 -8.37 55.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.813 -1.179 . . . . 0.0 108.123 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.522 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 4.7 m-85 -86.74 -26.01 24.42 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.681 0.753 . . . . 0.0 109.163 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 57' ' ' ASN . 4.2 m -67.36 95.91 0.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.705 -0.622 . . . . 0.0 111.088 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 56' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 117.923 -1.037 . . . . 0.0 108.38 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 1.189 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.151 0.501 . . . . 0.0 110.162 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 3' ' ' ASN . 14.3 p -82.4 164.27 2.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.739 -176.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.505 ' N ' HG22 ' A' ' 2' ' ' VAL . 1.3 m120 -47.87 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.991 -1.068 . . . . 0.0 109.493 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -158.66 -160.39 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.419 ' O ' ' CG ' ' A' ' 5' ' ' HIS . 44.8 p-80 -97.95 110.6 23.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.87 139.34 41.45 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.0 t -149.46 -178.47 6.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.282 -0.886 . . . . 0.0 108.792 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.96 -141.68 10.02 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.759 -1.737 . . . . 0.0 108.759 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' VAL . 3.3 p -84.07 -13.35 53.31 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.853 -1.381 . . . . 0.0 109.194 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -52.02 -27.68 14.44 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.935 HD23 ' OH ' ' A' ' 26' ' ' TYR . 22.4 tp -81.67 -37.25 27.74 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.614 HG13 ' CE1' ' A' ' 24' ' ' PHE . 13.8 t -58.73 -48.47 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 36.0 tt0 -47.74 -59.69 3.12 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.432 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.189 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -44.65 -61.76 1.45 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 mt -46.05 -45.55 16.14 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.552 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.22 -48.25 76.82 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.774 HD12 ' CD2' ' A' ' 1' ' ' PHE . 30.1 mt -55.75 -62.81 1.44 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 122.089 0.947 . . . . 0.0 110.836 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.4 m -64.18 -36.32 76.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.436 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.7 t -84.4 -22.68 30.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.929 -1.107 . . . . 0.0 110.559 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 70.76 -153.06 51.13 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 23' ' ' GLY . 14.7 mt-10 -83.66 3.61 32.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.244 . . . . 0.0 109.776 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.47 1.8 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 71.93 124.81 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.614 ' CE1' HG13 ' A' ' 12' ' ' VAL . 13.2 p90 -111.52 170.42 8.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -1.034 . . . . 0.0 110.845 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -98.5 134.85 40.89 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.579 0.704 . . . . 0.0 110.034 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.935 ' OH ' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -175.92 -149.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER 170.3 166.28 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.152 -0.967 . . . . 0.0 109.227 178.025 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.636 ' HB2' ' HG3' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -96.76 161.47 26.44 Favored Pre-proline 0 N--CA 1.487 1.397 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.56 -7.1 20.12 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 123.856 3.037 . . . . 0.0 110.493 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 28' ' ' ASP . 10.1 t -103.2 -28.28 12.01 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.749 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -76.85 -9.27 58.57 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 176.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 1.032 ' O ' ' O ' ' A' ' 33' ' ' GLY . 53.3 mt-10 107.89 119.9 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.574 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 1.032 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -6.14 147.86 0.0 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.993 ' HG3' HG21 ' A' ' 39' ' ' VAL . 86.0 Cg_endo -84.49 59.14 5.69 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 123.767 2.978 . . . . 0.0 115.774 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER 80.43 -37.04 0.14 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 111.187 177.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.564 ' CB ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 81.93 114.55 0.06 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.082 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.5 -60.64 0.42 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.528 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 3.3 tt -82.09 -44.63 19.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.733 -0.863 . . . . 0.0 110.065 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.993 HG21 ' HG3' ' A' ' 34' ' ' PRO . 43.7 t -70.47 -61.29 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 O-C-N 121.308 -0.87 . . . . 0.0 111.37 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.28 -24.55 28.98 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.089 -1.007 . . . . 0.0 110.156 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.542 ' NE2' HE22 ' A' ' 51' ' ' GLN . 20.2 tt0 -94.42 -47.76 6.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.914 -1.116 . . . . 0.0 110.284 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 31.3 m -76.85 -33.28 57.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.069 -1.019 . . . . 0.0 110.535 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.7 t -78.65 -29.26 45.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.851 -1.156 . . . . 0.0 109.874 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -102.42 -21.5 14.24 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.301 -0.874 . . . . 0.0 109.915 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 t -140.03 -171.33 3.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.225 -0.922 . . . . 0.0 109.858 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.3 mm -82.88 174.97 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.595 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.9 m -152.08 167.16 29.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.992 -1.068 . . . . 0.0 109.701 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.75 163.44 12.26 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.634 0.73 . . . . 0.0 109.246 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.675 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -81.95 -32.5 30.74 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.514 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.58 -28.06 69.67 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.648 1.213 . . . . 0.0 108.569 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.542 HE22 ' NE2' ' A' ' 41' ' ' GLN . 6.3 tt0 -71.55 -26.3 62.58 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.517 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.669 ' CD1' ' HZ ' ' A' ' 1' ' ' PHE . 47.7 mt -85.78 -23.75 27.11 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.116 -0.99 . . . . 0.0 108.501 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -71.73 -18.37 62.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.333 -0.855 . . . . 0.0 110.89 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 16.8 p30 -86.33 -9.19 56.89 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.526 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 5.7 m-85 -84.24 -28.14 27.46 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.4 t -67.33 112.46 4.58 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.843 0.83 . . . . 0.0 110.106 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.1 m120 . . . . . 0 C--N 1.292 -1.918 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.579 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 1.386 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 8.2 p90 . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 3' ' ' ASN . 11.2 p -56.38 169.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 119.101 -2.249 . . . . 0.0 108.902 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.543 ' N ' HG22 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -49.38 110.02 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.057 -1.027 . . . . 0.0 109.412 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -169.33 -165.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.06 -1.025 . . . . 0.0 110.018 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 30.9 p80 -93.71 132.15 38.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.373 -0.829 . . . . 0.0 109.723 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 1' ' ' PHE . 0.9 OUTLIER -129.5 127.8 41.55 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.4 m -136.15 -177.3 4.64 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.27 -0.894 . . . . 0.0 108.758 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.62 -147.78 2.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.45 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.5 p -79.9 -14.1 58.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.326 . . . . 0.0 109.133 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -51.94 -24.25 6.17 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.45 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.1 tp -81.22 -51.34 8.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.626 HG13 ' CE1' ' A' ' 24' ' ' PHE . 25.3 t -46.16 -46.7 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 121.908 0.861 . . . . 0.0 108.98 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.521 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.8 tt0 -47.78 -59.92 2.95 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.51 -176.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.386 ' HB1' ' CE2' ' A' ' 1' ' ' PHE . . . -44.99 -62.0 1.41 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.8 mt -45.53 -45.68 13.53 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.558 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.92 -52.01 65.6 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.8 mt -51.03 -62.33 1.68 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.028 0.918 . . . . 0.0 110.753 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.1 m -66.39 -34.92 73.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.409 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.0 m -88.53 -6.87 57.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.949 -1.095 . . . . 0.0 110.305 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 45.87 -142.58 4.46 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 23' ' ' GLY . 19.9 mt-10 -83.13 -3.26 57.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -1.116 . . . . 0.0 109.6 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -55.64 -4.82 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.772 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 72.8 127.83 0.1 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CE1' HG13 ' A' ' 12' ' ' VAL . 32.9 p90 -122.29 145.9 47.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.627 -0.925 . . . . 0.0 108.971 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -83.17 133.11 35.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.189 -0.944 . . . . 0.0 109.891 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.528 ' CE2' ' O ' ' A' ' 27' ' ' THR . 43.6 t80 -172.82 174.24 3.65 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.528 ' O ' ' CE2' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -153.18 -178.01 6.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.028 -1.045 . . . . 0.0 109.494 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.409 ' H ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -82.06 159.93 64.28 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.268 -0.895 . . . . 0.0 108.857 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.52 -24.43 9.13 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 124.188 3.259 . . . . 0.0 113.258 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.6 p -115.07 -27.49 7.31 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.57 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 32' ' ' GLU . 4.1 mm-40 -54.22 138.07 39.49 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.892 -1.13 . . . . 0.0 109.643 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.597 ' C ' ' O ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER 24.74 -105.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.443 ' H ' ' HB2' ' A' ' 32' ' ' GLU . . . -175.2 100.37 0.15 Allowed Glycine 0 C--N 1.29 -2.014 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.675 ' O ' ' C ' ' A' ' 35' ' ' ARG . 12.0 Cg_endo -51.23 120.41 6.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.407 2.738 . . . . 0.0 113.493 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.675 ' C ' ' O ' ' A' ' 34' ' ' PRO . 0.4 OUTLIER 11.0 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 122.041 -0.412 . . . . 0.0 111.349 177.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 40' ' ' GLU . 8.5 mmt-85 -59.6 102.18 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.5 -49.36 0.28 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 39' ' ' VAL . 9.6 tt -82.52 -44.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.608 -0.937 . . . . 0.0 110.894 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.568 ' N ' HG23 ' A' ' 38' ' ' ILE . 46.1 t -67.76 -62.61 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.379 -0.825 . . . . 0.0 111.448 -177.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 36' ' ' ARG . 15.2 mt-10 -55.29 -25.92 37.03 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.084 -1.01 . . . . 0.0 110.369 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' SER . 16.1 tt0 -93.92 -55.92 3.06 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.05 -1.031 . . . . 0.0 110.493 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 14.4 m -67.88 -33.93 75.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.053 -1.029 . . . . 0.0 111.238 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.6 t -77.95 -32.23 51.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.726 -1.234 . . . . 0.0 110.355 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -101.97 -18.33 15.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.059 -1.026 . . . . 0.0 109.781 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLN . 3.2 m -140.17 -179.38 5.95 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.221 -0.925 . . . . 0.0 109.235 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 47' ' ' CYS . 4.5 mm -78.16 173.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 108.921 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.579 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.5 m -152.11 167.45 28.46 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.197 -0.94 . . . . 0.0 109.559 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.97 163.42 12.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 109.338 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.42 -35.07 27.95 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.3 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.29 -26.26 66.37 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.729 1.252 . . . . 0.0 108.27 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.444 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 6.5 tt0 -74.69 -23.01 58.56 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.452 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.885 ' CD1' ' CZ ' ' A' ' 1' ' ' PHE . 57.4 mt -84.93 -36.75 21.23 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.75 -19.31 49.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.548 -0.72 . . . . 0.0 110.156 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -84.02 -8.51 59.12 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -90.03 -37.79 14.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.514 -0.741 . . . . 0.0 109.744 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.421 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 3.2 m -49.92 109.24 0.27 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.413 -0.804 . . . . 0.0 109.587 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.421 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 33.3 t-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.576 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 1.106 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 1.5 t80 . . . . . 0 C--O 1.174 -2.92 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 1' ' ' PHE . 16.7 m -166.79 -30.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 118.95 -2.344 . . . . 0.0 107.715 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 2' ' ' VAL . 22.4 m-80 -175.22 -102.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.652 HE22 HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER 33.81 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.265 1.031 . . . . 0.0 112.879 179.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 16.8 p-80 -101.37 110.96 23.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.764 -0.585 . . . . 0.0 109.778 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.533 ' C ' ' CE1' ' A' ' 10' ' ' HIS . 0.3 OUTLIER -102.02 104.02 14.66 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.729 ' N ' ' CE1' ' A' ' 10' ' ' HIS . 17.0 m -122.0 115.35 22.37 Favored 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.59 -141.16 15.86 Favored Glycine 0 N--CA 1.507 3.426 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 12' ' ' VAL . 7.4 p -87.23 -27.32 23.03 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 120.712 -1.463 . . . . 0.0 113.783 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.752 ' ND1' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -45.34 -22.66 0.14 Allowed 'General case' 0 N--CA 1.527 3.395 0 CA-C-N 121.525 1.966 . . . . 0.0 106.453 178.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.752 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 32.9 tp -79.46 -51.34 9.48 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.556 HG13 ' CE1' ' A' ' 24' ' ' PHE . 41.4 t -49.77 -53.39 10.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.517 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.3 tt0 -49.78 -59.4 3.86 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.557 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.53 -61.6 1.49 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.466 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 14.6 mt -46.43 -47.95 18.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.57 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.37 -55.15 31.52 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.89 HD12 ' CD1' ' A' ' 1' ' ' PHE . 31.7 mt -47.41 -62.17 1.56 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.156 0.979 . . . . 0.0 110.64 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -68.17 -26.6 34.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.88 -177.097 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 58.6 m -97.75 1.47 48.47 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.229 -0.919 . . . . 0.0 110.723 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 48.47 -152.2 2.57 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' GLY . 43.5 tt0 -83.58 -15.05 50.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -1.138 . . . . 0.0 109.915 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.6 ' H ' ' CD ' ' A' ' 22' ' ' ARG . 7.7 mpt_? -42.84 -18.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.679 -0.638 . . . . 0.0 110.438 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 95.04 138.54 9.59 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.556 ' CE1' HG13 ' A' ' 12' ' ' VAL . 26.6 p90 -129.29 178.0 6.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.65 -0.912 . . . . 0.0 109.047 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 55' ' ' TYR . 51.9 m-85 -104.71 132.53 50.85 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.064 -1.022 . . . . 0.0 111.244 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CD2' HG22 ' A' ' 12' ' ' VAL . 10.8 t80 -175.91 -143.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 10.2 t -172.49 -151.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.06 -1.025 . . . . 0.0 109.776 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.468 ' N ' ' OG1' ' A' ' 27' ' ' THR . 0.4 OUTLIER -112.45 165.24 13.43 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 31' ' ' GLU . 10.8 Cg_endo -73.85 -75.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.291 -2.485 0 C-N-CA 122.457 2.105 . . . . 0.0 111.087 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.35 -25.93 0.16 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' PRO . 4.1 mm-40 -94.43 86.11 4.77 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.12 96.89 0.1 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.155 -0.966 . . . . 0.0 111.369 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.664 ' N ' ' CD ' ' A' ' 34' ' ' PRO . . . -151.24 45.06 0.65 Allowed Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.508 -1.806 . . . . 0.0 111.218 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 30.9 Cg_endo -61.8 170.35 5.99 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 124.833 3.688 . . . . 0.0 112.757 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.448 ' HD3' HH21 ' A' ' 35' ' ' ARG . 3.6 ttm180 -86.52 -16.11 37.95 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.634 ' HE ' ' HG2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 69.02 53.67 0.47 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.546 -0.721 . . . . 0.0 110.026 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.4 -60.02 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.647 HG23 ' N ' ' A' ' 39' ' ' VAL . 18.2 tt -69.99 -47.54 68.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.72 -0.871 . . . . 0.0 110.117 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.647 ' N ' HG23 ' A' ' 38' ' ' ILE . 43.9 t -62.7 -61.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 121.723 -0.61 . . . . 0.0 111.101 -177.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.584 ' OE2' ' NH2' ' A' ' 36' ' ' ARG . 18.1 mt-10 -49.61 -26.54 3.69 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.393 -0.817 . . . . 0.0 110.11 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -94.56 -61.44 1.51 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.956 -1.09 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.435 ' O ' ' O ' ' A' ' 45' ' ' SER . 59.6 m -59.31 -28.74 67.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.31 -0.869 . . . . 0.0 110.466 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.9 t -85.61 -54.51 4.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.767 -1.208 . . . . 0.0 110.499 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.448 ' ND1' ' N ' ' A' ' 44' ' ' HIS . 3.1 m80 -71.37 -15.68 62.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.816 -1.177 . . . . 0.0 109.413 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 t -140.37 178.88 6.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 47' ' ' CYS . 5.4 mm -64.6 163.74 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.458 ' N ' HG22 ' A' ' 46' ' ' ILE . 9.0 t -108.55 140.43 41.91 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.237 -0.914 . . . . 0.0 111.169 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 m -98.65 145.37 26.94 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.4 tp -82.22 -40.97 20.91 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -54.09 -26.59 27.91 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 122.796 1.284 . . . . 0.0 108.478 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.539 HE22 ' CD2' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -78.81 -23.68 45.0 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.34 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.539 ' CD2' HE22 ' A' ' 51' ' ' GLN . 28.6 mt -84.82 -25.82 27.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.709 -1.244 . . . . 0.0 108.859 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -67.79 -19.19 65.07 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.582 -0.699 . . . . 0.0 111.189 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 15.7 p30 -88.32 -8.35 55.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.917 -1.114 . . . . 0.0 108.014 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.508 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 4.6 m-85 -85.3 -27.14 26.15 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.7 0.762 . . . . 0.0 109.201 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.456 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 3.2 m -67.99 110.92 4.12 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.432 -0.792 . . . . 0.0 110.115 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.456 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 5.4 m120 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.983 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.831 ' CG ' ' O ' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.436 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 3' ' ' ASN . 7.1 p -79.91 -42.35 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.341 -1.474 . . . . 0.0 108.48 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 4' ' ' GLN . 11.6 m120 -168.54 -98.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.542 ' O ' ' O ' ' A' ' 3' ' ' ASN . 5.1 pt20 32.22 -166.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 122.342 1.067 . . . . 0.0 112.992 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -98.14 146.47 25.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.0 109.01 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.662 HD23 ' HA ' ' A' ' 11' ' ' LEU . 1.2 tp -132.8 108.92 9.29 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 t -117.14 145.75 43.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.516 -0.74 . . . . 0.0 109.057 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.424 ' C ' ' N ' ' A' ' 10' ' ' HIS . . . 82.01 177.39 51.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 10' ' ' HIS . 2.6 p -54.16 -10.55 0.37 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.556 -1.555 . . . . 0.0 109.14 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.424 ' N ' ' C ' ' A' ' 8' ' ' GLY . 40.2 m80 -52.24 -29.38 22.52 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 177.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.662 ' HA ' HD23 ' A' ' 6' ' ' LEU . 10.9 tp -74.74 -49.36 21.28 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.603 HG13 ' CE1' ' A' ' 24' ' ' PHE . 5.0 t -49.89 -41.43 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 20.6 tt0 -47.69 -59.25 3.42 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.608 -177.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.488 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.62 -61.11 1.84 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.756 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.1 mt -46.32 -44.97 17.2 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.556 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.96 -50.9 69.51 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 19.5 mt -52.02 -62.75 1.44 Allowed 'General case' 0 C--N 1.291 -1.96 0 O-C-N 120.998 -1.064 . . . . 0.0 109.866 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -69.08 -58.21 6.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.578 -178.302 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.62 ' N ' ' O ' ' A' ' 15' ' ' LEU . 82.7 m -86.26 34.18 0.63 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.977 -1.077 . . . . 0.0 110.526 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . -54.7 -111.98 0.01 OUTLIER Glycine 0 N--CA 1.499 2.851 0 O-C-N 120.889 -1.132 . . . . 0.0 111.329 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -43.86 -15.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -1.053 . . . . 0.0 110.582 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 20' ' ' GLY . 3.9 mmp_? -74.58 -40.13 61.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.987 -1.07 . . . . 0.0 109.73 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.07 137.37 9.78 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.603 ' CE1' HG13 ' A' ' 12' ' ' VAL . 37.1 p90 -138.81 -173.33 3.53 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -154.43 118.54 4.73 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 119.928 -1.733 . . . . 0.0 112.607 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.756 ' CE2' HD13 ' A' ' 15' ' ' LEU . 32.4 m-85 -146.53 108.84 4.45 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -55.35 -166.12 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.148 -0.97 . . . . 0.0 109.799 -179.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.705 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -48.38 -172.04 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 28' ' ' ASP . 28.3 Cg_endo -85.89 -5.96 8.69 Favored 'Trans proline' 0 C--N 1.295 -2.256 0 C-N-CA 124.161 3.241 . . . . 0.0 111.308 174.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.694 ' OG1' ' N ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -145.19 -140.72 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.705 ' OE2' ' HB2' ' A' ' 28' ' ' ASP . 1.2 mt-10 65.1 92.07 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.126 -1.609 . . . . 0.0 108.897 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 59.21 -69.83 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.934 -0.479 . . . . 0.0 110.675 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.543 ' HA3' ' CZ ' ' A' ' 36' ' ' ARG . . . 168.41 169.53 31.98 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 117.765 -2.159 . . . . 0.0 112.575 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 59.1 Cg_endo -79.13 -125.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 124.346 3.364 . . . . 0.0 113.234 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.432 ' H ' ' HB2' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -94.57 -16.52 23.18 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.891 0.853 . . . . 0.0 108.904 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' CZ ' ' HA3' ' A' ' 33' ' ' GLY . 1.8 mpt_? 61.29 45.63 8.58 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.73 -83.95 0.05 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 117.285 -2.388 . . . . 0.0 109.012 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 39' ' ' VAL . 4.8 tt -48.7 -38.74 10.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.752 -0.852 . . . . 0.0 110.371 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.499 ' N ' HG23 ' A' ' 38' ' ' ILE . 39.3 t -72.87 -61.16 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.436 0.636 . . . . 0.0 111.013 -178.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -52.25 -27.07 13.54 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -93.46 -34.95 13.21 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.055 -1.028 . . . . 0.0 109.525 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' SER . 50.1 t -83.28 -49.96 8.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.721 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 39' ' ' VAL . 44.2 t -64.29 -23.94 67.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 110.018 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -102.72 -29.18 11.66 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.168 -0.957 . . . . 0.0 110.068 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 t -134.3 -172.98 3.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.375 -0.828 . . . . 0.0 109.794 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.8 mm -65.95 175.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.6 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -137.21 141.65 42.1 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.027 -1.046 . . . . 0.0 110.063 -178.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -93.43 151.08 19.97 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.2 tp -83.12 -42.08 17.79 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -55.84 -25.11 40.4 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 123.017 1.389 . . . . 0.0 107.925 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.486 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 7.6 tt0 -78.69 -23.35 45.66 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.102 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.1 mt -85.36 -36.36 20.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.454 -1.404 . . . . 0.0 108.497 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -58.11 -19.57 33.38 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.645 -0.66 . . . . 0.0 110.948 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -88.03 -7.97 56.27 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.072 -1.017 . . . . 0.0 108.792 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.486 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 5.7 m-85 -88.72 -25.59 22.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.529 -0.732 . . . . 0.0 110.636 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.8 110.61 0.37 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.07 -1.019 . . . . 0.0 109.629 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 t30 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.475 179.909 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.592 ' O ' ' N ' ' A' ' 3' ' ' ASN . 23.4 p90 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 2' ' ' VAL . 1.4 p -53.25 89.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 119.936 -1.727 . . . . 0.0 108.97 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 1' ' ' PHE . 1.6 m120 47.0 -132.17 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.645 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.02 166.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 109.646 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -76.73 142.19 40.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.643 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.68 124.89 34.69 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.3 m -128.05 -176.84 3.91 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.541 -0.724 . . . . 0.0 109.085 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.6 -151.44 1.07 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.452 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -77.12 -13.32 59.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.039 -1.271 . . . . 0.0 109.151 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -51.73 -23.73 4.91 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.452 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.8 tp -81.74 -50.94 8.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.641 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.5 t -46.26 -47.91 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.74 0.781 . . . . 0.0 108.979 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.514 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.5 tt0 -48.06 -59.71 3.17 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.579 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.539 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.72 -62.24 1.28 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 14.6 mt -44.94 -44.38 9.72 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -57.67 -49.71 75.6 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 29.1 mt -53.94 -62.84 1.39 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.117 0.96 . . . . 0.0 110.942 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.6 m -62.43 -37.17 78.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.955 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.1 t -81.23 -22.22 38.95 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.026 -1.046 . . . . 0.0 109.881 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 67.56 -146.66 47.49 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 23' ' ' GLY . 19.1 mt-10 -83.1 -1.72 53.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 0.0 109.363 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -61.92 1.69 0.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 110.033 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 64.73 120.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.641 ' CE1' HG13 ' A' ' 12' ' ' VAL . 13.8 p90 -99.63 171.69 7.76 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.542 -0.975 . . . . 0.0 109.62 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -104.59 119.6 39.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.503 -0.748 . . . . 0.0 109.732 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -152.54 4.14 0.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.277 -0.89 . . . . 0.0 108.76 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 31' ' ' GLU . 0.2 OUTLIER 60.53 175.28 0.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.507 -0.746 . . . . 0.0 109.787 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.67 165.63 0.29 Allowed Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.9 -15.04 45.98 Favored 'Trans proline' 0 C--N 1.288 -2.645 0 C-N-CA 122.214 1.942 . . . . 0.0 110.239 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 30' ' ' THR . 1.8 t -136.89 129.05 29.62 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' OE2' HG23 ' A' ' 30' ' ' THR . 35.9 mm-40 -171.78 167.23 6.41 Favored 'General case' 0 CA--C 1.586 2.354 0 CA-C-O 123.101 1.429 . . . . 0.0 111.868 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.16 48.98 0.82 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.092 -1.63 . . . . 0.0 111.306 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.682 ' H ' ' HD3' ' A' ' 34' ' ' PRO . . . 175.09 41.42 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.675 -1.726 . . . . 0.0 110.842 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.682 ' HD3' ' H ' ' A' ' 33' ' ' GLY . 73.0 Cg_endo -66.74 29.31 0.11 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 123.168 2.578 . . . . 0.0 110.127 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.733 ' O ' ' N ' ' A' ' 37' ' ' GLY . 12.6 ttm-85 69.53 -8.6 0.73 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.591 ' H ' ' C ' ' A' ' 34' ' ' PRO . 11.0 mmt180 32.69 27.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.733 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -106.64 -67.56 0.67 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 39' ' ' VAL . 9.2 tt -62.12 -41.24 90.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 122.118 0.961 . . . . 0.0 109.821 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.575 ' N ' HG23 ' A' ' 38' ' ' ILE . 45.2 t -65.39 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 O-C-N 121.678 -0.639 . . . . 0.0 111.403 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 36' ' ' ARG . 20.1 mt-10 -60.93 -22.04 64.0 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.033 -1.042 . . . . 0.0 110.31 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -93.31 -37.84 11.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.852 -1.155 . . . . 0.0 110.345 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 28.9 m -88.59 -36.84 16.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.076 -1.015 . . . . 0.0 110.344 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.9 t -76.36 -37.16 57.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.863 -1.148 . . . . 0.0 109.98 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -91.71 -22.29 20.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.0 -1.063 . . . . 0.0 109.395 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 42' ' ' CYS . 2.7 m -140.37 -174.52 3.97 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.241 -0.912 . . . . 0.0 109.36 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.602 HG22 ' H ' ' A' ' 47' ' ' CYS . 4.9 mm -83.53 174.14 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.864 . . . . 0.0 108.99 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.602 ' H ' HG22 ' A' ' 46' ' ' ILE . 2.0 m -151.05 167.83 26.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.002 -1.061 . . . . 0.0 110.069 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.71 163.73 12.35 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.624 0.726 . . . . 0.0 109.352 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.04 -31.56 30.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.61 -27.3 68.3 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.676 1.227 . . . . 0.0 108.53 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.43 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 12.1 tt0 -71.55 -24.51 61.95 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.433 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.2 mt -84.78 -34.02 22.87 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -62.57 -18.85 62.95 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.495 -0.753 . . . . 0.0 109.911 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.2 m-20 -82.85 -8.93 59.54 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.4 m-85 -91.6 -28.74 17.33 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.61 0.719 . . . . 0.0 109.394 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 35.5 t -68.77 112.48 5.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.394 -0.816 . . . . 0.0 109.703 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 t30 . . . . . 0 C--N 1.291 -1.973 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.491 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.726 ' CD1' HD12 ' A' ' 17' ' ' LEU . 6.0 p90 . . . . . 0 C--O 1.206 -1.196 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 3' ' ' ASN . 87.1 t -145.94 91.2 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 118.524 0.602 . . . . 0.0 110.0 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.482 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.7 m120 40.01 51.56 2.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.689 -0.632 . . . . 0.0 110.162 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.8 161.05 35.12 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.491 -0.756 . . . . 0.0 110.006 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 0.3 OUTLIER -50.43 124.93 11.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 110.334 -179.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.25 109.69 9.59 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.3 m -121.92 -177.88 3.7 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.32 -150.96 2.98 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.1 p -77.25 -12.64 59.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.952 -1.323 . . . . 0.0 109.135 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -51.63 -25.17 6.56 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.434 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.6 tp -81.31 -49.68 10.42 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.662 HG13 ' CE1' ' A' ' 24' ' ' PHE . 19.4 t -46.53 -46.48 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.521 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 35.7 tt0 -47.83 -59.69 3.13 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.429 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.516 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.02 -61.39 1.65 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.1 mt -45.86 -45.05 14.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.553 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.79 -49.81 74.22 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.726 HD12 ' CD1' ' A' ' 1' ' ' PHE . 29.1 mt -54.19 -62.42 1.67 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.098 0.951 . . . . 0.0 110.821 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.1 m -65.36 -36.75 78.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.169 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 41.9 t -80.55 -22.57 40.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.844 -1.16 . . . . 0.0 110.002 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 68.29 -146.05 45.3 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.589 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.8 mp0 -83.23 -17.13 43.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.16 -1.2 . . . . 0.0 109.211 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -45.56 -13.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.776 -0.577 . . . . 0.0 110.352 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 81.17 130.74 1.09 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.662 ' CE1' HG13 ' A' ' 12' ' ' VAL . 27.0 p90 -116.43 149.42 39.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.677 -0.896 . . . . 0.0 109.27 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -85.48 116.57 23.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.145 -0.972 . . . . 0.0 110.015 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -161.48 -11.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 28' ' ' ASP . 1.8 m 58.03 -140.43 0.78 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 109.69 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -103.09 167.07 10.76 Favored Pre-proline 0 N--CA 1.487 1.412 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.44 -19.62 19.14 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 123.007 2.471 . . . . 0.0 110.285 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -111.19 -128.92 0.29 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.908 -179.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.487 ' H ' ' HB ' ' A' ' 30' ' ' THR . 1.4 mt-10 60.35 -80.76 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -159.03 155.42 27.42 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.425 -1.31 . . . . 0.0 112.058 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.503 ' HA2' ' HD2' ' A' ' 34' ' ' PRO . . . -37.36 109.1 0.08 OUTLIER Glycine 0 N--CA 1.492 2.408 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.114 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.883 ' CG ' HG21 ' A' ' 39' ' ' VAL . 15.0 Cg_endo -50.35 -176.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 124.084 3.189 . . . . 0.0 112.914 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 34' ' ' PRO . 1.3 ttm180 -19.07 -31.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.836 -0.54 . . . . 0.0 111.967 -178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.872 ' N ' ' O ' ' A' ' 34' ' ' PRO . 1.8 tpp180 72.17 31.72 1.88 Allowed 'General case' 0 N--CA 1.511 2.578 0 O-C-N 120.555 -1.34 . . . . 0.0 107.825 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.54 -63.01 0.01 OUTLIER Glycine 0 C--N 1.274 -2.915 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.553 HG23 ' N ' ' A' ' 39' ' ' VAL . 5.4 tt -67.43 -39.3 82.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 122.106 0.955 . . . . 0.0 109.699 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.883 HG21 ' CG ' ' A' ' 34' ' ' PRO . 45.0 t -70.35 -61.87 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.74 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.87 -21.85 32.58 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.405 -0.81 . . . . 0.0 109.717 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -94.24 -49.22 5.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.158 -0.964 . . . . 0.0 110.699 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' SER . 3.0 t -80.03 -29.99 39.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.82 -1.175 . . . . 0.0 111.013 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.4 t -78.61 -49.67 12.83 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.658 -1.276 . . . . 0.0 109.708 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -80.94 -23.08 39.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.046 -1.034 . . . . 0.0 109.349 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 m -139.96 -173.04 3.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.305 -0.872 . . . . 0.0 108.951 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 47' ' ' CYS . 1.9 mm -86.5 168.33 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.174 -0.954 . . . . 0.0 108.791 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.508 ' N ' HG22 ' A' ' 46' ' ' ILE . 23.1 p -149.45 161.08 42.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.07 -1.019 . . . . 0.0 109.259 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.93 164.85 14.4 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.083 0.945 . . . . 0.0 111.079 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.569 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.74 -36.92 25.34 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.91 -26.3 62.01 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 122.757 1.265 . . . . 0.0 108.094 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.528 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 6.5 tt0 -76.49 -22.53 54.37 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.736 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.7 mt -85.28 -30.9 23.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.861 -1.15 . . . . 0.0 108.235 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -64.2 -19.29 65.24 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.564 -0.71 . . . . 0.0 111.049 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 14.8 p30 -87.51 -8.57 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.926 -1.109 . . . . 0.0 108.045 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.482 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 4.9 m-85 -84.78 -28.69 26.0 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.3 t -68.48 112.31 5.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.444 -0.785 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--N 1.29 -1.992 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.445 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.742 ' N ' ' CD1' ' A' ' 1' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.476 0.655 . . . . 0.0 109.815 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 4' ' ' GLN . 3.3 t 54.88 48.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.267 0.556 . . . . 0.0 110.021 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 4' ' ' GLN . 22.2 m-80 56.68 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.107 -0.996 . . . . 0.0 110.28 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 3' ' ' ASN . 5.8 pt20 35.43 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.69 -0.631 . . . . 0.0 111.498 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 51.8 p-80 -90.86 123.9 34.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.126 -0.984 . . . . 0.0 109.612 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -129.88 116.75 19.12 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.6 m -122.41 -176.91 3.48 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.542 -0.724 . . . . 0.0 109.123 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 44.02 -149.21 0.87 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.458 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.2 p -80.81 -9.48 59.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.942 -1.328 . . . . 0.0 108.865 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 9' ' ' SER . 50.6 m80 -52.29 -24.63 7.74 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.458 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.0 tp -77.76 -53.82 7.07 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.64 HG13 ' CE1' ' A' ' 24' ' ' PHE . 5.0 t -46.55 -42.56 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.531 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.6 tt0 -46.84 -59.21 3.22 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.635 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.49 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.37 -61.42 1.68 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.763 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.1 mt -46.14 -48.41 17.37 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -51.24 -48.47 62.13 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.61 HD12 ' CE1' ' A' ' 1' ' ' PHE . 19.6 mt -57.31 -63.66 1.15 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.168 -0.957 . . . . 0.0 110.532 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -64.55 -47.59 88.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.965 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.473 ' N ' ' O ' ' A' ' 15' ' ' LEU . 67.0 m -73.05 -20.81 60.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.908 -1.12 . . . . 0.0 109.756 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 42.55 -125.74 4.33 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -83.63 -15.2 49.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -1.015 . . . . 0.0 110.077 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -46.73 -29.12 1.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.103 -0.998 . . . . 0.0 109.481 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.45 127.54 4.29 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.705 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.64 ' CE1' HG13 ' A' ' 12' ' ' VAL . 29.1 p90 -132.83 176.29 8.6 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -154.01 125.75 7.66 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 119.589 -1.944 . . . . 0.0 112.527 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.763 ' CE2' HD13 ' A' ' 15' ' ' LEU . 20.3 m-85 -141.33 -179.93 6.41 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.572 HG22 ' CB ' ' A' ' 31' ' ' GLU . 1.4 m -152.35 171.88 17.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.001 -1.062 . . . . 0.0 109.629 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.449 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -74.64 164.77 59.02 Favored Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 121.493 -0.755 . . . . 0.0 108.969 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 28' ' ' ASP . 16.8 Cg_endo -53.93 -34.74 77.74 Favored 'Trans proline' 0 C--N 1.276 -3.27 0 C-N-CA 123.7 2.933 . . . . 0.0 111.559 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.895 ' C ' ' H ' ' A' ' 32' ' ' GLU . 14.3 t -102.54 -34.17 9.21 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.45 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.572 ' CB ' HG22 ' A' ' 27' ' ' THR . 46.7 mm-40 -62.28 10.19 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.895 ' H ' ' C ' ' A' ' 30' ' ' THR . 0.4 OUTLIER 106.99 123.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.708 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 32' ' ' GLU . . . -48.01 156.46 1.04 Allowed Glycine 0 N--CA 1.478 1.481 0 N-CA-C 107.261 -2.335 . . . . 0.0 107.261 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.58 ' HG2' HG21 ' A' ' 39' ' ' VAL . 42.7 Cg_endo -94.73 -147.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.288 -2.641 0 C-N-CA 123.34 2.694 . . . . 0.0 111.595 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.726 ' CG ' HH21 ' A' ' 35' ' ' ARG . 0.4 OUTLIER -63.07 84.06 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.5 -1.375 . . . . 0.0 109.004 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.574 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -47.22 110.73 0.33 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 158.2 -89.83 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -176.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.557 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.3 tt -46.9 -40.26 4.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 122.009 0.909 . . . . 0.0 109.982 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.58 HG21 ' HG2' ' A' ' 34' ' ' PRO . 47.1 t -69.45 -61.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 O-C-N 121.298 -0.876 . . . . 0.0 110.308 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.47 ' HG3' ' HD2' ' A' ' 36' ' ' ARG . 42.6 mt-10 -62.53 -19.42 63.62 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.141 -0.974 . . . . 0.0 109.724 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -94.18 -39.31 10.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.082 -1.011 . . . . 0.0 110.088 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 33.7 m -88.47 -40.43 13.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.967 -1.083 . . . . 0.0 110.365 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.0 t -71.02 -25.77 62.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.792 -1.192 . . . . 0.0 109.541 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -102.95 -25.88 13.3 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.334 -0.854 . . . . 0.0 109.195 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -137.41 -168.06 2.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.404 -0.81 . . . . 0.0 108.964 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 47' ' ' CYS . 4.2 mm -94.98 169.95 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.131 -0.98 . . . . 0.0 109.499 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.577 ' N ' HG22 ' A' ' 46' ' ' ILE . 98.3 m -149.21 167.85 24.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.088 -1.008 . . . . 0.0 110.104 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.21 165.24 12.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.831 . . . . 0.0 109.521 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -82.67 -35.24 27.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 178.167 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.17 -25.28 65.42 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.756 1.265 . . . . 0.0 108.238 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.474 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 14.1 tt0 -75.81 -22.41 56.36 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.545 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.9 mt -84.42 -33.29 23.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.852 -1.155 . . . . 0.0 107.983 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -64.19 -17.88 63.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.624 -0.672 . . . . 0.0 110.319 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -86.48 -8.41 57.61 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 108.607 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.554 ' CE2' ' HD3' ' A' ' 35' ' ' ARG . 5.0 m-85 -88.12 -39.85 14.24 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.765 0.793 . . . . 0.0 109.606 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.99 110.15 0.36 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.549 -0.719 . . . . 0.0 109.636 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.7 t30 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.485 179.916 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.842 ' CZ ' HD11 ' A' ' 52' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.236 0.541 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.753 HG22 ' N ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER 39.65 -96.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.272 -1.517 . . . . 0.0 110.792 176.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.753 ' N ' HG22 ' A' ' 2' ' ' VAL . 23.7 m-20 -139.06 -43.63 0.47 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.882 -1.136 . . . . 0.0 109.85 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.51 ' O ' ' O ' ' A' ' 3' ' ' ASN . 2.4 pt20 -18.28 143.55 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.56 ' N ' ' ND1' ' A' ' 5' ' ' HIS . 3.2 p-80 -46.21 141.98 3.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.592 -0.692 . . . . 0.0 110.284 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.69 HD22 ' CE1' ' A' ' 1' ' ' PHE . 0.7 OUTLIER -131.1 109.96 10.84 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.8 m -114.87 146.1 41.47 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.32 -0.862 . . . . 0.0 109.106 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.61 -175.57 54.84 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.9 p -56.05 -15.07 3.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.984 -1.304 . . . . 0.0 109.115 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -52.12 -24.16 6.53 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' A' ' 9' ' ' SER . 15.0 tp -81.83 -47.64 12.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.583 HG13 ' CE1' ' A' ' 24' ' ' PHE . 24.4 t -49.66 -46.66 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.53 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.8 tt0 -48.7 -59.97 3.11 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.484 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.721 ' HB1' ' CE2' ' A' ' 1' ' ' PHE . . . -44.45 -60.66 1.85 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.7 mt -45.81 -51.38 12.93 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -50.03 -50.95 45.88 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 27.0 mt -53.65 -62.33 1.72 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.179 0.99 . . . . 0.0 111.299 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -68.27 -40.71 83.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.662 -176.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.647 ' O ' ' NH2' ' A' ' 22' ' ' ARG . 95.4 m -78.31 -28.44 47.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.72 -1.238 . . . . 0.0 112.581 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.743 ' C ' HH22 ' A' ' 22' ' ' ARG . . . 86.89 -150.2 22.86 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.314 -1.422 . . . . 0.0 111.046 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 23' ' ' GLY . 30.6 tt0 -87.8 -18.72 28.72 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.63 -0.923 . . . . 0.0 113.338 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.747 ' NH1' ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -43.12 -15.07 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 O-C-N 120.798 -1.189 . . . . 0.0 110.932 -177.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.747 ' H ' ' NH1' ' A' ' 22' ' ' ARG . . . 85.8 93.43 0.83 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.703 ' N ' HH11 ' A' ' 22' ' ' ARG . 29.9 p90 -76.88 161.58 28.3 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.305 -1.115 . . . . 0.0 109.383 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.623 ' CB ' ' NH1' ' A' ' 35' ' ' ARG . 60.5 m-85 -89.9 132.69 35.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.303 -0.873 . . . . 0.0 110.631 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -173.16 -22.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.72 168.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.489 -0.757 . . . . 0.0 110.012 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -85.51 163.64 43.68 Favored Pre-proline 0 N--CA 1.485 1.316 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.829 ' O ' ' C ' ' A' ' 30' ' ' THR . 1.2 Cg_endo -48.24 -134.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 124.76 3.64 . . . . 0.0 113.099 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.829 ' C ' ' O ' ' A' ' 29' ' ' PRO . 69.2 p 9.95 -119.79 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.49 1.138 . . . . 0.0 108.278 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.743 ' C ' ' O ' ' A' ' 30' ' ' THR . 8.5 mt-10 3.07 90.11 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.215 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 46.58 -129.61 1.4 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.535 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -149.69 -173.16 19.9 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.169 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.754 ' HG3' HG21 ' A' ' 39' ' ' VAL . 72.5 Cg_endo -67.84 -126.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 124.163 3.242 . . . . 0.0 111.124 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.766 ' O ' ' O ' ' A' ' 36' ' ' ARG . 12.5 ttm180 -110.91 14.7 22.05 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.766 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 45.37 110.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.86 -67.32 0.36 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 116.138 -2.934 . . . . 0.0 107.745 -176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.612 HG23 ' N ' ' A' ' 39' ' ' VAL . 7.3 tt -67.78 -44.61 85.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.805 0.812 . . . . 0.0 109.348 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.754 HG21 ' HG3' ' A' ' 34' ' ' PRO . 44.4 t -65.53 -61.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.425 0.631 . . . . 0.0 111.078 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.56 ' OE2' ' HG3' ' A' ' 36' ' ' ARG . 3.0 mt-10 -51.7 -26.42 9.26 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.658 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 45' ' ' SER . 17.8 tt0 -93.96 -61.21 1.58 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.122 -0.986 . . . . 0.0 110.414 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 45' ' ' SER . 98.0 m -58.36 -37.0 74.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.139 -0.976 . . . . 0.0 110.652 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.19 -38.54 31.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.903 -1.123 . . . . 0.0 110.516 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -86.99 -17.31 33.34 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.838 -1.164 . . . . 0.0 109.249 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 41' ' ' GLN . 7.9 t -140.42 -164.89 1.81 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.432 -0.792 . . . . 0.0 109.071 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 47' ' ' CYS . 4.5 mm -76.46 167.4 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.082 -1.011 . . . . 0.0 109.328 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.589 ' N ' HG22 ' A' ' 46' ' ' ILE . 4.5 t -121.15 139.14 53.76 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.451 -0.781 . . . . 0.0 110.381 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -101.15 150.88 22.48 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.451 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.5 tp -82.34 -38.52 24.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.479 1.133 . . . . 0.0 108.038 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.53 -24.24 60.15 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 123.005 1.383 . . . . 0.0 108.199 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.76 HE21 HD21 ' A' ' 54' ' ' ASN . 6.5 tp60 -79.8 -24.62 41.29 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.033 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.842 HD11 ' CZ ' ' A' ' 1' ' ' PHE . 33.9 mt -85.3 -30.99 23.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.494 -1.379 . . . . 0.0 109.107 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -62.32 -20.81 64.73 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.682 -0.637 . . . . 0.0 111.549 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.76 HD21 HE21 ' A' ' 51' ' ' GLN . 15.6 p30 -88.53 -7.79 55.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.823 -1.173 . . . . 0.0 108.838 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.493 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 5.1 m-85 -83.72 -9.79 58.59 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.671 0.748 . . . . 0.0 109.465 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.429 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -91.42 115.82 28.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.569 -0.707 . . . . 0.0 109.351 -179.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.429 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 55.9 t-20 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.026 -1.046 . . . . 0.0 109.282 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.686 ' C ' ' CD1' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.728 0.299 . . . . 0.0 110.687 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 3' ' ' ASN . 14.0 p -66.02 163.62 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 119.967 -1.708 . . . . 0.0 108.708 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.506 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.1 m120 -49.04 98.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.04 -1.038 . . . . 0.0 109.531 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 2' ' ' VAL . 1.8 pt20 -159.03 -163.94 1.32 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.841 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -89.86 131.2 35.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.743 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.93 109.65 11.79 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.5 m -118.58 152.59 35.73 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.523 -0.736 . . . . 0.0 109.248 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.57 -163.24 54.34 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.456 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -66.47 -14.63 62.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.864 -1.374 . . . . 0.0 109.261 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' SER . 4.5 m-70 -51.18 -24.67 4.43 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.456 ' N ' ' C ' ' A' ' 9' ' ' SER . 14.1 tp -81.86 -46.67 13.8 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.636 HG13 ' CE1' ' A' ' 24' ' ' PHE . 18.7 t -50.15 -46.15 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.538 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 20.7 tt0 -49.16 -59.72 3.41 Favored 'General case' 0 C--N 1.289 -2.054 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.446 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.481 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.43 -60.67 1.84 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.2 mt -45.38 -53.68 8.3 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.554 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -47.75 -49.62 27.8 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 26.4 mt -56.01 -62.59 1.6 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.106 0.955 . . . . 0.0 111.304 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.9 OUTLIER -67.56 -48.12 77.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.643 -176.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.501 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 30.9 m -73.86 -26.48 60.59 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.868 -1.145 . . . . 0.0 112.787 -175.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.499 ' C ' ' HE ' ' A' ' 22' ' ' ARG . . . 85.15 -161.21 35.71 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 119.473 -2.017 . . . . 0.0 111.156 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 23' ' ' GLY . 11.8 mt-10 -86.85 -13.26 45.48 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -177.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.704 ' NE ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.66 0.1 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 O-C-N 119.513 -1.992 . . . . 0.0 110.712 -178.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.594 ' N ' ' CZ ' ' A' ' 22' ' ' ARG . . . 88.52 113.48 1.21 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.696 ' N ' HH12 ' A' ' 22' ' ' ARG . 26.9 p90 -98.45 141.83 30.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -1.024 . . . . 0.0 109.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.33 126.75 30.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.516 -0.74 . . . . 0.0 110.33 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 27' ' ' THR . 53.9 t80 -173.14 -22.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.595 -0.69 . . . . 0.0 109.164 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.917 HG21 ' OE2' ' A' ' 31' ' ' GLU . 56.6 m 49.29 -176.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.179 -0.951 . . . . 0.0 109.548 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.854 ' H ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -50.6 -171.91 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.338 -0.852 . . . . 0.0 108.94 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 28' ' ' ASP . 76.9 Cg_endo -92.36 -34.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.261 2.64 . . . . 0.0 108.913 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.99 HG23 ' N ' ' A' ' 31' ' ' GLU . 3.8 t -66.6 -92.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.68 1.228 . . . . 0.0 109.539 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.99 ' N ' HG23 ' A' ' 30' ' ' THR . 9.5 tp10 57.76 5.39 0.34 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.338 -1.476 . . . . 0.0 108.394 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.647 ' HG2' ' C ' ' A' ' 31' ' ' GLU . 2.6 pt-20 43.13 35.87 0.88 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.197 -0.939 . . . . 0.0 108.696 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.12 98.87 2.56 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 30.2 Cg_endo -87.38 -117.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 123.683 2.922 . . . . 0.0 112.439 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.628 ' O ' ' C ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -82.09 -13.91 56.59 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.212 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.709 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER 34.66 70.22 0.14 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.88 -83.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.409 0 CA-C-N 113.482 -1.69 . . . . 0.0 109.008 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.586 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.3 tt -55.31 -42.4 66.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.721 -0.87 . . . . 0.0 110.145 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.586 ' N ' HG23 ' A' ' 38' ' ' ILE . 42.2 t -63.93 -60.68 2.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.306 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.709 ' OE2' ' HD2' ' A' ' 36' ' ' ARG . 38.7 mt-10 -59.23 -20.11 51.33 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.215 -0.928 . . . . 0.0 109.872 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -94.58 -36.18 11.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.042 -1.037 . . . . 0.0 110.021 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' A' ' 45' ' ' SER . 92.2 m -88.46 -38.17 15.22 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.232 -0.917 . . . . 0.0 110.537 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.5 t -77.86 -44.92 25.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -0.996 . . . . 0.0 110.597 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -82.76 -20.35 36.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.992 -1.068 . . . . 0.0 109.822 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.8 m -140.38 -171.85 3.3 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.271 -0.893 . . . . 0.0 109.61 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 47' ' ' CYS . 6.5 mm -64.85 170.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 108.97 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.576 ' N ' HG22 ' A' ' 46' ' ' ILE . 8.3 t -128.19 122.51 32.02 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.459 -0.775 . . . . 0.0 110.157 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.5 m -79.75 146.72 32.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 108.728 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.1 tp -82.34 -40.5 21.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -57.15 -25.62 59.21 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.979 1.371 . . . . 0.0 108.147 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.477 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 7.0 tt0 -77.62 -24.12 49.66 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.933 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.3 mt -84.68 -29.48 25.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.777 -1.202 . . . . 0.0 108.487 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -64.6 -19.35 65.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.756 -0.59 . . . . 0.0 111.058 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -88.31 -7.24 57.05 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.027 -1.046 . . . . 0.0 109.188 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.477 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 5.1 m-85 -86.6 -6.72 58.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.579 -0.701 . . . . 0.0 111.147 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.87 113.86 20.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.148 -0.97 . . . . 0.0 110.314 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.4 t30 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.842 -179.932 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.62 ' O ' ' C ' ' A' ' 2' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.732 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.8 OUTLIER 32.23 -153.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 118.655 -2.528 . . . . 0.0 110.643 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.732 ' N ' HG13 ' A' ' 2' ' ' VAL . 1.6 m120 -101.74 93.95 5.59 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.053 -1.03 . . . . 0.0 109.551 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.524 ' NE2' HG12 ' A' ' 2' ' ' VAL . 16.4 pt20 -152.5 -178.81 7.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.217 -0.927 . . . . 0.0 109.26 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 5' ' ' HIS . 1.2 m-70 -75.54 133.2 41.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.999 -1.063 . . . . 0.0 109.378 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.95 120.01 24.14 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.7 m -127.18 -178.26 4.37 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.448 -0.782 . . . . 0.0 109.207 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.56 -149.05 2.29 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.439 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.4 p -77.97 -14.12 59.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.026 -1.279 . . . . 0.0 109.241 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -51.86 -24.07 5.69 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.439 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.7 tp -81.56 -51.14 8.56 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.618 HG13 ' CE1' ' A' ' 24' ' ' PHE . 24.6 t -45.44 -46.77 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.697 0.761 . . . . 0.0 108.988 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 35.8 tt0 -47.89 -59.81 3.06 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.378 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.05 -61.5 1.61 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.7 mt -45.66 -46.84 14.94 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.554 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.54 -48.73 71.66 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 24.7 mt -55.91 -62.8 1.46 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.156 0.979 . . . . 0.0 110.827 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -64.94 -31.93 56.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.221 -177.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.1 m -92.12 -7.38 48.68 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.999 -1.063 . . . . 0.0 110.096 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 47.4 -144.0 5.61 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 23' ' ' GLY . 14.3 tp10 -79.35 -19.29 50.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.594 -0.945 . . . . 0.0 109.996 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -42.58 -17.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.457 -0.777 . . . . 0.0 110.653 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 88.02 137.5 5.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CE1' HG13 ' A' ' 12' ' ' VAL . 34.1 p90 -131.33 144.95 51.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.69 -0.888 . . . . 0.0 109.473 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -87.89 127.55 35.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.327 -0.858 . . . . 0.0 109.646 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' ' 27' ' ' THR . 85.9 t80 -163.14 -48.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 108.961 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 28' ' ' ASP . 2.4 m 53.6 172.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.451 -0.781 . . . . 0.0 109.842 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.5 ' H ' HG22 ' A' ' 27' ' ' THR . 0.2 OUTLIER -82.82 171.04 12.65 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 31' ' ' GLU . 19.2 Cg_endo -52.12 -83.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.515 2.745 0 C-N-CA 123.699 2.932 . . . . 0.0 114.546 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.561 ' H ' ' HG2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER -43.65 4.09 0.0 OUTLIER 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 109.493 -3.503 . . . . 0.0 112.454 -176.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.921 ' O ' ' O ' ' A' ' 32' ' ' GLU . 1.1 tp10 -95.26 138.45 32.95 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 119.917 -1.74 . . . . 0.0 107.97 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.921 ' O ' ' O ' ' A' ' 31' ' ' GLU . 3.7 mp0 13.03 -140.93 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.396 -1.44 . . . . 0.0 109.161 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.41 ' HA2' ' HD2' ' A' ' 34' ' ' PRO . . . -121.66 97.95 0.63 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.41 ' HD2' ' HA2' ' A' ' 33' ' ' GLY . 39.4 Cg_endo -62.98 30.06 0.07 OUTLIER 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.906 3.07 . . . . 0.0 113.751 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.14 123.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.85 -1.156 . . . . 0.0 112.035 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.425 ' N ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -92.52 112.33 24.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.551 -0.718 . . . . 0.0 110.787 179.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.93 -48.49 0.06 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 39' ' ' VAL . 13.3 tt -82.21 -42.47 18.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.541 -0.976 . . . . 0.0 110.332 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.595 ' N ' HG23 ' A' ' 38' ' ' ILE . 54.1 t -69.42 -62.17 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 O-C-N 121.63 -0.669 . . . . 0.0 111.016 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -59.21 -22.01 60.39 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -94.31 -41.61 9.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.995 -1.065 . . . . 0.0 110.497 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 45' ' ' SER . 1.8 t -86.46 -29.73 22.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.867 -1.145 . . . . 0.0 110.737 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 51.8 t -81.58 -51.62 8.05 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.604 -1.31 . . . . 0.0 109.446 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -24.81 53.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.045 -1.034 . . . . 0.0 108.743 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' CYS . 5.1 m -140.52 -174.88 4.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.314 -0.866 . . . . 0.0 109.123 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.5 mt -90.64 148.92 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.233 -0.917 . . . . 0.0 109.216 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 20.6 p -128.88 167.39 17.45 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.378 -0.827 . . . . 0.0 109.775 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.82 165.3 13.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.303 -0.873 . . . . 0.0 110.79 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.68 -36.61 25.76 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.11 -25.27 61.15 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.862 1.315 . . . . 0.0 108.097 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.461 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 13.1 tt0 -77.8 -22.19 50.46 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.695 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.3 mt -84.5 -33.66 23.51 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.748 -1.22 . . . . 0.0 107.869 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -62.89 -18.72 63.38 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.554 -0.716 . . . . 0.0 110.162 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -84.84 -8.52 58.76 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -90.39 -37.33 14.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.695 -0.628 . . . . 0.0 109.643 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 m -49.8 110.94 0.44 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.507 -0.746 . . . . 0.0 109.718 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.1 t30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.464 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.63 ' HE2' HD11 ' A' ' 52' ' ' LEU . 1.9 t80 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 123.251 1.501 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.611 ' H ' HE21 ' A' ' 4' ' ' GLN . 6.1 p -90.23 84.55 2.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.335 -176.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 2' ' ' VAL . 1.1 m120 41.29 70.25 0.28 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.361 -0.837 . . . . 0.0 110.567 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.611 HE21 ' H ' ' A' ' 2' ' ' VAL . 14.0 pt20 -141.69 169.86 16.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.057 -1.027 . . . . 0.0 109.639 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -63.16 126.63 28.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.895 . . . . 0.0 110.482 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 1' ' ' PHE . 0.8 OUTLIER -129.89 123.75 31.52 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.3 m -130.77 179.47 5.95 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.344 -0.847 . . . . 0.0 108.929 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.51 -147.68 2.78 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.44 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -77.29 -14.38 59.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.026 -1.279 . . . . 0.0 109.328 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -52.53 -24.02 7.36 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.4 tp -81.29 -49.58 10.56 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.638 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.3 t -46.56 -45.73 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.514 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 14.8 tt0 -48.08 -60.03 2.93 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.244 -0.983 . . . . 0.0 109.476 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.526 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.0 -61.55 1.58 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 12.7 mt -45.65 -45.98 14.32 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.81 -51.52 67.19 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.0 mt -51.68 -62.38 1.66 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.113 0.959 . . . . 0.0 110.778 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -66.06 -36.7 78.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.23 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.8 m -87.09 -4.93 59.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.935 -1.103 . . . . 0.0 110.146 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 46.88 -146.75 3.47 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 23' ' ' GLY . 32.0 mt-10 -83.39 -0.11 48.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -1.176 . . . . 0.0 109.719 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -58.79 -0.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -0.895 . . . . 0.0 109.939 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 73.5 131.58 0.19 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.638 ' CE1' HG13 ' A' ' 12' ' ' VAL . 28.6 p90 -126.4 148.61 49.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.589 -0.947 . . . . 0.0 109.347 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -82.51 123.53 29.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.964 . . . . 0.0 110.042 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.47 ' CE2' ' O ' ' A' ' 27' ' ' THR . 36.4 t80 -172.27 160.44 5.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 109.21 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -154.73 -156.16 0.64 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.322 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.554 ' H ' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -91.86 172.17 6.82 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.603 ' O ' ' C ' ' A' ' 30' ' ' THR . 57.0 Cg_endo -68.66 -145.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 O-C-N 118.067 -1.596 . . . . 0.0 112.718 176.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.321 ' O ' ' N ' ' A' ' 32' ' ' GLU 0.255 36.8 m 14.14 -107.66 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.024 -1.443 . . . . 0.0 112.982 175.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.73 ' C ' ' O ' ' A' ' 30' ' ' THR . 18.9 mt-10 16.59 -56.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 123.622 1.677 . . . . 0.0 107.093 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 1.321 ' N ' ' O ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -156.16 -179.13 7.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.109 -2.314 . . . . 0.0 107.024 178.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.463 ' HA3' ' HD2' ' A' ' 36' ' ' ARG . . . -112.42 122.03 5.81 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.287 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.827 ' C ' ' H ' ' A' ' 36' ' ' ARG . 80.1 Cg_endo -75.08 81.26 2.26 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 124.217 3.278 . . . . 0.0 110.837 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.862 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 57.49 -10.65 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.827 ' H ' ' C ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER 30.12 21.35 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.973 -0.454 . . . . 0.0 110.327 -179.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.862 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -104.1 -36.57 3.12 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 107.779 -2.128 . . . . 0.0 107.779 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 39' ' ' VAL . 11.3 tt -81.83 -45.92 20.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.551 0.691 . . . . 0.0 110.344 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.618 ' N ' HG23 ' A' ' 38' ' ' ILE . 55.8 t -64.62 -61.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.78 -0.575 . . . . 0.0 111.726 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.52 -23.59 64.67 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.223 -0.923 . . . . 0.0 110.126 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.489 ' NE2' HE22 ' A' ' 51' ' ' GLN . 29.5 tt0 -94.33 -33.96 12.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.982 -1.074 . . . . 0.0 109.954 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 38' ' ' ILE . 51.0 t -88.51 -43.58 11.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.152 -0.967 . . . . 0.0 110.568 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.78 -24.22 62.55 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 110.73 -178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -104.82 -19.07 14.02 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.201 -0.937 . . . . 0.0 109.524 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -140.1 179.52 6.57 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.264 -0.898 . . . . 0.0 109.035 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.821 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.0 mm -64.62 -177.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.107 -0.996 . . . . 0.0 108.324 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.821 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -146.03 150.45 36.01 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.897 -1.127 . . . . 0.0 110.222 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -97.16 151.74 19.51 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -82.57 -40.46 20.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -57.67 -24.79 58.54 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 122.841 1.305 . . . . 0.0 107.943 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.489 HE22 ' NE2' ' A' ' 41' ' ' GLN . 7.7 tt0 -78.44 -23.03 46.78 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.802 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.63 HD11 ' HE2' ' A' ' 1' ' ' PHE . 46.1 mt -84.8 -36.89 21.36 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.69 -20.66 50.47 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.507 -0.746 . . . . 0.0 110.002 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -82.99 -8.94 59.51 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.7 m-85 -90.34 -36.72 14.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.551 -0.718 . . . . 0.0 109.316 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -51.51 110.49 0.46 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.376 -0.827 . . . . 0.0 109.565 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.6 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.505 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.851 ' CD1' ' O ' ' A' ' 1' ' ' PHE . 48.8 p90 . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 3' ' ' ASN . 9.1 p -55.27 167.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 116.145 -2.222 . . . . 0.0 108.976 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.585 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.6 m120 -52.78 105.77 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.002 -1.061 . . . . 0.0 109.952 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -164.49 -160.77 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.172 -0.955 . . . . 0.0 109.77 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -95.45 132.66 40.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.247 -0.908 . . . . 0.0 109.609 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.1 113.71 15.45 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.01 148.72 50.54 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.42 -169.99 53.05 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.412 ' C ' ' N ' ' A' ' 11' ' ' LEU . 4.3 p -60.95 -14.8 25.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.612 -1.523 . . . . 0.0 109.202 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -52.81 -25.74 12.33 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.501 HD13 ' SG ' ' A' ' 42' ' ' CYS . 13.0 tp -81.11 -47.9 12.88 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.618 HG13 ' CE1' ' A' ' 24' ' ' PHE . 27.2 t -48.08 -47.35 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.513 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.1 tt0 -47.51 -59.91 2.9 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.561 -176.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.627 ' HB1' ' CE2' ' A' ' 1' ' ' PHE . . . -45.23 -61.38 1.68 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.429 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 13.0 mt -45.76 -45.94 14.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.75 -52.46 63.86 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.7 mt -50.59 -62.32 1.67 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.079 0.942 . . . . 0.0 110.614 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -67.25 -31.92 55.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.036 -177.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 47.7 m -91.72 0.51 57.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.045 -1.034 . . . . 0.0 109.995 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 45.86 -158.7 0.29 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.32 -2.94 43.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -1.152 . . . . 0.0 109.354 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -46.62 -58.63 3.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.865 . . . . 0.0 109.487 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.58 131.18 2.71 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CE1' HG13 ' A' ' 12' ' ' VAL . 34.3 p90 -131.4 143.72 50.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.68 -0.894 . . . . 0.0 108.846 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -86.29 134.35 33.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.324 -0.86 . . . . 0.0 110.266 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' THR . 86.3 t80 -172.9 -24.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.44 -0.788 . . . . 0.0 109.399 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' TYR . 3.1 p 47.62 -175.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.734 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.84 ' O ' ' N ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -98.84 162.53 21.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.72 ' O ' HG22 ' A' ' 30' ' ' THR . 53.2 Cg_exo -42.51 32.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 124.212 3.275 . . . . 0.0 113.593 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.84 ' N ' ' O ' ' A' ' 28' ' ' ASP . 3.6 p -158.39 -101.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.708 -1.245 . . . . 0.0 111.437 -177.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.67 ' C ' ' O ' ' A' ' 30' ' ' THR . 14.5 mt-10 0.9 69.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.095 -1.003 . . . . 0.0 111.017 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.947 ' OE2' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER 62.49 -40.63 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.736 -1.227 . . . . 0.0 110.415 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 85.05 178.12 50.94 Favored Glycine 0 N--CA 1.503 3.113 0 O-C-N 119.824 -1.797 . . . . 0.0 109.23 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 94.3 Cg_endo -77.82 -148.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.893 3.062 . . . . 0.0 112.292 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.872 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -120.12 85.71 2.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.722 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -15.11 104.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.668 1.223 . . . . 0.0 109.368 -178.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.12 -54.25 0.02 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.584 HG23 ' N ' ' A' ' 39' ' ' VAL . 8.4 tt -81.9 -45.34 20.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.664 -0.904 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.584 ' N ' HG23 ' A' ' 38' ' ' ILE . 40.3 t -64.69 -62.24 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.625 -0.672 . . . . 0.0 111.962 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' CG ' ' HG3' ' A' ' 36' ' ' ARG . 25.3 mt-10 -47.77 -33.63 7.4 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 110.284 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 45' ' ' SER . 33.2 mt-30 -93.52 -59.54 1.99 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.003 -1.06 . . . . 0.0 109.415 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.501 ' SG ' HD13 ' A' ' 11' ' ' LEU . 17.6 t -52.8 -34.07 51.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.108 -0.995 . . . . 0.0 110.738 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.7 t -85.28 -53.03 5.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.863 -1.148 . . . . 0.0 110.831 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.446 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 2.3 m-70 -86.17 -5.06 59.27 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.966 -1.084 . . . . 0.0 110.511 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLN . 2.0 m -140.39 -177.82 5.21 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.054 -1.029 . . . . 0.0 109.362 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.0 mm -64.66 -178.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.173 -0.954 . . . . 0.0 108.524 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.804 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.3 t -134.91 130.46 35.93 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.162 -0.961 . . . . 0.0 110.543 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.7 m -95.03 145.97 24.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.5 tp -82.5 -40.33 21.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -56.41 -24.97 48.4 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 122.945 1.355 . . . . 0.0 108.147 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.472 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 9.3 tt0 -79.39 -22.83 43.79 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.142 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.542 HD12 ' CZ ' ' A' ' 1' ' ' PHE . 38.8 mt -85.46 -38.33 18.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.597 -1.314 . . . . 0.0 108.223 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.31 -20.17 26.82 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.487 -0.758 . . . . 0.0 110.368 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -83.87 -8.69 59.14 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.472 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 3.6 m-85 -90.55 -39.18 12.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.6 -0.688 . . . . 0.0 109.758 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.4 m -49.67 110.65 0.4 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.353 -0.842 . . . . 0.0 109.546 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.6 t30 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.509 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.828 ' CD2' HD12 ' A' ' 17' ' ' LEU . 33.3 p90 . . . . . 0 CA--C 1.56 1.364 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.507 HG12 ' ND2' ' A' ' 3' ' ' ASN . 60.1 t 42.55 -99.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.409 -1.432 . . . . 0.0 109.23 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.519 ' O ' ' O ' ' A' ' 4' ' ' GLN . 1.9 m-20 -147.46 -30.77 0.32 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.07 -1.019 . . . . 0.0 109.89 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.519 ' O ' ' O ' ' A' ' 3' ' ' ASN . 4.3 pt20 -25.44 152.92 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.959 0.885 . . . . 0.0 112.98 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -45.77 136.07 6.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.327 -0.858 . . . . 0.0 109.603 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 1' ' ' PHE . 1.1 tp -134.38 109.38 8.75 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' GLY . 59.5 m -106.64 -176.39 3.06 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.153 -0.967 . . . . 0.0 109.685 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 7' ' ' CYS . . . 43.26 -164.43 0.03 OUTLIER Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.467 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.0 p -69.0 -8.65 46.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.985 -1.303 . . . . 0.0 109.23 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -53.33 -22.84 7.95 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.467 ' N ' ' C ' ' A' ' 9' ' ' SER . 9.0 tp -78.99 -52.33 8.39 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.628 HG13 ' CE1' ' A' ' 24' ' ' PHE . 4.4 t -48.11 -40.72 9.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.528 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.2 tt0 -48.36 -59.39 3.49 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 118.73 -1.188 . . . . 0.0 108.534 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.49 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.45 -61.28 1.74 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.794 HD13 ' CE2' ' A' ' 26' ' ' TYR . 6.6 mt -45.74 -49.17 15.06 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.553 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -50.45 -48.71 56.38 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.828 HD12 ' CD2' ' A' ' 1' ' ' PHE . 19.2 mt -56.96 -63.87 1.06 Allowed 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.962 0.887 . . . . 0.0 110.464 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.4 m -64.12 -51.46 68.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.601 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' LEU . 78.6 m -72.88 -1.57 17.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.028 -1.045 . . . . 0.0 109.346 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 40.2 -142.74 0.63 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.36 -6.89 59.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.608 -0.937 . . . . 0.0 109.793 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 22' ' ' ARG . 44.0 mtp85 -42.48 -59.11 1.98 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.844 -0.535 . . . . 0.0 109.767 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.4 102.85 0.81 Allowed Glycine 0 N--CA 1.498 2.816 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.628 ' CE1' HG13 ' A' ' 12' ' ' VAL . 35.6 p90 -103.68 -170.48 1.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 63.4 t80 -154.33 120.58 5.37 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 119.638 -1.914 . . . . 0.0 112.9 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.794 ' CE2' HD13 ' A' ' 15' ' ' LEU . 32.4 m-85 -150.25 92.8 1.91 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -54.3 -171.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 -179.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.578 ' N ' ' OG1' ' A' ' 27' ' ' THR . 0.1 OUTLIER -85.58 168.34 20.42 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HB2' ' H ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -54.26 -125.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.196 0 C-N-CA 123.829 3.019 . . . . 0.0 113.724 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.05 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER 27.91 -132.17 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.042 0 O-C-N 121.329 -0.857 . . . . 0.0 110.808 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 1.135 ' O ' ' N ' ' A' ' 33' ' ' GLY . 2.7 mt-10 -12.62 168.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.147 0.498 . . . . 0.0 111.204 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.669 ' C ' ' O ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -17.69 58.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.563 0.697 . . . . 0.0 109.938 178.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 1.135 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 10.37 -138.48 0.0 OUTLIER Glycine 0 N--CA 1.499 2.897 0 CA-C-O 122.14 0.856 . . . . 0.0 112.892 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.587 ' HG2' ' H ' ' A' ' 35' ' ' ARG . 69.5 Cg_endo -80.22 -89.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 123.538 2.826 . . . . 0.0 113.183 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.79 ' O ' ' CB ' ' A' ' 36' ' ' ARG . 62.8 ttt180 -127.56 -46.74 1.44 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.347 -0.846 . . . . 0.0 108.929 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.79 ' CB ' ' O ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER 101.4 73.31 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.803 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.06 -79.32 0.14 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.61 HG23 ' N ' ' A' ' 39' ' ' VAL . 5.0 tt -56.04 -44.05 77.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.816 -0.814 . . . . 0.0 109.491 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.61 ' N ' HG23 ' A' ' 38' ' ' ILE . 46.6 t -65.29 -61.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.622 -0.674 . . . . 0.0 110.39 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.513 ' OE2' ' HG3' ' A' ' 36' ' ' ARG . 2.4 mt-10 -57.56 -18.47 19.65 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.141 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 45' ' ' SER . 44.8 tt0 -94.08 -51.92 4.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.224 -0.922 . . . . 0.0 110.755 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -75.69 -54.06 7.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.745 -1.222 . . . . 0.0 110.091 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 48.6 t -52.73 -23.45 6.77 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.025 -1.047 . . . . 0.0 110.406 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -111.82 -29.13 7.79 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.062 -1.024 . . . . 0.0 110.122 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -132.83 -163.96 1.41 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.365 -0.834 . . . . 0.0 109.232 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.5 mm -106.46 159.64 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.269 -0.894 . . . . 0.0 109.233 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 m -145.61 168.82 19.74 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.951 -1.093 . . . . 0.0 109.943 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.43 165.76 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.908 0.861 . . . . 0.0 110.182 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.783 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -82.59 -33.33 28.03 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.29 -25.88 68.1 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.794 1.283 . . . . 0.0 108.177 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.528 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 8.5 tt0 -73.11 -23.07 60.46 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.33 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.9 mt -84.62 -28.98 26.13 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -67.59 -18.19 64.9 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.602 -0.686 . . . . 0.0 110.856 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 13.7 p30 -88.19 -8.84 54.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.818 -1.176 . . . . 0.0 108.368 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.604 ' CE2' ' NH2' ' A' ' 35' ' ' ARG . 6.4 m-85 -82.88 -38.12 23.37 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.576 0.703 . . . . 0.0 109.318 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 m -49.81 110.5 0.39 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.741 -0.599 . . . . 0.0 109.816 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.551 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.885 ' CG ' ' O ' ' A' ' 1' ' ' PHE . 1.6 p90 . . . . . 0 C--O 1.195 -1.784 0 CA-C-O 122.333 1.063 . . . . 0.0 108.613 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.715 ' H ' HE21 ' A' ' 4' ' ' GLN . 3.9 t -92.56 50.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.294 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.989 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 4' ' ' GLN . 0.6 OUTLIER 69.86 -33.95 0.27 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.389 -0.819 . . . . 0.0 109.57 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.715 HE21 ' H ' ' A' ' 2' ' ' VAL . 8.5 pt20 -28.81 157.99 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.921 0.867 . . . . 0.0 112.338 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -44.35 125.71 4.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.382 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -130.75 109.2 10.43 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.6 m -114.91 -176.49 2.91 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.433 -0.792 . . . . 0.0 109.403 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.79 -152.95 0.85 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.47 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.1 p -79.16 -9.24 59.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.895 -1.356 . . . . 0.0 108.888 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 9' ' ' SER . 14.9 m-70 -52.0 -24.39 6.53 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.47 ' N ' ' C ' ' A' ' 9' ' ' SER . 8.7 tp -78.22 -54.02 6.69 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.616 HG13 ' CE1' ' A' ' 24' ' ' PHE . 4.7 t -46.4 -41.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.525 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 19.4 tt0 -47.24 -58.94 3.54 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.939 -1.104 . . . . 0.0 108.385 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.486 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.53 -61.4 1.7 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.794 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.6 mt -46.01 -48.01 16.73 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -51.75 -49.01 63.43 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 19.5 mt -56.58 -63.64 1.13 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.002 0.906 . . . . 0.0 110.651 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -64.7 -48.27 85.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.761 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' LEU . 60.9 m -73.26 -15.24 61.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.045 -1.034 . . . . 0.0 109.852 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 43.01 -133.09 5.17 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -83.75 -9.7 58.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -1.044 . . . . 0.0 110.016 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -47.12 -25.53 0.89 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 109.613 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.7 117.95 2.26 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.273 -0.965 . . . . 0.0 110.73 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.616 ' CE1' HG13 ' A' ' 12' ' ' VAL . 32.8 p90 -122.06 -178.91 3.98 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.509 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 64.3 m-85 -150.72 125.92 9.98 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 119.552 -1.968 . . . . 0.0 112.783 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.794 ' CE2' HD13 ' A' ' 15' ' ' LEU . 29.7 m-85 -151.47 114.78 4.8 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -57.35 -163.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.068 -1.02 . . . . 0.0 108.8 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.718 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -49.17 -178.54 0.02 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 108.625 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.718 ' HD2' ' CG ' ' A' ' 28' ' ' ASP . 29.5 Cg_endo -66.85 -114.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.676 2.251 . . . . 0.0 111.235 177.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.036 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -61.65 -15.12 37.04 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.504 -0.747 . . . . 0.0 111.844 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 1.036 ' O ' ' O ' ' A' ' 30' ' ' THR . 1.2 pp20? -6.78 -146.78 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 122.157 0.98 . . . . 0.0 112.541 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.466 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -71.08 -125.01 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.251 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 32' ' ' GLU . . . -100.48 135.54 12.2 Favored Glycine 0 N--CA 1.504 3.23 0 C-N-CA 119.681 -1.247 . . . . 0.0 111.649 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.937 ' O ' ' HG2' ' A' ' 36' ' ' ARG . 18.5 Cg_endo -94.97 173.42 1.28 Allowed 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 124.872 3.714 . . . . 0.0 112.446 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.752 ' O ' ' O ' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -54.03 -5.11 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.937 ' HG2' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 48.82 164.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.54 -77.53 0.43 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 118.797 -1.668 . . . . 0.0 109.553 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 39' ' ' VAL . 8.8 tt -65.34 -45.99 91.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.403 -1.057 . . . . 0.0 111.188 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.634 ' N ' HG23 ' A' ' 38' ' ' ILE . 55.7 t -65.88 -61.03 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.72 -0.612 . . . . 0.0 110.946 -177.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 40' ' ' GLU . 14.7 mt-10 -57.23 -22.42 40.95 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 109.228 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.689 ' NE2' HE22 ' A' ' 51' ' ' GLN . 26.2 tt0 -94.22 -32.79 13.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.16 -0.963 . . . . 0.0 109.569 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 38' ' ' ILE . 99.7 m -89.7 -47.75 7.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.034 -1.041 . . . . 0.0 109.992 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' VAL . 44.9 t -66.89 -52.52 42.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 110.855 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -85.89 -18.04 33.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.923 -1.111 . . . . 0.0 110.47 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 42' ' ' CYS . 13.1 m -140.59 179.84 6.45 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.078 -1.013 . . . . 0.0 109.613 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 mm -95.92 139.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.317 -0.864 . . . . 0.0 108.802 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.65 168.22 14.03 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.309 -0.87 . . . . 0.0 109.978 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.1 166.89 14.1 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.071 0.939 . . . . 0.0 111.044 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -82.93 -36.88 24.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -57.98 -25.37 60.95 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 122.898 1.332 . . . . 0.0 108.172 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.689 HE22 ' NE2' ' A' ' 41' ' ' GLN . 6.9 tt0 -76.28 -21.82 55.82 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.559 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.3 mt -84.49 -35.46 22.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.856 -1.153 . . . . 0.0 107.941 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -62.29 -18.29 60.91 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.63 -0.669 . . . . 0.0 110.148 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 2.3 m-20 -85.43 -8.67 58.28 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.485 ' HE2' ' HD2' ' A' ' 35' ' ' ARG . 4.6 m-85 -89.23 -40.67 12.69 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.818 0.818 . . . . 0.0 109.316 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.5 m -49.77 110.28 0.37 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.739 -0.601 . . . . 0.0 109.993 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.0 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.491 179.699 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 1.083 ' CZ ' HD13 ' A' ' 17' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.65 76.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.538 -0.726 . . . . 0.0 109.132 167.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 4' ' ' GLN . 3.8 m120 53.63 -102.06 0.13 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.219 -0.925 . . . . 0.0 109.37 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ASN . 14.6 pt20 37.8 -162.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.541 0.686 . . . . 0.0 111.392 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.568 ' O ' HD12 ' A' ' 6' ' ' LEU . 6.4 p80 -93.19 137.12 32.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.351 -0.843 . . . . 0.0 109.639 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 5' ' ' HIS . 1.3 mp -133.72 109.63 9.28 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 m -118.78 -176.95 3.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.501 -0.749 . . . . 0.0 109.186 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.67 -145.97 3.66 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.2 p -81.66 -12.89 58.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.061 -1.258 . . . . 0.0 109.471 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -51.22 -24.54 4.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.2 tp -81.83 -49.86 9.88 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.657 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.1 t -46.84 -48.3 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.6 tt0 -47.42 -59.7 3.04 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.528 -176.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.89 -61.65 1.53 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ALA . 14.6 mt -45.77 -45.46 14.65 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.554 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.12 -49.44 73.89 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.083 HD13 ' CZ ' ' A' ' 1' ' ' PHE . 27.5 mt -54.85 -62.85 1.39 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.101 0.953 . . . . 0.0 110.909 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -64.23 -37.69 80.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.943 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 42.5 t -80.25 -22.41 41.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.977 -1.077 . . . . 0.0 110.039 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 68.87 -146.73 45.4 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.6 tt0 -83.16 -15.26 51.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.333 -1.098 . . . . 0.0 109.656 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -47.45 -9.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.665 -0.647 . . . . 0.0 110.529 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 78.6 131.42 0.68 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.657 ' CE1' HG13 ' A' ' 12' ' ' VAL . 23.0 p90 -116.91 157.0 26.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.642 -0.916 . . . . 0.0 109.925 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -85.52 122.1 29.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.388 -0.82 . . . . 0.0 110.113 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.4 ' CD2' HG22 ' A' ' 12' ' ' VAL . 39.2 t80 -170.42 71.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.841 . . . . 0.0 108.911 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.607 HG21 ' HB3' ' A' ' 31' ' ' GLU . 1.3 m -47.65 171.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.74 . . . . 0.0 109.717 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -75.9 168.94 23.32 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.942 ' O ' HG23 ' A' ' 30' ' ' THR . 57.1 Cg_endo -71.76 90.18 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.635 2.223 . . . . 0.0 111.439 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.942 HG23 ' O ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER 145.65 -55.67 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.452 0.644 . . . . 0.0 109.898 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.607 ' HB3' HG21 ' A' ' 27' ' ' THR . 0.1 OUTLIER -35.44 78.3 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.185 -178.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.822 ' N ' ' O ' ' A' ' 30' ' ' THR . 2.6 mt-10 51.47 19.21 0.78 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.52 ' N ' ' C ' ' A' ' 31' ' ' GLU . . . 58.73 176.3 0.71 Allowed Glycine 0 N--CA 1.479 1.555 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' HG2' ' H ' ' A' ' 36' ' ' ARG . 40.0 Cg_endo -83.25 -97.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 123.49 2.794 . . . . 0.0 109.828 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.794 ' O ' ' O ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -158.0 9.27 0.16 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.985 -1.072 . . . . 0.0 108.233 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.794 ' O ' ' O ' ' A' ' 35' ' ' ARG . 1.2 mpt_? 43.81 133.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.429 1.109 . . . . 0.0 108.434 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.16 -63.77 0.36 Allowed Glycine 0 C--N 1.275 -2.826 0 C-N-CA 117.493 -2.289 . . . . 0.0 108.402 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 39' ' ' VAL . 8.1 tt -80.61 -41.12 19.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.618 -0.93 . . . . 0.0 109.712 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.605 ' N ' HG23 ' A' ' 38' ' ' ILE . 55.0 t -70.75 -61.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.317 0.58 . . . . 0.0 110.876 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -59.15 -18.9 40.21 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.3 -0.875 . . . . 0.0 110.01 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.485 ' NE2' HE22 ' A' ' 51' ' ' GLN . 13.3 tt0 -94.29 -43.59 8.35 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.047 -1.033 . . . . 0.0 110.439 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 45' ' ' SER . 1.8 t -88.1 -31.46 19.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.89 -1.131 . . . . 0.0 110.82 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.6 t -76.91 -48.97 16.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.815 -1.178 . . . . 0.0 109.841 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -83.15 -22.94 33.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.063 -1.023 . . . . 0.0 109.47 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 42' ' ' CYS . 4.5 m -140.14 -170.04 2.88 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.374 -0.829 . . . . 0.0 108.917 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 47' ' ' CYS . 4.0 mm -89.01 168.32 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.032 -1.043 . . . . 0.0 108.831 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.481 ' N ' HG22 ' A' ' 46' ' ' ILE . 19.7 p -150.7 167.27 27.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.138 -0.976 . . . . 0.0 109.728 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.18 164.94 12.28 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 122.047 0.927 . . . . 0.0 111.153 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.53 -36.94 25.89 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.82 -25.95 61.34 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.843 1.306 . . . . 0.0 108.282 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.485 HE22 ' NE2' ' A' ' 41' ' ' GLN . 6.5 tt0 -76.72 -22.08 54.39 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.577 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 mt -84.82 -33.39 22.92 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.941 -1.099 . . . . 0.0 108.036 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -62.81 -18.78 63.3 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 110.34 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -84.51 -8.72 58.84 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.55 ' CE2' ' NH1' ' A' ' 35' ' ' ARG . 3.7 m-85 -90.11 -27.59 19.54 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.62 -0.675 . . . . 0.0 109.648 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.9 t -66.97 112.04 4.13 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.845 0.831 . . . . 0.0 109.793 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 . . . . . 0 C--N 1.291 -1.972 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.429 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.781 ' HB2' HD21 ' A' ' 6' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.896 0.855 . . . . 0.0 108.758 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 3' ' ' ASN . 4.0 p -55.97 -20.31 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -177.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 2' ' ' VAL . 13.4 m-20 154.82 71.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -151.04 170.72 18.69 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.673 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 5.2 p80 -61.2 136.59 58.11 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.012 -1.055 . . . . 0.0 109.252 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.781 HD21 ' HB2' ' A' ' 1' ' ' PHE . 1.0 OUTLIER -134.07 110.06 9.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.39 -0.819 . . . . 0.0 108.883 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.5 m -122.61 -176.89 3.49 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 47.2 -149.54 2.6 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.433 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.2 p -79.49 -12.75 59.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.912 -1.346 . . . . 0.0 109.291 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -52.39 -24.04 7.05 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.477 ' HA ' HD23 ' A' ' 6' ' ' LEU . 9.5 tp -80.59 -52.43 7.6 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.686 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.6 t -44.13 -47.66 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.626 0.727 . . . . 0.0 109.225 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 28.3 tt0 -46.62 -59.52 2.96 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.471 -176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.15 -61.81 1.5 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.8 mt -45.97 -43.96 14.53 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.558 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -57.58 -50.45 73.08 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 29.6 mt -52.68 -62.68 1.49 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.211 1.005 . . . . 0.0 110.789 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -65.14 -42.36 94.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.432 -177.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.0 t -75.15 -22.45 58.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.779 -1.201 . . . . 0.0 110.118 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 69.33 -151.57 51.12 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 23' ' ' GLY . 22.5 mt-10 -83.24 0.53 45.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -1.209 . . . . 0.0 109.694 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -62.42 1.36 0.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.173 -0.954 . . . . 0.0 109.988 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 68.65 121.05 0.03 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.686 ' CE1' HG13 ' A' ' 12' ' ' VAL . 16.1 p90 -105.34 170.25 7.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.569 -0.959 . . . . 0.0 109.58 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -98.54 123.67 42.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.33 -0.856 . . . . 0.0 110.135 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' THR . 49.5 t80 -172.45 86.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.503 -0.748 . . . . 0.0 109.141 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -53.12 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.294 -0.879 . . . . 0.0 109.296 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.527 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -83.62 177.18 3.15 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 28' ' ' ASP . 51.0 Cg_endo -60.12 -6.06 4.62 Favored 'Trans proline' 0 N--CA 1.525 3.355 0 C-N-CA 124.267 3.311 . . . . 0.0 116.523 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.106 ' O ' ' O ' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -121.84 -168.63 1.73 Allowed 'General case' 0 C--N 1.284 -2.267 0 O-C-N 120.051 -1.656 . . . . 0.0 111.36 -178.354 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 1.106 ' O ' ' O ' ' A' ' 30' ' ' THR . 0.3 OUTLIER 33.12 134.64 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 1.17 ' O ' ' O ' ' A' ' 33' ' ' GLY . 25.0 mp0 13.01 48.92 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.35 -0.844 . . . . 0.0 111.243 -177.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 1.17 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -25.49 -139.16 0.0 OUTLIER Glycine 0 N--CA 1.506 3.365 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.997 ' HG2' HG21 ' A' ' 39' ' ' VAL . 32.5 Cg_exo -61.94 148.25 93.51 Favored 'Trans proline' 0 N--CA 1.51 2.453 0 C-N-CA 122.698 2.265 . . . . 0.0 112.282 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.857 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -55.63 7.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 119.544 -1.973 . . . . 0.0 108.355 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.857 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 75.9 92.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.732 -1.23 . . . . 0.0 110.351 -179.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.19 -53.86 0.21 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 117.005 -2.522 . . . . 0.0 109.371 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 39' ' ' VAL . 7.1 tt -75.58 -42.16 41.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.705 -0.88 . . . . 0.0 110.487 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.997 HG21 ' HG2' ' A' ' 34' ' ' PRO . 49.0 t -65.75 -60.62 2.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.268 0.556 . . . . 0.0 111.029 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 40' ' ' GLU . 12.3 mt-10 -58.5 -21.34 51.63 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.671 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.525 ' NE2' ' OE1' ' A' ' 51' ' ' GLN . 8.8 tt0 -94.08 -36.32 12.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.237 -0.914 . . . . 0.0 109.85 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.419 ' O ' ' O ' ' A' ' 45' ' ' SER . 96.6 m -88.35 -50.42 6.34 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.112 -0.993 . . . . 0.0 109.96 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.3 t -62.51 -50.43 71.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.292 -0.88 . . . . 0.0 110.882 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -83.84 -26.24 29.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.86 -1.15 . . . . 0.0 110.752 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 41' ' ' GLN . 37.2 m -140.6 -179.43 6.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.969 -1.082 . . . . 0.0 110.249 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mm -84.55 157.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 p -143.16 167.22 22.62 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.893 -1.13 . . . . 0.0 109.474 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.28 161.86 21.33 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.078 0.942 . . . . 0.0 110.682 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.7 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -83.04 -35.14 26.0 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -59.62 -25.95 65.08 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.674 1.226 . . . . 0.0 108.203 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.531 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 6.8 tt0 -74.45 -23.33 58.89 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.41 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 1' ' ' PHE . 66.9 mt -84.64 -27.41 27.16 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.039 -1.038 . . . . 0.0 108.303 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -68.08 -18.65 64.73 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.564 -0.71 . . . . 0.0 110.887 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 15.7 p30 -87.27 -9.03 56.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.499 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 5.0 m-85 -84.32 -32.26 24.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.8 t -60.88 112.28 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.873 0.844 . . . . 0.0 109.932 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 t30 . . . . . 0 C--N 1.292 -1.902 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.533 179.866 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.521 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 2.6 p90 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 1' ' ' PHE . 87.7 t -158.71 87.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 O-C-N 120.532 -1.355 . . . . 0.0 109.252 -171.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.515 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.2 m120 42.49 51.1 4.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.639 -0.663 . . . . 0.0 110.069 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -128.79 165.05 21.7 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.484 -0.76 . . . . 0.0 109.812 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.459 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 31.8 p80 -60.05 130.07 44.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.38 -0.825 . . . . 0.0 110.35 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 11' ' ' LEU . 1.2 tp -135.12 118.92 17.22 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.0 t -123.28 -176.82 3.53 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.459 -0.776 . . . . 0.0 109.408 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.23 -152.82 0.69 Allowed Glycine 0 N--CA 1.499 2.898 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.453 ' C ' ' N ' ' A' ' 11' ' ' LEU . 2.0 p -77.93 -10.18 59.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.73 -1.453 . . . . 0.0 108.734 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 9' ' ' SER . 68.7 m80 -53.01 -22.96 6.4 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.592 ' HA ' HD23 ' A' ' 6' ' ' LEU . 9.4 tp -79.82 -50.99 9.71 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG13 ' CE1' ' A' ' 24' ' ' PHE . 4.0 t -47.36 -40.06 6.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 18.0 tt0 -48.68 -59.36 3.6 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.661 -177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.494 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.53 -60.64 2.07 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.751 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.3 mt -46.37 -47.54 18.69 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.55 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -52.49 -48.34 66.0 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 20.1 mt -56.8 -63.34 1.24 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 122.01 0.909 . . . . 0.0 110.542 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -65.56 -46.16 90.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.014 -177.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 15' ' ' LEU . 58.6 m -72.97 -22.51 60.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.96 -1.088 . . . . 0.0 109.596 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 39.67 -120.92 1.4 Allowed Glycine 0 N--CA 1.496 2.662 0 O-C-N 121.284 -0.885 . . . . 0.0 111.131 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -81.67 -20.75 38.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.547 -0.972 . . . . 0.0 110.001 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -46.26 -34.04 4.15 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.343 -0.848 . . . . 0.0 109.402 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.36 137.04 8.53 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.644 ' CE1' HG13 ' A' ' 12' ' ' VAL . 28.1 p90 -140.99 174.83 10.13 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 25' ' ' PHE . 7.2 p90 -154.37 125.92 7.51 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.69 -1.881 . . . . 0.0 112.439 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.751 ' CE2' HD13 ' A' ' 15' ' ' LEU . 18.7 m-85 -139.38 3.26 2.12 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 26' ' ' TYR . 1.8 p 45.88 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.807 0.813 . . . . 0.0 110.28 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.518 ' O ' ' C ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -69.02 167.53 20.03 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.518 ' C ' ' O ' ' A' ' 28' ' ' ASP . 2.5 Cg_endo -33.89 -45.06 0.37 Allowed 'Trans proline' 0 C--N 1.278 -3.148 0 C-N-CA 121.706 1.604 . . . . 0.0 111.604 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.821 ' OG1' ' N ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -114.82 -144.88 0.39 Allowed 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.527 0.679 . . . . 0.0 109.656 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 1.071 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 5.3 mt-10 72.99 65.94 0.11 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.113 -0.992 . . . . 0.0 112.334 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 1.071 ' HB2' ' O ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER 103.21 -57.17 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.232 0 O-C-N 120.789 -1.194 . . . . 0.0 112.553 177.458 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.649 ' C ' ' H ' ' A' ' 35' ' ' ARG . . . 152.85 122.73 0.94 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 117.435 -2.317 . . . . 0.0 113.22 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.536 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 5.4 Cg_exo -56.91 11.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.92 2.413 . . . . 0.0 111.376 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.823 ' NH2' ' CE2' ' A' ' 55' ' ' TYR . 9.1 ttt-85 84.88 -16.57 0.49 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.487 HH21 ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER 53.07 -173.79 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.095 -1.003 . . . . 0.0 110.671 179.087 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.49 -81.45 0.08 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 39' ' ' VAL . 4.5 tt -52.0 -40.36 28.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.856 -0.791 . . . . 0.0 110.757 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.52 ' N ' HG23 ' A' ' 38' ' ' ILE . 40.3 t -71.63 -61.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.724 -0.61 . . . . 0.0 110.565 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -55.7 -23.47 28.92 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.369 -0.832 . . . . 0.0 109.135 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -94.53 -34.45 12.67 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.277 -0.889 . . . . 0.0 109.852 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 38' ' ' ILE . 42.0 t -88.35 -46.29 9.3 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.052 -1.03 . . . . 0.0 110.233 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.8 t -63.59 -34.24 77.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 110.643 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -103.34 -15.4 15.95 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.167 -0.958 . . . . 0.0 110.28 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER -140.07 -179.14 5.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.109 -0.994 . . . . 0.0 109.19 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.803 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.3 mm -66.2 -179.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 0.0 109.305 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.803 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -146.93 134.49 20.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.042 -1.037 . . . . 0.0 109.365 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 m -87.68 155.27 20.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.438 -0.789 . . . . 0.0 109.182 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.4 tp -82.83 -39.83 21.16 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -57.95 -23.34 53.24 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 123.179 1.466 . . . . 0.0 107.826 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.506 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 10.5 tp-100 -80.69 -23.28 39.67 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.109 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.05 -38.52 19.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.399 -1.438 . . . . 0.0 108.213 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -58.24 -19.61 35.39 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.646 -0.659 . . . . 0.0 110.293 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -85.15 -8.57 58.55 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 108.634 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.823 ' CE2' ' NH2' ' A' ' 35' ' ' ARG . 4.4 m-85 -90.54 -40.29 12.05 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.937 0.875 . . . . 0.0 109.212 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.2 m -49.74 110.67 0.41 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.259 0.552 . . . . 0.0 110.03 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.55 179.829 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 1.067 ' CE1' ' HA ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 122.304 1.05 . . . . 0.0 110.072 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 2' ' ' VAL . 10.5 m -73.37 55.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 120.778 -1.201 . . . . 0.0 109.114 175.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 1.067 ' HA ' ' CE1' ' A' ' 1' ' ' PHE . 0.8 OUTLIER 67.42 -88.4 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.365 -0.834 . . . . 0.0 109.096 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 3' ' ' ASN . 28.4 pt20 31.46 -151.83 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.463 -0.773 . . . . 0.0 111.787 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.582 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 7.6 p80 -98.92 132.59 44.14 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.367 -0.833 . . . . 0.0 109.236 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 1' ' ' PHE . 1.4 mp -133.81 111.12 10.26 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.6 m -123.36 -177.57 3.74 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.84 -148.19 5.0 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.432 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -80.31 -13.38 59.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.947 -1.325 . . . . 0.0 109.425 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -52.01 -24.45 6.65 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.432 ' N ' ' C ' ' A' ' 9' ' ' SER . 12.0 tp -81.67 -49.01 10.98 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.65 HG13 ' CE1' ' A' ' 24' ' ' PHE . 20.9 t -47.41 -46.61 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.522 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 27.5 tt0 -47.9 -59.76 3.1 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.499 -176.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.06 -61.49 1.61 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.4 mt -45.61 -46.8 14.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.555 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.83 -50.18 69.24 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 27.9 mt -53.75 -62.69 1.49 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 122.111 0.958 . . . . 0.0 110.727 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.1 m -65.38 -31.83 55.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.006 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.6 m -93.11 -0.52 56.99 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.08 -1.013 . . . . 0.0 109.936 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 47.9 -148.79 3.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.6 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 2.0 mp0 -83.21 -15.18 51.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.357 -1.084 . . . . 0.0 109.328 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -42.73 -18.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.8 -0.562 . . . . 0.0 110.568 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 92.74 138.19 8.46 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.65 ' CE1' HG13 ' A' ' 12' ' ' VAL . 21.6 p90 -129.82 155.84 45.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.591 -0.946 . . . . 0.0 109.71 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' HD1' ' HE ' ' A' ' 35' ' ' ARG . 48.1 t80 -84.51 124.05 30.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 0.0 110.193 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 27' ' ' THR . 44.4 t80 -172.47 77.97 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 109.324 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -52.33 -176.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.08 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 27' ' ' THR . 0.4 OUTLIER -82.51 154.52 68.75 Favored Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 121.133 -0.979 . . . . 0.0 108.606 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.899 ' O ' HG23 ' A' ' 30' ' ' THR . 59.2 Cg_endo -75.07 57.42 4.61 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.307 2.671 . . . . 0.0 111.766 -175.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.899 HG23 ' O ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -162.6 -61.7 0.04 OUTLIER 'General case' 0 C--N 1.262 -3.234 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.786 ' O ' ' N ' ' A' ' 33' ' ' GLY . 4.9 mm-40 -54.98 122.53 11.09 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 117.778 -1.569 . . . . 0.0 108.703 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 1.1 pt-20 39.67 7.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.43 -0.794 . . . . 0.0 110.531 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.786 ' N ' ' O ' ' A' ' 31' ' ' GLU . . . 82.86 168.06 42.12 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 118.356 -1.878 . . . . 0.0 109.246 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.97 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 28.5 Cg_endo -63.84 -28.41 67.58 Favored 'Trans proline' 0 C--N 1.285 -2.781 0 C-N-CA 122.804 2.336 . . . . 0.0 117.421 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.97 ' HB2' ' O ' ' A' ' 34' ' ' PRO . 9.2 ttt-85 151.71 7.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 119.79 -1.819 . . . . 0.0 107.119 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.592 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER 29.4 102.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.747 0.784 . . . . 0.0 109.924 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.47 -68.79 0.3 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.4 tt -73.83 -41.28 53.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.594 -0.945 . . . . 0.0 109.74 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.738 HG21 ' CG ' ' A' ' 34' ' ' PRO . 44.9 t -68.99 -61.05 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.329 0.585 . . . . 0.0 110.774 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -57.28 -22.0 38.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.343 -0.848 . . . . 0.0 109.802 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -94.57 -43.15 8.44 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.025 -1.047 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 45' ' ' SER . 0.9 OUTLIER -85.44 -29.22 24.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.88 -1.137 . . . . 0.0 110.642 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.7 t -80.9 -54.16 5.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.798 -1.189 . . . . 0.0 109.802 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -76.12 -24.53 54.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.996 -1.065 . . . . 0.0 109.121 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 42' ' ' CYS . 9.9 m -140.23 -173.99 3.81 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.2 mt -93.9 146.13 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.024 -1.048 . . . . 0.0 109.445 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p -122.04 165.37 16.15 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.606 -0.684 . . . . 0.0 109.263 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.74 166.74 13.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.242 -0.911 . . . . 0.0 110.52 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.572 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.31 -36.65 26.77 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.384 -1.709 . . . . 0.0 106.384 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -58.77 -25.54 63.15 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.837 1.303 . . . . 0.0 108.199 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.429 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 6.4 tt0 -77.31 -22.19 52.32 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.694 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.3 mt -84.63 -34.53 23.06 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -61.58 -19.28 62.02 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 110.209 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -84.02 -8.72 59.06 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -89.91 -37.79 14.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.689 -0.632 . . . . 0.0 109.529 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.3 m -50.64 110.61 0.43 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.316 -0.865 . . . . 0.0 109.477 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.469 -179.815 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.859 ' C ' ' CD1' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 120.685 0.279 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.513 HG22 ' N ' ' A' ' 3' ' ' ASN . 11.7 p -69.66 167.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 170.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.513 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.3 m120 -49.18 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.039 -1.038 . . . . 0.0 109.485 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 2' ' ' VAL . 1.7 pt20 -157.64 -177.81 6.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 110.119 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -78.09 135.33 37.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.401 -0.812 . . . . 0.0 109.316 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.585 HD23 ' HA ' ' A' ' 11' ' ' LEU . 1.4 tp -134.6 109.82 8.91 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -118.11 174.65 6.09 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.71 -153.07 29.95 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 10' ' ' HIS . 3.3 p -78.41 -11.12 59.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.026 -1.279 . . . . 0.0 109.671 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 9' ' ' SER . 1.8 t-80 -53.24 -30.56 38.81 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.585 ' HA ' HD23 ' A' ' 6' ' ' LEU . 14.6 tp -74.91 -48.18 25.98 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.623 HG13 ' CE1' ' A' ' 24' ' ' PHE . 24.5 t -48.81 -46.3 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.513 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 16.8 tt0 -49.05 -60.19 2.99 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.492 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.508 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.03 -60.96 1.82 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.433 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 13.5 mt -45.81 -46.84 15.71 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.72 -51.02 66.9 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.2 mt -52.84 -62.49 1.62 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.101 0.953 . . . . 0.0 110.718 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -67.09 -30.86 50.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.209 -177.068 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 56.4 m -90.4 -10.85 42.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.002 -1.061 . . . . 0.0 110.325 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 43.71 -131.42 6.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.605 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.9 mp0 -83.91 -19.08 35.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.492 -1.005 . . . . 0.0 110.354 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -46.0 -12.84 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.348 -0.845 . . . . 0.0 110.174 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 76.04 133.54 0.45 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.623 ' CE1' HG13 ' A' ' 12' ' ' VAL . 38.3 p90 -124.36 142.34 51.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.841 -0.8 . . . . 0.0 109.374 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -83.34 138.13 33.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.428 -0.795 . . . . 0.0 109.776 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.421 ' O ' ' O ' ' A' ' 27' ' ' THR . 39.0 t80 -171.86 -39.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.356 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 28' ' ' ASP . 1.6 m 53.93 172.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.262 -0.899 . . . . 0.0 109.359 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' H ' HG22 ' A' ' 27' ' ' THR . 0.1 OUTLIER -81.18 158.61 69.41 Favored Pre-proline 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 108.715 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 1.245 ' O ' HG23 ' A' ' 30' ' ' THR . 87.7 Cg_endo -82.98 96.19 0.83 Allowed 'Trans proline' 1 C--N 1.253 -4.487 0 N-CA-C 114.932 1.089 . . . . 0.0 114.932 -172.151 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.245 HG23 ' O ' ' A' ' 29' ' ' PRO . 13.9 p 157.45 -54.17 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.646 0 CA-C-O 122.762 1.268 . . . . 0.0 108.951 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 30' ' ' THR . 79.2 mm-40 -31.9 -76.03 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.749 -1.219 . . . . 0.0 112.285 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.36 -26.15 4.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.898 -1.126 . . . . 0.0 109.379 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.01 148.98 5.36 Favored Glycine 0 N--CA 1.513 3.794 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.647 ' O ' ' CB ' ' A' ' 35' ' ' ARG . 80.2 Cg_endo -78.79 26.13 0.54 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 CA-C-N 119.741 1.77 . . . . 0.0 111.524 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.647 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER 83.42 -20.46 0.33 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -178.372 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 38' ' ' ILE . 43.6 mtt-85 52.48 -159.32 0.12 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' C ' HE21 ' A' ' 41' ' ' GLN . . . 62.44 -81.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.535 HG23 ' N ' ' A' ' 39' ' ' VAL . 6.2 tt -55.6 -41.83 66.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.736 -0.861 . . . . 0.0 109.973 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.535 ' N ' HG23 ' A' ' 38' ' ' ILE . 41.8 t -72.41 -60.68 2.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.546 0.689 . . . . 0.0 111.214 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -49.42 -31.84 10.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.604 -0.685 . . . . 0.0 110.771 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 45' ' ' SER . 5.9 pt20 -93.58 -37.11 12.06 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.842 -1.161 . . . . 0.0 110.068 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.3 t -78.14 -55.29 5.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.04 -1.038 . . . . 0.0 109.69 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.8 t -54.89 -27.84 45.94 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.432 -0.792 . . . . 0.0 110.516 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -111.35 -15.53 13.57 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.235 -0.916 . . . . 0.0 110.451 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -140.43 -173.83 3.79 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.934 -1.104 . . . . 0.0 109.78 -179.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.716 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.5 mm -64.94 178.73 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.716 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -143.99 127.77 17.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.957 -1.09 . . . . 0.0 109.866 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 m -80.79 149.32 29.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.333 -0.854 . . . . 0.0 109.171 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.2 tp -82.83 -41.59 18.88 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -55.79 -25.72 42.68 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 123.02 1.39 . . . . 0.0 108.128 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.533 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 18.6 tt0 -77.98 -22.34 49.54 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.029 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.0 mt -85.38 -28.17 25.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.661 -1.274 . . . . 0.0 108.584 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -65.49 -19.73 66.05 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.631 -0.668 . . . . 0.0 111.354 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 15.2 p30 -88.01 -8.37 55.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.813 -1.179 . . . . 0.0 108.123 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.522 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 4.7 m-85 -86.74 -26.01 24.42 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.681 0.753 . . . . 0.0 109.163 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 57' ' ' ASN . 4.2 m -67.36 95.91 0.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.705 -0.622 . . . . 0.0 111.088 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 56' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 117.923 -1.037 . . . . 0.0 108.38 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 1.189 ' CZ ' ' HB1' ' A' ' 14' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.151 0.501 . . . . 0.0 110.162 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 3' ' ' ASN . 14.3 p -82.4 164.27 2.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.739 -176.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.505 ' N ' HG22 ' A' ' 2' ' ' VAL . 1.3 m120 -47.87 101.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.991 -1.068 . . . . 0.0 109.493 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -158.66 -160.39 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.419 ' O ' ' CG ' ' A' ' 5' ' ' HIS . 44.8 p-80 -97.95 110.6 23.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.87 139.34 41.45 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.0 t -149.46 -178.47 6.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.282 -0.886 . . . . 0.0 108.792 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.96 -141.68 10.02 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.759 -1.737 . . . . 0.0 108.759 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' VAL . 3.3 p -84.07 -13.35 53.31 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.853 -1.381 . . . . 0.0 109.194 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -52.02 -27.68 14.44 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.935 HD23 ' OH ' ' A' ' 26' ' ' TYR . 22.4 tp -81.67 -37.25 27.74 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.614 HG13 ' CE1' ' A' ' 24' ' ' PHE . 13.8 t -58.73 -48.47 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 36.0 tt0 -47.74 -59.69 3.12 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.432 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.189 ' HB1' ' CZ ' ' A' ' 1' ' ' PHE . . . -44.65 -61.76 1.45 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 mt -46.05 -45.55 16.14 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.552 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -56.22 -48.25 76.82 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.774 HD12 ' CD2' ' A' ' 1' ' ' PHE . 30.1 mt -55.75 -62.81 1.44 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 122.089 0.947 . . . . 0.0 110.836 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.4 m -64.18 -36.32 76.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.436 -177.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.7 t -84.4 -22.68 30.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.929 -1.107 . . . . 0.0 110.559 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 70.76 -153.06 51.13 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 23' ' ' GLY . 14.7 mt-10 -83.66 3.61 32.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.244 . . . . 0.0 109.776 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.47 1.8 0.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 71.93 124.81 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.614 ' CE1' HG13 ' A' ' 12' ' ' VAL . 13.2 p90 -111.52 170.42 8.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.442 -1.034 . . . . 0.0 110.845 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -98.5 134.85 40.89 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.579 0.704 . . . . 0.0 110.034 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.935 ' OH ' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -175.92 -149.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER 170.3 166.28 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.152 -0.967 . . . . 0.0 109.227 178.025 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.636 ' HB2' ' HG3' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -96.76 161.47 26.44 Favored Pre-proline 0 N--CA 1.487 1.397 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.56 -7.1 20.12 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 123.856 3.037 . . . . 0.0 110.493 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 28' ' ' ASP . 10.1 t -103.2 -28.28 12.01 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.749 ' O ' ' HB2' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -76.85 -9.27 58.57 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 176.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 1.032 ' O ' ' O ' ' A' ' 33' ' ' GLY . 53.3 mt-10 107.89 119.9 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.574 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 1.032 ' O ' ' O ' ' A' ' 32' ' ' GLU . . . -6.14 147.86 0.0 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.993 ' HG3' HG21 ' A' ' 39' ' ' VAL . 86.0 Cg_endo -84.49 59.14 5.69 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 123.767 2.978 . . . . 0.0 115.774 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.564 ' O ' ' CB ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER 80.43 -37.04 0.14 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 111.187 177.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.564 ' CB ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 81.93 114.55 0.06 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.082 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.5 -60.64 0.42 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.528 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 3.3 tt -82.09 -44.63 19.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.733 -0.863 . . . . 0.0 110.065 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.993 HG21 ' HG3' ' A' ' 34' ' ' PRO . 43.7 t -70.47 -61.29 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 O-C-N 121.308 -0.87 . . . . 0.0 111.37 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.28 -24.55 28.98 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.089 -1.007 . . . . 0.0 110.156 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.542 ' NE2' HE22 ' A' ' 51' ' ' GLN . 20.2 tt0 -94.42 -47.76 6.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.914 -1.116 . . . . 0.0 110.284 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 31.3 m -76.85 -33.28 57.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.069 -1.019 . . . . 0.0 110.535 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.7 t -78.65 -29.26 45.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.851 -1.156 . . . . 0.0 109.874 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -102.42 -21.5 14.24 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.301 -0.874 . . . . 0.0 109.915 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 t -140.03 -171.33 3.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.225 -0.922 . . . . 0.0 109.858 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.595 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.3 mm -82.88 174.97 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.595 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.9 m -152.08 167.16 29.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.992 -1.068 . . . . 0.0 109.701 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.75 163.44 12.26 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.634 0.73 . . . . 0.0 109.246 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.675 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -81.95 -32.5 30.74 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.514 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.58 -28.06 69.67 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.648 1.213 . . . . 0.0 108.569 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.542 HE22 ' NE2' ' A' ' 41' ' ' GLN . 6.3 tt0 -71.55 -26.3 62.58 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.517 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.669 ' CD1' ' HZ ' ' A' ' 1' ' ' PHE . 47.7 mt -85.78 -23.75 27.11 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.116 -0.99 . . . . 0.0 108.501 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -71.73 -18.37 62.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.333 -0.855 . . . . 0.0 110.89 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 16.8 p30 -86.33 -9.19 56.89 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.526 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 5.7 m-85 -84.24 -28.14 27.46 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.4 t -67.33 112.46 4.58 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.843 0.83 . . . . 0.0 110.106 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.1 m120 . . . . . 0 C--N 1.292 -1.918 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.579 179.938 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 1.386 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 8.2 p90 . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 3' ' ' ASN . 11.2 p -56.38 169.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 119.101 -2.249 . . . . 0.0 108.902 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.543 ' N ' HG22 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -49.38 110.02 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.057 -1.027 . . . . 0.0 109.412 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -169.33 -165.06 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.06 -1.025 . . . . 0.0 110.018 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 30.9 p80 -93.71 132.15 38.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.373 -0.829 . . . . 0.0 109.723 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 1' ' ' PHE . 0.9 OUTLIER -129.5 127.8 41.55 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.4 m -136.15 -177.3 4.64 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.27 -0.894 . . . . 0.0 108.758 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 46.62 -147.78 2.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.45 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.5 p -79.9 -14.1 58.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.326 . . . . 0.0 109.133 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -51.94 -24.25 6.17 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.45 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.1 tp -81.22 -51.34 8.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.626 HG13 ' CE1' ' A' ' 24' ' ' PHE . 25.3 t -46.16 -46.7 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 121.908 0.861 . . . . 0.0 108.98 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.521 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.8 tt0 -47.78 -59.92 2.95 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.51 -176.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.386 ' HB1' ' CE2' ' A' ' 1' ' ' PHE . . . -44.99 -62.0 1.41 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 14' ' ' ALA . 13.8 mt -45.53 -45.68 13.53 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.558 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.92 -52.01 65.6 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 28.8 mt -51.03 -62.33 1.68 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.028 0.918 . . . . 0.0 110.753 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.1 m -66.39 -34.92 73.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.409 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.0 m -88.53 -6.87 57.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.949 -1.095 . . . . 0.0 110.305 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 45.87 -142.58 4.46 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 23' ' ' GLY . 19.9 mt-10 -83.13 -3.26 57.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -1.116 . . . . 0.0 109.6 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -55.64 -4.82 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.772 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 72.8 127.83 0.1 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.626 ' CE1' HG13 ' A' ' 12' ' ' VAL . 32.9 p90 -122.29 145.9 47.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.627 -0.925 . . . . 0.0 108.971 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -83.17 133.11 35.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.189 -0.944 . . . . 0.0 109.891 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.528 ' CE2' ' O ' ' A' ' 27' ' ' THR . 43.6 t80 -172.82 174.24 3.65 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.528 ' O ' ' CE2' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -153.18 -178.01 6.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.028 -1.045 . . . . 0.0 109.494 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.409 ' H ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -82.06 159.93 64.28 Favored Pre-proline 0 N--CA 1.486 1.336 0 O-C-N 121.268 -0.895 . . . . 0.0 108.857 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.52 -24.43 9.13 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 124.188 3.259 . . . . 0.0 113.258 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.6 p -115.07 -27.49 7.31 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 119.094 -1.042 . . . . 0.0 110.57 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.597 ' O ' ' C ' ' A' ' 32' ' ' GLU . 4.1 mm-40 -54.22 138.07 39.49 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.892 -1.13 . . . . 0.0 109.643 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.597 ' C ' ' O ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER 24.74 -105.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.443 ' H ' ' HB2' ' A' ' 32' ' ' GLU . . . -175.2 100.37 0.15 Allowed Glycine 0 C--N 1.29 -2.014 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.675 ' O ' ' C ' ' A' ' 35' ' ' ARG . 12.0 Cg_endo -51.23 120.41 6.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.407 2.738 . . . . 0.0 113.493 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.675 ' C ' ' O ' ' A' ' 34' ' ' PRO . 0.4 OUTLIER 11.0 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 122.041 -0.412 . . . . 0.0 111.349 177.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 40' ' ' GLU . 8.5 mmt-85 -59.6 102.18 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.5 -49.36 0.28 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 39' ' ' VAL . 9.6 tt -82.52 -44.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.608 -0.937 . . . . 0.0 110.894 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.568 ' N ' HG23 ' A' ' 38' ' ' ILE . 46.1 t -67.76 -62.61 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.379 -0.825 . . . . 0.0 111.448 -177.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 36' ' ' ARG . 15.2 mt-10 -55.29 -25.92 37.03 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.084 -1.01 . . . . 0.0 110.369 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 45' ' ' SER . 16.1 tt0 -93.92 -55.92 3.06 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.05 -1.031 . . . . 0.0 110.493 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 14.4 m -67.88 -33.93 75.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.053 -1.029 . . . . 0.0 111.238 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.6 t -77.95 -32.23 51.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.726 -1.234 . . . . 0.0 110.355 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -101.97 -18.33 15.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.059 -1.026 . . . . 0.0 109.781 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' GLN . 3.2 m -140.17 -179.38 5.95 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.221 -0.925 . . . . 0.0 109.235 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 47' ' ' CYS . 4.5 mm -78.16 173.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 108.921 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.579 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.5 m -152.11 167.45 28.46 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.197 -0.94 . . . . 0.0 109.559 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.97 163.42 12.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 109.338 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.42 -35.07 27.95 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.3 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.29 -26.26 66.37 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 122.729 1.252 . . . . 0.0 108.27 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.444 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 6.5 tt0 -74.69 -23.01 58.56 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.452 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.885 ' CD1' ' CZ ' ' A' ' 1' ' ' PHE . 57.4 mt -84.93 -36.75 21.23 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.75 -19.31 49.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.548 -0.72 . . . . 0.0 110.156 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -84.02 -8.51 59.12 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.8 m-85 -90.03 -37.79 14.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.514 -0.741 . . . . 0.0 109.744 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.421 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 3.2 m -49.92 109.24 0.27 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.413 -0.804 . . . . 0.0 109.587 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.421 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 33.3 t-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.576 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 1.106 ' O ' ' CD2' ' A' ' 1' ' ' PHE . 1.5 t80 . . . . . 0 C--O 1.174 -2.92 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 1' ' ' PHE . 16.7 m -166.79 -30.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 118.95 -2.344 . . . . 0.0 107.715 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 2' ' ' VAL . 22.4 m-80 -175.22 -102.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.652 HE22 HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER 33.81 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.265 1.031 . . . . 0.0 112.879 179.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 16.8 p-80 -101.37 110.96 23.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.764 -0.585 . . . . 0.0 109.778 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.533 ' C ' ' CE1' ' A' ' 10' ' ' HIS . 0.3 OUTLIER -102.02 104.02 14.66 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.729 ' N ' ' CE1' ' A' ' 10' ' ' HIS . 17.0 m -122.0 115.35 22.37 Favored 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 175.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.59 -141.16 15.86 Favored Glycine 0 N--CA 1.507 3.426 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 12' ' ' VAL . 7.4 p -87.23 -27.32 23.03 Favored 'General case' 0 N--CA 1.517 2.896 0 O-C-N 120.712 -1.463 . . . . 0.0 113.783 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.752 ' ND1' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -45.34 -22.66 0.14 Allowed 'General case' 0 N--CA 1.527 3.395 0 CA-C-N 121.525 1.966 . . . . 0.0 106.453 178.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.752 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 32.9 tp -79.46 -51.34 9.48 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.556 HG13 ' CE1' ' A' ' 24' ' ' PHE . 41.4 t -49.77 -53.39 10.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.517 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.3 tt0 -49.78 -59.4 3.86 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.557 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.53 -61.6 1.49 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.466 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 14.6 mt -46.43 -47.95 18.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.57 ' CD2' ' C ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -54.37 -55.15 31.52 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.89 HD12 ' CD1' ' A' ' 1' ' ' PHE . 31.7 mt -47.41 -62.17 1.56 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.156 0.979 . . . . 0.0 110.64 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -68.17 -26.6 34.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.88 -177.097 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 15' ' ' LEU . 58.6 m -97.75 1.47 48.47 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.229 -0.919 . . . . 0.0 110.723 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 48.47 -152.2 2.57 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' GLY . 43.5 tt0 -83.58 -15.05 50.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -1.138 . . . . 0.0 109.915 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.6 ' H ' ' CD ' ' A' ' 22' ' ' ARG . 7.7 mpt_? -42.84 -18.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.679 -0.638 . . . . 0.0 110.438 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLU . . . 95.04 138.54 9.59 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.556 ' CE1' HG13 ' A' ' 12' ' ' VAL . 26.6 p90 -129.29 178.0 6.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.65 -0.912 . . . . 0.0 109.047 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 55' ' ' TYR . 51.9 m-85 -104.71 132.53 50.85 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.064 -1.022 . . . . 0.0 111.244 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CD2' HG22 ' A' ' 12' ' ' VAL . 10.8 t80 -175.91 -143.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 10.2 t -172.49 -151.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.06 -1.025 . . . . 0.0 109.776 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.468 ' N ' ' OG1' ' A' ' 27' ' ' THR . 0.4 OUTLIER -112.45 165.24 13.43 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 31' ' ' GLU . 10.8 Cg_endo -73.85 -75.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.291 -2.485 0 C-N-CA 122.457 2.105 . . . . 0.0 111.087 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.35 -25.93 0.16 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' PRO . 4.1 mm-40 -94.43 86.11 4.77 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.12 96.89 0.1 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.155 -0.966 . . . . 0.0 111.369 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.664 ' N ' ' CD ' ' A' ' 34' ' ' PRO . . . -151.24 45.06 0.65 Allowed Glycine 0 N--CA 1.499 2.86 0 C-N-CA 118.508 -1.806 . . . . 0.0 111.218 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 30.9 Cg_endo -61.8 170.35 5.99 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 124.833 3.688 . . . . 0.0 112.757 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.448 ' HD3' HH21 ' A' ' 35' ' ' ARG . 3.6 ttm180 -86.52 -16.11 37.95 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.634 ' HE ' ' HG2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 69.02 53.67 0.47 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.546 -0.721 . . . . 0.0 110.026 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.4 -60.02 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.647 HG23 ' N ' ' A' ' 39' ' ' VAL . 18.2 tt -69.99 -47.54 68.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.72 -0.871 . . . . 0.0 110.117 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.647 ' N ' HG23 ' A' ' 38' ' ' ILE . 43.9 t -62.7 -61.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 O-C-N 121.723 -0.61 . . . . 0.0 111.101 -177.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.584 ' OE2' ' NH2' ' A' ' 36' ' ' ARG . 18.1 mt-10 -49.61 -26.54 3.69 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.393 -0.817 . . . . 0.0 110.11 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -94.56 -61.44 1.51 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.956 -1.09 . . . . 0.0 110.021 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.435 ' O ' ' O ' ' A' ' 45' ' ' SER . 59.6 m -59.31 -28.74 67.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.31 -0.869 . . . . 0.0 110.466 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.9 t -85.61 -54.51 4.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.767 -1.208 . . . . 0.0 110.499 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.448 ' ND1' ' N ' ' A' ' 44' ' ' HIS . 3.1 m80 -71.37 -15.68 62.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.816 -1.177 . . . . 0.0 109.413 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 t -140.37 178.88 6.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 47' ' ' CYS . 5.4 mm -64.6 163.74 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.458 ' N ' HG22 ' A' ' 46' ' ' ILE . 9.0 t -108.55 140.43 41.91 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.237 -0.914 . . . . 0.0 111.169 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 m -98.65 145.37 26.94 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.4 tp -82.22 -40.97 20.91 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -54.09 -26.59 27.91 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-O 122.796 1.284 . . . . 0.0 108.478 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.539 HE22 ' CD2' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -78.81 -23.68 45.0 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.34 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.539 ' CD2' HE22 ' A' ' 51' ' ' GLN . 28.6 mt -84.82 -25.82 27.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.709 -1.244 . . . . 0.0 108.859 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -67.79 -19.19 65.07 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.582 -0.699 . . . . 0.0 111.189 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 51' ' ' GLN . 15.7 p30 -88.32 -8.35 55.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.917 -1.114 . . . . 0.0 108.014 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.508 ' CD1' ' OD1' ' A' ' 54' ' ' ASN . 4.6 m-85 -85.3 -27.14 26.15 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.7 0.762 . . . . 0.0 109.201 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.456 ' O ' ' OXT' ' A' ' 57' ' ' ASN . 3.2 m -67.99 110.92 4.12 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.432 -0.792 . . . . 0.0 110.115 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.456 ' OXT' ' O ' ' A' ' 56' ' ' CYS . 5.4 m120 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.983 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.831 ' CG ' ' O ' ' A' ' 1' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.436 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 3' ' ' ASN . 7.1 p -79.91 -42.35 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.341 -1.474 . . . . 0.0 108.48 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 4' ' ' GLN . 11.6 m120 -168.54 -98.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.542 ' O ' ' O ' ' A' ' 3' ' ' ASN . 5.1 pt20 32.22 -166.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 122.342 1.067 . . . . 0.0 112.992 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -98.14 146.47 25.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.0 109.01 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.662 HD23 ' HA ' ' A' ' 11' ' ' LEU . 1.2 tp -132.8 108.92 9.29 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 t -117.14 145.75 43.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.516 -0.74 . . . . 0.0 109.057 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.424 ' C ' ' N ' ' A' ' 10' ' ' HIS . . . 82.01 177.39 51.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 10' ' ' HIS . 2.6 p -54.16 -10.55 0.37 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.556 -1.555 . . . . 0.0 109.14 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.424 ' N ' ' C ' ' A' ' 8' ' ' GLY . 40.2 m80 -52.24 -29.38 22.52 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 177.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.662 ' HA ' HD23 ' A' ' 6' ' ' LEU . 10.9 tp -74.74 -49.36 21.28 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.603 HG13 ' CE1' ' A' ' 24' ' ' PHE . 5.0 t -49.89 -41.43 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 20.6 tt0 -47.69 -59.25 3.42 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.608 -177.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.488 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -45.62 -61.11 1.84 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.756 HD13 ' CE2' ' A' ' 26' ' ' TYR . 7.1 mt -46.32 -44.97 17.2 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.556 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -55.96 -50.9 69.51 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 19.5 mt -52.02 -62.75 1.44 Allowed 'General case' 0 C--N 1.291 -1.96 0 O-C-N 120.998 -1.064 . . . . 0.0 109.866 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -69.08 -58.21 6.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.578 -178.302 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.62 ' N ' ' O ' ' A' ' 15' ' ' LEU . 82.7 m -86.26 34.18 0.63 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.977 -1.077 . . . . 0.0 110.526 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . -54.7 -111.98 0.01 OUTLIER Glycine 0 N--CA 1.499 2.851 0 O-C-N 120.889 -1.132 . . . . 0.0 111.329 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -43.86 -15.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -1.053 . . . . 0.0 110.582 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 20' ' ' GLY . 3.9 mmp_? -74.58 -40.13 61.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.987 -1.07 . . . . 0.0 109.73 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.07 137.37 9.78 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.603 ' CE1' HG13 ' A' ' 12' ' ' VAL . 37.1 p90 -138.81 -173.33 3.53 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -154.43 118.54 4.73 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 119.928 -1.733 . . . . 0.0 112.607 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.756 ' CE2' HD13 ' A' ' 15' ' ' LEU . 32.4 m-85 -146.53 108.84 4.45 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -55.35 -166.12 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.148 -0.97 . . . . 0.0 109.799 -179.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.705 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -48.38 -172.04 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 28' ' ' ASP . 28.3 Cg_endo -85.89 -5.96 8.69 Favored 'Trans proline' 0 C--N 1.295 -2.256 0 C-N-CA 124.161 3.241 . . . . 0.0 111.308 174.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.694 ' OG1' ' N ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -145.19 -140.72 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -176.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.705 ' OE2' ' HB2' ' A' ' 28' ' ' ASP . 1.2 mt-10 65.1 92.07 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.126 -1.609 . . . . 0.0 108.897 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 59.21 -69.83 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.934 -0.479 . . . . 0.0 110.675 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.543 ' HA3' ' CZ ' ' A' ' 36' ' ' ARG . . . 168.41 169.53 31.98 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 117.765 -2.159 . . . . 0.0 112.575 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' A' ' 35' ' ' ARG . 59.1 Cg_endo -79.13 -125.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 124.346 3.364 . . . . 0.0 113.234 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.432 ' H ' ' HB2' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -94.57 -16.52 23.18 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.891 0.853 . . . . 0.0 108.904 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' CZ ' ' HA3' ' A' ' 33' ' ' GLY . 1.8 mpt_? 61.29 45.63 8.58 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.73 -83.95 0.05 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 117.285 -2.388 . . . . 0.0 109.012 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 39' ' ' VAL . 4.8 tt -48.7 -38.74 10.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.752 -0.852 . . . . 0.0 110.371 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.499 ' N ' HG23 ' A' ' 38' ' ' ILE . 39.3 t -72.87 -61.16 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 121.436 0.636 . . . . 0.0 111.013 -178.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -52.25 -27.07 13.54 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -93.46 -34.95 13.21 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.055 -1.028 . . . . 0.0 109.525 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' SER . 50.1 t -83.28 -49.96 8.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.721 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 39' ' ' VAL . 44.2 t -64.29 -23.94 67.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 110.018 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -102.72 -29.18 11.66 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.168 -0.957 . . . . 0.0 110.068 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 42' ' ' CYS . 3.2 t -134.3 -172.98 3.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.375 -0.828 . . . . 0.0 109.794 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 47' ' ' CYS . 5.8 mm -65.95 175.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.6 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -137.21 141.65 42.1 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.027 -1.046 . . . . 0.0 110.063 -178.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -93.43 151.08 19.97 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.2 tp -83.12 -42.08 17.79 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -55.84 -25.11 40.4 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 123.017 1.389 . . . . 0.0 107.925 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.486 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 7.6 tt0 -78.69 -23.35 45.66 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.102 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.1 mt -85.36 -36.36 20.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.454 -1.404 . . . . 0.0 108.497 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -58.11 -19.57 33.38 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.645 -0.66 . . . . 0.0 110.948 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -88.03 -7.97 56.27 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.072 -1.017 . . . . 0.0 108.792 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.486 ' CE1' ' O ' ' A' ' 51' ' ' GLN . 5.7 m-85 -88.72 -25.59 22.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.529 -0.732 . . . . 0.0 110.636 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 m -48.8 110.61 0.37 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.07 -1.019 . . . . 0.0 109.629 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 t30 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.475 179.909 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.592 ' O ' ' N ' ' A' ' 3' ' ' ASN . 23.4 p90 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 2' ' ' VAL . 1.4 p -53.25 89.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 119.936 -1.727 . . . . 0.0 108.97 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 1' ' ' PHE . 1.6 m120 47.0 -132.17 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 109.645 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.02 166.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.547 -0.721 . . . . 0.0 109.646 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -76.73 142.19 40.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.643 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.68 124.89 34.69 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.3 m -128.05 -176.84 3.91 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.541 -0.724 . . . . 0.0 109.085 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.6 -151.44 1.07 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.452 ' C ' ' N ' ' A' ' 11' ' ' LEU . 3.3 p -77.12 -13.32 59.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.039 -1.271 . . . . 0.0 109.151 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -51.73 -23.73 4.91 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.452 ' N ' ' C ' ' A' ' 9' ' ' SER . 11.8 tp -81.74 -50.94 8.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.641 HG13 ' CE1' ' A' ' 24' ' ' PHE . 22.5 t -46.26 -47.91 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.74 0.781 . . . . 0.0 108.979 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.514 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 17.5 tt0 -48.06 -59.71 3.17 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.579 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.539 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -44.72 -62.24 1.28 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' ALA . 14.6 mt -44.94 -44.38 9.72 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -57.67 -49.71 75.6 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 13' ' ' GLU . 29.1 mt -53.94 -62.84 1.39 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.117 0.96 . . . . 0.0 110.942 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.6 m -62.43 -37.17 78.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.955 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 38.1 t -81.23 -22.22 38.95 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.026 -1.046 . . . . 0.0 109.881 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . 67.56 -146.66 47.49 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 23' ' ' GLY . 19.1 mt-10 -83.1 -1.72 53.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 0.0 109.363 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -61.92 1.69 0.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 110.033 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 64.73 120.56 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.641 ' CE1' HG13 ' A' ' 12' ' ' VAL . 13.8 p90 -99.63 171.69 7.76 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.542 -0.975 . . . . 0.0 109.62 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -104.59 119.6 39.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.503 -0.748 . . . . 0.0 109.732 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -152.54 4.14 0.36 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.277 -0.89 . . . . 0.0 108.76 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 31' ' ' GLU . 0.2 OUTLIER 60.53 175.28 0.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.507 -0.746 . . . . 0.0 109.787 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.67 165.63 0.29 Allowed Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.9 -15.04 45.98 Favored 'Trans proline' 0 C--N 1.288 -2.645 0 C-N-CA 122.214 1.942 . . . . 0.0 110.239 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 30' ' ' THR . 1.8 t -136.89 129.05 29.62 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' OE2' HG23 ' A' ' 30' ' ' THR . 35.9 mm-40 -171.78 167.23 6.41 Favored 'General case' 0 CA--C 1.586 2.354 0 CA-C-O 123.101 1.429 . . . . 0.0 111.868 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.16 48.98 0.82 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.092 -1.63 . . . . 0.0 111.306 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.682 ' H ' ' HD3' ' A' ' 34' ' ' PRO . . . 175.09 41.42 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.675 -1.726 . . . . 0.0 110.842 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.682 ' HD3' ' H ' ' A' ' 33' ' ' GLY . 73.0 Cg_endo -66.74 29.31 0.11 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 123.168 2.578 . . . . 0.0 110.127 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.733 ' O ' ' N ' ' A' ' 37' ' ' GLY . 12.6 ttm-85 69.53 -8.6 0.73 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.591 ' H ' ' C ' ' A' ' 34' ' ' PRO . 11.0 mmt180 32.69 27.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.733 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -106.64 -67.56 0.67 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 39' ' ' VAL . 9.2 tt -62.12 -41.24 90.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 122.118 0.961 . . . . 0.0 109.821 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.575 ' N ' HG23 ' A' ' 38' ' ' ILE . 45.2 t -65.39 -61.08 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 O-C-N 121.678 -0.639 . . . . 0.0 111.403 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 36' ' ' ARG . 20.1 mt-10 -60.93 -22.04 64.0 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.033 -1.042 . . . . 0.0 110.31 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -93.31 -37.84 11.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.852 -1.155 . . . . 0.0 110.345 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 38' ' ' ILE . 28.9 m -88.59 -36.84 16.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.076 -1.015 . . . . 0.0 110.344 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.9 t -76.36 -37.16 57.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.863 -1.148 . . . . 0.0 109.98 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -91.71 -22.29 20.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.0 -1.063 . . . . 0.0 109.395 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 42' ' ' CYS . 2.7 m -140.37 -174.52 3.97 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.241 -0.912 . . . . 0.0 109.36 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.602 HG22 ' H ' ' A' ' 47' ' ' CYS . 4.9 mm -83.53 174.14 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.864 . . . . 0.0 108.99 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.602 ' H ' HG22 ' A' ' 46' ' ' ILE . 2.0 m -151.05 167.83 26.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.002 -1.061 . . . . 0.0 110.069 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.71 163.73 12.35 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.624 0.726 . . . . 0.0 109.352 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -82.04 -31.56 30.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -65.61 -27.3 68.3 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.676 1.227 . . . . 0.0 108.53 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.43 ' O ' ' CE1' ' A' ' 55' ' ' TYR . 12.1 tt0 -71.55 -24.51 61.95 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.433 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.2 mt -84.78 -34.02 22.87 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -62.57 -18.85 62.95 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.495 -0.753 . . . . 0.0 109.911 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.2 m-20 -82.85 -8.93 59.54 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 3.4 m-85 -91.6 -28.74 17.33 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.61 0.719 . . . . 0.0 109.394 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 35.5 t -68.77 112.48 5.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.394 -0.816 . . . . 0.0 109.703 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 t30 . . . . . 0 C--N 1.291 -1.973 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.491 -179.985 . . . . . . . . 0 0 . 1 stop_ save_